Psyllid ID: psy2651

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340--
Protein Sequence
METHRRASRRYSGFRSETLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGSVSFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL
Secondary Structure (PSIPRED)
cHHHHHHHcccccccccccEEEEEEEEEEEEcccccEEEEEEEccccHHHHHHHHHHHHHHHccccccHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccEEEccHHHHHHHHHHHHcccHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEEHHccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHccccccccccccccccccHHEEEHHHHccccccccccccccccccEEcccccEEEEcccccccccccEEEcccccEEEEEEccccccEEEEccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccHcccccccccccccEEEEEEEEEEEHHHHHHHHHHHHHHHHHHHHccccHcHEEEEcccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHcccccEEEcHHHHHHHHHHHHHHccHHHHHHHHcHccccccccccHHHHHHHHHHHHHHHHHHccccccEccEEEEEEEEEccccEccHHHccccccccccEEEEccccHHHHHHHHHHHHHHHccccccccccHHHccccccEEEEEEEEEEEcEcccccHHHcEEEEEcccccccEEEEEEEEEEEEEEEEEHHHccEEEEEEEEccccEEEEEEEcccccccc
Coil and Loop (DISEMBL)
methrrasrrysgfrsetLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHsatsyclldgdkvpkLIACCalgsvsfssildqrfngklhkkedfkpfsIQLSTLVEWNLAankkenaiisPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQlskspelkiANKIYfakdielnpayqtqAVDNFnselgkvdfsqppaaakEMNDWVSNhtndkikdlikadsldaSTKLVLINAIhfkgkwtvpfkpeatkdgpfylddtnsvqvplmfvKDSFYMYEEAGEDGfkmlelpygvsiSFIIKSqvvpemgrl
Flexible Loop (DISEMBL)
methrrasrrysgfrsetlgiRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGSVSFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAihfkgkwtvpfkpEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSIsfiiksqvvpemgrl
Low Complexity Region (SEG)
METHRRASRRYSGFRSETLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGSVSFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL
Disordered region (IsUnstruct)
*************FRSETLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGSVSFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNS*******************WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQV*******
Disordered Region (DISOPRED)
*************FRSETLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGSV*********************PFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHS***********DQLSKDYKG**DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMG**
Disordered Region (DISEMBL)
***********SGFRSETLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGSVSFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL
Disordered Region (DISPRO)
*************FRSETLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGS***************HKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPE****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METHRRASRRYSGFRSETLGIRVTYVKVITTLEYSLVFQYSALTTNFHLFFYCHSATSYCLLDGDKVPKLIACCALGSVSFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	342	2.2.26 [Sep-21-2011]
Q5MGH0	383	Serine protease inhibitor	N/A	N/A	0.599	0.535	0.375	7e-34
Q9JLD2	410	Neuroserpin OS=Rattus nor	yes	N/A	0.652	0.543	0.325	3e-30
Q99574	410	Neuroserpin OS=Homo sapie	yes	N/A	0.631	0.526	0.331	9e-30
O35684	410	Neuroserpin OS=Mus muscul	yes	N/A	0.637	0.531	0.310	1e-29
Q90935	410	Neuroserpin OS=Gallus gal	yes	N/A	0.616	0.514	0.333	6e-29
Q80X76	445	Serine protease inhibitor	no	N/A	0.625	0.480	0.327	1e-28
P93692	398	Serpin-Z2B OS=Triticum ae	N/A	N/A	0.622	0.535	0.340	3e-28
Q9ST58	398	Serpin-Z1C OS=Triticum ae	N/A	N/A	0.622	0.535	0.336	4e-28
P22922	392	Antitrypsin OS=Bombyx mor	N/A	N/A	0.672	0.586	0.318	1e-27
Q03734	418	Serine protease inhibitor	no	N/A	0.631	0.516	0.334	2e-27

>sp|Q5MGH0|SPI3_LONON Serine protease inhibitor 3/4 (Fragment) OS=Lonomia obliqua PE=1 SV=1

 Score =  144 bits (364), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 81/216 (37%), Positives = 123/216 (56%), Gaps = 11/216 (5%)

Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           N  +N + S FS+   L   +  +AG + + +   +   +        K +   L+++ K
Sbjct: 49  NPNKNIVFSAFSVMSPLAQLAIASAGESRDELFSAIGFPNENVT----KAVFTDLNRELK 104

Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
            +     K   LKIANKIY A   ELN  +   + D FNSE+ K+DF+Q   AAK +N W
Sbjct: 105 SV-----KGVTLKIANKIYIANGFELNDQFAVVSKDVFNSEVQKLDFAQNKVAAKTINTW 159

Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
           V +HTN++IKDL+  +SLD  T+ VL+NA++FKG W   F  E+T D PF++D+T ++QV
Sbjct: 160 VEDHTNNRIKDLVDPNSLDDYTRAVLVNALYFKGSWKNKFDKESTIDRPFHVDNTKTIQV 219

Query: 297 PLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           P M  +   Y Y E+ E   K++E+PY G   S +I
Sbjct: 220 PTMH-RSGQYSYGESRELNAKIIEMPYEGDETSLVI 254

Lonomia obliqua (taxid: 304329)

>sp|Q9JLD2|NEUS_RAT Neuroserpin OS=Rattus norvegicus GN=Serpini1 PE=2 SV=1

 Score =  132 bits (333), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/246 (32%), Positives = 124/246 (50%), Gaps = 23/246 (9%)

Query: 108 TLVEWNL-------AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL 160
           T+ EW++       A  + EN + SP S+ + +G+   GA GST +       I+HS   
Sbjct: 25  TIAEWSVNVYNHLRATGEDENILFSPLSIALAMGVMELGAQGSTLK------EIRHSMGY 78

Query: 161 LKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGK 220
                G      +D+  ++        +KIAN ++      +N  +       FN+E+  
Sbjct: 79  ESLKSGEEFSFLRDFSSMVSAEEGQYVMKIANSLFVQNGFHINEEFLQMMKMYFNAEVNH 138

Query: 221 VDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEA 280
           VDFS+  A A  +N WV N+TN  +KDL+     DA T L LINA++FKG W   F+PE 
Sbjct: 139 VDFSENVAVANYINKWVENYTNSLLKDLVSPGDFDAVTHLALINAVYFKGNWKSQFRPEN 198

Query: 281 TKDGPFYLDDTNSVQVPLMFVKDSFYMYE------EAGEDGFKMLELPY---GVSISFII 331
           T+   F  DD + VQ+P+M+ +  FY  E      EAG   +++LE+PY    +S+  ++
Sbjct: 199 TRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAG-GIYQVLEIPYEGDEISMMLVL 257

Query: 332 KSQVVP 337
             Q VP
Sbjct: 258 SRQEVP 263

Serine protease inhibitor that inhibits plasminogen activators and plasmin but not thrombin. May be involved in the formation or reorganization of synaptic connections as well as for synaptic plasticity in the adult nervous system. May protect neurons from cell damage by tissue-type plasminogen activator.

Rattus norvegicus (taxid: 10116)

>sp|Q99574|NEUS_HUMAN Neuroserpin OS=Homo sapiens GN=SERPINI1 PE=1 SV=1

 Score =  131 bits (329), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 119/232 (51%), Gaps = 16/232 (6%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A  + EN + SP S+ + +G+   GA GST +       I+HS        G      K+
Sbjct: 39  ATGEDENILFSPLSIALAMGMMELGAQGSTQK------EIRHSMGYDSLKNGEEFSFLKE 92

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           +  ++        +KIAN ++      +N  +       FN+ +  VDFSQ  A A  +N
Sbjct: 93  FSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYIN 152

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV N+TN+ +KDL+     DA+T L LINA++FKG W   F+PE T+   F  DD + V
Sbjct: 153 KWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEV 212

Query: 295 QVPLMFVKDSFYMYE------EAGEDGFKMLELPY---GVSISFIIKSQVVP 337
           Q+P+M+ +  FY  E      EAG   +++LE+PY    +S+  ++  Q VP
Sbjct: 213 QIPMMYQQGEFYYGEFSDGSNEAG-GIYQVLEIPYEGDEISMMLVLSRQEVP 263

Serine protease inhibitor that inhibits plasminogen activators and plasmin but not thrombin. May be involved in the formation or reorganization of synaptic connections as well as for synaptic plasticity in the adult nervous system. May protect neurons from cell damage by tissue-type plasminogen activator.

Homo sapiens (taxid: 9606)

>sp|O35684|NEUS_MOUSE Neuroserpin OS=Mus musculus GN=Serpini1 PE=1 SV=1

 Score =  130 bits (327), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 124/251 (49%), Gaps = 33/251 (13%)

Query: 108 TLVEWNL-------AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMM-----KGLRIK 155
           T+ EW++          + EN + SP S+ + +G+   GA GST + +      +GL+  
Sbjct: 25  TITEWSVNMYNHLRGTGEDENILFSPLSIALAMGMMELGAQGSTRKEIRHSMGYEGLKGG 84

Query: 156 HSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFN 215
              + L+D+  +       Y            +K+AN ++      +N  +       FN
Sbjct: 85  EEFSFLRDFSNMASAEENQYV-----------MKLANSLFVQNGFHVNEEFLQMLKMYFN 133

Query: 216 SELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVP 275
           +E+  VDFSQ  A A  +N WV N+TN  +KDL+  +  D  T L LINA++FKG W   
Sbjct: 134 AEVNHVDFSQNVAVANSINKWVENYTNSLLKDLVSPEDFDGVTNLALINAVYFKGNWKSQ 193

Query: 276 FKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYE------EAGEDGFKMLELPY---GVS 326
           F+PE T+   F  DD + VQ+P+M+ +  FY  E      EAG   +++LE+PY    +S
Sbjct: 194 FRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAG-GIYQVLEIPYEGDEIS 252

Query: 327 ISFIIKSQVVP 337
           +   +  Q VP
Sbjct: 253 MMLALSRQEVP 263

Serine protease inhibitor that inhibits plasminogen activators and plasmin but not thrombin. May be involved in the formation or reorganization of synaptic connections as well as for synaptic plasticity in the adult nervous system. May protect neurons from cell damage by tissue-type plasminogen activator.

Mus musculus (taxid: 10090)

>sp|Q90935|NEUS_CHICK Neuroserpin OS=Gallus gallus GN=SERPINI1 PE=1 SV=1

 Score =  128 bits (322), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 118/237 (49%), Gaps = 26/237 (10%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGL---RIKHSE--TLLKDYKGIID 169
           AA + EN +  P S+ + +G+   GA G+T + +   L    +K+ E  T LKD   +  
Sbjct: 39  AAREDENILFCPLSIAIAMGMIELGAHGTTLKEIRHSLGFDSLKNGEEFTFLKDLSDMAT 98

Query: 170 QLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAA 229
                Y            L +AN +Y      ++  +       F +E+  +DFSQ  A 
Sbjct: 99  TEESHYV-----------LNMANSLYVQNGFHVSEKFLQLVKKYFKAEVENIDFSQSAAV 147

Query: 230 AKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLD 289
           A  +N WV NHTN+ IKD + +    A T LVLINAI+FKG W   F+PE T+   F  D
Sbjct: 148 ATHINKWVENHTNNMIKDFVSSRDFSALTHLVLINAIYFKGNWKSQFRPENTRTFSFTKD 207

Query: 290 DTNSVQVPLMFVKDSFYMYE------EAGEDGFKMLELPY---GVSISFIIKSQVVP 337
           D   VQ+P+M+ +  FY  E      EAG   +++LE+PY    +S+  ++  Q VP
Sbjct: 208 DETEVQIPMMYQQGEFYYGEFSDGSNEAG-GIYQVLEIPYEGDEISMMIVLSRQEVP 263

Serine protease inhibitor that inhibits plasminogen activators and plasmin but not thrombin. May be involved in the formation or reorganization of synaptic connections as well as for synaptic plasticity in the adult nervous system. May protect neurons from cell damage by tissue-type plasminogen activator.

Gallus gallus (taxid: 9031)

>sp|Q80X76|SPA3F_MOUSE Serine protease inhibitor A3F OS=Mus musculus GN=Serpina3f PE=1 SV=3

 Score =  127 bits (318), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 126/229 (55%), Gaps = 15/229 (6%)

Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           N  EN + SPFS+   L L S GA  +T + +++GL+   +ET   D       + + ++
Sbjct: 56  NPDENVVFSPFSICTALALLSLGAKSNTLKEILEGLKFNLTETPEPD-------IHQGFR 108

Query: 177 GIIDQLSK---SPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            ++D LS+     ++   + ++  K +++   ++ +A   + +E    DF QP  A K +
Sbjct: 109 YLLDLLSQPGNQVQISTGSALFIEKHLQILAEFKEKARALYQAEAFTADFQQPLEATKLI 168

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           ND+VSNHT  KIK+LI    LD  T +VL+N I+FKGKW +PF P+ T    FYLD+  S
Sbjct: 169 NDYVSNHTQGKIKELIS--DLDKRTLMVLVNYIYFKGKWEMPFDPDDTCKSEFYLDENRS 226

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
           V+VP+M + +    Y    E    ++EL Y  + S +    ++P+ G++
Sbjct: 227 VKVPMMKINNLTTPYFRDEELSCTVVELKYTGNASAMF---ILPDQGKM 272

Mus musculus (taxid: 10090)

>sp|P93692|SPZ2B_WHEAT Serpin-Z2B OS=Triticum aestivum PE=1 SV=1

 Score =  125 bits (315), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 76/223 (34%), Positives = 116/223 (52%), Gaps = 10/223 (4%)

Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           F+ +L++ +  N   +   NA  SP SLHV L L + GA G+T   +   L     E L 
Sbjct: 19  FAFRLASAISSN-PESTVNNAAFSPVSLHVALSLITAGAGGATRNQLAATLGEGEVEGLH 77

Query: 162 KDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKV 221
              + ++  +  D   I       P +  AN ++    ++L P++Q  AV  + +E   V
Sbjct: 78  ALAEQVVQFVLADASNI-----GGPRVAFANGVFVDASLQLKPSFQELAVCKYKAEAQSV 132

Query: 222 DFSQPPA-AAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEA 280
           DF    A    ++N WV   T   IKD++ A S+D +T+LVL NA++FKG WT  F P A
Sbjct: 133 DFQTKAAEVTAQVNSWVEKVTTGLIKDILPAGSIDNTTRLVLGNALYFKGAWTDQFDPRA 192

Query: 281 TKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY 323
           T+   FYL D +S+Q P M+  +  Y+   +  DG K+L+LPY
Sbjct: 193 TQSDDFYLLDGSSIQTPFMYSSEEQYI---SSSDGLKVLKLPY 232

Inhibits chymotrypsin, cathepsin G and trypsin in vitro.

Triticum aestivum (taxid: 4565)

>sp|Q9ST58|SPZ1C_WHEAT Serpin-Z1C OS=Triticum aestivum PE=1 SV=1

 Score =  125 bits (315), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 75/223 (33%), Positives = 119/223 (53%), Gaps = 10/223 (4%)

Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           F+++L++ +  N   +   NA+ SP SLHV L L + GA  +T + ++  L     E L 
Sbjct: 19  FALRLASTISSN-PKSAASNAVFSPVSLHVALSLLAAGAGSATRDQLVATLGTGEVEGLH 77

Query: 162 KDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKV 221
              + ++  +  D        +  P +  AN ++    + L P++Q  AV  + ++   V
Sbjct: 78  ALAEQVVQFVLADASS-----AGGPHVAFANGVFVDASLPLKPSFQELAVCKYKADTQSV 132

Query: 222 DFSQPPA-AAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEA 280
           DF    A  A ++N WV   T+ +IKD++ + S+D +TKLVL NA++FKG WT  F    
Sbjct: 133 DFQTKAAEVATQVNSWVEKVTSGRIKDILPSGSVDNTTKLVLANALYFKGAWTDQFDSSG 192

Query: 281 TKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY 323
           TK+  FYL D +SVQ P M   D  Y+   +  DG K+L+LPY
Sbjct: 193 TKNDYFYLPDGSSVQTPFMSSMDDQYL---SSSDGLKVLKLPY 232

Inhibits chymotrypsin and cathepsin G in vitro.

Triticum aestivum (taxid: 4565)

>sp|P22922|A1AT_BOMMO Antitrypsin OS=Bombyx mori PE=1 SV=2

 Score =  124 bits (310), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 137/254 (53%), Gaps = 24/254 (9%)

Query: 71  IACCALGSVS-FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSL 129
           IA  A+ +V+  S++L    NG  +       F+ ++ T V  N   N  ++ ++S FS+
Sbjct: 10  IAIAAMAAVTNLSNVLK---NGNDN-------FTARMFTEVVKN---NPGKSIVLSAFSV 56

Query: 130 HVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELK 189
              L   +  + G T E ++K +     + +  ++       S+D + I     K  ELK
Sbjct: 57  LPPLAQLALASDGETHEELLKAIGFPDDDAIRTEFAS----KSRDLRSI-----KGVELK 107

Query: 190 IANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLI 249
           +ANK+Y     +L+  +   + D FNS++  +DFS+   AAK +NDWV  +TN++IKDL+
Sbjct: 108 MANKVYVHDGGKLDENFAVVSRDVFNSDVQNIDFSKNTVAAKSINDWVEENTNNRIKDLV 167

Query: 250 KADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYE 309
             DSL ++T  VL+NAI+FKG W+  F    T D  FY+    +++VP+M+ K   Y Y 
Sbjct: 168 NPDSLSSATAAVLVNAIYFKGAWSSKFDERLTSDRDFYVSKDKTIKVPMMY-KRGDYKYG 226

Query: 310 EAGEDGFKMLELPY 323
           E+     +++E+PY
Sbjct: 227 ESAVLNAQLIEIPY 240

May play a role in the prophenoloxydase activating system in the silkworm hemolymph.

Bombyx mori (taxid: 7091)

>sp|Q03734|SPA3M_MOUSE Serine protease inhibitor A3M OS=Mus musculus GN=Serpina3m PE=1 SV=2

 Score =  123 bits (309), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 120/227 (52%), Gaps = 11/227 (4%)

Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKD-YKGIIDQLSKDY 175
           N  +N + SP S+   L L S GA G+T E +++GL+   +ET   D ++G    L +  
Sbjct: 66  NPDKNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTETSEADIHQGFGHLLQR-- 123

Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
              + Q     ++ I N ++  KD+++   +  +    + +E    DF QP  A K +ND
Sbjct: 124 ---LSQPEDQDQINIGNAMFIEKDLQILAEFHEKTRALYQTEAFTADFQQPTEATKLIND 180

Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           +VSN T   IK LI    LD  T +VL+N I+FKGKW + F P+ T +  FYLD+  SV+
Sbjct: 181 YVSNQTQGMIKKLIS--ELDDRTLMVLVNYIYFKGKWKISFDPQDTFESEFYLDEKRSVK 238

Query: 296 VPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
           VP+M +K     +    E    +LEL Y  + S +    ++P+ GR+
Sbjct: 239 VPMMKMKFLTTRHFRDEELSCSVLELKYTGNASALF---ILPDQGRM 282

Mus musculus (taxid: 10090)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	342
118421175	378	serpin [Anopheles sinensis]	0.666	0.603	0.4	1e-40
170058774	377	serine protease inhibitor 4, serpin-4 [C	0.652	0.591	0.409	2e-37
157116803	379	serine protease inhibitor 4, serpin-4 [A	0.608	0.548	0.415	1e-36
157116799	376	serine protease inhibitor 4, serpin-4 [A	0.608	0.553	0.415	1e-36
157116805	373	serine protease inhibitor 4, serpin-4 [A	0.608	0.557	0.415	2e-36
157116801	386	serine protease inhibitor 4, serpin-4 [A	0.608	0.538	0.415	2e-36
187441032	241	SRPN10 protein [Anopheles gambiae]	0.593	0.842	0.405	2e-35
187441010	241	SRPN10 protein [Anopheles arabiensis] gi	0.593	0.842	0.405	2e-35
187441022	241	SRPN10 protein [Anopheles gambiae] gi|18	0.593	0.842	0.405	2e-35
187441004	241	SRPN10 protein [Anopheles arabiensis] gi	0.593	0.842	0.405	2e-35

>gi|118421175|gb|ABK88283.1| serpin [Anopheles sinensis]

 Score =  173 bits (439), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 98/245 (40%), Positives = 141/245 (57%), Gaps = 17/245 (6%)

Query: 82  SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAA 141
           S  +D++F G+ ++      F+I+L  LV    A N  EN +ISPFS+   L LA+ GA 
Sbjct: 2   SEAVDRQFVGQSNE------FAIKLFQLVS---AQNAGENVVISPFSISACLSLAAMGAG 52

Query: 142 GSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIE 201
           G TAE M  GL    + +       +   ++ +Y+ ++ +L     + +ANKIY  K+  
Sbjct: 53  GLTAEQMFTGLNYGSAGS-------VKSTVADNYRRLLTRLDSDSTVNVANKIYVMKNYG 105

Query: 202 LNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLV 261
           +  A+   A D+F SE   VDF+Q  AAAK +N WV + TN+KIKDLI  DSLD  +++V
Sbjct: 106 IKSAFNAIATDSFRSEAESVDFAQSVAAAKTINGWVESKTNNKIKDLISPDSLDDLSRMV 165

Query: 262 LINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLEL 321
           L+NA+HFKG WT  F P+ T+  PF+  +T S  VP+M +K  F  Y    + GF  LEL
Sbjct: 166 LVNAVHFKGTWTYQFNPQLTRPFPFWTSETESRDVPMMNIKKEF-AYNNFEDQGFSALEL 224

Query: 322 PYGVS 326
            YG S
Sbjct: 225 TYGGS 229

Source: Anopheles sinensis

Species: Anopheles sinensis

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170058774|ref|XP_001865070.1| serine protease inhibitor 4, serpin-4 [Culex quinquefasciatus] gi|167877746|gb|EDS41129.1| serine protease inhibitor 4, serpin-4 [Culex quinquefasciatus]

 Score =  162 bits (410), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/242 (40%), Positives = 137/242 (56%), Gaps = 19/242 (7%)

Query: 82  SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAA 141
           +S LD +F+ K ++      F+++L       + +++ +N IISPFS+   L LA+FGAA
Sbjct: 2   TSALDIQFSSKTNE------FALELYK----QIISSENKNVIISPFSISTCLSLAAFGAA 51

Query: 142 GSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIE 201
           G TA  M   L  K+++  LK    +I      Y  ++   + +P +KIANK+Y      
Sbjct: 52  GHTANEMFSVL--KYTDAELKAAVALI------YGKVLKDFNANPTVKIANKVYVMNKYS 103

Query: 202 LNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLV 261
           +   +   A  NF+SE   V+F +   AAK++N WV   TNDKIKDLI  DSLD ST+LV
Sbjct: 104 VKAGFDEVARKNFHSEAETVNFGENVIAAKKINGWVEQKTNDKIKDLISPDSLDGSTRLV 163

Query: 262 LINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLEL 321
           L+NAIHFKG W   F PE TK  PF++  T SV VP+M  K  F  Y +  E G   LEL
Sbjct: 164 LVNAIHFKGTWKQQFDPEVTKPMPFWVTATESVDVPMMMNKKHFR-YGKFDELGLSALEL 222

Query: 322 PY 323
            Y
Sbjct: 223 TY 224

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157116803|ref|XP_001658643.1| serine protease inhibitor 4, serpin-4 [Aedes aegypti] gi|108876284|gb|EAT40509.1| AAEL007765-PD [Aedes aegypti]

 Score =  160 bits (404), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/219 (41%), Positives = 125/219 (57%), Gaps = 11/219 (5%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           + AN+K+N +ISPFS+   L LA+ GA G TAE M +GL+   ++            +++
Sbjct: 24  IIANEKKNVVISPFSISTCLSLAAMGAGGLTAEEMFRGLKYDPAQK---------SSIAE 74

Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            Y  I+  L  +  LKIANK+Y  +   +   +   A   F SE   V+F    A AK++
Sbjct: 75  SYGNIMKNLDGNKSLKIANKMYIMQKYSVKSNFHEIAQKGFRSEAESVNFQDNTATAKKI 134

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WV   TNDKIKDLI  DSLD  T+LVL+NAIHFKG WT  F PE+T+  PF++ +T S
Sbjct: 135 NTWVEQKTNDKIKDLISPDSLDDMTRLVLVNAIHFKGTWTHQFNPESTRPMPFWISETES 194

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS-ISFII 331
           V VP+M  K  F  +    + G   LEL Y  S +S +I
Sbjct: 195 VDVPMMNTKKHFK-HGVFDDLGLAALELTYSDSDVSMLI 232

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157116799|ref|XP_001658641.1| serine protease inhibitor 4, serpin-4 [Aedes aegypti] gi|108876282|gb|EAT40507.1| AAEL007765-PC [Aedes aegypti]

 Score =  159 bits (403), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/219 (41%), Positives = 125/219 (57%), Gaps = 11/219 (5%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           + AN+K+N +ISPFS+   L LA+ GA G TAE M +GL+   ++            +++
Sbjct: 24  IIANEKKNVVISPFSISTCLSLAAMGAGGLTAEEMFRGLKYDPAQK---------SSIAE 74

Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            Y  I+  L  +  LKIANK+Y  +   +   +   A   F SE   V+F    A AK++
Sbjct: 75  SYGNIMKNLDGNKSLKIANKMYIMQKYSVKSNFHEIAQKGFRSEAESVNFQDNTATAKKI 134

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WV   TNDKIKDLI  DSLD  T+LVL+NAIHFKG WT  F PE+T+  PF++ +T S
Sbjct: 135 NTWVEQKTNDKIKDLISPDSLDDMTRLVLVNAIHFKGTWTHQFNPESTRPMPFWISETES 194

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS-ISFII 331
           V VP+M  K  F  +    + G   LEL Y  S +S +I
Sbjct: 195 VDVPMMNTKKHFK-HGVFDDLGLAALELTYSDSDVSMLI 232

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157116805|ref|XP_001658644.1| serine protease inhibitor 4, serpin-4 [Aedes aegypti] gi|108876285|gb|EAT40510.1| AAEL007765-PB [Aedes aegypti]

 Score =  159 bits (402), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/219 (41%), Positives = 125/219 (57%), Gaps = 11/219 (5%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           + AN+K+N +ISPFS+   L LA+ GA G TAE M +GL+   ++            +++
Sbjct: 24  IIANEKKNVVISPFSISTCLSLAAMGAGGLTAEEMFRGLKYDPAQK---------SSIAE 74

Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            Y  I+  L  +  LKIANK+Y  +   +   +   A   F SE   V+F    A AK++
Sbjct: 75  SYGNIMKNLDGNKSLKIANKMYIMQKYSVKSNFHEIAQKGFRSEAESVNFQDNTATAKKI 134

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WV   TNDKIKDLI  DSLD  T+LVL+NAIHFKG WT  F PE+T+  PF++ +T S
Sbjct: 135 NTWVEQKTNDKIKDLISPDSLDDMTRLVLVNAIHFKGTWTHQFNPESTRPMPFWISETES 194

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS-ISFII 331
           V VP+M  K  F  +    + G   LEL Y  S +S +I
Sbjct: 195 VDVPMMNTKKHFK-HGVFDDLGLAALELTYSDSDVSMLI 232

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157116801|ref|XP_001658642.1| serine protease inhibitor 4, serpin-4 [Aedes aegypti] gi|108876283|gb|EAT40508.1| AAEL007765-PA [Aedes aegypti]

 Score =  159 bits (402), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/219 (41%), Positives = 125/219 (57%), Gaps = 11/219 (5%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           + AN+K+N +ISPFS+   L LA+ GA G TAE M +GL+   ++            +++
Sbjct: 24  IIANEKKNVVISPFSISTCLSLAAMGAGGLTAEEMFRGLKYDPAQK---------SSIAE 74

Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            Y  I+  L  +  LKIANK+Y  +   +   +   A   F SE   V+F    A AK++
Sbjct: 75  SYGNIMKNLDGNKSLKIANKMYIMQKYSVKSNFHEIAQKGFRSEAESVNFQDNTATAKKI 134

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WV   TNDKIKDLI  DSLD  T+LVL+NAIHFKG WT  F PE+T+  PF++ +T S
Sbjct: 135 NTWVEQKTNDKIKDLISPDSLDDMTRLVLVNAIHFKGTWTHQFNPESTRPMPFWISETES 194

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS-ISFII 331
           V VP+M  K  F  +    + G   LEL Y  S +S +I
Sbjct: 195 VDVPMMNTKKHFK-HGVFDDLGLAALELTYSDSDVSMLI 232

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|187441032|emb|CAO83830.1| SRPN10 protein [Anopheles gambiae]

 Score =  156 bits (394), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/212 (40%), Positives = 124/212 (58%), Gaps = 9/212 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A +  EN +ISPFS+   L LA+ GA G TAE M   L     E    D K  +   + +
Sbjct: 25  AXHAGENVVISPFSISACLSLAAMGAGGLTAEQMYSVL-----EFGAPDXKQTV---ADN 76

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           Y+ ++++L+    + +ANKIY  ++  +  A+   A  +F SE   V+F++  AAAK++N
Sbjct: 77  YRRLMERLATDSTVNVANKIYVMQNYAVKGAFNAIATGSFRSEAESVNFAESAAAAKKIN 136

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV   TN+KIKDLI  D+LD  +++VL+NA+HFKG WT  F P  T+  PF+L +T S 
Sbjct: 137 GWVEEKTNNKIKDLISPDALDELSRMVLVNAVHFKGTWTYQFDPSLTRPFPFWLSETESR 196

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS 326
            VP+M +K  F  +    E GF  LEL YG S
Sbjct: 197 DVPMMNIKKHF-AFNNFEELGFSALELTYGGS 227

Source: Anopheles gambiae

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|187441010|emb|CAO83819.1| SRPN10 protein [Anopheles arabiensis] gi|187441016|emb|CAO83822.1| SRPN10 protein [Anopheles arabiensis]

 Score =  156 bits (394), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/212 (40%), Positives = 124/212 (58%), Gaps = 9/212 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A +  EN +ISPFS+   L LA+ GA G TAE M   L     E    D K  +   + +
Sbjct: 25  AKHAGENVVISPFSISACLSLAAMGAGGLTAEQMYSVL-----EFGAPDRKQTV---ADN 76

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           Y+ ++++L+    + +ANKIY  ++  +  A+   A  +F SE   V+F++  AAAK++N
Sbjct: 77  YRRLMERLATDSTVNVANKIYVMQNYXVKGAFNAIATGSFRSEAESVNFAESAAAAKKIN 136

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV   TN+KIKDLI  D+LD  +++VL+NA+HFKG WT  F P  T+  PF+L +T S 
Sbjct: 137 GWVEEKTNNKIKDLISPDALDELSRMVLVNAVHFKGTWTYQFDPSLTRPFPFWLSETESR 196

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS 326
            VP+M +K  F  +    E GF  LEL YG S
Sbjct: 197 DVPMMNIKKHF-AFNNFEELGFSALELTYGGS 227

Source: Anopheles arabiensis

Species: Anopheles arabiensis

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|187441022|emb|CAO83825.1| SRPN10 protein [Anopheles gambiae] gi|187441026|emb|CAO83827.1| SRPN10 protein [Anopheles gambiae] gi|187441030|emb|CAO83829.1| SRPN10 protein [Anopheles gambiae]

 Score =  155 bits (393), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/212 (40%), Positives = 124/212 (58%), Gaps = 9/212 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A +  EN +ISPFS+   L LA+ GA G TAE M   L     E    D K  +   + +
Sbjct: 25  AKHAGENVVISPFSISACLSLAAMGAGGLTAEQMYSVL-----EFGAPDXKQTV---ADN 76

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           Y+ ++++L+    + +ANKIY  ++  +  A+   A  +F SE   V+F++  AAAK++N
Sbjct: 77  YRRLMERLATDSTVNVANKIYVMQNYAVKGAFNAIATGSFRSEAESVNFAESAAAAKKIN 136

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV   TN+KIKDLI  D+LD  +++VL+NA+HFKG WT  F P  T+  PF+L +T S 
Sbjct: 137 GWVEEKTNNKIKDLISPDALDELSRMVLVNAVHFKGTWTYQFDPSLTRPFPFWLSETESR 196

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS 326
            VP+M +K  F  +    E GF  LEL YG S
Sbjct: 197 DVPMMNIKKHF-AFNNFEELGFSALELTYGGS 227

Source: Anopheles gambiae

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|187441004|emb|CAO83816.1| SRPN10 protein [Anopheles arabiensis] gi|187441006|emb|CAO83817.1| SRPN10 protein [Anopheles arabiensis] gi|187441008|emb|CAO83818.1| SRPN10 protein [Anopheles arabiensis] gi|187441012|emb|CAO83820.1| SRPN10 protein [Anopheles arabiensis] gi|187441014|emb|CAO83821.1| SRPN10 protein [Anopheles arabiensis] gi|187441018|emb|CAO83823.1| SRPN10 protein [Anopheles arabiensis] gi|187441020|emb|CAO83824.1| SRPN10 protein [Anopheles gambiae] gi|187441024|emb|CAO83826.1| SRPN10 protein [Anopheles gambiae] gi|187441028|emb|CAO83828.1| SRPN10 protein [Anopheles gambiae] gi|187441034|emb|CAO83831.1| SRPN10 protein [Anopheles gambiae] gi|187441036|emb|CAO83832.1| SRPN10 protein [Anopheles gambiae] gi|187441038|emb|CAO83833.1| SRPN10 protein [Anopheles gambiae] gi|187441040|emb|CAO83834.1| SRPN10 protein [Anopheles gambiae] gi|187441044|emb|CAO83836.1| SRPN10 protein [Anopheles gambiae] gi|187441046|emb|CAO83837.1| SRPN10 protein [Anopheles gambiae]

 Score =  155 bits (393), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/212 (40%), Positives = 124/212 (58%), Gaps = 9/212 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A +  EN +ISPFS+   L LA+ GA G TAE M   L     E    D K  +   + +
Sbjct: 25  AKHAGENVVISPFSISACLSLAAMGAGGLTAEQMYSVL-----EFGAPDRKQTV---ADN 76

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           Y+ ++++L+    + +ANKIY  ++  +  A+   A  +F SE   V+F++  AAAK++N
Sbjct: 77  YRRLMERLATDSTVNVANKIYVMQNYAVKGAFNAIATGSFRSEAESVNFAESAAAAKKIN 136

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV   TN+KIKDLI  D+LD  +++VL+NA+HFKG WT  F P  T+  PF+L +T S 
Sbjct: 137 GWVEEKTNNKIKDLISPDALDELSRMVLVNAVHFKGTWTYQFDPSLTRPFPFWLSETESR 196

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS 326
            VP+M +K  F  +    E GF  LEL YG S
Sbjct: 197 DVPMMNIKKHF-AFNNFEELGFSALELTYGGS 227

Source: Anopheles arabiensis

Species: Anopheles arabiensis

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	342
UNIPROTKB|Q8WSX7	395	spi21F "AGAP005246-PA" [Anophe	0.593	0.513	0.405	4.4e-36
FB|FBgn0024294	393	Spn43Aa "Serpin 43Aa" [Drosoph	0.614	0.534	0.358	8.8e-31
RGD|619896	410	Serpini1 "serpin peptidase inh	0.654	0.546	0.326	3e-30
UNIPROTKB|E2RLA3	410	SERPINI1 "Uncharacterized prot	0.628	0.524	0.347	4.9e-30
UNIPROTKB|Q99574	410	SERPINI1 "Neuroserpin" [Homo s	0.716	0.597	0.309	4.9e-30
UNIPROTKB|F1SH33	410	SERPINI1 "Uncharacterized prot	0.695	0.580	0.325	6.2e-30
UNIPROTKB|E1BCA5	410	SERPINI1 "Uncharacterized prot	0.634	0.529	0.337	1.3e-29
MGI|MGI:1194506	410	Serpini1 "serine (or cysteine)	0.643	0.536	0.325	1.3e-29
MGI|MGI:2182838	445	Serpina3f "serine (or cysteine	0.634	0.487	0.331	5.6e-29
UNIPROTKB|Q90935	410	SERPINI1 "Neuroserpin" [Gallus	0.675	0.563	0.334	7.1e-29

UNIPROTKB|Q8WSX7 spi21F "AGAP005246-PA" [Anopheles gambiae (taxid:7165)]

 Score = 389 (142.0 bits), Expect = 4.4e-36, P = 4.4e-36
 Identities = 86/212 (40%), Positives = 124/212 (58%)

Query:   115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
             A +  EN +ISPFS+   L LA+ GA G TAE M   L     E    D K  +   + +
Sbjct:    29 AKHAGENVVISPFSISACLSLAAMGAGGLTAEQMYSVL-----EFGAPDRKQTV---ADN 80

Query:   175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
             Y+ ++++L+    + +ANKIY  ++  +  A+   A  +F SE   V+F++  AAAK++N
Sbjct:    81 YRRLMERLATDSTVNVANKIYVMQNYAVKGAFNAIATGSFRSEAESVNFAESAAAAKKIN 140

Query:   235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
              WV   TN+KIKDLI  D+LD  +++VL+NA+HFKG WT  F P  T+  PF+L +T S 
Sbjct:   141 GWVEEKTNNKIKDLISPDALDELSRMVLVNAVHFKGTWTYQFDPSLTRPFPFWLSETESR 200

Query:   295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVS 326
              VP+M +K  F  +    E GF  LEL YG S
Sbjct:   201 DVPMMNIKKHF-AFNNFEELGFSALELTYGGS 231

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=ISS

GO:0010951 "negative regulation of endopeptidase activity" evidence=ISS

GO:0030162 "regulation of proteolysis" evidence=ISS

FB|FBgn0024294 Spn43Aa "Serpin 43Aa" [Drosophila melanogaster (taxid:7227)]

 Score = 339 (124.4 bits), Expect = 8.8e-31, P = 8.8e-31
 Identities = 81/226 (35%), Positives = 135/226 (59%)

Query:   114 LAANKK-ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLS 172
             LA +++ EN IISP S+ + LGLA +GA G TA  + K L   H+    K+ K   D L+
Sbjct:    41 LATDRQDENVIISPVSIQLALGLAYYGAEGRTAAELQKTL---HASA--KESK---DGLA 92

Query:   173 KDYKGIIDQLSKSPE-LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK 231
             + Y  ++    KS   L+IANK+Y  +++ ++  ++  A   F+SE+  +DFS+   A +
Sbjct:    93 ESYHNLLHSYIKSKTVLEIANKVYTRQNLTVSSHFREVAQKYFDSEVEPLDFSRETEAVE 152

Query:   232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
             ++N WV   T +KI+ ++  +SL+  T + L+NAI+FK +W  PF  E T+D  F+L ++
Sbjct:   153 QINRWVKQQTENKIERVV--ESLEPDTNVALVNAIYFKARWARPFNDEDTRDREFWLSES 210

Query:   292 NSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY---GVSISFIIKSQ 334
              S+QVP MF  D++Y Y +  E   K +EL +    +++ FI+ +Q
Sbjct:   211 RSIQVPTMFA-DNWYYYADYPELDAKAIELFFENINLTMWFILPNQ 255

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=ISS;IBA

GO:0045861 "negative regulation of proteolysis" evidence=ISM

GO:0005615 "extracellular space" evidence=ISM

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

RGD|619896 Serpini1 "serpin peptidase inhibitor, clade I (neuroserpin), member 1" [Rattus norvegicus (taxid:10116)]

 Score = 334 (122.6 bits), Expect = 3.0e-30, P = 3.0e-30
 Identities = 80/245 (32%), Positives = 125/245 (51%)

Query:   108 TLVEWNL-------AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL 160
             T+ EW++       A  + EN + SP S+ + +G+   GA GST +       I+HS   
Sbjct:    25 TIAEWSVNVYNHLRATGEDENILFSPLSIALAMGVMELGAQGSTLK------EIRHSMGY 78

Query:   161 LKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGK 220
                  G      +D+  ++        +KIAN ++      +N  +       FN+E+  
Sbjct:    79 ESLKSGEEFSFLRDFSSMVSAEEGQYVMKIANSLFVQNGFHINEEFLQMMKMYFNAEVNH 138

Query:   221 VDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEA 280
             VDFS+  A A  +N WV N+TN  +KDL+     DA T L LINA++FKG W   F+PE 
Sbjct:   139 VDFSENVAVANYINKWVENYTNSLLKDLVSPGDFDAVTHLALINAVYFKGNWKSQFRPEN 198

Query:   281 TKDGPFYLDDTNSVQVPLMFVKDSFYMYE---EAGEDG--FKMLELPY-G--VSISFIIK 332
             T+   F  DD + VQ+P+M+ +  FY  E    + E G  +++LE+PY G  +S+  ++ 
Sbjct:   199 TRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLS 258

Query:   333 SQVVP 337
              Q VP
Sbjct:   259 RQEVP 263

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IDA

GO:0005576 "extracellular region" evidence=IEA

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030155 "regulation of cell adhesion" evidence=IDA

GO:0030162 "regulation of proteolysis" evidence=IBA

UNIPROTKB|E2RLA3 SERPINI1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 332 (121.9 bits), Expect = 4.9e-30, P = 4.9e-30
 Identities = 81/233 (34%), Positives = 123/233 (52%)

Query:   115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLS-- 172
             A  + EN + SP S+   +G+   GA GST    +K +R       LK+  G  D+ S  
Sbjct:    39 ATGEDENILFSPLSVTFAMGMMELGAQGST----LKEIRHSMGYDSLKN--G--DEFSFL 90

Query:   173 KDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
             KD+  ++        +KIAN ++      +N  +       F +E+  VDFSQ  A A  
Sbjct:    91 KDFSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMLKKYFKAEVNHVDFSQNIAVANL 150

Query:   233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
             +N WV N+TN+ +KDL+     DA T L LINA++FKG W   F+PE T+   F  DD +
Sbjct:   151 VNKWVENNTNNLLKDLVSPRDFDAGTHLALINAVYFKGNWKSQFRPENTRTFSFTKDDES 210

Query:   293 SVQVPLMFVKDSFYMYE---EAGEDG--FKMLELPY-G--VSISFIIKSQVVP 337
              VQ+P+M+ +  FY  E    + E G  +++LE+PY G  +S+  ++  Q VP
Sbjct:   211 EVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMMLVLSRQEVP 263

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

UNIPROTKB|Q99574 SERPINI1 "Neuroserpin" [Homo sapiens (taxid:9606)]

 Score = 332 (121.9 bits), Expect = 4.9e-30, P = 4.9e-30
 Identities = 81/262 (30%), Positives = 129/262 (49%)

Query:    84 ILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGS 143
             +L     G    +E     S+ +   +    A  + EN + SP S+ + +G+   GA GS
Sbjct:    11 VLQSMATGATFPEEAIADLSVNMYNRLR---ATGEDENILFSPLSIALAMGMMELGAQGS 67

Query:   144 TAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELN 203
             T +       I+HS        G      K++  ++        +KIAN ++      +N
Sbjct:    68 TQK------EIRHSMGYDSLKNGEEFSFLKEFSNMVTAKESQYVMKIANSLFVQNGFHVN 121

Query:   204 PAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLI 263
               +       FN+ +  VDFSQ  A A  +N WV N+TN+ +KDL+     DA+T L LI
Sbjct:   122 EEFLQMMKKYFNAAVNHVDFSQNVAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALI 181

Query:   264 NAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYE---EAGEDG--FKM 318
             NA++FKG W   F+PE T+   F  DD + VQ+P+M+ +  FY  E    + E G  +++
Sbjct:   182 NAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQV 241

Query:   319 LELPY-G--VSISFIIKSQVVP 337
             LE+PY G  +S+  ++  Q VP
Sbjct:   242 LEIPYEGDEISMMLVLSRQEVP 263

GO:0030155 "regulation of cell adhesion" evidence=IEA

GO:0005576 "extracellular region" evidence=IEA

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IBA

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

GO:0007417 "central nervous system development" evidence=TAS

GO:0007422 "peripheral nervous system development" evidence=TAS

UNIPROTKB|F1SH33 SERPINI1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 331 (121.6 bits), Expect = 6.2e-30, P = 6.2e-30
 Identities = 83/255 (32%), Positives = 125/255 (49%)

Query:    91 GKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMK 150
             G     E    FS+ +   +    A  + EN + SP S+ + +G+   GA GST +    
Sbjct:    18 GTTFTDETITEFSVNMYNHLR---ATGEDENILFSPLSVTLAMGMLELGAQGSTLK---- 70

Query:   151 GLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQA 210
                I+HS        G      KD   ++        +KIAN ++      +N  +    
Sbjct:    71 --EIRHSMGYESLKSGEEFSFLKDLSHMVTAEESQYVMKIANSLFVQNGFHVNDEFLQML 128

Query:   211 VDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKG 270
                FN+E+  VDFSQ  A A  +N WV N+TN  +KDL+     DA T L LINA++FKG
Sbjct:   129 KKYFNAEVNHVDFSQNVAVANYINKWVENNTNSLLKDLLSPTDFDAVTHLALINAVYFKG 188

Query:   271 KWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYE---EAGEDG--FKMLELPY-G 324
              W   F+PE T+   F  DD + VQ+P+M+ +  FY  E    + E G  +++LE+PY G
Sbjct:   189 NWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEG 248

Query:   325 --VSISFIIKSQVVP 337
               +S+  ++  Q VP
Sbjct:   249 DEISMMLVLSRQEVP 263

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

UNIPROTKB|E1BCA5 SERPINI1 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 328 (120.5 bits), Expect = 1.3e-29, P = 1.3e-29
 Identities = 78/231 (33%), Positives = 119/231 (51%)

Query:   115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
             A  + EN + SP S+ + +G+   GA GST    +K +R       LK+  G      KD
Sbjct:    39 ATGEDENILFSPLSVTLAMGMLELGAQGST----LKEIRHSMGYDSLKN--GEEFSFLKD 92

Query:   175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
                ++        +KIAN ++      ++  +       FN+E+  VDFSQ  A A  +N
Sbjct:    93 LSHMVTAEESQYVMKIANSLFVQNGFHISEEFLQMIKKYFNAEVNHVDFSQNVAVANYIN 152

Query:   235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
              WV N+TN  +KDL+     DA T L LINA++FKG W   F+PE T+   F  DD + V
Sbjct:   153 KWVENNTNSLLKDLVSPRDFDAVTHLALINAVYFKGSWKSQFRPENTRTFSFTKDDESEV 212

Query:   295 QVPLMFVKDSFYMYE---EAGEDG--FKMLELPY---GVSISFIIKSQVVP 337
             Q+P+M+ +  FY  E    + E G  +++LE+PY    +S+  ++  Q VP
Sbjct:   213 QIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDAISMMLVLSRQEVP 263

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

MGI|MGI:1194506 Serpini1 "serine (or cysteine) peptidase inhibitor, clade I, member 1" [Mus musculus (taxid:10090)]

 Score = 328 (120.5 bits), Expect = 1.3e-29, P = 1.3e-29
 Identities = 81/249 (32%), Positives = 128/249 (51%)

Query:   108 TLVEWNL-------AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL 160
             T+ EW++          + EN + SP S+ + +G+   GA GST +       I+HS   
Sbjct:    25 TITEWSVNMYNHLRGTGEDENILFSPLSIALAMGMMELGAQGSTRK------EIRHS--- 75

Query:   161 LKDYKGII--DQLS--KDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNS 216
                Y+G+   ++ S  +D+  +         +K+AN ++      +N  +       FN+
Sbjct:    76 -MGYEGLKGGEEFSFLRDFSNMASAEENQYVMKLANSLFVQNGFHVNEEFLQMLKMYFNA 134

Query:   217 ELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPF 276
             E+  VDFSQ  A A  +N WV N+TN  +KDL+  +  D  T L LINA++FKG W   F
Sbjct:   135 EVNHVDFSQNVAVANSINKWVENYTNSLLKDLVSPEDFDGVTNLALINAVYFKGNWKSQF 194

Query:   277 KPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYE---EAGEDG--FKMLELPY-GVSISFI 330
             +PE T+   F  DD + VQ+P+M+ +  FY  E    + E G  +++LE+PY G  IS +
Sbjct:   195 RPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMM 254

Query:   331 I--KSQVVP 337
             +    Q VP
Sbjct:   255 LALSRQEVP 263

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=ISO;IBA

GO:0005576 "extracellular region" evidence=IEA

GO:0010466 "negative regulation of peptidase activity" evidence=IEA

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030155 "regulation of cell adhesion" evidence=ISO

GO:0030162 "regulation of proteolysis" evidence=IBA

GO:0030414 "peptidase inhibitor activity" evidence=IEA

MGI|MGI:2182838 Serpina3f "serine (or cysteine) peptidase inhibitor, clade A, member 3F" [Mus musculus (taxid:10090)]

 Score = 322 (118.4 bits), Expect = 5.6e-29, P = 5.6e-29
 Identities = 75/226 (33%), Positives = 122/226 (53%)

Query:   117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
             N  EN + SPFS+   L L S GA  +T + +++GL+   +ET   D    I Q  +   
Sbjct:    56 NPDENVVFSPFSICTALALLSLGAKSNTLKEILEGLKFNLTETPEPD----IHQGFRYLL 111

Query:   177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
              ++ Q     ++   + ++  K +++   ++ +A   + +E    DF QP  A K +ND+
Sbjct:   112 DLLSQPGNQVQISTGSALFIEKHLQILAEFKEKARALYQAEAFTADFQQPLEATKLINDY 171

Query:   237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
             VSNHT  KIK+LI    LD  T +VL+N I+FKGKW +PF P+ T    FYLD+  SV+V
Sbjct:   172 VSNHTQGKIKELIS--DLDKRTLMVLVNYIYFKGKWEMPFDPDDTCKSEFYLDENRSVKV 229

Query:   297 PLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
             P+M + +    Y    E    ++EL Y  + S +    ++P+ G++
Sbjct:   230 PMMKINNLTTPYFRDEELSCTVVELKYTGNASAMF---ILPDQGKM 272

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IBA

GO:0005576 "extracellular region" evidence=IBA

GO:0010466 "negative regulation of peptidase activity" evidence=IEA

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

GO:0030414 "peptidase inhibitor activity" evidence=IEA

GO:0034097 "response to cytokine stimulus" evidence=IDA

GO:0043434 "response to peptide hormone stimulus" evidence=IDA

UNIPROTKB|Q90935 SERPINI1 "Neuroserpin" [Gallus gallus (taxid:9031)]

 Score = 321 (118.1 bits), Expect = 7.1e-29, P = 7.1e-29
 Identities = 86/257 (33%), Positives = 132/257 (51%)

Query:    96 KEDFKPFSI-QLSTLVEWNL-AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGL- 152
             K +F   +I +LS  V   L AA + EN +  P S+ + +G+   GA G+T + +   L 
Sbjct:    18 KTNFPDETIAELSVNVYNQLRAAREDENILFCPLSIAIAMGMIELGAHGTTLKEIRHSLG 77

Query:   153 --RIKHSE--TLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQT 208
                +K+ E  T LKD   + D  + +    +        L +AN +Y      ++  +  
Sbjct:    78 FDSLKNGEEFTFLKD---LSDMATTEESHYV--------LNMANSLYVQNGFHVSEKFLQ 126

Query:   209 QAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHF 268
                  F +E+  +DFSQ  A A  +N WV NHTN+ IKD + +    A T LVLINAI+F
Sbjct:   127 LVKKYFKAEVENIDFSQSAAVATHINKWVENHTNNMIKDFVSSRDFSALTHLVLINAIYF 186

Query:   269 KGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYE---EAGEDG--FKMLELPY 323
             KG W   F+PE T+   F  DD   VQ+P+M+ +  FY  E    + E G  +++LE+PY
Sbjct:   187 KGNWKSQFRPENTRTFSFTKDDETEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPY 246

Query:   324 -G--VSISFIIKSQVVP 337
              G  +S+  ++  Q VP
Sbjct:   247 EGDEISMMIVLSRQEVP 263

GO:0005576 "extracellular region" evidence=IEA

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IBA

GO:0010951 "negative regulation of endopeptidase activity" evidence=IBA

GO:0030162 "regulation of proteolysis" evidence=IBA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	342
pfam00079	369	pfam00079, Serpin, Serpin (serine protease inhibit	6e-72
cd00172	364	cd00172, SERPIN, SERine Proteinase INhibitors (ser	6e-69
smart00093	359	smart00093, SERPIN, SERine Proteinase INhibitors	6e-56
cd02049	364	cd02049, bacterial_SERPIN, SERine Proteinase INhib	5e-44
cd02043	381	cd02043, plant_SERPIN, SERine Proteinase INhibitor	8e-41
cd02048	388	cd02048, neuroserpin, Neuroserpin is a inhibitory	7e-39
cd02051	377	cd02051, PAI-1_nexin-1, Plasminogen activator inhi	9e-39
cd02058	380	cd02058, PAI-2, Plasminogen Activator Inhibitor-2	6e-38
cd02059	389	cd02059, ovalbumin_like, The ovalbumin_like group	4e-31
cd02056	361	cd02056, alpha-1-antitrypsin_like, alpha-1-antitry	4e-31
cd02044	370	cd02044, ov-serpin, ovalbumin family of serpins (o	3e-30
COG4826	410	COG4826, COG4826, Serine protease inhibitor [Postt	3e-30
cd02045	381	cd02045, antithrombin-III_like, Antithrombin is a	6e-29
cd02055	365	cd02055, PZI, Protein Z-dependent protease inhibit	3e-22
cd02050	352	cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protea	5e-19
cd02053	351	cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) i	7e-18
cd02052	374	cd02052, PEDF, Pigment epithelium-derived factor (	6e-17
cd02057	372	cd02057, maspin_like, Maspin (mammary serine prote	1e-16
cd02047	436	cd02047, HCII, Heparin cofactor II (HCII) inhibits	7e-14
cd02046	366	cd02046, hsp47, Heat shock protein 47 (Hsp47), als	8e-13
cd02054	372	cd02054, angiotensinogen, Angiotensinogen is part	4e-12
PHA02948	373	PHA02948, PHA02948, serine protease inhibitor-like	5e-04

>gnl|CDD|215699 pfam00079, Serpin, Serpin (serine protease inhibitor)

 Score =  227 bits (581), Expect = 6e-72
 Identities = 83/219 (37%), Positives = 125/219 (57%), Gaps = 11/219 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHS--ETLLKDYKGIIDQLS 172
             +  +N   SP S+   L +   GA G TAE ++  L       E + + ++ ++  L+
Sbjct: 16  KESPDKNIFFSPLSISTALAMLYLGARGETAEQLLSVLGFPELDDEEIHEGFQSLLSSLN 75

Query: 173 KDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
           K  KG          LKIAN+++  K ++L P +       + +E+  VDFS P  A K+
Sbjct: 76  KPDKG--------YTLKIANRLFVDKGLKLKPDFLQLLKKYYGAEVESVDFSDPAEARKQ 127

Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
           +N WV   TN KIKDL+   SLD  T+LVL+NAI+FKGKW  PF PE TK+ PF++D+  
Sbjct: 128 INSWVEKKTNGKIKDLLPEGSLDPDTRLVLVNAIYFKGKWKTPFDPELTKEEPFHVDNGT 187

Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
           +V+VP+M  + +F   E+  E G K+LELPY  ++S +I
Sbjct: 188 TVKVPMMSQEGTFRYAEDE-ELGCKVLELPYKGNLSMLI 225

Structure is a multi-domain fold containing a bundle of helices and a beta sandwich. Length = 369

>gnl|CDD|238101 cd00172, SERPIN, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms

 Score =  219 bits (560), Expect = 6e-69
 Identities = 86/233 (36%), Positives = 129/233 (55%), Gaps = 15/233 (6%)

Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRI--KHSET 159
           F++ L   +     +   EN + SP S+   L L   GA G T E + K L +     E 
Sbjct: 5   FALDLYKQL---AKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDDED 61

Query: 160 LLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELG 219
           + + +K ++  L    KG         ELK+AN+++  K + +   +   A   +++E+ 
Sbjct: 62  VHQAFKSLLSSLKDSEKG--------VELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVE 113

Query: 220 KVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPE 279
            VDF+ P AAA ++N+WV   TN KIKDL+  D+LD  T+LVL+NAI+FKGKW  PF PE
Sbjct: 114 SVDFANPEAAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLVLVNAIYFKGKWKTPFDPE 173

Query: 280 ATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
            T+  PFY+ +  SVQVP+M+    F   E+  E   ++LELPY G  +S +I
Sbjct: 174 LTRKRPFYVSEGESVQVPMMYQTGKFRYAEDE-ELDAQVLELPYKGSDLSMLI 225

Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 364

>gnl|CDD|214513 smart00093, SERPIN, SERine Proteinase INhibitors

 Score =  185 bits (473), Expect = 6e-56
 Identities = 80/229 (34%), Positives = 125/229 (54%), Gaps = 10/229 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
             +  +N   SP S+   L + S GA GSTA  +++ L    +ET   D    I Q  + 
Sbjct: 9   KESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTETSEAD----IHQGFQH 64

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              ++++     ELK AN ++  K ++L  ++       + +E+  VDFS     AK+ +
Sbjct: 65  LLHLLNRPDSQLELKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQI 124

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           NDWV   T  KIKDL+    LD+ T+LVL+NAI+FKGKW  PF PE T++  F++D+T +
Sbjct: 125 NDWVEKKTQGKIKDLLS--DLDSDTRLVLVNAIYFKGKWKTPFDPELTREEDFHVDETTT 182

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
           V+VP+M      + Y    E   ++LELPY  + S +I   ++P+ G L
Sbjct: 183 VKVPMMSQTGRTFNYGHDEELNCQVLELPYKGNASMLI---ILPDEGGL 228

Length = 359

>gnl|CDD|239004 cd02049, bacterial_SERPIN, SERine Proteinase INhibitors (serpins), prokaryotic subgroup

 Score =  154 bits (392), Expect = 5e-44
 Identities = 72/227 (31%), Positives = 115/227 (50%), Gaps = 23/227 (10%)

Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           F  +L + +      + ++N  ISP S+ + L +   GA G+T + M+K L         
Sbjct: 8   FGFKLFSELN---KEDVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALG-------- 56

Query: 162 KDYKGI-IDQLSKDYKGIIDQLS---KSPELKIANKIYFAKDIELNPAYQTQAVDNFNSE 217
                I ++ L+     ++DQL+   K+ EL IAN I+      L P +     D + + 
Sbjct: 57  --LDNIDLEDLNSALATLMDQLNTHDKTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAY 114

Query: 218 LGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFK 277
           + ++DF  P AAA+E+N WV   T  KI  ++  D +D    + LINA++FKG W  PF 
Sbjct: 115 VLELDFQSP-AAAEEINRWVKEKTKGKIDKIV--DKIDPDDVMFLINAVYFKGDWQEPFD 171

Query: 278 PEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYG 324
            ++T + PFYL D ++ +VP M    +F   E     GF+ + LPYG
Sbjct: 172 KQSTYEAPFYLPDGSTKEVPFMSRTGNFRYLE---TPGFQAVRLPYG 215

Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. Length = 364

>gnl|CDD|238998 cd02043, plant_SERPIN, SERine Proteinase INhibitors (serpins), plant specific subgroup

 Score =  146 bits (370), Expect = 8e-41
 Identities = 78/210 (37%), Positives = 114/210 (54%), Gaps = 9/210 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           AA K  N I SP S++V L L + GA G T + ++  L    ++ L      I+D +  D
Sbjct: 17  AAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTDELHAVAASIVDLVLAD 76

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEM 233
                   S  P L  AN ++  K + L P+++  A +++ +E   VDF ++     +E+
Sbjct: 77  -----ASASGGPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEVRREV 131

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WV   TN  IKD++   S+D+STKLVL NA++FKG W+  F    TKD  F+L D  S
Sbjct: 132 NSWVEKATNGLIKDILPPGSVDSSTKLVLANALYFKGAWSSKFDASDTKDRDFHLLDGTS 191

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY 323
           V+VP M  +   Y+   A  DGFK+L LPY
Sbjct: 192 VRVPFMSSEKDQYV---AAFDGFKVLRLPY 218

It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 381

>gnl|CDD|239003 cd02048, neuroserpin, Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA)

 Score =  141 bits (357), Expect = 7e-39
 Identities = 80/228 (35%), Positives = 118/228 (51%), Gaps = 22/228 (9%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLR---IKHSE--TLLKDYKGIID 169
           A+ + EN I SP S  + LG+   GA GS  + +   L    +K+ E  + LKD   +I 
Sbjct: 17  ASKEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGEEFSFLKDLSSMIT 76

Query: 170 QLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAA 229
              K+Y              +AN +Y      +   +       FN+ +  VDFSQ  A 
Sbjct: 77  AKEKEYV-----------FNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQVKAV 125

Query: 230 AKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLD 289
           A+ +N WV NHTN+KIKD+  +      T+LVL+NA++FKG W   F+PE T+   F  D
Sbjct: 126 AEHINKWVENHTNNKIKDMFSSRDFTPLTRLVLVNALYFKGNWKSQFRPENTRTFSFTKD 185

Query: 290 DTNSVQVPLMFVKDSFYMYE---EAGEDG--FKMLELPY-GVSISFII 331
           D + VQ+P+M+ +  FY  E    + E G  +++LELPY G  IS +I
Sbjct: 186 DESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGDEISLMI 233

It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. Length = 388

>gnl|CDD|239006 cd02051, PAI-1_nexin-1, Plasminogen activator inhibitor-1_like

 Score =  141 bits (356), Expect = 9e-39
 Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 13/222 (5%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
             A  +EN ++SP  +  VLG+   GA G T + +   +R K          G+   L K
Sbjct: 23  AQARPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYK--------INGVAKALKK 74

Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
             K I+ + +K   +  AN ++     ++   +  +  + F  E+  VDFS P  AA  +
Sbjct: 75  LNKAIVSKKNKD-IVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSDPETAAFSI 133

Query: 234 NDWVSNHTNDKIKDLIKADSLDAS-TKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
           NDWV N T   I +L+  D  D + T+LVL+NA++FKG W   F+PE+TK   F+  D  
Sbjct: 134 NDWVKNETKGMIDNLLSPDLADDALTRLVLVNALYFKGLWKSRFQPESTKKRTFHAGDGK 193

Query: 293 SVQVPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFII 331
           + QVP++     F     +  +G  + ++ELPY G SIS +I
Sbjct: 194 TYQVPMLAQLSVFRSGSASTPNGLWYNIIELPYHGESISMLI 235

Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 377

>gnl|CDD|239013 cd02058, PAI-2, Plasminogen Activator Inhibitor-2 (PAI-2)

 Score =  138 bits (350), Expect = 6e-38
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 15/222 (6%)

Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           ++  +N   SP+S+   L +   GA G+TA  M K L+            G  + +   +
Sbjct: 19  SSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVG-------GNSEDIHSGF 71

Query: 176 KGIIDQLSKSPE---LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA-K 231
           + ++ +++K      LK AN++Y  K       +       + +E   VDF +    A K
Sbjct: 72  QSLLSEINKPGTNYLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEAAEQARK 131

Query: 232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
           E+N WV   T  KI++L+   S+D+ T+LVL+NAI+FKG W   F  E T++ PF L+  
Sbjct: 132 EINSWVERQTEGKIQNLLPPGSVDSLTRLVLVNAIYFKGNWEEKFLKENTRERPFRLNKN 191

Query: 292 NSVQVPLMFVKDSFYM-YEEAGEDGFKMLELPY-GVSISFII 331
            +  V +MF+K  F + Y E  E   ++LELPY G  +S  I
Sbjct: 192 TTKPVQMMFLKKKFPITYIE--ELKAQVLELPYVGKELSMFI 231

PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. Length = 380

>gnl|CDD|239014 cd02059, ovalbumin_like, The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily

 Score =  120 bits (303), Expect = 4e-31
 Identities = 74/229 (32%), Positives = 112/229 (48%), Gaps = 18/229 (7%)

Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH---------SETLLKDYKGI 167
           +K +N   SP S+   LG+   GA   TA  + K L   H         + +   +  G 
Sbjct: 20  HKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGG 79

Query: 168 IDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP 227
           +    KD    I++ +   EL IAN++Y  K    +  Y       + ++L  VDF    
Sbjct: 80  VHSQFKDLLSQINKPNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAA 139

Query: 228 AAAKEM-NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPF 286
            A+++  N WV + TN KIK+L    ++D+ST LVL+NAI+FKGKW   F+ E T D PF
Sbjct: 140 EASRKKINSWVESQTNGKIKNLFGKGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPF 199

Query: 287 YLDDTNSVQVPLMFVKDSF---YMYEEAGEDGFKMLELPY-GVSISFII 331
            L++  +  V +M+    F    + E       K+LELPY G  +S I+
Sbjct: 200 KLNENENKPVQMMYQIGKFKLASIEEP----KMKILELPYAGGGLSMIV 244

Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. Length = 389

>gnl|CDD|239011 cd02056, alpha-1-antitrypsin_like, alpha-1-antitrypsin_like

 Score =  120 bits (302), Expect = 4e-31
 Identities = 63/231 (27%), Positives = 118/231 (51%), Gaps = 16/231 (6%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + +  +N   SP S+   L + S GA  ST   +++GL    +E   ++    I Q    
Sbjct: 15  SESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEEE----IHQG--- 67

Query: 175 YKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK 231
           ++ ++  L++     +L + N ++  K ++    +       + SE    DF     A K
Sbjct: 68  FQHLLHLLNQPDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQDSAEAKK 127

Query: 232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
           ++ND+V   T+ KI DL+K   LD+ T +VL+N I+FKGKW  PF PE T++  F++D+ 
Sbjct: 128 QINDYVEKKTHGKIVDLVK--DLDSDTVMVLVNYIYFKGKWEKPFDPELTQEEDFFVDEK 185

Query: 292 NSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
            +V+VP+M     +    ++ E    ++++PY  + +      V+P+ G++
Sbjct: 186 TTVKVPMMHQTGRYDYLHDS-ELSCTVVQMPYKGNATAFF---VLPDEGKM 232

This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 361

>gnl|CDD|238999 cd02044, ov-serpin, ovalbumin family of serpins (ov-serpins)

 Score =  118 bits (296), Expect = 3e-30
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 10/206 (4%)

Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N   SP ++   L +   GA GSTA  + K L   + + +   ++ ++  ++K      
Sbjct: 23  QNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHFDNVKDVHSSFQTLLSDINK------ 76

Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-MNDWVS 238
             L+    LK+ N++Y  K     P + +     +  EL  VDF       +  +N W+ 
Sbjct: 77  --LNSFYSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIK 134

Query: 239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPL 298
           + T  KI++L+  +S+D+ T +V++NA +FKGKW   F  E TK+ PF ++ T +  V +
Sbjct: 135 DQTKGKIENLLPENSVDSQTAMVVVNAAYFKGKWMKKFSEEETKESPFRVNKTETKPVQM 194

Query: 299 MFVKDSFYMYEEAGEDGFKMLELPYG 324
           M+++ +F M         K+LELP+ 
Sbjct: 195 MYMEATFNMGNIESL-KMKILELPFA 219

Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 370

>gnl|CDD|227163 COG4826, COG4826, Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones]

 Score =  118 bits (297), Expect = 3e-30
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 13/208 (6%)

Query: 119 KENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKD-YKGIIDQLSKDYKG 177
            EN + SP+S+   + +   GA GST E M        ++T+LK   K + D+       
Sbjct: 60  AENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKVREKSLNDK------- 112

Query: 178 IIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-MNDW 236
            I+  + S EL+ AN ++  +D  L   Y     + +++E+  +DF   P A+++ +N W
Sbjct: 113 -INSPNDSYELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTINKW 171

Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
           V   TN KIKDL+  D +   T+LVL NAI+F GKW   F  + T    FY        V
Sbjct: 172 VEEKTNGKIKDLVPEDYIGPDTRLVLTNAIYFNGKWWPEFDKQMTGKRTFYPAKGEDKSV 231

Query: 297 PLMFVKDSFYMYEEAGEDGFKMLELPYG 324
            +M +   F   E +     K++ELPY 
Sbjct: 232 DMMSICGDFNYGETS---KAKIVELPYK 256

Length = 410

>gnl|CDD|239000 cd02045, antithrombin-III_like, Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation

 Score =  114 bits (287), Expect = 6e-29
 Identities = 70/236 (29%), Positives = 127/236 (53%), Gaps = 18/236 (7%)

Query: 113 NLAANK--KENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQ 170
           +LA +K   EN  +SP S+     +   GA  +T E +M+   +   +T+ +      DQ
Sbjct: 19  HLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLME---VFQFDTISEKTS---DQ 72

Query: 171 L----SKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP 226
           +    +K    +  + +KS EL  AN+++  K +  N  YQ  +   + ++L  +DF + 
Sbjct: 73  VHFFFAKLNCRLYRKANKSSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEK 132

Query: 227 PAAAKE-MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGP 285
           P  ++  +N+W++N T ++I D+I   ++D +T LVL+NAI+FKG W   F  E T+   
Sbjct: 133 PELSRITINEWIANKTENRITDVIPEGAIDTNTVLVLVNAIYFKGLWKSKFDKENTRKDL 192

Query: 286 FYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMG 340
           F+        VP+M+ ++S + Y +  ED  ++LELPY G  I+ ++   ++P+ G
Sbjct: 193 FHKAPGEKCPVPMMY-QESKFRYAKIPEDKVQVLELPYKGDDITMVL---ILPKEG 244

It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. Length = 381

>gnl|CDD|239010 cd02055, PZI, Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10)

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 69/225 (30%), Positives = 112/225 (49%), Gaps = 20/225 (8%)

Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYK-GIIDQLSKDYKGII 179
           N I SPF + + +      A G T   + K L + H+   LKD   G++  L   +KG+ 
Sbjct: 24  NIIFSPFGMSLAMAGLLLAAEGETERQIAKALHL-HA---LKDRDPGLLPAL---FKGLK 76

Query: 180 DQLSKSPELKIANKI--YFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWV 237
           D +S++ EL     I  +  KD ++  A+   +   F+ E   +DF     A   +N  +
Sbjct: 77  DNISRNEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQNASQAKFLINHNI 136

Query: 238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVP 297
              T  KI +L   D +D  +KL+L++ I FKGKW  PF PE T+   F++D   S++VP
Sbjct: 137 KKETKGKIPELF--DEIDPESKLILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIKVP 194

Query: 298 LMFVKDSFYMYEEAGEDGFK--MLELPYGVSISFIIKSQVVPEMG 340
           +MF  D F       ++ F+  +++LPY    + +I   V+ E G
Sbjct: 195 MMFGADKF---ASTFDENFRCHVIKLPYKGKATMLI---VIMEKG 233

ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Length = 365

>gnl|CDD|239005 cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 22/192 (11%)

Query: 114 LAANKK--ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQL 171
           L+ + K   N + SP S+ ++L     GA G T   +   L   H    +          
Sbjct: 13  LSESAKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHDFACVHSA------- 65

Query: 172 SKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK 231
                  + +L     L  A++I+   D+ L  ++  ++   + +     + S       
Sbjct: 66  -------LKKLKNKLGLLSASQIFHHPDLHLRESFTNESWQFYKAR--PRELSNNSELNL 116

Query: 232 EM-NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           EM N WV+  TN+KI  L+  DSL + T+LVL+NA++F+ +W   F  + T   PF  + 
Sbjct: 117 EMINSWVAKATNNKIPRLL--DSLPSETRLVLLNAVYFQAQWKKKFDTKHTVLLPFKRNG 174

Query: 291 TNSVQVPLMFVK 302
            + V+VP+M+ K
Sbjct: 175 -DPVKVPVMYSK 185

It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. Length = 352

>gnl|CDD|239008 cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 18/198 (9%)

Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           FS  L + V      + K N I+SP S+ + L   + GA   T + ++K L   H+E+L 
Sbjct: 8   FSTDLLSEVA---QESTKPNLILSPLSIALALSHLALGAQNETEQRLLKTL---HAESL- 60

Query: 162 KDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKV 221
                ++ +L +D             L++A ++Y  K  E+  ++  ++   + ++   +
Sbjct: 61  PCLHHLLSRLRQDLGPGA--------LRLATRMYLQKGFEIKESFLEESEKLYGAKPVSL 112

Query: 222 DFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEAT 281
             ++    A  +N WV   T  +I + +    L   T L+L+NAIHFKG W   F P  T
Sbjct: 113 TGTKEDDLA-NINKWVKEATEGQIPNFLS--DLPHDTVLLLLNAIHFKGFWRNKFDPSLT 169

Query: 282 KDGPFYLDDTNSVQVPLM 299
           +   F+LDD  +V V +M
Sbjct: 170 QRDAFHLDDDFTVSVEMM 187

Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. Length = 351

>gnl|CDD|239007 cd02052, PEDF, Pigment epithelium-derived factor (PEDF)_like

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 16/226 (7%)

Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           +   N  +SP S+   L   S GA   T   + + L       LL D      +L   YK
Sbjct: 34  DPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYD----LLND-----PELHDTYK 84

Query: 177 GIIDQLSKSPE-LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
            ++  L+   + LK A++I   + + L   +  Q V+    E  ++  +      +E+ND
Sbjct: 85  DLLASLTAPAKGLKSASRILLERKLRLRLEFVNQ-VEKSYGERPRI-LAGNALDLQEIND 142

Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV   T  K+   +K   +  +  ++L+ + +FKG+W   F    T    F+LD+  +V 
Sbjct: 143 WVQQQTGGKVDRFVK--EIPRNVSILLLGSAYFKGQWITKFDKRNTVLTDFHLDEQRTVV 200

Query: 296 VPLMFVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQVVPEM 339
           VP+M   ++   Y    +   K+ +LP   GVSI F +  +V   +
Sbjct: 201 VPMMSDPNAPVRYGLDSDLNCKIAQLPLTGGVSIMFFLPDKVTQNL 246

PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. Length = 374

>gnl|CDD|239012 cd02057, maspin_like, Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 10/204 (4%)

Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP  L   L LA  GA G TA  + K L  ++    +KD       ++ D    + 
Sbjct: 24  NVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFEN----VKDVPFGFQTVTSD----VS 75

Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK-EMNDWVSN 239
           +LS    LK+  ++Y  K + L+  +       +  EL  VDF       + ++N+ +  
Sbjct: 76  KLSSFYSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKE 135

Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T+   ++++  +S++  TK++++NA +F G W   F    TK+ PF ++ T +  V +M
Sbjct: 136 LTDGHFENILNENSVNDQTKILVVNAAYFVGNWMKKFPESETKECPFRVNKTETKPVQMM 195

Query: 300 FVKDSFYMYEEAGEDGFKMLELPY 323
            ++ +F M     E   K+LELP+
Sbjct: 196 NLEATFSM-GYIDELNTKILELPF 218

Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372

>gnl|CDD|239002 cd02047, HCII, Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 12/226 (5%)

Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            N  +N +++P  +   +G+ S G  G T E ++  L  K        Y+  I  +   +
Sbjct: 84  VNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSKYE--ITTVHNLF 141

Query: 176 KGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
           + +  +L +      L+  N +Y  KD  +   ++      + +E    DFS P    K 
Sbjct: 142 RKLTHRLFRRNFGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSDPAFITK- 200

Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N+ +   T   IK+ ++  ++D +T ++++N I+FKG W   F  E T +  F L++  
Sbjct: 201 TNNRIQKLTKGLIKEALE--NVDPATLMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKE 258

Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPE 338
            V+VP+M  K +F    +  E    +L+LPY  +IS +I   VVP 
Sbjct: 259 VVKVPMMQTKGNFLAAADP-ELDCDILQLPYVGNISMLI---VVPH 300

HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. Length = 436

>gnl|CDD|239001 cd02046, hsp47, Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen

 Score = 68.4 bits (167), Expect = 8e-13
 Identities = 52/229 (22%), Positives = 108/229 (47%), Gaps = 12/229 (5%)

Query: 113 NLAANKK-ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQL 171
            +A +K  EN ++SP  +   LGL S G   STA      L    ++ L  ++  +   L
Sbjct: 17  AMAKDKGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLS---ADKLKDEH--VHTGL 71

Query: 172 SKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK 231
           S+    + +  +++   KI N++Y    +     +   +  ++N E  K++F    +A  
Sbjct: 72  SELLNEVSNSTARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRDKRSALN 131

Query: 232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
            +N+W +  T+ K+ ++ K   ++ +   +++NA+ FK  W   F  +   +  F +  +
Sbjct: 132 SINEWAAQTTDGKLPEVTK--DVEKTDGALIVNAMFFKPHWDEKFHHKMVDNRGFMVTRS 189

Query: 292 NSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSIS---FIIKSQVVP 337
            +V VP+M     +  Y++  E+  +++E+P    +S   FI+   V P
Sbjct: 190 YTVSVPMMHRTGLYGYYDDE-ENKLQIVEMPLAHKLSSMIFIMPYHVEP 237

It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. Length = 366

>gnl|CDD|239009 cd02054, angiotensinogen, Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 27/111 (24%), Positives = 59/111 (53%), Gaps = 5/111 (4%)

Query: 221 VDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEA 280
           VDF++P  A +++N++V   ++ K+K  +K   L   + L+   ++HF+G W    + E 
Sbjct: 130 VDFTEPDVAEEKINNFVQATSDGKVKSSLK--GLSPDSDLLFATSVHFQGNWKTASQLEE 187

Query: 281 TKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            ++  F++D+  SV VP++    +F    +  ++ F + +LP       ++
Sbjct: 188 PQE--FWVDNNTSVSVPMLSHTGTFKYLSDIQDN-FSITQLPLSKRACLLL 235

It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372

>gnl|CDD|165258 PHA02948, PHA02948, serine protease inhibitor-like protein; Provisional

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 46/209 (22%), Positives = 92/209 (44%), Gaps = 16/209 (7%)

Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            N+ +N + SPF     + ++   A+G+T   ++K + ++  + L   +  +I  L+K  
Sbjct: 35  GNEDDNIVFSPFGYSFSMFMSLLPASGNTRVELLKTMDLRKRD-LGPAFTELISGLAKL- 92

Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
                + SK     +  + +    + + P+Y  Q    F   L +++F +      ++N 
Sbjct: 93  -----KTSKYTYTDLTYQSFVDNTVCIKPSYYQQ-YHRFG--LYRLNFRRDAV--NKINS 142

Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
            V   +   + +++ +  LD +T   +IN I+FKG W  PF    T +  F  +   +  
Sbjct: 143 IVERRSG--MSNVVDSTMLDNNTLWAIINTIYFKGTWQYPFDITKTHNASF-TNKYGTKT 199

Query: 296 VPLMFVKDSFYMYEEAGED-GFKMLELPY 323
           VP+M V           +D  + M+ LPY
Sbjct: 200 VPMMNVVTKLQGNTITIDDEEYDMVRLPY 228

Length = 373

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	342
cd02057	372	maspin_like Maspin (mammary serine proteinase inhi	100.0
cd02048	388	neuroserpin Neuroserpin is a inhibitory member of	100.0
cd00172	364	SERPIN SERine Proteinase INhibitors (serpins) exhi	100.0
COG4826	410	Serine protease inhibitor [Posttranslational modif	100.0
cd02044	370	ov-serpin ovalbumin family of serpins (ov-serpins)	100.0
cd02054	372	angiotensinogen Angiotensinogen is part of the ren	100.0
cd02046	366	hsp47 Heat shock protein 47 (Hsp47), also called c	100.0
cd02059	389	ovalbumin_like The ovalbumin_like group of serpins	100.0
cd02058	380	PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2). P	100.0
cd02056	361	alpha-1-antitrypsin_like alpha-1-antitrypsin_like.	100.0
cd02045	381	antithrombin-III_like Antithrombin is a serine pro	100.0
cd02051	377	PAI-1_nexin-1 Plasminogen activator inhibitor-1_li	100.0
KOG2392|consensus	380		100.0
cd02052	374	PEDF Pigment epithelium-derived factor (PEDF)_like	100.0
cd02049	364	bacterial_SERPIN SERine Proteinase INhibitors (ser	100.0
cd02055	365	PZI Protein Z-dependent protease inhibitor (ZPI) i	100.0
smart00093	359	SERPIN SERine Proteinase INhibitors.	100.0
PF00079	371	Serpin: Serpin (serine protease inhibitor); InterP	100.0
cd02047	436	HCII Heparin cofactor II (HCII) inhibits thrombin,	100.0
cd02043	381	plant_SERPIN SERine Proteinase INhibitors (serpins	100.0
PHA02948	373	serine protease inhibitor-like protein; Provisiona	100.0
cd02053	351	alpha2AP Alpha2-antiplasmin (alpha2AP) is the prim	100.0
cd02050	352	C1_inh C1 inhibitor (C1-Inh) is a protease inhibit	100.0
PHA02660	364	serpin-like protein; Provisional	100.0

>cd02057 maspin_like Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages

Probab=100.00  E-value=1.5e-48  Score=383.20  Aligned_cols=220  Identities=26%  Similarity=0.482  Sum_probs=204.1

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++...  +     
T Consensus         7 ~F~~~l~~-----------------~~~~~~~~~Nvv~SP~si~~aL~ml~~Ga~g~T~~el~~~L~~~~~~--~-----   62 (372)
T cd02057           7 AFAVDLFK-----------------KLCEKEPTGNVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFENVK--D-----   62 (372)
T ss_pred             HHHHHHHH-----------------HHhccCCCCcEEECHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCChh--H-----
Confidence            89999999                 88765 78999999999999999999999999999999999997433  3     


Q ss_pred             hhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchhhhcccC
Q psy2651         167 IIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDWVSNHTN  242 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~WV~~~T~  242 (342)
                          ++..++.+...+.+..   .++++|++|++++++++++|.+.++++|+++++.+||.+. ..+++.||+||+++|+
T Consensus        63 ----~~~~~~~~~~~~~~~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~  138 (372)
T cd02057          63 ----VPFGFQTVTSDVSKLSSFYSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKELTD  138 (372)
T ss_pred             ----HHHHHHHHHHHHhcCCccchhHhhhhhhhhCCCCccHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhcc
Confidence                6777888877765432   7999999999999999999999999999999999999765 5688999999999999


Q ss_pred             CccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEe
Q psy2651         243 DKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELP  322 (342)
Q Consensus       243 g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELP  322 (342)
                      |+|++++++++++++|+++|+||+||||.|+++|++..|++++||.++|+.++||||++.+. |+|+++++++++|||||
T Consensus       139 g~I~~l~~~~~i~~~t~l~lvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~vv~LP  217 (372)
T cd02057         139 GHFENILNENSVNDQTKILVVNAAYFVGNWMKKFPESETKECPFRVNKTETKPVQMMNLEAT-FSMGYIDELNTKILELP  217 (372)
T ss_pred             ChhhhcCCCCCCCCCCceeeeehheeccccCCCCCccccccCCCEECCCceEeeEhhheece-EEeEEeCCcCceEEEee
Confidence            99999999889999999999999999999999999999999999999999999999999998 99999999999999999


Q ss_pred             C-CCcEEEEEeecCCCCC
Q psy2651         323 Y-GVSISFIIKSQVVPEM  339 (342)
Q Consensus       323 Y-~~~~SMlI~~~ILP~~  339 (342)
                      | ++++||+|   |||++
T Consensus       218 y~~~~~sm~i---iLP~~  232 (372)
T cd02057         218 FQNKHLSMLI---LLPKD  232 (372)
T ss_pred             cCCCCEEEEE---EecCc
Confidence            9 99999999   89985

Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>cd02048 neuroserpin Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA)

Probab=100.00  E-value=7.6e-49  Score=387.21  Aligned_cols=226  Identities=32%  Similarity=0.562  Sum_probs=208.0

Q ss_pred             cccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchh
Q psy2651          84 ILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLK  162 (342)
Q Consensus        84 ~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~  162 (342)
                      +++ +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++.....+ 
T Consensus         3 ~~~-~Fa~~l~~-----------------~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~-   63 (388)
T cd02048           3 AIA-ELSVDLYN-----------------ALRASKEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGE-   63 (388)
T ss_pred             hhh-HHHHHHHH-----------------HhhccCCCCcEEEChHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCCChHH-
Confidence            445 89999999                 88776 78999999999999999999999999999999999998654323 


Q ss_pred             cccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhc
Q psy2651         163 DYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN  239 (342)
Q Consensus       163 ~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~  239 (342)
                              ....++++...+...+   .++++|++|++++++++++|.+.++++|+++++.+||.++..+++.||+||++
T Consensus        64 --------~~~~~~~~~~~~~~~~~~~~l~~an~i~v~~~~~l~~~f~~~~~~~f~~~~~~vdF~~~~~~~~~IN~wv~~  135 (388)
T cd02048          64 --------EFSFLKDLSSMITAKEKEYVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQVKAVAEHINKWVEN  135 (388)
T ss_pred             --------HHHHHHHHHHHhccCCCccchHHhhhhHhhcCCCccHHHHHHHHHHhcCeeEEECCCChHHHHHHHHHHHHH
Confidence                    5566777777664432   89999999999999999999999999999999999999988889999999999


Q ss_pred             ccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC------
Q psy2651         240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE------  313 (342)
Q Consensus       240 ~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~------  313 (342)
                      +|+|+|++++++.+++++|+++|+||+||||.|+++|++..|+..+||..+|++++||||++.+. |+|+++++      
T Consensus       136 ~T~g~I~~l~~~~~l~~~t~lvlvNai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~-~~y~~~~~~~~~~~  214 (388)
T cd02048         136 HTNNKIKDMFSSRDFTPLTRLVLVNALYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGE-FYYGEFSDGSNEAG  214 (388)
T ss_pred             hccCchhhcCCCccCCHHHHHHhhheEEEeeeccCCCCHHHCeeccEEECCCceEEeehhcccCc-EEEEeccccccccc
Confidence            99999999999889999999999999999999999999999999999999999999999999998 99999887      


Q ss_pred             CCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         314 DGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       314 l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ++++|||||| ++++||+|   |||+++
T Consensus       215 ~~~~vv~LPy~~~~~sm~i---iLP~~~  239 (388)
T cd02048         215 GIYQVLELPYEGDEISLMI---ILSRQE  239 (388)
T ss_pred             cCcEEEEEecCCCceEEEE---EccCCC
Confidence            8899999999 99999999   899975

It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily.

>cd00172 SERPIN SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms

Probab=100.00  E-value=1.9e-48  Score=380.48  Aligned_cols=223  Identities=39%  Similarity=0.703  Sum_probs=209.3

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++..+..+     
T Consensus         4 ~Fa~~l~~-----------------~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~-----   61 (364)
T cd00172           4 DFALDLYK-----------------QLAKSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDDED-----   61 (364)
T ss_pred             hHHHHHHH-----------------HHhhcCCCCCEEEcHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHH-----
Confidence            89999999                 88776 78999999999999999999999999999999999998522123     


Q ss_pred             hhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccCC
Q psy2651         167 IIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTND  243 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~g  243 (342)
                          ++..++.+++.+.+..   .+.++|++|++++++++++|.+.++++|+++++.+||.+++.+++.||+||+++|+|
T Consensus        62 ----~~~~~~~~~~~l~~~~~~~~l~~an~~~~~~~~~~~~~f~~~~~~~~~~~~~~~dF~~~~~a~~~IN~wv~~~T~g  137 (364)
T cd00172          62 ----VHQAFKSLLSSLKDSEKGVELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFANPEAAAAQINNWVEEKTNG  137 (364)
T ss_pred             ----HHHHHHHHHHHHhCCCCCceeeeehhhhhhCCCchhHHHHHHHHHHhcCeeEEEcCCChHHHHHHHHHHHHhhhcc
Confidence                8889999998886652   899999999999999999999999999999999999999877999999999999999


Q ss_pred             ccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEeC
Q psy2651         244 KIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY  323 (342)
Q Consensus       244 ~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELPY  323 (342)
                      +|++++++++++++|+++|+||+||+|.|+++|++..|..++|+..+|+.++||||++.+. |+|+++++++++||||||
T Consensus       138 ~I~~~~~~~~i~~~t~l~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~l~~~vv~lpy  216 (364)
T cd00172         138 KIKDLLSPDALDPDTRLVLVNAIYFKGKWKTPFDPELTRKRPFYVSEGESVQVPMMYQTGK-FRYAEDEELDAQVLELPY  216 (364)
T ss_pred             cchhhCCCCCCCcccceeeeeheeeeeccCCCCChhhceecccEeCCCcEEEEeCccccCc-EEEEEcCccCcEEEEeec
Confidence            9999999888999999999999999999999999999999999999999999999999998 999999999999999999


Q ss_pred             -CCcEEEEEeecCCCCCC
Q psy2651         324 -GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       324 -~~~~SMlI~~~ILP~~g  340 (342)
                       ++++||+|   |||+++
T Consensus       217 ~~~~~sm~i---ilP~~~  231 (364)
T cd00172         217 KGSDLSMLI---ILPKEV  231 (364)
T ss_pred             CCCceEEEE---EecCCC
Confidence             88999999   899986

Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia.

>COG4826 Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones]

Probab=100.00  E-value=4.9e-49  Score=365.16  Aligned_cols=228  Identities=31%  Similarity=0.515  Sum_probs=209.8

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHS  157 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~  157 (342)
                      ....+.| .|+++||.                 ++++.  +.+|++|||+||+.++||.|.||.|.|++||..+++++.+
T Consensus        37 ~ia~ANN-aF~FdlyS-----------------~~~~~~~~~~Ni~fSPySV~~AmAmcY~GaeGsTkeqmsnvfyfp~n   98 (410)
T COG4826          37 DIAAANN-AFAFDLYS-----------------ELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPIN   98 (410)
T ss_pred             chhhccc-chhHHHHH-----------------HHHhhcccccceeeccHHHHHHHHHHhcccCcchHHHHHhheecccc
Confidence            3445667 99999999                 88866  6889999999999999999999999999999999999966


Q ss_pred             ccchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhh
Q psy2651         158 ETLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEM  233 (342)
Q Consensus       158 ~~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~I  233 (342)
                      . ..         +...++.+...+..++   .|..||++||++++++++.|+..++.+|.+++.++||.+. ..++..|
T Consensus        99 ~-~v---------l~~~~~~~nd~i~sp~~~y~le~AnalWvqedyplke~yv~n~r~yy~aevtnlDF~~~p~~s~dtI  168 (410)
T COG4826          99 K-TV---------LKVREKSLNDKINSPNDSYELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTI  168 (410)
T ss_pred             c-hH---------hhhhHHhhcccccCCccchhhhhhhhHHHhcCCCCCHHHHHHHHhhhhcceeecccccCchHHHHHH
Confidence            5 44         6777777777776655   9999999999999999999999999999999999999764 6688899


Q ss_pred             chhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC
Q psy2651         234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE  313 (342)
Q Consensus       234 N~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~  313 (342)
                      |+||+++|+|+|+++++++.|.++++++|+|||||+|+|...||+..|.++.|+...|..+.|+||++.+. |+|++  .
T Consensus       169 NkWvEekT~gkIkdlVp~~~i~~d~rlvltnAiYFnGkW~~efDk~~t~krtFy~a~~~d~sv~mMs~~g~-fny~e--t  245 (410)
T COG4826         169 NKWVEEKTNGKIKDLVPEDYIGPDTRLVLTNAIYFNGKWWPEFDKQMTGKRTFYPAKGEDKSVDMMSICGD-FNYGE--T  245 (410)
T ss_pred             HHHHHHhhcchHhhcCCccccCCceeEEEEeeEEEcCeeccccchhhccceeeecCChhhhcchhHHhcCC-CCccc--C
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999 99996  6


Q ss_pred             CCeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         314 DGFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       314 l~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      .++++||||| |.++||+|   +||++-+
T Consensus       246 ~kakiveLPy~gd~lSmYI---vLPk~nN  271 (410)
T COG4826         246 SKAKIVELPYKGDDLSMYI---VLPKDNN  271 (410)
T ss_pred             cCceEEEcccCCCceEEEE---EeeCCCC
Confidence            7899999999 99999999   8999764

>cd02044 ov-serpin ovalbumin family of serpins (ov-serpins)

Probab=100.00  E-value=1.9e-48  Score=381.89  Aligned_cols=221  Identities=28%  Similarity=0.543  Sum_probs=207.1

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++...  +     
T Consensus         7 ~F~~~l~~-----------------~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~--~-----   62 (370)
T cd02044           7 AFAVDVFK-----------------ELSKKSALQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHFDNVK--D-----   62 (370)
T ss_pred             HHHHHHHH-----------------HHhhcCCCCcEEECHHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCHH--H-----
Confidence            89999999                 88776 78999999999999999999999999999999999996432  3     


Q ss_pred             hhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchhhhcccC
Q psy2651         167 IIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDWVSNHTN  242 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~WV~~~T~  242 (342)
                          ++..++.++..+.+.+   .++++|++|+++++++.++|.+.++++|+++++.+||.++ ..+++.||+||+++|+
T Consensus        63 ----~~~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~  138 (370)
T cd02044          63 ----VHSSFQTLLSDINKLNSFYSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIKDQTK  138 (370)
T ss_pred             ----HHHHHHHHHHHHhcCCCCceEeeeeehhhcCCCcccHHHHHHHHHhhccceEeccccCCHHHHHHHHHHHHHHhcC
Confidence                8888999988876543   8999999999999999999999999999999999999875 5688899999999999


Q ss_pred             CccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEe
Q psy2651         243 DKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELP  322 (342)
Q Consensus       243 g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELP  322 (342)
                      |+|++++++++++++|.++|+||+||||.|+.+|++..|+..+|+..+|.+++||||++.+. |+|++.+++++++||||
T Consensus       139 g~I~~lv~~~~l~~~t~lvlvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~vv~LP  217 (370)
T cd02044         139 GKIENLLPENSVDSQTAMVVVNAAYFKGKWMKKFSEEETKESPFRVNKTETKPVQMMYMEAT-FNMGNIESLKMKILELP  217 (370)
T ss_pred             CchhhcCCCCCCCcchhheeeeeeeEcccccCCCChhhCccCcCCcCCCcEEEeeCccccCc-eeeEEcCCCCeEEEEcc
Confidence            99999999999999999999999999999999999999999999999999999999999998 99999999999999999


Q ss_pred             C-CCcEEEEEeecCCCCCC
Q psy2651         323 Y-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       323 Y-~~~~SMlI~~~ILP~~g  340 (342)
                      | ++++||+|   |||+++
T Consensus       218 y~~~~~sm~i---iLP~~~  233 (370)
T cd02044         218 FANKDLSMFI---LLPDEV  233 (370)
T ss_pred             cCCCceEEEE---EcCCCC
Confidence            9 88999999   899986

Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia.

>cd02054 angiotensinogen Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis

Probab=100.00  E-value=6.5e-48  Score=378.75  Aligned_cols=227  Identities=22%  Similarity=0.375  Sum_probs=198.4

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++++. +++|+|+||+||+.+|+|++.||+|+|++||.++||++...... .+..
T Consensus         8 ~f~~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~-~~~~   69 (372)
T cd02054           8 VLGLRMYG-----------------MLSELWVHTNTLLSPTSVFGTLASLYLGASKKTADSLQALLGLPWKSKNS-DCTS   69 (372)
T ss_pred             HHHHHHHH-----------------HHHhhCCCCCEEEChHHHHHHHHHHHcCCCccHHHHHHHHhCCCcccccc-cccc
Confidence            89999999                 88766 78899999999999999999999999999999999997543110 0000


Q ss_pred             --hhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccc-cEEecCCCcHHHHHhhchhhhcc
Q psy2651         167 --IIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSE-LGKVDFSQPPAAAKEMNDWVSNH  240 (342)
Q Consensus       167 --~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~-v~~vdF~~~~~a~~~IN~WV~~~  240 (342)
                        ....+...++.+...+...+   .+..+|++|++++++++++|++.++++|+++ ++.+||.+++.+++.||+||+++
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~~i~~~~~~~l~~~f~~~~~~~y~a~~~~~vdF~~~~~a~~~IN~WV~~~  149 (372)
T cd02054          70 RVDGHKVLSTLQAIQSLVDAQGRQLLLSTVVWTFTAPGIHLSQPFVQGLADFSDASFPRSVDFTEPDVAEEKINNFVQAT  149 (372)
T ss_pred             cccHHHHHHHHHHHHHHHcCCCCccEEEEEEEEEecCCCCccHHHHHHHHHHhCcccceeecCCChHHHHHHHHHHHHHH
Confidence              01125667777766665443   7889999999999999999999999999997 99999998887889999999999


Q ss_pred             cCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEE
Q psy2651         241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLE  320 (342)
Q Consensus       241 T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLE  320 (342)
                      |+|+|++++.  +++++|+++|+||+||||.|+++|+++.|+  +|+..+|..++||||++.+. |+|+++++++++|||
T Consensus       150 T~g~I~~ll~--~~~~~t~lvLvNaiyFkg~W~~~F~~~~T~--~f~~~~~~~~~V~mM~~~~~-~~y~~~~~~~~~vle  224 (372)
T cd02054         150 SDGKVKSSLK--GLSPDSDLLFATSVHFQGNWKTASQLEEPQ--EFWVDNNTSVSVPMLSHTGT-FKYLSDIQDNFSITQ  224 (372)
T ss_pred             hcCchhhhcc--CCCCCCeEEEEEEEEEEHhhcCCCCcccce--eEEeCCCCEEEEeeeeccCc-EEEEEecCCCcEEEE
Confidence            9999999996  688999999999999999999999999997  69999999999999999998 999999999999999


Q ss_pred             EeCCCcEEEEEeecCCCCCC
Q psy2651         321 LPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       321 LPY~~~~SMlI~~~ILP~~g  340 (342)
                      |||++++||+|   |||+++
T Consensus       225 LPy~~~~sm~i---iLP~~~  241 (372)
T cd02054         225 LPLSKRACLLL---VQPHEG  241 (372)
T ss_pred             EeeCCCeEEEE---EeCCCC
Confidence            99944699999   899975

It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>cd02046 hsp47 Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen

Probab=100.00  E-value=3.1e-48  Score=380.27  Aligned_cols=221  Identities=23%  Similarity=0.428  Sum_probs=204.3

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+|+||+||+.+|+|++.||+|+|++||.++||++.....+     
T Consensus         9 ~f~~~l~~-----------------~~~~~~~~~N~v~SP~si~~aLa~l~~Ga~g~T~~ql~~~L~~~~~~~~~-----   66 (366)
T cd02046           9 GLAFNLYH-----------------AMAKDKGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLSADKLKDEH-----   66 (366)
T ss_pred             HHHHHHHH-----------------HhhccCCCCeEEEChHHHHHHHHHHHhhcCccHHHHHHHHhCCCCCCcHH-----
Confidence            89999999                 88776 78899999999999999999999999999999999986433223     


Q ss_pred             hhHHHHHHHHHHHHHhCCC---c-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccC
Q psy2651         167 IIDQLSKDYKGIIDQLSKS---P-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTN  242 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~---~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~  242 (342)
                          ++..++++...+...   + .+.++|++|+++++.++++|.+.++++|+++++.+||.++..+++.||+||+++|+
T Consensus        67 ----~~~~~~~l~~~l~~~~~~~~~l~~an~~~~~~~~~l~~~F~~~~~~~y~~~~~~vdF~~~~~a~~~IN~wv~~~T~  142 (366)
T cd02046          67 ----VHTGLSELLNEVSNSTARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRDKRSALNSINEWAAQTTD  142 (366)
T ss_pred             ----HHHHHHHHHHHhhcCCCCCcEEEEeeehhhcCCCChhHHHHHHHHHHhcCeeEEecCCChHHHHHHHHHHHHHhcC
Confidence                788888888776432   2 79999999999999999999999999999999999999988888999999999999


Q ss_pred             CccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEe
Q psy2651         243 DKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELP  322 (342)
Q Consensus       243 g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELP  322 (342)
                      |+|++++.  +++++|+++|+||+||||.|+.+|++..|+.++||..+|+.++||||++.+. ++|+++++++++|||||
T Consensus       143 g~I~~~~~--~i~~~t~l~lvnaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-~~y~~~~~~~~~vl~LP  219 (366)
T cd02046         143 GKLPEVTK--DVEKTDGALIVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVSVPMMHRTGL-YGYYDDEENKLQIVEMP  219 (366)
T ss_pred             CchhHhhc--cCCcchHhhhhheEEEcchhcCCCCHHhceeccEEeCCCeEEEhhHhhccCc-eeeEEeCCCCeEEEEEE
Confidence            99999985  7899999999999999999999999999999999999999999999999998 99999989999999999


Q ss_pred             C-CCcEEEEEeecCCCCCC
Q psy2651         323 Y-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       323 Y-~~~~SMlI~~~ILP~~g  340 (342)
                      | ++++||+|   |||+++
T Consensus       220 y~~~~~sm~i---iLP~~~  235 (366)
T cd02046         220 LAHKLSSMIF---IMPYHV  235 (366)
T ss_pred             cCCCcEEEEE---EecCCC
Confidence            9 89999999   899986

It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H.

>cd02059 ovalbumin_like The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily

Probab=100.00  E-value=1e-47  Score=379.19  Aligned_cols=234  Identities=34%  Similarity=0.555  Sum_probs=208.7

Q ss_pred             cccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchh
Q psy2651          84 ILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLK  162 (342)
Q Consensus        84 ~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~  162 (342)
                      +.+ +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++.......
T Consensus         4 ~~~-~Fa~~l~~-----------------~~~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~   65 (389)
T cd02059           4 ANT-EFCFDLFK-----------------ELKKNHKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGS   65 (389)
T ss_pred             hhh-HHHHHHHH-----------------HHhhcCCCCCEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCccccccc
Confidence            345 99999999                 88776 789999999999999999999999999999999999975321000


Q ss_pred             -------cccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcH-HHHH
Q psy2651         163 -------DYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-AAAK  231 (342)
Q Consensus       163 -------~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~-~a~~  231 (342)
                             .|+ ....++..|+.++..+.+.+   .++++|+||++++++++++|.+.++++|+++++.+||.++. .+++
T Consensus        66 ~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~~~~  144 (389)
T cd02059          66 SKPAASAQCN-QSGGVHSQFKDLLSQINKPNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAAEASRK  144 (389)
T ss_pred             cccccccccc-cHHHHHHHHHHHHHHHcCCCCCcEEEEeeehhhhCCCCccHHHHHHHHHHhcCeeEEEcCCCCHHHHHH
Confidence                   000 01127888999988875433   79999999999999999999999999999999999998864 5778


Q ss_pred             hhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEe
Q psy2651         232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEA  311 (342)
Q Consensus       232 ~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~  311 (342)
                      .||+||+++|+|+|++++++++++++|+++|+||+||+|.|+.+|++..|+.++|+..+|++++||||++.+. |+|+++
T Consensus       145 ~IN~wv~~~T~g~I~~~~~~~~i~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~-~~~~~~  223 (389)
T cd02059         145 KINSWVESQTNGKIKNLFGKGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPFKLNENENKPVQMMYQIGK-FKLASI  223 (389)
T ss_pred             HHHHHHHHhccchhhhcCCCCCCCcccceeeEeeeEEeeeccCCCCcccCccCccEeCCCceEEeehhcccCc-EEEEEe
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998 999999


Q ss_pred             CCCCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         312 GEDGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       312 ~~l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ++++++|||||| ++++||+|   |||+++
T Consensus       224 ~~~~~~vl~LPy~~~~~sm~i---iLP~~~  250 (389)
T cd02059         224 EEPKMKILELPYAGGGLSMIV---LLPDEI  250 (389)
T ss_pred             CCCCcEEEEeecCCCceEEEE---EccCCC
Confidence            999999999999 88999999   899985

Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin.

>cd02058 PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2)

Probab=100.00  E-value=5.1e-48  Score=380.12  Aligned_cols=227  Identities=32%  Similarity=0.532  Sum_probs=208.6

Q ss_pred             ccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhc
Q psy2651          85 LDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKD  163 (342)
Q Consensus        85 ~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~  163 (342)
                      .+ +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++......  
T Consensus         5 ~~-~F~~~l~~-----------------~~~~~~~~~N~v~SP~si~~aL~~l~~GA~g~T~~el~~~L~~~~~~~~~--   64 (380)
T cd02058           5 NT-SFALNLFK-----------------KLAESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNS--   64 (380)
T ss_pred             hh-HHHHHHHH-----------------HHhhcCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCcCccccch--
Confidence            45 99999999                 88776 78999999999999999999999999999999999997653101  


Q ss_pred             ccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchhhhc
Q psy2651         164 YKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDWVSN  239 (342)
Q Consensus       164 ~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~WV~~  239 (342)
                           +.++..|+.++..+.+++   .++++|+||++++++++++|.+.++++|+++++.+||.++ ..+++.||+||++
T Consensus        65 -----~~~~~~~~~l~~~~~~~~~~~~l~~~n~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~  139 (380)
T cd02058          65 -----EDIHSGFQSLLSEINKPGTNYLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEAAEQARKEINSWVER  139 (380)
T ss_pred             -----HHHHHHHHHHHHHHhCCCCccEeehhhhhhhcCCCcHhHHHHHHHHhhhcCceEEecCCCCHHHHHHHHHHHHHH
Confidence                 128888999988876543   7999999999999999999999999999999999999764 5688999999999


Q ss_pred             ccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEE
Q psy2651         240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKML  319 (342)
Q Consensus       240 ~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vL  319 (342)
                      +|+|+|++++++++++++|+++|+||+||+|.|+.+|+++.|..++|+..+|.+++||||++.+. |+|++.+++++++|
T Consensus       140 ~T~g~I~~~~~~~~i~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~vv  218 (380)
T cd02058         140 QTEGKIQNLLPPGSVDSLTRLVLVNAIYFKGNWEEKFLKENTRERPFRLNKNTTKPVQMMFLKKK-FPITYIEELKAQVL  218 (380)
T ss_pred             hcccchhhcCCcCCCChhHHhHhhheeEEccccCCCCCcccCCcccccCCCCceEEeechhhcCc-eeeEEcCCCCcEEE
Confidence            99999999999889999999999999999999999999999999999999999999999999998 99999999999999


Q ss_pred             EEeC-CCcEEEEEeecCCCCCC
Q psy2651         320 ELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       320 ELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      |||| ++++||+|   |||+++
T Consensus       219 ~LPy~~~~~sm~i---iLP~~~  237 (380)
T cd02058         219 ELPYVGKELSMFI---LLPDEI  237 (380)
T ss_pred             EccCCCCceEEEE---Eecccc
Confidence            9999 99999999   899975

PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration.

>cd02056 alpha-1-antitrypsin_like alpha-1-antitrypsin_like

Probab=100.00  E-value=8.8e-48  Score=375.88  Aligned_cols=224  Identities=30%  Similarity=0.567  Sum_probs=205.8

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+|+||+||+.+|+|++.||+|+|++||.++||++..+...+    
T Consensus         4 ~F~~~l~~-----------------~~~~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~----   62 (361)
T cd02056           4 DFAFRLYR-----------------QLASESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEE----   62 (361)
T ss_pred             HHHHHHHH-----------------HHhhcCCCCcEEEChHHHHHHHHHHHCccchhHHHHHHHHhcCCccCCCHH----
Confidence            89999999                 88776 789999999999999999999999999999999999975542211    


Q ss_pred             hhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccCC
Q psy2651         167 IIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTND  243 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~g  243 (342)
                         .++..++++...+.+..   .+.++|+||++++++++++|.+.++++|+++++.+||.++.++++.||+||+++|+|
T Consensus        63 ---~~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~~dF~~~~~~~~~IN~wv~~~T~g  139 (361)
T cd02056          63 ---EIHQGFQHLLHLLNQPDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQDSAEAKKQINDYVEKKTHG  139 (361)
T ss_pred             ---HHHHHHHHHHHHHcCCCCcceEEeeeehhhhCCCChhHHHHHHHHHHhcCceEeeCCCChHHHHHHHHHHHHHHhhh
Confidence               28888999998886543   799999999999999999999999999999999999998888999999999999999


Q ss_pred             ccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEeC
Q psy2651         244 KIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY  323 (342)
Q Consensus       244 ~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELPY  323 (342)
                      +|+++++  +++++|+++|+||+||+|.|+.+|++..|+.++|+..+|+.++||||++.+. |+|++++++++++|||||
T Consensus       140 ~I~~~~~--~i~~~t~lvlvna~~Fk~~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~l~~~~veLPy  216 (361)
T cd02056         140 KIVDLVK--DLDSDTVMVLVNYIYFKGKWEKPFDPELTQEEDFFVDEKTTVKVPMMHQTGR-YDYLHDSELSCTVVQMPY  216 (361)
T ss_pred             hHHhhcC--CCCCCceEEEEEEEeeeehccCCCCcccCcccCCEeCCCcEEEeecccccCc-EeeEEcCCCCcEEEEEec
Confidence            9999996  7999999999999999999999999999999999999999999999999998 999999999999999999


Q ss_pred             CCcEEEEEeecCCCCCCC
Q psy2651         324 GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       324 ~~~~SMlI~~~ILP~~g~  341 (342)
                      ++++||+|   |||+++.
T Consensus       217 ~~~~sm~i---iLP~~~~  231 (361)
T cd02056         217 KGNATAFF---VLPDEGK  231 (361)
T ss_pred             CCCcEEEE---EecCcch
Confidence            33589999   8999863

This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia.

>cd02045 antithrombin-III_like Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation

Probab=100.00  E-value=9.7e-48  Score=378.60  Aligned_cols=230  Identities=30%  Similarity=0.526  Sum_probs=205.0

Q ss_pred             ccccccccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          83 SILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        83 ~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      ...+ +||++||+                 ++...  +++|+|+||+||+.+|+||+.||+|+|++||.++||++.....
T Consensus         7 ~~~~-~Fa~~l~~-----------------~l~~~~~~~~Niv~SP~si~~aL~ml~~GA~g~T~~el~~~L~~~~~~~~   68 (381)
T cd02045           7 KANS-RFALAFYK-----------------HLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEK   68 (381)
T ss_pred             hhhh-HHHHHHHH-----------------HHhcccCCCCCEEECcHHHHHHHHHHhhhcCCcHHHHHHHHhCCCccccc
Confidence            3445 99999999                 88754  6789999999999999999999999999999999999642100


Q ss_pred             hhcccchhHHHHHHHHHHHHHhC-C--Cc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhch
Q psy2651         161 LKDYKGIIDQLSKDYKGIIDQLS-K--SP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMND  235 (342)
Q Consensus       161 ~~~~~~~~~~v~~~~~~l~~~l~-~--~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~  235 (342)
                      .      .+.++..++.+...+. .  .+ .+.++|++|++++++++++|.+.++++|+++++.+||.++ ..++..||+
T Consensus        69 ~------~~~~~~~~~~l~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~~~~~~vdF~~~~~~~~~~IN~  142 (381)
T cd02045          69 T------SDQVHFFFAKLNCRLYRKANKSSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKPELSRITINE  142 (381)
T ss_pred             c------HHHHHHHHHHHHHHHhcccCCcchhhhhhhhhhcCCCchhHHHHHHHHHhhcCeeEEecCCCCHHHHHHHHHH
Confidence            0      0127777888776662 2  22 8999999999999999999999999999999999999754 557789999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|++++++++++++|+++|+||+||||.|+.+|++..|+.++||..+|++++||||++.+. |+|+++++++
T Consensus       143 wv~~~T~g~I~~ll~~~~l~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~-~~y~~~~~~~  221 (381)
T cd02045         143 WIANKTENRITDVIPEGAIDTNTVLVLVNAIYFKGLWKSKFDKENTRKDLFHKAPGEKCPVPMMYQESK-FRYAKIPEDK  221 (381)
T ss_pred             HHHHHHhhHHHhhCCCCCCCCccceeeEeeeEEeccccCCCCcccCcccccCcCCCcEEEEeccCccce-eeeEecCCCC
Confidence            999999999999999889999999999999999999999999999999999999999999999999998 9999999999


Q ss_pred             eEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         316 FKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       316 ~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      +++||||| ++++||+|   |||+++
T Consensus       222 ~~~l~LPy~~~~~sm~i---ilP~~~  244 (381)
T cd02045         222 VQVLELPYKGDDITMVL---ILPKEG  244 (381)
T ss_pred             cEEEEeecCCCceEEEE---EeCCCC
Confidence            99999999 99999999   899975

It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily.

>cd02051 PAI-1_nexin-1 Plasminogen activator inhibitor-1_like

Probab=100.00  E-value=1.3e-47  Score=377.13  Aligned_cols=224  Identities=31%  Similarity=0.537  Sum_probs=204.4

Q ss_pred             ccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccch
Q psy2651          83 SILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL  161 (342)
Q Consensus        83 ~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~  161 (342)
                      ...+ +|+++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++...   
T Consensus         9 ~~~~-~F~~~l~~-----------------~~~~~~~~~N~v~SP~si~~~L~~l~~GA~g~T~~el~~~L~~~~~~---   67 (377)
T cd02051           9 ELGS-DFGIQVFN-----------------QVAQARPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKING---   67 (377)
T ss_pred             HHHh-HHHHHHHH-----------------HHHhcCCCCcEEECcHHHHHHHHHHHhhcCCcHHHHHHHHhCCChhH---
Confidence            3445 99999999                 88776 88999999999999999999999999999999999997533   


Q ss_pred             hcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhh
Q psy2651         162 KDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS  238 (342)
Q Consensus       162 ~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~  238 (342)
                               +...++.+.+.+....   .+.++|++|++++++++++|.+.++++|+++++.+||.+++.+++.||+||+
T Consensus        68 ---------~~~~~~~l~~~l~~~~~~~~l~~an~i~~~~~~~l~~~f~~~~~~~f~a~~~~vdF~~~~~a~~~IN~Wv~  138 (377)
T cd02051          68 ---------VAKALKKLNKAIVSKKNKDIVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSDPETAAFSINDWVK  138 (377)
T ss_pred             ---------HHHHHHHHHHHHhccCCccchHHHHHHHhcCCCchhHHHHHHHHHHhcCeeEEECCCCHHHHHHHHHHHHH
Confidence                     6677777777764332   8999999999999999999999999999999999999988889999999999


Q ss_pred             cccCCccccCCCCC-CCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC---C
Q psy2651         239 NHTNDKIKDLIKAD-SLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE---D  314 (342)
Q Consensus       239 ~~T~g~I~~ll~~~-~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~---l  314 (342)
                      ++|+|+|++++++. .++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. |+|++.++   +
T Consensus       139 ~~T~g~I~~~l~~~~~i~~~t~l~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~  217 (377)
T cd02051         139 NETKGMIDNLLSPDLADDALTRLVLVNALYFKGLWKSRFQPESTKKRTFHAGDGKTYQVPMLAQLSV-FRSGSASTPNGL  217 (377)
T ss_pred             HhcCCCccccCCCCCCCCccceEEEEeeeEeeeeecCCCChhhCcccccCcCCCcEEeehhhcccCc-eeeEeecccccc
Confidence            99999999999877 7889999999999999999999999999999999999999999999999998 99998753   4


Q ss_pred             CeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         315 GFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       315 ~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      +++|||||| ++++||+|   |||+++
T Consensus       218 ~~~vv~LPy~~~~~sm~i---iLP~~~  241 (377)
T cd02051         218 WYNIIELPYHGESISMLI---ALPTEK  241 (377)
T ss_pred             ccEEEEEecCCCeEEEEE---Eecccc
Confidence            589999999 99999999   899864

Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>KOG2392|consensus

Probab=100.00  E-value=2.1e-47  Score=375.75  Aligned_cols=225  Identities=37%  Similarity=0.645  Sum_probs=209.0

Q ss_pred             ccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCccc-chhcc
Q psy2651          87 QRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET-LLKDY  164 (342)
Q Consensus        87 ~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~-~~~~~  164 (342)
                      .+|+++||+                 .++.. +++|+||||+||+.+|+|+++||+|+|++||+++|+++..+. .+   
T Consensus        12 ~~f~~~l~~-----------------~~~~~~~~~Ni~fSP~SI~~aL~m~~lGa~g~T~~qi~~~L~~~~~~~~~~---   71 (380)
T KOG2392|consen   12 ADFALDLYR-----------------QLAKSAPDENVVFSPLSISSALAMVSLGAKGETADQILKALHFNSTDEENE---   71 (380)
T ss_pred             hHHHHHHHH-----------------HHHhhCCCCCEEEChHHHHHHHHHHHhcCCccHHHHHHHHhCCCCCcchHH---
Confidence            389999999                 88866 899999999999999999999999999999999999997652 22   


Q ss_pred             cchhHHHHHHHHHHHHHhCCC--c-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCC-CcHHHHHhhchhhhcc
Q psy2651         165 KGIIDQLSKDYKGIIDQLSKS--P-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFS-QPPAAAKEMNDWVSNH  240 (342)
Q Consensus       165 ~~~~~~v~~~~~~l~~~l~~~--~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~-~~~~a~~~IN~WV~~~  240 (342)
                            ++..++.++..+...  + .++++|++|+++++.+.++|.+.++++|+++++++||. +++++++.||+||+++
T Consensus        72 ------~~~~~~~~~~~~~~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~~dF~~~~e~~~~~IN~wv~~~  145 (380)
T KOG2392|consen   72 ------VHESFQSLLLLLNSTESGYELKLANRLFVSKSLKLLQKFLELVKKLYKAEAESLDFSNDTEEAAKEINEWVEEH  145 (380)
T ss_pred             ------HHHHHHHHHHHhccccCCceEEEeeeheecCCccccHHHHHHHHHHHhCcceeecCccChHHHHHHHHHHHHHH
Confidence                  888888877533222  2 89999999999999999999999999999999999999 6788999999999999


Q ss_pred             cCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEE
Q psy2651         241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLE  320 (342)
Q Consensus       241 T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLE  320 (342)
                      |+|+|+++++++++++.|.++|+|||||||.|+++|+++.|+..+|+.++++.++||||++.+. |+|+++.++.++++|
T Consensus       146 T~gkI~~ll~~~~~~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~VpmM~~~~~-f~~~~~~~l~~~vl~  224 (380)
T KOG2392|consen  146 TNGKIKDLLSPDSIDSLTVLVLVNAIYFKGKWEKKFDKELTKESDFFLSEGTSVKVPMMHQEGS-FRYAEDEDLFAVVLE  224 (380)
T ss_pred             cCCchhhhcCCCCCCcchhheeeehheeehhhcCCCChhhccccccEECCCeEEEeechhccCc-cceEEeCCcceEEEE
Confidence            9999999999999999999999999999999999999999999999999999999999999999 999999999999999


Q ss_pred             EeC-CCcEEEEEeecCCCCCCC
Q psy2651         321 LPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       321 LPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ||| +.++||+|   |||+++.
T Consensus       225 LpY~~~~~sm~i---~LP~~~~  243 (380)
T KOG2392|consen  225 LPYKGSNLSMLI---LLPDERD  243 (380)
T ss_pred             CccCCCCeEEEE---EeCCCCC
Confidence            999 99999999   8999853

>cd02052 PEDF Pigment epithelium-derived factor (PEDF)_like

Probab=100.00  E-value=5.9e-47  Score=372.18  Aligned_cols=218  Identities=24%  Similarity=0.423  Sum_probs=200.9

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+++||+||+.+|+||+.||+|+|++||.++||++.....+     
T Consensus        21 ~Fa~~l~~-----------------~l~~~~~~~Nvv~SP~si~~~L~ml~~GA~g~T~~ql~~~L~~~~~~~~~-----   78 (374)
T cd02052          21 NFGYDLYR-----------------QQASRDPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLLNDPE-----   78 (374)
T ss_pred             HHHHHHHH-----------------HHhccCCCCcEEEChHHHHHHHHHHHhccChHHHHHHHHHhCCCCCChHH-----
Confidence            89999999                 88766 78999999999999999999999999999999999986543223     


Q ss_pred             hhHHHHHHHHHHHHHhCCCc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccCCcc
Q psy2651         167 IIDQLSKDYKGIIDQLSKSP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKI  245 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~g~I  245 (342)
                          ++..++.++..+..++ .++++|++|++++++++++|.+.++++|+++++.+||..  ++++.||+||+++|+|+|
T Consensus        79 ----~~~~~~~l~~~l~~~~~~l~~an~i~v~~~~~l~~~f~~~~~~~~~~~~~~~~~~~--~~~~~IN~wv~~~T~g~I  152 (374)
T cd02052          79 ----LHDTYKDLLASLTAPAKGLKSASRILLERKLRLRLEFVNQVEKSYGERPRILAGNA--LDLQEINDWVQQQTGGKV  152 (374)
T ss_pred             ----HHHHHHHHHHHhcCCCccchhhhHHHHhCCCchhHHHHHHHHHHhhCccccccCCH--HHHHHHHHHHHHhhcCcH
Confidence                8889999999887655 899999999999999999999999999999999999854  588899999999999999


Q ss_pred             ccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeec-ceeeeEEEeCCCCeEEEEEeC-
Q psy2651         246 KDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVK-DSFYMYEEAGEDGFKMLELPY-  323 (342)
Q Consensus       246 ~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~-~~~f~y~~~~~l~~~vLELPY-  323 (342)
                      +++++  +++++|+++|+||+||||.|+.+|++..|+.++||.++|++++||||++. +. ++|+++++++++|||||| 
T Consensus       153 ~~~l~--~i~~~t~l~lvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-~~y~~~~~~~~~vveLPy~  229 (374)
T cd02052         153 DRFVK--EIPRNVSILLLGSAYFKGQWITKFDKRNTVLTDFHLDEQRTVVVPMMSDPNAP-VRYGLDSDLNCKIAQLPLT  229 (374)
T ss_pred             HHhCC--CCCCccceEEEeeEEEechhcCCCCcccCccccEEcCCCcEEEEEeeccCCcc-eeeEEcCCCCcEEEEEecC
Confidence            99997  49999999999999999999999999999999999999999999999985 46 999999999999999999 


Q ss_pred             CCcEEEEEeecCCCCCC
Q psy2651         324 GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       324 ~~~~SMlI~~~ILP~~g  340 (342)
                      + ++||+|   |||++.
T Consensus       230 ~-~~sm~i---iLP~~~  242 (374)
T cd02052         230 G-GVSIMF---FLPDKV  242 (374)
T ss_pred             C-CeEEEE---EecCCC
Confidence            6 699999   899874

PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily.

>cd02049 bacterial_SERPIN SERine Proteinase INhibitors (serpins), prokaryotic subgroup

Probab=100.00  E-value=5.4e-47  Score=370.86  Aligned_cols=220  Identities=33%  Similarity=0.607  Sum_probs=202.4

Q ss_pred             ccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhc
Q psy2651          85 LDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKD  163 (342)
Q Consensus        85 ~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~  163 (342)
                      .+ +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++..+..+  
T Consensus         5 ~~-~F~~~l~~-----------------~~~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~ql~~~L~~~~~~~~~--   64 (364)
T cd02049           5 NT-RFGFKLFS-----------------ELNKEDVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALGLDNIDLED--   64 (364)
T ss_pred             hh-HHHHHHHH-----------------HHhhcCCCCCEEECHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHH--
Confidence            45 99999999                 88776 78999999999999999999999999999999999998644233  


Q ss_pred             ccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcc
Q psy2651         164 YKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH  240 (342)
Q Consensus       164 ~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~  240 (342)
                             ++..++.+...+.+.+   .+.++|++|++++++++++|.+.++++|+++++.+||.++ .++++||+||+++
T Consensus        65 -------~~~~~~~l~~~l~~~~~~~~l~~an~i~~~~~~~~~~~f~~~~~~~~~~~v~~~dF~~~-~a~~~IN~wv~~~  136 (364)
T cd02049          65 -------LNSALATLMDQLNTHDKTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDFQSP-AAAEEINRWVKEK  136 (364)
T ss_pred             -------HHHHHHHHHHHHhcCCCCcEEEeehhhHhhCCCCccHHHHHHHHHhhcccceeeCCCCH-HHHHHHHHHHHHh
Confidence                   8888888888876542   8999999999999999999999999999999999999986 4889999999999


Q ss_pred             cCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEE
Q psy2651         241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLE  320 (342)
Q Consensus       241 T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLE  320 (342)
                      |+|+|++++.  .++++|+++|+||+||+|.|+++|++..|++++|+..+|+.++||||++.+. |+|++.+  ++++||
T Consensus       137 T~g~I~~~~~--~i~~~t~lvlvna~~fk~~W~~~F~~~~T~~~~F~~~~~~~~~v~mM~~~~~-~~y~~~~--~~~~l~  211 (364)
T cd02049         137 TKGKIDKIVD--KIDPDDVMFLINAVYFKGDWQEPFDKQSTYEAPFYLPDGSTKEVPFMSRTGN-FRYLETP--GFQAVR  211 (364)
T ss_pred             hcChHHHhcC--CCCCCceEEEEeeEEEeeeecCCCChhhcccCcCCCCCCCEEECcccCCcCc-EeeEEcC--CCeEEE
Confidence            9999999997  4999999999999999999999999999999999999999999999999998 9998854  578999


Q ss_pred             EeC-CCcEEEEEeecCCCCCC
Q psy2651         321 LPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       321 LPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ||| ++++||+|   |||+++
T Consensus       212 Lpy~~~~~sm~i---iLP~~~  229 (364)
T cd02049         212 LPYGDGRLSMYV---FLPKEN  229 (364)
T ss_pred             eecCCCcEEEEE---EecCCC
Confidence            999 89999999   899985

Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors.

>cd02055 PZI Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10)

Probab=100.00  E-value=5.6e-47  Score=371.27  Aligned_cols=230  Identities=27%  Similarity=0.457  Sum_probs=201.0

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhccCCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      |++..+ +||++||+                 ++...+++|+|+||+||+.+|+|+++||+|+|++||.++||++.....
T Consensus         2 ~~~~~~-~Fa~~l~~-----------------~~~~~~~~Nvv~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~   63 (365)
T cd02055           2 FAEETA-NFGFNLLR-----------------KIAMKHDGNIIFSPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDR   63 (365)
T ss_pred             cchhhh-HHHHHHHH-----------------HHhcCCCCcEEEChHHHHHHHHHHHhhcCchHHHHHHHHcCCCCCccc
Confidence            445566 99999999                 876556789999999999999999999999999999999999753210


Q ss_pred             hhcccchhHHHHHHHHHHHHHhCCCcc--hhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhh
Q psy2651         161 LKDYKGIIDQLSKDYKGIIDQLSKSPE--LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS  238 (342)
Q Consensus       161 ~~~~~~~~~~v~~~~~~l~~~l~~~~~--l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~  238 (342)
                      .      .+.++..++.+.+.+.....  +..++++|++++++++++|.+.++++|+++++.+||.++.++++.||+||+
T Consensus        64 ~------~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~v~~~~~l~~~F~~~~~~~y~~~~~~vdF~~~~~a~~~IN~wv~  137 (365)
T cd02055          64 D------PGLLPALFKGLKDNISRNEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQNASQAKFLINHNIK  137 (365)
T ss_pred             c------HHHHHHHHHHHHHHhcCCcceehHHHHHHHHHCCCCccHHHHHHHHHHhcCeeEEECCCChHHHHHHHHHHHH
Confidence            0      01156677777777654334  444455699999999999999999999999999999988878899999999


Q ss_pred             cccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEE
Q psy2651         239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKM  318 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~v  318 (342)
                      ++|+|+|+++++  +++++|+++|+||+||||.|+.+|++..|..++||.++|+.++||||++.+. |+|+++++++++|
T Consensus       138 ~~T~g~I~~~~~--~i~~~t~l~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~v  214 (365)
T cd02055         138 KETKGKIPELFD--EIDPESKLILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIKVPMMFGADK-FASTFDENFRCHV  214 (365)
T ss_pred             HhhcchHHHHhh--cCCccchhhhhHHHHHHHHHhCCCChhhCccceEEcCCCcEEEehhhcccCc-eeeEEeCCCCeEE
Confidence            999999999996  7899999999999999999999999999999999999999999999999998 9999999999999


Q ss_pred             EEEeCCCcEEEEEeecCCCCCC
Q psy2651         319 LELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       319 LELPY~~~~SMlI~~~ILP~~g  340 (342)
                      |+|||+++.+|+|   |||+++
T Consensus       215 v~LPy~~~~sm~i---iLP~~~  233 (365)
T cd02055         215 IKLPYKGKATMLI---VIMEKG  233 (365)
T ss_pred             EEeeeCCCcEEEE---EEcCCC
Confidence            9999933589999   799975

ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms.

>smart00093 SERPIN SERine Proteinase INhibitors

Probab=100.00  E-value=2.3e-46  Score=365.55  Aligned_cols=215  Identities=37%  Similarity=0.665  Sum_probs=195.7

Q ss_pred             hhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccchhHHHHHHHHHHHHHhCCCc---ch
Q psy2651         113 NLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSP---EL  188 (342)
Q Consensus       113 ~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l  188 (342)
                      ++... +++|+|+||+||+.+|+|++.||+|+|++||.++||++..+....       .++..++.++..+...+   .+
T Consensus         6 ~l~~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~-------~~~~~~~~l~~~l~~~~~~~~l   78 (359)
T smart00093        6 ELAKESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTELSEA-------DIHQGFQHLLQLLNRPDSQLEL   78 (359)
T ss_pred             HHhccCCCCeEEEChHHHHHHHHHHHcccCchHHHHHHHHcCCCCCCCCHH-------HHHHHHHHHHHHHhCCCCcceE
Confidence            77666 788999999999999999999999999999999999986542111       28888999988886543   79


Q ss_pred             hhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeecc
Q psy2651         189 KIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIH  267 (342)
Q Consensus       189 ~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiy  267 (342)
                      .++|++|++++++++++|.+.++++|+++++.+||.++ +.+++.||+||+++|+|+|+++++  +++++|+++|+||+|
T Consensus        79 ~~an~i~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~lvlvnaiy  156 (359)
T smart00093       79 KTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQINDWVEKKTQGKIKDLLS--DLDSDTRLVLVNAIY  156 (359)
T ss_pred             EeeeeehccCCCchhHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhhhchHHHhcc--cCCCCceEEEEeeEE
Confidence            99999999999999999999999999999999999985 569999999999999999999997  489999999999999


Q ss_pred             ccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         268 FKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       268 Fkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      |||.|+.+|++..|.+++|+..+|+.++||||++.+..|+|+++++++++|||||| + ++||+|   |||+++
T Consensus       157 Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~y~~~~~~~~~vv~Lpy~~-~~sm~i---ilP~~~  226 (359)
T smart00093      157 FKGKWKTPFDPELTREEDFHVDETTTVKVPMMSQTGRTFNYGHDEELNCQVLELPYKG-NASMLI---ILPDEG  226 (359)
T ss_pred             EeeECCCCCCcccceecccEeCCCeEEEEeceeccCceeEEEEcCCCCcEEEEEecCC-CeeEEE---EccCcc
Confidence            99999999999999999999999999999999998743899999999999999999 7 799999   899975

>PF00079 Serpin: Serpin (serine protease inhibitor); InterPro: IPR023796 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively

Probab=100.00  E-value=1e-46  Score=368.01  Aligned_cols=224  Identities=40%  Similarity=0.728  Sum_probs=209.5

Q ss_pred             ccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhc
Q psy2651          85 LDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKD  163 (342)
Q Consensus        85 ~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~  163 (342)
                      .+ +||++||+                 .+... +++|+|+||+||+.+|+||+.||+|+|++||.++||++..+..+  
T Consensus         3 ~~-~f~~~L~~-----------------~~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~--   62 (371)
T PF00079_consen    3 NN-QFALKLFK-----------------ALSKSNPDENFVFSPLSIYSALAMLYLGASGETRKELRKVLGLPGSDDEE--   62 (371)
T ss_dssp             HH-HHHHHHHH-----------------HHHHHSTTSSEEE-HHHHHHHHHHHHHTSCHHHHHHHHHHTTCTTSTHHH--
T ss_pred             HH-HHHHHHHH-----------------HHHhhCCCCcEEEChHHHHHHHHHHHhhccCCHHHHHHHHhhhccccccc--
Confidence            35 89999999                 88877 79999999999999999999999999999999999998654334  


Q ss_pred             ccchhHHHHHHHHHHHHHhCC-C--c-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhc
Q psy2651         164 YKGIIDQLSKDYKGIIDQLSK-S--P-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN  239 (342)
Q Consensus       164 ~~~~~~~v~~~~~~l~~~l~~-~--~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~  239 (342)
                             ++..++.++..+.. .  . .+.++|++|++++++++++|.+.++++|+++++.+||.++..+++.||+||++
T Consensus        63 -------~~~~~~~l~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~~~~IN~wv~~  135 (371)
T PF00079_consen   63 -------IHEYFKKLLQSLNSSPSDNPQLKLANKLFVDKNLPLKPEFKKTLKKYFNAEVESVDFSDPPQAAKEINKWVSE  135 (371)
T ss_dssp             -------HHHHHHHHHHHHHSCSTSSSEEEEEEEEEEETTSEBEHHHHHHHHHHHSEEEEEEETTSHHHHHHHHHHHHHH
T ss_pred             -------chhhhhhhhhhhhccccccccceeeeeeecccccccccccchhhhhccccccccccccccchhhhhhcchhhh
Confidence                   88899999998876 2  2 89999999999999999999999999999999999999998899999999999


Q ss_pred             ccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEE
Q psy2651         240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKML  319 (342)
Q Consensus       240 ~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vL  319 (342)
                      +|+|+|++++++++++++|.++|+||+||+|.|+.+|++.+|..++|+..+|+.++||||++.+. ++|++.++++++||
T Consensus       136 ~T~g~I~~~v~~~~i~~~t~~vlina~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~-~~~~~~~~l~~~~v  214 (371)
T PF00079_consen  136 KTNGKIKNLVSPNDIDPDTRLVLINAIYFKGKWKYPFDPENTEKRPFYVSDGKSVSVPMMHQSGR-FRYAEDEDLDAQVV  214 (371)
T ss_dssp             HTTTSSSTSSSTTSSSTTEEEEEEEEEEEEEEBSSTEEGGGEEEEEEECSSSEEEEEEEEEEEEE-EEEEEETTTTEEEE
T ss_pred             hccceeeccccccchhhHHHHhhcccccccccccccccccccccccccccccccceEEEEecccc-cccccccccceeEE
Confidence            99999999999989999999999999999999999999999999999999999999999999999 99999999999999


Q ss_pred             EEeC-CCcEEEEEeecCCCCCC
Q psy2651         320 ELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       320 ELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      |||| + ++||+|   |||+++
T Consensus       215 ~Lp~~~-~~sm~i---ilP~~~  232 (371)
T PF00079_consen  215 ELPYKG-NFSMLI---ILPDEG  232 (371)
T ss_dssp             EEEBST-SEEEEE---EEESST
T ss_pred             Eecccc-ceeeEE---EEeccc
Confidence            9999 7 999999   899975

In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. Serpins (SERine Proteinase INhibitors) [, , ] belong to MEROPS inhibitor family I4, clan ID. Serpins are proteins that are primarily known as irreversible serine protease inhibitors active against S1 (IPR001254 from INTERPRO), S8 (IPR000209 from INTERPRO) and C14 (IPR002398 from INTERPRO) peptidases. There are both extra- and intra-cellular serpins, which are found in all groups of organisms with the notable exception of fungi [, ]. In contrast to "rigid" proteinase inhibitors, such as those of the Kunitz or Kazal families, the serpins are metastable proteins (active-state proteins) which interact with their substrate and irreversibly trap the acyl intermediate as a result of a major conformational change []; they are best described as suicide substrate inhibitors. The common structure of these proteins is a multi-domain fold containing a bundle of 8 or 9 alpha helices and a beta sandwich formed by 3 beta sheets. The reactive centre loop (RCL) is found in the C-terminal part of these proteins. Serpins and their homologues are a group of high molecular weight (40 to 50 kDa) structurally related proteins involved in a number of fundamental biological processes such as blood coagulation, complement activation, fibrinolysis, angiogenesis, inflammation, tumour suppression and hormone transport. All known serpins have been classified into 16 clades and 10 orphan sequences; the vertebrate serpins can be conveniently classified into six sub-groups []. In human plasma they represent approximately 2% of the total protein, of which 70% is alpha-1-antitrypsin. On the basis of strong sequence similarities, a number of proteins with no known inhibitory activity also belong to this family, these include: angiotensinogen, corticosteroid-binding globulin and thyroxin-binding globulin []. This entry represents the structural domain of serpins. It consists of a cluster of helices and a beta-sandwich.; PDB: 3PZF_A 3B9F_I 1MTP_A 1SNG_A 1ANT_I 2ZNH_B 1BR8_I 1SR5_A 1E03_L 1AZX_L ....

>cd02047 HCII Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade

Probab=100.00  E-value=7.9e-46  Score=370.53  Aligned_cols=226  Identities=26%  Similarity=0.471  Sum_probs=199.7

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYK  165 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~  165 (342)
                      +||++||+                 .+...  +++|+++||+||+.+|+||+.||+|+|++||.++||++.......+  
T Consensus        71 ~Fa~~L~~-----------------~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~Lg~~~~~~~~~~--  131 (436)
T cd02047          71 NFGFNLYR-----------------VLKDQVNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSK--  131 (436)
T ss_pred             HHHHHHHH-----------------HHhhccCCCCcEEEChHHHHHHHHHHHhhcccHHHHHHHHHhccccccccccc--
Confidence            89999999                 88753  6789999999999999999999999999999999999641000000  


Q ss_pred             chhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccC
Q psy2651         166 GIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTN  242 (342)
Q Consensus       166 ~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~  242 (342)
                      .....+++.|+.+.+.+....   .+.++|++|++++++++++|.+.++++|+++++.+||.++. ++..||+||+++|+
T Consensus       132 ~~~~~~~~~~~~l~~~l~~~~~~~~L~~an~l~v~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~-~~~~IN~wV~~~T~  210 (436)
T cd02047         132 YEITTVHNLFRKLTHRLFRRNFGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSDPA-FITKTNNRIQKLTK  210 (436)
T ss_pred             ccHHHHHHHHHHHHHHhhcCCCCcEEeeeeehhhhCCCCccHHHHHHHHHHhcCceEEeCCCCHH-HHHHHHHHHHHhcC
Confidence            001127788888887764432   79999999999999999999999999999999999998875 45689999999999


Q ss_pred             CccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEe
Q psy2651         243 DKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELP  322 (342)
Q Consensus       243 g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELP  322 (342)
                      |+|++++.  .++++|+++|+||+||||.|+.+|++..|..++|+.++|++++||||++.+. |+|++.++++++|||||
T Consensus       211 g~I~~~l~--~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~MM~~~~~-~~y~~~~~l~~~vleLP  287 (436)
T cd02047         211 GLIKEALE--NVDPATLMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKEVVKVPMMQTKGN-FLAAADPELDCDILQLP  287 (436)
T ss_pred             Cccccccc--cCCcccceeeeeeeEEechhhCcCCcccccCcCCEeCCCCEEEEehhcccce-EEEEEcCCcCcEEEEec
Confidence            99999996  7899999999999999999999999999999999999999999999999998 99999999999999999


Q ss_pred             C-CCcEEEEEeecCCCCCC
Q psy2651         323 Y-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       323 Y-~~~~SMlI~~~ILP~~g  340 (342)
                      | + ++||+|   |||+++
T Consensus       288 y~~-~~SM~i---iLP~~~  302 (436)
T cd02047         288 YVG-NISMLI---VVPHKL  302 (436)
T ss_pred             CCC-CeeEEE---EeCccc
Confidence            9 7 599999   899875

HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily.

>cd02043 plant_SERPIN SERine Proteinase INhibitors (serpins), plant specific subgroup

Probab=100.00  E-value=7.2e-46  Score=365.17  Aligned_cols=219  Identities=35%  Similarity=0.549  Sum_probs=198.0

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYK  165 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~  165 (342)
                      +||++||+                 ++...  +++|+|+||+||+.+|+||++||+|+|++||.++||++...  +    
T Consensus         5 ~~~~~l~~-----------------~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~--~----   61 (381)
T cd02043           5 LVAMRLSG-----------------HVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTD--E----   61 (381)
T ss_pred             HHHHHHHH-----------------HHhccCCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCChH--H----
Confidence            89999999                 88776  67899999999999999999999999999999999987433  3    


Q ss_pred             chhHHHHHHHHHHHHHhCC-----Cc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCC-cHHHHHhhchhhh
Q psy2651         166 GIIDQLSKDYKGIIDQLSK-----SP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQ-PPAAAKEMNDWVS  238 (342)
Q Consensus       166 ~~~~~v~~~~~~l~~~l~~-----~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~-~~~a~~~IN~WV~  238 (342)
                           ++..++.+...+..     .. .+.++|+||+++++++.++|.+.++++|+++++.+||.+ ++++++.||+||+
T Consensus        62 -----~~~~~~~l~~~~~~~~~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~  136 (381)
T cd02043          62 -----LHAVAASIVDLVLADASASGGPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEVRREVNSWVE  136 (381)
T ss_pred             -----HHHHHHHHHHHHhhhcccCCCcEEehhhhHHHhCCCCcCHHHHHHHHhhhhccceeecCCCCHHHHHHHHHHHHH
Confidence                 67777777666532     12 899999999999999999999999999999999999976 5678999999999


Q ss_pred             cccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEE
Q psy2651         239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKM  318 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~v  318 (342)
                      ++|+|+|++++++++++++|+++|+||+||+|.|+++|++..|..++||..+|++++||||++.+. +.|++.+  ++++
T Consensus       137 ~~T~g~I~~~~~~~~i~~~t~l~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~-~~~~~~~--~~~~  213 (381)
T cd02043         137 KATNGLIKDILPPGSVDSSTKLVLANALYFKGAWSSKFDASDTKDRDFHLLDGTSVRVPFMSSEKD-QYVAAFD--GFKV  213 (381)
T ss_pred             HHhcChHHhhCCCCCcCCCceEEEEeeeEEeeeeccCCccccCccccceeCCCCeEEeeeeeccCc-ccccccC--CCEE
Confidence            999999999999889999999999999999999999999999999999999999999999999987 7776654  5899


Q ss_pred             EEEeC-CC------cEEEEEeecCCCCCC
Q psy2651         319 LELPY-GV------SISFIIKSQVVPEMG  340 (342)
Q Consensus       319 LELPY-~~------~~SMlI~~~ILP~~g  340 (342)
                      ||||| ++      ++||+|   |||+++
T Consensus       214 veLPy~~~~~~~~~~~sm~i---iLP~~~  239 (381)
T cd02043         214 LRLPYKRGGHDDARQFSMYI---YLPDKK  239 (381)
T ss_pred             EEcCCCCCCCCCCCcEEEEE---EccCCC
Confidence            99999 65      599999   899975

It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.

>PHA02948 serine protease inhibitor-like protein; Provisional

Probab=100.00  E-value=2.2e-45  Score=360.78  Aligned_cols=211  Identities=21%  Similarity=0.416  Sum_probs=187.7

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+||||+||+.+|+|++.||+|+|++||.++||++..+        
T Consensus        23 ~f~~~l~~-----------------~l~~~~~~~Nv~~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~--------   77 (373)
T PHA02948         23 NAGILAYK-----------------NIQDGNEDDNIVFSPFGYSFSMFMSLLPASGNTRVELLKTMDLRKRD--------   77 (373)
T ss_pred             HHHHHHHH-----------------HHHhcCCCCCEEEchHHHHHHHHHHHhccCCcHHHHHHHHhCCCchh--------
Confidence            89999999                 88776 78899999999999999999999999999999999996433        


Q ss_pred             hhHHHHHHHHHHHHHhCCC---c-c-hhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhccc
Q psy2651         167 IIDQLSKDYKGIIDQLSKS---P-E-LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHT  241 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~---~-~-l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T  241 (342)
                          ++..++.+...+...   + . +.++|++|+++++.++++|.+   .+|+++++.+||.+  .++.+||+||+++|
T Consensus        78 ----~~~~~~~l~~~~~~~~~~~~~~~~~an~~~v~~~~~~~~~f~~---~~~~~~v~~vdF~~--~a~~~IN~WV~~~T  148 (373)
T PHA02948         78 ----LGPAFTELISGLAKLKTSKYTYTDLTYQSFVDNTVCIKPSYYQ---QYHRFGLYRLNFRR--DAVNKINSIVERRS  148 (373)
T ss_pred             ----HHHHHHHHHHHHhcccccCcchHHHHHHHHHhcCCCccHHHHH---HHhhCceEecCccH--HHHHHHHHHHHhcC
Confidence                777788887776542   2 3 479999999999999999997   45667999999973  58899999999998


Q ss_pred             CCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeee--EEEeCCCCeEEE
Q psy2651         242 NDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYM--YEEAGEDGFKML  319 (342)
Q Consensus       242 ~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~--y~~~~~l~~~vL  319 (342)
                        +|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|+ ++||||++.+. +.  |.+.++.+++++
T Consensus       149 --~I~~~~~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~-~~V~mM~~~~~-~~~~~~~~~~~~~~vl  224 (373)
T PHA02948        149 --GMSNVVDSTMLDNNTLWAIINTIYFKGTWQYPFDITKTHNASFTNKYGT-KTVPMMNVVTK-LQGNTITIDDEEYDMV  224 (373)
T ss_pred             --CCcccCCCCCCCCCceEEEEEEEEEeeeecCCCCcccCeeceeEeCCCC-EEchhheeccc-cccceeeccCcCceEE
Confidence              5999998889999999999999999999999999999999999988884 79999999887 74  566778899999


Q ss_pred             EEeC-CCcEEEEEeecCCCCC
Q psy2651         320 ELPY-GVSISFIIKSQVVPEM  339 (342)
Q Consensus       320 ELPY-~~~~SMlI~~~ILP~~  339 (342)
                      |||| ++++||+|   |||++
T Consensus       225 ~LPY~~~~~sM~i---iLP~~  242 (373)
T PHA02948        225 RLPYKDANISMYL---AIGDN  242 (373)
T ss_pred             EEecCCCcEEEEE---EcCCc
Confidence            9999 99999999   79974

>cd02053 alpha2AP Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots

Probab=100.00  E-value=2.9e-45  Score=357.24  Aligned_cols=217  Identities=25%  Similarity=0.480  Sum_probs=188.7

Q ss_pred             ccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhc
Q psy2651          85 LDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKD  163 (342)
Q Consensus        85 ~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~  163 (342)
                      .+ +||++||+                 ++... +++|+|+||+||+.+|+|++.||+|+|++||.++||++...  .  
T Consensus         5 ~~-~F~~~l~~-----------------~~~~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~--~--   62 (351)
T cd02053           5 MM-GFSTDLLS-----------------EVAQESTKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHAESLP--C--   62 (351)
T ss_pred             hh-hHHHHHHH-----------------HHHhhCCCCcEEECcHHHHHHHHHHHhhcChHHHHHHHHhcCCCChH--H--
Confidence            44 89999999                 88776 78999999999999999999999999999999999986432  2  


Q ss_pred             ccchhHHHHHHHHHHHHHhCCCcchhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCC-cHHHHHhhchhhhcccC
Q psy2651         164 YKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQ-PPAAAKEMNDWVSNHTN  242 (342)
Q Consensus       164 ~~~~~~~v~~~~~~l~~~l~~~~~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~-~~~a~~~IN~WV~~~T~  242 (342)
                             ++..++.+.+... ...+.++|++|++++++++++|.+.++++|++++  +||.+ +..+++.||+||+++|+
T Consensus        63 -------~~~~~~~l~~~~~-~~~l~~an~i~v~~~~~~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~IN~wv~~~T~  132 (351)
T cd02053          63 -------LHHLLSRLRQDLG-PGALRLATRMYLQKGFEIKESFLEESEKLYGAKP--VSLTGTKEDDLANINKWVKEATE  132 (351)
T ss_pred             -------HHHHHHHHhccCC-ccEeehhhHHHHhCCCchhHHHHHHHHHHcCCEE--eecCCCCHHHHHHHHHHHHHhcc
Confidence                   4444433332221 1289999999999999999999999999999976  55543 45688999999999999


Q ss_pred             CccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeec-ceeeeEEEeCCCCeEEEEE
Q psy2651         243 DKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVK-DSFYMYEEAGEDGFKMLEL  321 (342)
Q Consensus       243 g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~-~~~f~y~~~~~l~~~vLEL  321 (342)
                      |+|+++++  +++++|.++|+||+||||.|+++|++..|++.+||..+|++++||||++. .. ++|+++++++++||||
T Consensus       133 g~I~~~~~--~~~~~t~~vlvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-~~~~~~~~~~~~vleL  209 (351)
T cd02053         133 GQIPNFLS--DLPHDTVLLLLNAIHFKGFWRNKFDPSLTQRDAFHLDDDFTVSVEMMQASTYP-LRWFHLEQPEIQVAKF  209 (351)
T ss_pred             CchhHhcC--CCCcchHhheeeEEEEeeeecCCCChhcCeecceEECCCceEEeehhcccccc-eeeEecCCCCeEEEEE
Confidence            99999996  78999999999999999999999999999999999999999999999875 35 8899999999999999


Q ss_pred             eC-CCcEEEEEeecCCCCCC
Q psy2651         322 PY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       322 PY-~~~~SMlI~~~ILP~~g  340 (342)
                      || + ++||+|   |||+++
T Consensus       210 Py~~-~~Sm~i---iLP~~~  225 (351)
T cd02053         210 PFKG-NMSFVV---LMPTPF  225 (351)
T ss_pred             ecCC-CeEEEE---Eecccc
Confidence            99 7 599999   899874

Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily.

>cd02050 C1_inh C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family

Probab=100.00  E-value=2.4e-44  Score=351.00  Aligned_cols=215  Identities=24%  Similarity=0.373  Sum_probs=189.1

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYK  165 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~  165 (342)
                      +||++||+                 ++...  +++|+|+||+||+.+|+||+.||+|+|++||.++||++... .+    
T Consensus         4 ~F~~~l~~-----------------~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~-~~----   61 (352)
T cd02050           4 EFSLKLYQ-----------------HLSESAKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHDF-AC----   61 (352)
T ss_pred             hHHHHHHH-----------------HHhhccCCCCCEEEChHHHHHHHHHHhcccCccHHHHHHHhcCCCCch-hH----
Confidence            89999999                 88754  57899999999999999999999999999999999997543 22    


Q ss_pred             chhHHHHHHHHHHHHHhCCCcchhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccCCcc
Q psy2651         166 GIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKI  245 (342)
Q Consensus       166 ~~~~~v~~~~~~l~~~l~~~~~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~g~I  245 (342)
                           ++..++++.+.    ..+.++|+||++++++++++|.+.++++|++++..+||.. +.+++.||+||+++|+|+|
T Consensus        62 -----~~~~~~~l~~~----~~l~~an~i~~~~~~~l~~~f~~~~~~~y~~~~~~~~~~~-~~a~~~IN~wv~~~T~g~I  131 (352)
T cd02050          62 -----VHSALKKLKNK----LGLLSASQIFHHPDLHLRESFTNESWQFYKARPRELSNNS-ELNLEMINSWVAKATNNKI  131 (352)
T ss_pred             -----HHHHHHHhhhc----chhHHHHHHHHhCCCCccHHHHHHHHHHhCCcceeecCCh-HHHHHHHHHHHHHHhcchH
Confidence                 66666665443    2699999999999999999999999999999999999954 5678899999999999999


Q ss_pred             ccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEeCCC
Q psy2651         246 KDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGV  325 (342)
Q Consensus       246 ~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELPY~~  325 (342)
                      +++++  +++++|+++|+||+||||.|+++|++..|+..+|+.+++ +++||||++....+.|++.+++++++++|||.+
T Consensus       132 ~~~~~--~i~~~t~l~lvnaiyFkg~W~~~F~~~~T~~~~F~~~~~-~~~V~mM~~~~~~~~~~~~~~l~~~v~~lp~~~  208 (352)
T cd02050         132 PRLLD--SLPSETRLVLLNAVYFQAQWKKKFDTKHTVLLPFKRNGD-PVKVPVMYSKKYPVASFTDPRLKAQVGRLELSG  208 (352)
T ss_pred             HHHhc--ccCCCceEEEEeeEEEeeecCCCCCcccCccCceeECCc-eEEeeEeecCccceeeEEcCCcCeEEEEecCCC
Confidence            99995  799999999999999999999999999999999998755 899999997642256677889999999999944


Q ss_pred             cEEEEEeecCCCCCC
Q psy2651         326 SISFIIKSQVVPEMG  340 (342)
Q Consensus       326 ~~SMlI~~~ILP~~g  340 (342)
                      ++||+|   |||+++
T Consensus       209 ~~sm~i---iLP~~~  220 (352)
T cd02050         209 GLSLVV---LVPRGP  220 (352)
T ss_pred             ceEEEE---EeeCCC
Confidence            699999   899863

It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily.

>PHA02660 serpin-like protein; Provisional

Probab=100.00  E-value=7.8e-42  Score=334.73  Aligned_cols=197  Identities=23%  Similarity=0.378  Sum_probs=175.6

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhccCCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccch
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGI  167 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~~  167 (342)
                      +||++||+                 ++.   ++|+|+||+||+.+|+|++.||+|+|++||.++||+....         
T Consensus        17 ~f~~~l~~-----------------~~~---~~Nvv~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~---------   67 (364)
T PHA02660         17 DLGFCILK-----------------SLH---RFNIVFSPESLKAFLHVLYLGSERETKNELSKYIGHAYSP---------   67 (364)
T ss_pred             HHHHHHHH-----------------hcC---CCCEEEChHHHHHHHHHHHhhcCchHHHHHHHHhCccccc---------
Confidence            89999999                 774   5899999999999999999999999999999999975322         


Q ss_pred             hHHHHHHHHHHHHHhCCCcchhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchhhhcccCCccc
Q psy2651         168 IDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDWVSNHTNDKIK  246 (342)
Q Consensus       168 ~~~v~~~~~~l~~~l~~~~~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~WV~~~T~g~I~  246 (342)
                         +..            ..+..+|+||++++++++++|++.+++ |+++++.+||.+. +.+++.||+||+++|+  |+
T Consensus        68 ---~~~------------~~l~~an~l~v~~~~~l~~~F~~~~~~-~~~~v~~vdF~~~~~~a~~~IN~WV~~~T~--I~  129 (364)
T PHA02660         68 ---IRK------------NHIHNITKVYVDSHLPIHSAFVASMND-MGIDVILADLANHAEPIRRSINEWVYEKTN--II  129 (364)
T ss_pred             ---cch------------hhHHHHHHHHHhcCCchhHHHHHHHHH-cCCceEEeccccCHHHHHHHHHHHHHhccC--Cc
Confidence               110            135679999999999999999999987 8999999999764 5688999999999999  99


Q ss_pred             cCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEeC-CC
Q psy2651         247 DLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GV  325 (342)
Q Consensus       247 ~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELPY-~~  325 (342)
                      +++   +++++|+++|+||+||||.|+++|++..|++++||.++|+.++||||++.+. |+|++++  ++++||||| ++
T Consensus       130 ~~~---~~~~~t~l~LvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~--~~~vleLPY~~~  203 (364)
T PHA02660        130 NFL---HYMPDTSILIINAVQFNGLWKYPFLRKKTTMDIFNIDKVSFKYVNMMTTKGI-FNAGRYH--QSNIIEIPYDNC  203 (364)
T ss_pred             ccc---ccCCCchhhhhhhhhcccHhhcCCCcccCcccccccCCCceEeceeccccCe-eeeeecC--CCeEEECccCCC
Confidence            987   4778999999999999999999999999999999999999999999999998 9998864  589999999 74


Q ss_pred             -cEEEEEeecCCCCCC
Q psy2651         326 -SISFIIKSQVVPEMG  340 (342)
Q Consensus       326 -~~SMlI~~~ILP~~g  340 (342)
                       .+||+|   |||+++
T Consensus       204 ~~~sM~i---iLP~~~  216 (364)
T PHA02660        204 SRSHMWI---VFPDAI  216 (364)
T ss_pred             CceEEEE---EeeCCc
Confidence             579999   899974

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	342
3f5n_A	407	Structure Of Native Human Neuroserpin Length = 407		9e-31
3fgq_A	397	Crystal Structure Of Native Human Neuroserpin Lengt		1e-30
3f02_A	359	Cleaved Human Neuroserpin Length = 359		1e-30
2dut_A	423	Crystal Structure Of A M-Loop Deletion Variant Of M		9e-29
2h4q_A	382	Crystal Structure Of A M-Loop Deletion Variant Of M		1e-28
1sek_A	378	The Structure Of Active Serpin K From Manduca Sexta		3e-28
1k9o_I	378	Crystal Structure Of Michaelis Serpin-Trypsin Compl		8e-28
3ozq_A	376	Crystal Structure Of Serpin48, Which Is A Highly Sp		1e-27
2h4r_A	415	Crystal Structure Of Wildtype Ment In The Native Co		1e-25
2h4p_A	394	Crystal Structure Of Wildtype Ment In The Cleaved C		2e-25
1hle_A	345	Crystal Structure Of Cleaved Equine Leucocyte Elast		8e-25
3lw2_A	379	Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Len		8e-25
1jjo_C	261	Crystal Structure Of Mouse Neuroserpin (Cleaved For		1e-24
3le2_A	393	Structure Of Arabidopsis Atserpin1. Native Stressed		2e-24
1c5g_A	402	Plasminogen Activator Inhibitor-1 Length = 402		6e-24
1dvn_A	379	Latent Form Of Plasminogen Activator Inhibitor-1 (P		7e-24
9pai_A	346	Cleaved Substrate Variant Of Plasminogen Activator		7e-24
1a7c_A	379	Human Plasminogen Activator Inhibitor Type-1 In Com		7e-24
4aqh_A	383	Plasminogen Activator Inhibitor Type-1 In Complex W		8e-24
1b3k_A	379	Plasminogen Activator Inhibitor-1 Length = 379		8e-24
3eox_A	379	High Quality Structure Of Cleaved Pai-1-Stab Length		8e-24
3ut3_A	375	A Novel Pai-i Inhibitor And Its Structural Mechanis		9e-24
1db2_A	377	Crystal Structure Of Native Plasminogen Activator I		9e-24
3cvm_A	392	High Resolution Structure Of A Stable Plasminogen A		9e-24
3r4l_A	379	Human Very Long Half Life Plasminogen Activator Inh		2e-23
4dy0_A	379	Crystal Structure Of Native Protease Nexin-1 With H		2e-23
1yxa_A	398	Serpina3n, A Murine Orthologue Of Human Antichymotr		4e-23
1dvm_A	379	Active Form Of Human Pai-1 Length = 379		4e-23
4ga7_A	389	Crystal Structure Of Human Serpinb1 Mutant Length =		7e-23
3caa_A	341	Cleaved Antichymotrypsin A347r Length = 341		7e-23
1as4_A	341	Cleaved Antichymotrypsin A349r Length = 341		7e-23
4caa_A	341	Cleaved Antichymotrypsin T345r Length = 341		8e-23
2ach_A	360	Crystal Structure Of Cleaved Human Alpha1-antichymo		1e-22
3dlw_A	411	Antichymotrypsin Length = 411		1e-22
3q02_A	379	Crystal Structure Of Plasminogen Activator Inhibito		1e-22
3pzf_A	397	1.75a Resolution Structure Of Serpin-2 From Anophel		4e-22
1qmn_A	401	Alpha1-Antichymotrypsin Serpin In The Delta Conform		5e-22
4bb2_A	340	Crystal Structure Of Cleaved Corticosteroid-binding		5e-21
2vdx_A	373	Crystal Structure Of The Reactive Loop Cleaved Cort		1e-20
3nda_A	377	Crystal Structure Of Serpin From Tick Ixodes Ricinu		2e-20
2zv6_A	401	Crystal Structure Of Human Squamous Cell Carcinoma		3e-20
3vvj_A	392	Structure Of Ovalbumin From Emu (Dromaius Novaeholl		4e-20
1att_A	429	Crystal Structure Of Cleaved Bovine Antithrombin Ii		3e-19
2b4x_L	427	Crystal Structure Of Antithrombin-Iii Length = 427		4e-19
2hij_I	432	Crystal Structure Of P14 Alanine Variant Of Antithr		5e-19
1ath_A	432	The Intact And Cleaved Human Antithrombin Iii Compl		5e-19
1dzg_I	432	N135q-S380c-Antithrombin-Iii Length = 432		6e-19
1dzh_I	432	P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length		7e-19
2gd4_I	443	Crystal Structure Of The Antithrombin-S195a Factor		8e-19
1by7_A	382	Human Plasminogen Activator Inhibitor-2. Loop (66-9		8e-19
1tb6_I	432	2.5a Crystal Structure Of The Antithrombin-Thrombin		9e-19
1oyh_I	432	Crystal Structure Of P13 Alanine Variant Of Antithr		1e-18
3kcg_I	432	Crystal Structure Of The Antithrombin-Factor Ixa- P		1e-18
2b4x_I	427	Crystal Structure Of Antithrombin-Iii Length = 427		2e-18
4if8_A	414	Structure Of Vaspin Length = 414		2e-18
3f1s_A	385	Crystal Structure Of Protein Z Complexed With Prote		2e-18
3h5c_A	423	X-Ray Structure Of Protein Z-Protein Z Inhibitor Co		2e-18
4afx_A	387	Crystal Structure Of The Reactive Loop Cleaved Zpi		3e-18
2xn6_A	350	Crystal Structure Of Thyroxine-Binding Globulin Com		3e-18
2arq_A	382	Human Plasminogen Activator Inhibitor-2.[loop (66-9		3e-18
2riw_A	338	The Reactive Loop Cleaved Human Thyroxine Binding G		7e-18
2ceo_A	379	Thyroxine-Binding Globulin Complex With Thyroxine L		8e-18
2riv_A	343	Crystal Structure Of The Reactive Loop Cleaved Huma		9e-18
2xn5_A	350	Crystal Structure Of Thyroxine-Binding Globulin Com		9e-18
1atu_A	374	Uncleaved Alpha-1-Antitrypsin Length = 374		2e-17
4eb1_I	440	Hyperstable In-Frame Insertion Variant Of Antithrom		2e-17
2d26_A	358	Active Site Distortion Is Sufficient For Proteinase		3e-17
1iz2_A	394	Interactions Causing The Kinetic Trap In Serpin Pro		3e-17
1oo8_A	394	Crystal Structure Of A1pi-Pittsburgh In The Native		4e-17
1kct_A	394	Alpha1-Antitrypsin Length = 394		6e-17
1qmb_A	326	Cleaved Alpha-1-Antitrypsin Polymer Length = 326		8e-17
1hp7_A	394	A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-An		2e-16
1ova_B	386	Crystal Structure Of Uncleaved Ovalbumin At 1.95 An		2e-16
1ova_C	386	Crystal Structure Of Uncleaved Ovalbumin At 1.95 An		2e-16
1ova_A	386	Crystal Structure Of Uncleaved Ovalbumin At 1.95 An		2e-16
2v95_A	371	Struture Of Corticosteroid-Binding Globulin In Comp		2e-16
1jti_A	385	Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin		2e-16
1uhg_A	385	Crystal Structure Of S-ovalbumin At 1.9 Angstrom Re		2e-16
1d5s_A	334	Crystal Structure Of Cleaved Antitrypsin Polymer Le		4e-16
1ezx_A	335	Crystal Structure Of A Serpin:protease Complex Leng		4e-16
7api_A	347	The S Variant Of Human Alpha1-Antitrypsin, Structur		5e-16
2hi9_A	363	Crystal Structure Of Human Native Protein C Inhibit		5e-16
3dy0_A	336	Crystal Structure Of Cleaved Pci Bound To Heparin L		5e-16
1lq8_A	346	Crystal Structure Of Cleaved Protein C Inhibitor Le		5e-16
3ndf_A	343	Cleaved Antitrypsin With P8-P6 Asp Length = 343		5e-16
2ol2_A	395	High Resolution Structure Of Native Pci In Space Gr		6e-16
3t1p_A	371	Crystal Structure Of An Alpha-1-Antitrypsin Trimer		6e-16
3ndd_A	343	Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Len		6e-16
1psi_A	394	Intact Recombined Alpha1-Antitrypsin Mutant Phe 51		6e-16
3drm_A	404	2.2 Angstrom Crystal Structure Of Thr114phe Alpha1-		8e-16
3ne4_A	424	1.8 Angstrom Structure Of Intact Native Wild-Type A		8e-16
1qlp_A	394	2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsi		9e-16
2qug_A	394	Crystal Structure Of Alpha-1-Antitrypsin, Crystal F		1e-15
3dru_A	404	Crystal Structure Of Gly117phe Alpha1-Antitrypsin L		2e-15
1xu8_A	380	The 2.8 A Structure Of A Tumour Suppressing Serpin		7e-15
1wz9_A	375	The 2.1 A Structure Of A Tumour Suppressing Serpin		1e-14
1xqg_A	389	3.10 A Crystal Structure Of Maspin, Space Group P 4		2e-14
1f0c_A	305	Structure Of The Viral Serpin Crma Length = 305		6e-14
4ajt_A	427	The Cystal Structure Of Mouse Protein-Z Dependent P		8e-14
1c8o_A	300	2.9 A Structure Of Cleaved Viral Serpin Crma Length		1e-13
1jmo_A	480	Crystal Structure Of The Heparin Cofactor Ii-S195a		7e-13
1jmj_A	480	Crystal Structure Of Native Heparin Cofactor Ii Len		1e-12
3sto_A	406	Serpin From The Trematode Schistosoma Haematobium L		5e-12
1imv_A	398	2.85 A Crystal Structure Of Pedf Length = 398		6e-11
2r9y_A	430	Structure Of Antiplasmin Length = 430		8e-11
4au2_A	392	Crystal Structure Of A Hsp47-Collagen Complex Lengt		8e-11
2oay_A	390	Crystal Structure Of Latent Human C1-Inhibitor Leng		2e-10
4au3_A	392	Crystal Structure Of A Hsp47-Collagen Complex Lengt		5e-09
4au3_B	392	Crystal Structure Of A Hsp47-Collagen Complex Lengt		5e-09
1m93_B	245	1.65 A Structure Of Cleaved Viral Serpin Crma Lengt		9e-09
2pef_A	373	Crystal Structure Of A Thermophilic Serpin, Tengpin		2e-07
2pee_A	387	Crystal Structure Of A Thermophilic Serpin, Tengpin		2e-07
2vh4_A	381	Structure Of A Loop C-sheet Serpin Polymer Length =		2e-07
1mtp_A	323	The X-Ray Crystal Structure Of A Serpin From A Ther		4e-07
1sng_A	370	Structure Of A Thermophilic Serpin In The Native St		1e-06

>pdb|3F5N|A Chain A, Structure Of Native Human Neuroserpin Length = 407

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 119/232 (51%), Gaps = 16/232 (6%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A  + EN + SP S+ + +G+   GA GST +       I+HS        G      K+
Sbjct: 36  ATGEDENILFSPLSIALAMGMMELGAQGSTQK------EIRHSMGYDSLKNGEEFSFLKE 89
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           +  ++        +KIAN ++      +N  +       FN+ +  VDFSQ  A A  +N
Sbjct: 90  FSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYIN 149
Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV N+TN+ +KDL+     DA+T L LINA++FKG W   F+PE T+   F  DD + V
Sbjct: 150 KWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEV 209
Query: 295 QVPLMFVKDSFYMYE------EAGEDGFKMLELPY---GVSISFIIKSQVVP 337
           Q+P+M+ +  FY  E      EAG   +++LE+PY    +S+  ++  Q VP
Sbjct: 210 QIPMMYQQGEFYYGEFSDGSNEAG-GIYQVLEIPYEGDEISMMLVLSRQEVP 260

>pdb|3FGQ|A Chain A, Crystal Structure Of Native Human Neuroserpin Length = 397

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 119/232 (51%), Gaps = 16/232 (6%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A  + EN + SP S+ + +G+   GA GST +       I+HS        G      K+
Sbjct: 36  ATGEDENILFSPLSIALAMGMMELGAQGSTQK------EIRHSMGYDSLKNGEEFSFLKE 89
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           +  ++        +KIAN ++      +N  +       FN+ +  VDFSQ  A A  +N
Sbjct: 90  FSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYIN 149
Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV N+TN+ +KDL+     DA+T L LINA++FKG W   F+PE T+   F  DD + V
Sbjct: 150 KWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEV 209
Query: 295 QVPLMFVKDSFYMYE------EAGEDGFKMLELPY---GVSISFIIKSQVVP 337
           Q+P+M+ +  FY  E      EAG   +++LE+PY    +S+  ++  Q VP
Sbjct: 210 QIPMMYQQGEFYYGEFSDGSNEAG-GIYQVLEIPYEGDEISMMLVLSRQEVP 260

>pdb|3F02|A Chain A, Cleaved Human Neuroserpin Length = 359

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 123/237 (51%), Gaps = 26/237 (10%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGL---RIKHSE--TLLKDYKGIID 169
           A  + EN + SP S+ + +G+   GA GST + +   +    +K+ E  + LK++  ++ 
Sbjct: 36  ATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFSFLKEFSNMVT 95
Query: 170 QLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAA 229
                Y            +KIAN ++      +N  +       FN+ +  VDFSQ  A 
Sbjct: 96  AKESQYV-----------MKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAV 144
Query: 230 AKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLD 289
           A  +N WV N+TN+ +KDL+     DA+T L LINA++FKG W   F+PE T+   F  D
Sbjct: 145 ANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKD 204
Query: 290 DTNSVQVPLMFVKDSFYMYE------EAGEDGFKMLELPY---GVSISFIIKSQVVP 337
           D + VQ+P+M+ +  FY  E      EAG   +++LE+PY    +S+  ++  Q VP
Sbjct: 205 DESEVQIPMMYQQGEFYYGEFSDGSNEAG-GIYQVLEIPYEGDEISMMLVLSRQEVP 260

>pdb|2DUT|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Native Conformation Length = 423

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 112/211 (53%), Gaps = 14/211 (6%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            N+ +N   SP+S+   L L    A GSTA  M + L  + +E +   +K ++   +K  
Sbjct: 63  TNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFEQAENIHSGFKELLTAFNKPR 122
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEMN 234
                       L+ AN+IY  K   L P Y   +   + +E  KV+F + P  + KE+N
Sbjct: 123 NNY--------SLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEIN 174
Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV   T  KIK+L+ +D + A+T+L+L+NAI+FK +W V F+ E T   PF L    S 
Sbjct: 175 TWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSK 234
Query: 295 QVPLMFVKDSF--YMYEEAGEDGFKMLELPY 323
            V +M+++D+F   + E+     FKM+ELPY
Sbjct: 235 PVKMMYMRDTFPVLIMEKM---NFKMIELPY 262

>pdb|2H4Q|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Cleaved Conformation Length = 382

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 112/210 (53%), Gaps = 14/210 (6%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           N+ +N   SP+S+   L L    A GSTA  M + L  + +E +   +K ++   +K   
Sbjct: 64  NRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFEQAENIHSGFKELLTAFNKPRN 123
Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEMND 235
                      L+ AN+IY  K   L P Y   +   + +E  KV+F + P  + KE+N 
Sbjct: 124 NY--------SLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINT 175
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV   T  KIK+L+ +D + A+T+L+L+NAI+FK +W V F+ E T   PF L    S  
Sbjct: 176 WVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKP 235
Query: 296 VPLMFVKDSF--YMYEEAGEDGFKMLELPY 323
           V +M+++D+F   + E+     FKM+ELPY
Sbjct: 236 VKMMYMRDTFPVLIMEKM---NFKMIELPY 262

>pdb|1SEK|A Chain A, The Structure Of Active Serpin K From Manduca Sexta And A Model For Serpin-Protease Complex Formation Length = 378

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 78/237 (32%), Positives = 130/237 (54%), Gaps = 14/237 (5%)
Query: 96  KEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIK 155
           +E    F+ Q+ + V   + AN  +N ++S FS+   LG  +  + G + + +++ L + 
Sbjct: 12  RESNDQFTAQMFSEV---VKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALP 68
Query: 156 HSETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFN 215
           + + + KD    +++  +  KG+        +LK+A+KIY AK +ELN  +   + D F 
Sbjct: 69  N-DNVTKDVFADLNRGVRAVKGV--------DLKMASKIYVAKGLELNDDFAAVSRDVFG 119
Query: 216 SELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVP 275
           SE+  VDF +   AA  +N WV + TN++IK+L+  D+LD +T+ VL+NAI+FKG W   
Sbjct: 120 SEVQNVDFVKSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDK 179
Query: 276 FKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           F  E T D  F++    +++VP M  K     Y +  E   KM+E+ Y G   S II
Sbjct: 180 FNKERTMDRDFHVSKDKTIKVPTMIGKKDVR-YADVPELDAKMIEMSYEGDQASMII 235

>pdb|1K9O|I Chain I, Crystal Structure Of Michaelis Serpin-Trypsin Complex Length = 378

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 121/217 (55%), Gaps = 11/217 (5%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           AN  +N ++S FS+   LG  +  + G + + +++ L + + + + KD    +++  +  
Sbjct: 29  ANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPN-DNVTKDVFADLNRGVRAV 87
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           KG+        +LK+A+KIY AK +ELN  +   + D F SE+  VDF +   AA  +N 
Sbjct: 88  KGV--------DLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSVEAAGAINK 139
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV + TN++IK+L+  D+LD +T+ VL+NAI+FKG W   F  E T D  F++    +++
Sbjct: 140 WVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFVKERTMDRDFHVSKDKTIK 199
Query: 296 VPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           VP M  K     Y +  E   KM+E+ Y G   S II
Sbjct: 200 VPTMIGKKDVR-YADVPELDAKMIEMSYEGDQASMII 235

>pdb|3OZQ|A Chain A, Crystal Structure Of Serpin48, Which Is A Highly Specific Serpin In The Insect Tenebrio Molitor Length = 376

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 117/221 (52%), Gaps = 13/221 (5%)
Query: 118 KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKG 177
           +K N ++SPFS   +L LA  G  G TAE + + L           + G  ++     K 
Sbjct: 30  EKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLH----------FVGDREKAEGAVKE 79
Query: 178 IIDQLSKSP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
           ++ +L+     L  ANKIY   +  +   +Q  AV+ + ++   VDFS+   AAK MN W
Sbjct: 80  VLSKLTNEEYTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFSEKNDAAKLMNAW 139
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
           V   T  KI++L+  + L+  T++VLINA++F  KW VPF P  T+   F+      VQV
Sbjct: 140 VEEQTQHKIQNLVDPEILNNLTRVVLINALYFNAKWLVPFPPFHTRKSDFHKSAKEVVQV 199
Query: 297 PLMFVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQV 335
             M++ + ++ Y E      K+LELP+  G S++ ++ +Q+
Sbjct: 200 DTMYLDEQYFNYYECHHLDAKLLELPFKGGASLTIVLSNQI 240

>pdb|2H4R|A Chain A, Crystal Structure Of Wildtype Ment In The Native Conformation Length = 415

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH-----SETLLKDYKGIIDQL 171
           N+ +N   SP+S+   L L    A GSTA  M + L         S ++ +  +G   + 
Sbjct: 28  NRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRPKRR 87
Query: 172 SKD------------YKGIIDQLSKSPE---LKIANKIYFAKDIELNPAYQTQAVDNFNS 216
             D            +K ++   +K      L+ AN+IY  K   L P Y   +   + +
Sbjct: 88  RMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKA 147
Query: 217 ELGKVDF-SQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVP 275
           E  KV+F + P  + KE+N WV   T  KIK+L+ +D + A+T+L+L+NAI+FK +W V 
Sbjct: 148 EPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVK 207
Query: 276 FKPEATKDGPFYLDDTNSVQVPLMFVKDSF--YMYEEAGEDGFKMLELPY 323
           F+ E T   PF L    S  V +M+++D+F   + E+     FKM+ELPY
Sbjct: 208 FQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKM---NFKMIELPY 254

>pdb|2H4P|A Chain A, Crystal Structure Of Wildtype Ment In The Cleaved Conformation Length = 394

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH-----SETLLKDYKGIIDQL 171
           N+ +N   SP+S+   L L    A GSTA  M + L         S ++ +  +G   + 
Sbjct: 48  NRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRPKRR 107
Query: 172 SKD------------YKGIIDQLSKSPE---LKIANKIYFAKDIELNPAYQTQAVDNFNS 216
             D            +K ++   +K      L+ AN+IY  K   L P Y   +   + +
Sbjct: 108 RMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKA 167
Query: 217 ELGKVDF-SQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVP 275
           E  KV+F + P  + KE+N WV   T  KIK+L+ +D + A+T+L+L+NAI+FK +W V 
Sbjct: 168 EPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVK 227
Query: 276 FKPEATKDGPFYLDDTNSVQVPLMFVKDSF--YMYEEAGEDGFKMLELPY 323
           F+ E T   PF L    S  V +M+++D+F   + E+     FKM+ELPY
Sbjct: 228 FQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIMEKM---NFKMIELPY 274

>pdb|1HLE|A Chain A, Crystal Structure Of Cleaved Equine Leucocyte Elastase Inhibitor Determined At 1.95 Angstroms Resolution Length = 345

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 108/214 (50%), Gaps = 13/214 (6%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N  ISP S+   L +   G  G+TA  + K L     E +   ++ +   ++K     I 
Sbjct: 28  NIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTVEDIHSRFQSLNADINKPGAPYI- 86
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPA-AAKEMNDWVSN 239
                  LK+AN++Y  K       +       + +EL  VDF Q P  A KE+N+WV  
Sbjct: 87  -------LKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWVKG 139
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T  KI +L+    +D  TKLVL+NAI+FKG W   F  EAT+D PF L+  ++  V +M
Sbjct: 140 QTEGKIPELLVKGMVDNMTKLVLVNAIYFKGNWQQKFMKEATRDAPFRLNKKDTKTVKMM 199
Query: 300 FVKDSF-YMYEEAGEDGFKMLELPY-GVSISFII 331
           + K  F Y Y E  +   ++LELPY G  +S II
Sbjct: 200 YQKKKFPYNYIE--DLKCRVLELPYQGKELSMII 231

>pdb|3LW2|A Chain A, Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 113/223 (50%), Gaps = 10/223 (4%)
Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           + A+K  N + SP+ +  VL +     AG T   +   +  K +E   K     + QLSK
Sbjct: 24  VQASKDRNVVFSPYGVSSVLAMLQMTTAGKTRRQIQDAMGFKVNE---KGTAHALRQLSK 80
Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
           +  G  ++     E+  A+ I+  +D+EL   +       F + + +VDFS+   A   +
Sbjct: 81  ELMGPWNK----NEISTADAIFVQRDLELVQGFMPHFFKLFQTMVKQVDFSEVERARFII 136
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           NDWV  HT   I DL+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++
Sbjct: 137 NDWVERHTKGMINDLLAKGAVDELTRLVLVNALYFSGQWKTPFLEASTHQRLFHKSDGST 196
Query: 294 VQVPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           V VP+M   + F   E    DG  + ++ELPY G ++S  I +
Sbjct: 197 VSVPMMAQSNKFNYTEFTTPDGLEYDVVELPYQGDTLSMFIAA 239

>pdb|1JJO|C Chain C, Crystal Structure Of Mouse Neuroserpin (Cleaved Form) Length = 261

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/159 (37%), Positives = 88/159 (55%), Gaps = 10/159 (6%)
Query: 188 LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKD 247
           +K+AN ++      +N  +       FN+E+  VDFSQ  A A  +N WV N+TN  +KD
Sbjct: 6   MKLANSLFVQNGFHVNEEFLQMLKMYFNAEVNHVDFSQNVAVANSINKWVENYTNSLLKD 65
Query: 248 LIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYM 307
           L+  +  D  T L LINA++FKG W   F+PE T+   F  DD + VQ+P+M+ +  FY 
Sbjct: 66  LVSPEDFDGVTNLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYY 125
Query: 308 YE------EAGEDGFKMLELPY---GVSISFIIKSQVVP 337
            E      EAG   +++LE+PY    +S+   +  Q VP
Sbjct: 126 GEFSDGSNEAG-GIYQVLEIPYEGDEISMMLALSRQEVP 163

>pdb|3LE2|A Chain A, Structure Of Arabidopsis Atserpin1. Native Stressed Conforma Length = 393

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 113/228 (49%), Gaps = 15/228 (6%)
Query: 103 SIQLSTLVEWNLA------ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH 156
           SI L   V  NLA       ++  N I SP S++VVL + + G+AG+T + ++  L+   
Sbjct: 8   SISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFSS 67
Query: 157 SETLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNS 216
           ++ L      I+  +  D        +  P+L +AN  +  K +   P+++    D++ +
Sbjct: 68  TDQLNSFSSEIVSAVLADGSA-----NGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKA 122
Query: 217 ELGKVDF-SQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVP 275
              + DF S+      E+N W    TN  I +++   S D+ TKL+  NA++FKG W   
Sbjct: 123 ASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEK 182
Query: 276 FKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY 323
           F    T++G F+L D N V  P M  K   Y+   +  DGFK+L LPY
Sbjct: 183 FDESLTQEGEFHLLDGNKVTAPFMTSKKKQYV---SAYDGFKVLGLPY 227

>pdb|1C5G|A Chain A, Plasminogen Activator Inhibitor-1 Length = 402

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 49  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 102
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 103 KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 161
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I +L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 162 WVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 221
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 222 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 262

>pdb|1DVN|A Chain A, Latent Form Of Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I +L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|9PAI|A Chain A, Cleaved Substrate Variant Of Plasminogen Activator Inhibitor-1 Length = 346

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I +L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|1A7C|A Chain A, Human Plasminogen Activator Inhibitor Type-1 In Complex With A Pentapeptide Length = 379

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I +L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|4AQH|A Chain A, Plasminogen Activator Inhibitor Type-1 In Complex With The Inhibitor Az3976 Length = 383

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 30  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 83
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 84  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 142
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I +L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 143 WVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 202
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 203 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 243

>pdb|1B3K|A Chain A, Plasminogen Activator Inhibitor-1 Length = 379

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I  L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|3EOX|A Chain A, High Quality Structure Of Cleaved Pai-1-Stab Length = 379

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I  L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|3UT3|A Chain A, A Novel Pai-i Inhibitor And Its Structural Mechanism Length = 375

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 22  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 75
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 76  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 134
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I  L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 135 WVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 194
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 195 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 235

>pdb|1DB2|A Chain A, Crystal Structure Of Native Plasminogen Activator Inhibitor- 1 Length = 377

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 24  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 77
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 78  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 136
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I  L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 137 WVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 196
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 197 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 237

>pdb|3CVM|A Chain A, High Resolution Structure Of A Stable Plasminogen Activator Inhibitor Type-1 In Its Protease Cleaved Form Length = 392

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 39  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 92
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 93  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 151
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I  L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 152 WVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 211
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 212 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 252

>pdb|3R4L|A Chain A, Human Very Long Half Life Plasminogen Activator Inhibitor Type-1 Length = 379

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I +L+   ++D  T+LVL+NA++F G W  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGCWKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|4DY0|A Chain A, Crystal Structure Of Native Protease Nexin-1 With Heparin Length = 379

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 13/216 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N +ISP  +  VLG+   GA G T + +   +R            G+   L K  K I+
Sbjct: 30  DNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRY--------GVNGVGKILKKINKAIV 81
Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN 239
            + +K   + +AN ++     E+   + T+  D F  E+  V+F  P +A   +N WV N
Sbjct: 82  SKKNKD-IVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFEDPASACDSINAWVKN 140
Query: 240 HTNDKIKDLIKADSLDAS-TKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPL 298
            T D I +L+  D +D   T+LVL+NA++FKG W   F+PE TK   F   D  S QVP+
Sbjct: 141 ETRDMIDNLLSPDLIDGVLTRLVLVNAVYFKGLWKSRFQPENTKKRTFVAADGKSYQVPM 200
Query: 299 MFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFII 331
           +     F     +  +   +  +ELPY G SIS +I
Sbjct: 201 LAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLI 236

>pdb|1YXA|A Chain A, Serpina3n, A Murine Orthologue Of Human Antichymotrypsin Length = 398

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 112/227 (49%), Gaps = 11/227 (4%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKD-YKGIIDQLSKDY 175
           N   N + SP S+   L L S GA G+T E +++GL+   +ET   D ++G    L +  
Sbjct: 46  NPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTETSEADIHQGFGHLLQR-- 103
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
              ++Q     ++   + ++  K  ++   +Q +A   + +E    DF QP  A K +ND
Sbjct: 104 ---LNQPKDQVQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADFQQPRQAKKLIND 160
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           +V   T   IK+L+    LD  T +VL+N I+FK KW VPF P  T    FY      V 
Sbjct: 161 YVRKQTQGMIKELVS--DLDKRTLMVLVNYIYFKAKWKVPFDPLDTFKSEFYCGKRRPVI 218
Query: 296 VPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
           VP+M ++D    Y    E    ++EL Y  + S +    ++P+ GR+
Sbjct: 219 VPMMSMEDLTTPYFRDEELSCTVVELKYTGNASALF---ILPDQGRM 262

>pdb|1DVM|A Chain A, Active Form Of Human Pai-1 Length = 379

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I  L+   ++   T+LVL+NA++F G+W  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISHLLGTGAVQQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|4GA7|A Chain A, Crystal Structure Of Human Serpinb1 Mutant Length = 389

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 13/218 (5%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           N   N  ISPFS+   + +   G  G+TA  + K       E +   ++ +   ++K   
Sbjct: 33  NPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVEEVHSRFQSLNADINKRGA 92
Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPA-AAKEMND 235
             I        LK+AN++Y  K     P +       + ++L  VDF      A K +N 
Sbjct: 93  SYI--------LKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQ 144
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV   T  KI +L+ +  +D  TKLVL+NAI+FKG W   F  EAT + PF L+  +   
Sbjct: 145 WVKGQTEGKIPELLASGMVDNMTKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKT 204
Query: 296 VPLMFVKDSF-YMYEEAGEDGFKMLELPY-GVSISFII 331
           V +M+ K  F Y Y E  +   ++LELPY G  +S +I
Sbjct: 205 VKMMYQKKKFAYGYIE--DLKCRVLELPYQGEELSMVI 240

>pdb|3CAA|A Chain A, Cleaved Antichymotrypsin A347r Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 103/217 (47%), Gaps = 8/217 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N I SP S+   L   S GA  +T   ++KGL+   +ET     +  I Q  +     +
Sbjct: 29  KNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTET----SEAEIHQSFQHLLRTL 84
Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN 239
           +Q S   +L + N ++  + + L   +   A   + SE    DF    AA K +ND+V N
Sbjct: 85  NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKN 144
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL     V VP+M
Sbjct: 145 GTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMM 202
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQ 334
            +      Y    E    ++EL Y    S  FI+  Q
Sbjct: 203 SLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQ 239

>pdb|1AS4|A Chain A, Cleaved Antichymotrypsin A349r Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 103/217 (47%), Gaps = 8/217 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N I SP S+   L   S GA  +T   ++KGL+   +ET     +  I Q  +     +
Sbjct: 29  KNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTET----SEAEIHQSFQHLLRTL 84
Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN 239
           +Q S   +L + N ++  + + L   +   A   + SE    DF    AA K +ND+V N
Sbjct: 85  NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKN 144
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL     V VP+M
Sbjct: 145 GTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMM 202
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQ 334
            +      Y    E    ++EL Y    S  FI+  Q
Sbjct: 203 SLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQ 239

>pdb|4CAA|A Chain A, Cleaved Antichymotrypsin T345r Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 103/217 (47%), Gaps = 8/217 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N I SP S+   L   S GA  +T   ++KGL+   +ET     +  I Q  +     +
Sbjct: 29  KNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTET----SEAEIHQSFQHLLRTL 84
Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN 239
           +Q S   +L + N ++  + + L   +   A   + SE    DF    AA K +ND+V N
Sbjct: 85  NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKN 144
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL     V VP+M
Sbjct: 145 GTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMM 202
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQ 334
            +      Y    E    ++EL Y    S  FI+  Q
Sbjct: 203 SLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQ 239

>pdb|2ACH|A Chain A, Crystal Structure Of Cleaved Human Alpha1-antichymotrypsin At 2.7 Angstroms Resolution And Its Comparison With Other Serpins Length = 360

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 103/217 (47%), Gaps = 8/217 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N I SP S+   L   S GA  +T   ++KGL+   +ET     +  I Q  +     +
Sbjct: 48  KNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTET----SEAEIHQSFQHLLRTL 103
Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN 239
           +Q S   +L + N ++  + + L   +   A   + SE    DF    AA K +ND+V N
Sbjct: 104 NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKN 163
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL     V VP+M
Sbjct: 164 GTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMM 221
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQ 334
            +      Y    E    ++EL Y    S  FI+  Q
Sbjct: 222 SLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQ 258

>pdb|3DLW|A Chain A, Antichymotrypsin Length = 411

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 103/217 (47%), Gaps = 8/217 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N I SP S+   L   S GA  +T   ++KGL+   +ET     +  I Q  +     +
Sbjct: 59  KNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTET----SEAEIHQSFQHLLRTL 114
Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN 239
           +Q S   +L + N ++  + + L   +   A   + SE    DF    AA K +ND+V N
Sbjct: 115 NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKN 174
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL     V VP+M
Sbjct: 175 GTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMM 232
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQ 334
            +      Y    E    ++EL Y    S  FI+  Q
Sbjct: 233 SLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQ 269

>pdb|3Q02|A Chain A, Crystal Structure Of Plasminogen Activator Inhibitor-1 In A Metastable Active Conformation. Length = 379

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+K  N + SP+ +  VL +      G T + +   +  K       D KG+   L   Y
Sbjct: 26  ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFK------IDDKGMAPALRHLY 79
Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND 235
           K ++   +K  E+   + I+  +D++L   +       F S + +VDFS+   A   +ND
Sbjct: 80  KELMGPWNKD-EISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIND 138
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WV  HT   I +L+   ++D  T+LVL+NA++F G++  PF   +T    F+  D ++V 
Sbjct: 139 WVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQFKTPFPDSSTHRRLFHKSDGSTVS 198
Query: 296 VPLMFVKDSFYMYEEAGEDG--FKMLELPY-GVSISFIIKS 333
           VP+M   + F   E    DG  + +LELPY G ++S  I +
Sbjct: 199 VPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAA 239

>pdb|3PZF|A Chain A, 1.75a Resolution Structure Of Serpin-2 From Anopheles Gambiae Length = 397

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 117 NKKENAIISPFSLHVVLGL------ASFGAAGSTAE----AMMKGLRIKHSETLLKDYKG 166
           N   N ++SPFS+ ++L L       SFG A S  +    ++++   I H+ +  K    
Sbjct: 36  NHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQNDNIDHTRSYYKQLLE 95
Query: 167 IIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP 226
              Q +KDY           +L IA   +    IE+   YQ  A  ++++ L KV +S P
Sbjct: 96  SAQQDNKDY-----------DLNIATNFFVDDFIEVINKYQQIANTHYHAMLEKVSYSNP 144
Query: 227 PAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPF 286
              A  +N+WVS HTN ++++++  DSL+ +  + L+N I+FKG WT PF   A    PF
Sbjct: 145 TQTAATINNWVSEHTNGRLREIVTPDSLEGAV-ITLVNVIYFKGLWTYPFPEVANNVKPF 203
Query: 287 YLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY 323
           Y           M     FY Y+ + + G ++L LPY
Sbjct: 204 YGTRGKPTNAQYMEQNGQFY-YDNSADLGAQILRLPY 239

>pdb|1QMN|A Chain A, Alpha1-Antichymotrypsin Serpin In The Delta Conformation (Partial Loop Insertion) Length = 401

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 103/217 (47%), Gaps = 8/217 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N I SP S+   L   S GA  +T   ++KGL+   +ET     +  I Q  +     +
Sbjct: 49  KNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTET----SEAEIHQSFQHLLRTL 104
Query: 180 DQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN 239
           +Q S   +L + N ++  + + L   +   A   + SE    DF    AA K +ND+V N
Sbjct: 105 NQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKN 164
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL     V VP+M
Sbjct: 165 GTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMM 222
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY--GVSISFIIKSQ 334
            +      Y    E    ++EL Y    S  FI+  Q
Sbjct: 223 SLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQ 259

>pdb|4BB2|A Chain A, Crystal Structure Of Cleaved Corticosteroid-binding Globulin In Complex With Progesterone Length = 340

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 116/230 (50%), Gaps = 12/230 (5%)
Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           +A + K+N  ISP S+ + L + S G  G T   +++GL    +E    +    I Q  +
Sbjct: 24  VALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETE----IHQGFQ 79
Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
               +  +   S E+ + N ++    +EL  ++       + SE+  ++F     A++++
Sbjct: 80  HLHQLFAKSDTSLEMTMGNALFLDGSLELLESFSADIAHYYESEVLAMNFQDWATASRQI 139
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N +V N T  KI DL     LD+   LVL+N I FKG WT PF   +T++  FY+D+T  
Sbjct: 140 NSYVKNKTQGKIVDLFSG--LDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTV 197
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMGRL 342
           V+VP+M ++ S   Y    E   +++++ Y G    F I    +P+ G++
Sbjct: 198 VKVPMM-LQSSTISYLHDSELPCQLVQMNYVGNGTVFFI----LPDKGKM 242

>pdb|2VDX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Corticosteroid Binding Globulin Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 116/230 (50%), Gaps = 12/230 (5%)
Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           +A + K+N  ISP S+ + L + S G  G T   +++GL    +E    +    I Q  +
Sbjct: 23  VALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETE----IHQGFQ 78
Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
               +  +   S E+ + N ++    +EL  ++       + SE+  ++F     A++++
Sbjct: 79  HLHQLFAKSDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATASRQI 138
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N +V N T  KI DL     LD+   LVL+N I FKG WT PF   +T++  FY+D+T  
Sbjct: 139 NSYVKNKTQGKIVDLFSG--LDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTV 196
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMGRL 342
           V+VP+M ++ S   Y    E   +++++ Y G    F I    +P+ G++
Sbjct: 197 VKVPMM-LQSSTISYLHDSELPCQLVQMNYVGNGTVFFI----LPDKGKM 241

>pdb|3NDA|A Chain A, Crystal Structure Of Serpin From Tick Ixodes Ricinus Length = 377

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 113/214 (52%), Gaps = 13/214 (6%)
Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           L +  ++N   SP+S+   +G+A  GA G T + + +GL    S+  L D  G++D    
Sbjct: 22  LPSGPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGF--SDVDLTD-AGVLDA--- 75
Query: 174 DYKGIIDQLSKSPE---LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFS-QPPAA 229
            Y    ++L  +P    L +AN     + + L  +Y++    +F +EL KVDF+ +P AA
Sbjct: 76  -YTHHTERLKSTPSNSTLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFAGEPQAA 134
Query: 230 AKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLD 289
              +N+WV   T+DKI+ L   + LD  T LVL+NAI+FKG+W   F  E T+   F+  
Sbjct: 135 VDFVNNWVKRKTHDKIEKLFN-EPLDPDTLLVLLNAIYFKGEWNTAFVKEHTEKRQFFNG 193
Query: 290 DTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY 323
               V+V  M + ++   Y    +   +++ELPY
Sbjct: 194 GVTPVEVDTMRL-EARIKYRFFDDLQVEVVELPY 226

>pdb|2ZV6|A Chain A, Crystal Structure Of Human Squamous Cell Carcinoma Antigen 1 Length = 401

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 17/227 (7%)
Query: 118 KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKG 177
           K+ N   SP S+   LG+   GA  +TA+ + K L   H + + ++  G       D  G
Sbjct: 34  KENNIFYSPISITSALGMVLLGAKDNTAQQIKKVL---HFDQVTENTTGKAATYHVDRSG 90
Query: 178 --------IIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP 226
                   ++ + +KS    ELKIANK++  K       Y       + + +  VDF+  
Sbjct: 91  NVHHQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANA 150
Query: 227 PAAA-KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGP 285
           P  + K++N WV + TN+KIK+LI   ++ ++T LVL+NAI+FKG+W   F  E TK+  
Sbjct: 151 PEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEK 210
Query: 286 FYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           F+ +      + +M    SF+ +    +   K+LE+PY G  +S I+
Sbjct: 211 FWPNKNTYKSIQMMRQYTSFH-FASLEDVQAKVLEIPYKGKDLSMIV 256

>pdb|3VVJ|A Chain A, Structure Of Ovalbumin From Emu (Dromaius Novaehollandiae) Length = 392

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 8/212 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGL---RIKHSETLLKDYKGIIDQLSKDYK 176
           EN I SP S+  +L +   GA  +T   M K +   +I      L+   G    +    K
Sbjct: 26  ENIIYSPLSIISILSMVFLGARENTKTQMEKVIHFDKITGFGESLESQCGTSVSVHASLK 85
Query: 177 GIIDQLSKSPE---LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            I+ +++K  +   L +A+K+Y  +   + P Y     + +   L  V F      A+E+
Sbjct: 86  DILSEITKPSDNYSLSLASKLYAEETYPVLPEYLQCIKELYKGSLETVSFQTAADQAREL 145
Query: 234 -NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N WV   TN  IK+ ++  S+D  T++VL++AI+FKG W   FK E T++ PF + +  
Sbjct: 146 INSWVETQTNGVIKNFLQPGSVDPQTEMVLVDAIYFKGTWEKAFKDEDTQEVPFRITEQE 205
Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYG 324
           S  V +M+   SF +   A E   K+LELPY 
Sbjct: 206 SKPVQMMYQAGSFKVATVAAEK-MKILELPYA 236

>pdb|1ATT|A Chain A, Crystal Structure Of Cleaved Bovine Antithrombin Iii At 3.2 Angstroms Resolution Length = 429

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 111/229 (48%), Gaps = 9/229 (3%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA  +T   +M+  +         D        +K 
Sbjct: 66  SKNNNDNIFLSPLSISTAFAMTKLGACNNTLTQLMEVFKFDTISEKTSDQIHFF--FAKL 123
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK-EM 233
              +  + +KS EL  AN+++  K I  N  YQ  +   + ++L  +DF      ++  +
Sbjct: 124 NCRLYRKANKSSELVSANRLFGDKSITFNETYQDISEVVYGAKLQPLDFKGNAEQSRLTI 183
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N W+SN T  +I D+I   +++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 184 NQWISNKTEGRITDVIPPQAINEFTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 243
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMGR 341
             V LM  ++S + Y    E   ++LELP+ G  I+ ++   ++P++ +
Sbjct: 244 CSV-LMMYQESKFRYRRVAEST-QVLELPFKGDDITMVL---ILPKLEK 287

>pdb|2B4X|L Chain L, Crystal Structure Of Antithrombin-Iii Length = 427

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 65  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 122
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  + +KS +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 123 NCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 182
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 183 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 242
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 243 CSASMMYQEGKFR-YRRVAE-GTQVLELPFKGDDITMVL 279

>pdb|2HIJ|I Chain I, Crystal Structure Of P14 Alanine Variant Of Antithrombin Length = 432

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 6/217 (2%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           N  +N  +SP S+     +   GA   T + +M+  +         D        +K   
Sbjct: 71  NDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKLNC 128
Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-MND 235
            +  + +KS +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +N 
Sbjct: 129 RLYRKAAKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINK 188
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S  
Sbjct: 189 WVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCS 248
Query: 296 VPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
             +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 249 ASMMYQEGKF-RYRRVAE-GTQVLELPFKGDDITMVL 283

>pdb|1ATH|A Chain A, The Intact And Cleaved Human Antithrombin Iii Complex As A Model For Serpin-Proteinase Interactions Length = 432

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 126
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  + +KS +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 127 NCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 246
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 247 CSASMMYQEGKF-RYRRVAE-GTQVLELPFKGDDITMVL 283

>pdb|1DZG|I Chain I, N135q-S380c-Antithrombin-Iii Length = 432

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 126
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  +  KS +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 127 NCRLYRKAQKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 246
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 247 CSASMMYQEGKF-RYRRVAE-GTQVLELPFKGDDITMVL 283

>pdb|1DZH|I Chain I, P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length = 432

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 126
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  +  KS +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 127 NCRLYRKAQKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 246
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 247 CSASMMYQEGKF-RYRRVAE-GTQVLELPFKGDDITMVL 283

>pdb|2GD4|I Chain I, Crystal Structure Of The Antithrombin-S195a Factor Xa-Pentasaccharide Complex Length = 443

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 6/217 (2%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           N  +N  +SP S+     +   GA   T + +M+  +         D        +K   
Sbjct: 82  NDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKLNC 139
Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-MND 235
            +  + +K+ +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +N 
Sbjct: 140 RLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINK 199
Query: 236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQ 295
           WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S  
Sbjct: 200 WVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCS 259
Query: 296 VPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
             +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 260 ASMMYQEGKFR-YRRVAE-GTQVLELPFKGDDITMVL 294

>pdb|1BY7|A Chain A, Human Plasminogen Activator Inhibitor-2. Loop (66-98) Deletion Mutant Length = 382

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 14/221 (6%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+  +N  +SP+S+   + +   G+ GST + M K L+         +     D++   +
Sbjct: 22  ASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQ-------FNEVGAAADKIHSSF 74
Query: 176 KGIIDQLSKSPE---LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQ-PPAAAK 231
           + +   ++ S     L+  NK++  K       Y       ++SE   VDF +    A K
Sbjct: 75  RSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARK 134
Query: 232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
           ++N WV   T  KI +L+   S+D  T++VL+NA++FKGKW  PF+ +     PF ++  
Sbjct: 135 KINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSA 194
Query: 292 NSVQVPLMFVKDSFYM-YEEAGEDGFKMLELPYGVSISFII 331
               V +M++++   + Y E  +   ++LELPY   +S  +
Sbjct: 195 QRTPVQMMYLREKLNIGYIE--DLKAQILELPYAGDVSMFL 233

>pdb|1TB6|I Chain I, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin Ternary Complex Length = 432

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 126
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  + +K+ +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 127 NCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 246
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 247 CSASMMYQEGKF-RYRRVAE-GTQVLELPFKGDDITMVL 283

>pdb|1OYH|I Chain I, Crystal Structure Of P13 Alanine Variant Of Antithrombin Length = 432

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 126
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  + +K+ +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 127 NCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 246
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 247 CSASMMYQEGKF-RYRRVAE-GTQVLELPFKGDDITMVL 283

>pdb|3KCG|I Chain I, Crystal Structure Of The Antithrombin-Factor Ixa- Pentasaccharide Complex Length = 432

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 126
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  + +K+ +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 127 NCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 246
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 247 CSASMMYQEGKF-RYRRVAE-GTQVLELPFKGDDITMVL 283

>pdb|2B4X|I Chain I, Crystal Structure Of Antithrombin-Iii Length = 427

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 6/219 (2%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 65  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 122
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  + +KS +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 123 NCRLYRKAAKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 182
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I FKG W   F PE T+   FY  D  S
Sbjct: 183 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTILFKGLWKSKFSPENTRKELFYKADGES 242
Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 243 CSASMMYQEGKFR-YRRVAE-GTQVLELPFKGDDITMVL 279

>pdb|4IF8|A Chain A, Structure Of Vaspin Length = 414

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 115/228 (50%), Gaps = 16/228 (7%)
Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH--SETLLKDYKGIIDQLSKD 174
           N   N  +SP S+     +   GA  ST + + +G   +    + L + +  II +L+  
Sbjct: 67  NPGRNIFLSPLSISTAFSMLCLGAQDSTLDEIKQGFNFRKMPEKDLHEGFHYIIHELT-- 124
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
                 Q ++  +L I N ++  + ++    +   A + +++E    +F     A K++N
Sbjct: 125 ------QKTQDLKLSIGNTLFIDQRLQPQRKFLEDAKNFYSAETILTNFQNLEMAQKQIN 178
Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
           D++S  T+ KI +LI  +++D  T ++L N I F+ +W   F P  TK+  F+L+  +SV
Sbjct: 179 DFISQKTHGKINNLI--ENIDPGTVMLLANYIFFRARWKHEFDPNVTKEEDFFLEKNSSV 236
Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
           +VP+MF +   Y      +    +LE+PY  +I+ I    ++P+ G+L
Sbjct: 237 KVPMMF-RSGIYQVGYDDKLSCTILEIPYQKNITAIF---ILPDEGKL 280

>pdb|3F1S|A Chain A, Crystal Structure Of Protein Z Complexed With Protein Z-Dependent Inhibitor Length = 385

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SPF + + +     GA G T   + +GL   H + L     G++  L   +KG+ +
Sbjct: 38  NMVFSPFGMSLAMTGLMLGATGPTETQIKRGL---HLQALKPTKPGLLPSL---FKGLRE 91
Query: 181 QLSKSPELKIANK--IYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS 238
            LS++ EL +      +  KD ++   +   +   F++E   ++F     A + MN +++
Sbjct: 92  TLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLMNHYIN 151
Query: 239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPL 298
             T  KI  L   D ++  TKL+L++ I FKGKW  PF P  T+   F+LD   +++VP+
Sbjct: 152 KETRGKIPKLF--DEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPM 209
Query: 299 MFVKDSFYMYEEAGEDGFK--MLELPYGVSISFII 331
           M+    F       +  F+  +L+LPY  + + ++
Sbjct: 210 MYGAGKF---ASTFDKNFRCHVLKLPYQGNATMLV 241

>pdb|3H5C|A Chain A, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex Length = 423

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SPF + + +     GA G T   + +GL   H + L     G++  L   +KG+ +
Sbjct: 76  NMVFSPFGMSLAMTGLMLGATGPTETQIKRGL---HLQALKPTKPGLLPSL---FKGLRE 129
Query: 181 QLSKSPELKIANK--IYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS 238
            LS++ EL +      +  KD ++   +   +   F++E   ++F     A + MN +++
Sbjct: 130 TLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLMNHYIN 189
Query: 239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPL 298
             T  KI  L   D ++  TKL+L++ I FKGKW  PF P  T+   F+LD   +++VP+
Sbjct: 190 KETRGKIPKLF--DEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPM 247
Query: 299 MFVKDSFYMYEEAGEDGFK--MLELPYGVSISFII 331
           M+    F       +  F+  +L+LPY  + + ++
Sbjct: 248 MYGAGKF---ASTFDKNFRCHVLKLPYQGNATMLV 279

>pdb|4AFX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Zpi In I2 Space Group Length = 387

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SPF + + +     GA G T   + +GL   H + L     G++  L   +KG+ +
Sbjct: 76  NMVFSPFGMSLAMTGLMLGATGPTETQIKRGL---HLQALKPTKPGLLPSL---FKGLRE 129
Query: 181 QLSKSPELKIANK--IYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS 238
            LS++ EL +      +  KD ++   +   +   F++E   ++F     A + MN +++
Sbjct: 130 TLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLMNHYIN 189
Query: 239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPL 298
             T  KI  L   D ++  TKL+L++ I FKGKW  PF P  T+   F+LD   +++VP+
Sbjct: 190 KETRGKIPKLF--DEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPM 247
Query: 299 MFVKDSFYMYEEAGEDGFK--MLELPYGVSISFII 331
           M+    F       +  F+  +L+LPY  + + ++
Sbjct: 248 MYGAGKF---ASTFDKNFRCHVLKLPYQGNATMLV 279

>pdb|2XN6|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Thyroxine-Fluoresein Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N   SP S+   L + SFGA  ST   +++ L    ++T +        ++   ++ +I
Sbjct: 33  KNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMV-------EIQHGFQHLI 85
Query: 180 DQLS---KSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
             L+   K  EL+I N ++  K ++    +       + +E+   DFS   AA +E+N  
Sbjct: 86  CSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSH 145
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKD-GPFYLDDTNSVQ 295
           V   T  K+  LI+   L  +T +VL+N IHFK +W  PF P  T+D   F +D T +VQ
Sbjct: 146 VEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQ 203
Query: 296 VPLMFVKDSFY 306
           VP+M   D +Y
Sbjct: 204 VPMMHQMDQYY 214

>pdb|2ARQ|A Chain A, Human Plasminogen Activator Inhibitor-2.[loop (66-98) Deletion Mutant] Complexed With Peptide N-Acetyl-Teaaagdggvmtgr-Oh Length = 382

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
           A+  +N  +SP+S+   + +   G+ GST + M   L+         +     D++   +
Sbjct: 22  ASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQ-------FNEVGAAADKIHSSF 74
Query: 176 KGIIDQLSKSPE---LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQ-PPAAAK 231
           + +   ++ S     L+  NK++  K       Y       ++SE   VDF +    A K
Sbjct: 75  RSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARK 134
Query: 232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
           ++N WV   T  KI +L+   S+D  T++VL+NA++FKGKW  PF+ +     PF ++  
Sbjct: 135 KINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLFPFRVNSA 194
Query: 292 NSVQVPLMFVKDSFYM-YEEAGEDGFKMLELPYGVSISFII 331
               V +M++++   + Y E  +   ++LELPY   +S  +
Sbjct: 195 QRTPVQMMYLREKLNIGYIE--DLKAQILELPYAGDVSMFL 233

>pdb|2RIW|A Chain A, The Reactive Loop Cleaved Human Thyroxine Binding Globulin Complexed With Thyroxine Length = 338

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N   SP S+   L + SFGA  ST   +++ L    ++T + +       +   ++ +I
Sbjct: 27  KNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE-------IQHGFQHLI 79
Query: 180 DQLS---KSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
             L+   K  EL+I N ++  K ++    +       + +E+   DFS   AA +E+N  
Sbjct: 80  CSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSH 139
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKD-GPFYLDDTNSVQ 295
           V   T  K+  LI+   L  +T +VL+N IHFK +W  PF P  T+D   F +D T +VQ
Sbjct: 140 VEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQ 197
Query: 296 VPLMFVKDSFY 306
           VP+M   + +Y
Sbjct: 198 VPMMHQMEQYY 208

>pdb|2CEO|A Chain A, Thyroxine-Binding Globulin Complex With Thyroxine Length = 379

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N   SP S+   L + SFGA  ST   +++ L    ++T + +       +   ++ +I
Sbjct: 28  KNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE-------IQHGFQHLI 80
Query: 180 DQLS---KSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
             L+   K  EL+I N ++  K ++    +       + +E+   DFS   AA +E+N  
Sbjct: 81  CSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSH 140
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKD-GPFYLDDTNSVQ 295
           V   T  K+  LI+   L  +T +VL+N IHFK +W  PF P  T+D   F +D T +VQ
Sbjct: 141 VEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQ 198
Query: 296 VPLMFVKDSFY 306
           VP+M   + +Y
Sbjct: 199 VPMMHQMEQYY 209

>pdb|2RIV|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Human Thyroxine Binding Globulin Length = 343

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N   SP S+   L + SFGA  ST   +++ L    ++T + +       +   ++ +I
Sbjct: 32  KNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE-------IQHGFQHLI 84
Query: 180 DQLS---KSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
             L+   K  EL+I N ++  K ++    +       + +E+   DFS   AA +E+N  
Sbjct: 85  CSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSH 144
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKD-GPFYLDDTNSVQ 295
           V   T  K+  LI+   L  +T +VL+N IHFK +W  PF P  T+D   F +D T +VQ
Sbjct: 145 VEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQ 202
Query: 296 VPLMFVKDSFY 306
           VP+M   + +Y
Sbjct: 203 VPMMHQMEQYY 213

>pdb|2XN5|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Furosemide Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 96/191 (50%), Gaps = 13/191 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGII 179
           +N   SP S+   L + SFGA  ST   +++ L    ++T + +       +   ++ +I
Sbjct: 33  KNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE-------IQHGFQHLI 85
Query: 180 DQLS---KSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
             L+   K  EL+I N ++  K ++    +       + +E+   DFS   AA +E+N  
Sbjct: 86  CSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSH 145
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKD-GPFYLDDTNSVQ 295
           V   T  K+  LI+   L  +T +VL+N IHFK +W  PF P  T+D   F +D T +VQ
Sbjct: 146 VEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQ 203
Query: 296 VPLMFVKDSFY 306
           VP+M   + +Y
Sbjct: 204 VPMMHQMEQYY 214

>pdb|1ATU|A Chain A, Uncleaved Alpha-1-Antitrypsin Length = 374

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP S+     + S GA G T + +++GL    +E      +  I +  ++    ++
Sbjct: 29  NILFSPVSIAAAFAMLSLGAKGDTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 84
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 85  QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 144
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 145 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 201

>pdb|4EB1|I Chain I, Hyperstable In-Frame Insertion Variant Of Antithrombin Length = 440

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 14/227 (6%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D        +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFF--FAKL 126
Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-M 233
              +  + +K+ +L  AN+++  K +  N  YQ  +   + ++L  +DF +    ++  +
Sbjct: 127 NCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186
Query: 234 NDWVSNHTNDKIKDLIKADSLD--------ASTKLVLINAIHFKGKWTVPFKPEATKDGP 285
           N WVSN T  +I D+I +++++         ST LVL+N I+FKG W   F PE T+   
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINVLVLVNTRTSTVLVLVNTIYFKGLWKSKFSPENTRKEL 246
Query: 286 FYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           FY  D  S    +M+ +  F  Y    E G ++LELP+ G  I+ ++
Sbjct: 247 FYKADGESCSASMMYQEGKFR-YRRVAE-GTQVLELPFKGDDITMVL 291

>pdb|2D26|A Chain A, Active Site Distortion Is Sufficient For Proteinase Inhibit Second Crystal Structure Of Covalent Serpin-Proteinase Complex Length = 358

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP S+     + S GA G T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NILFSPVSIAAAFAMLSLGAKGDTHDEILEGLNFNLTEI----PEAQIHEGFQELLHTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|1IZ2|A Chain A, Interactions Causing The Kinetic Trap In Serpin Protein Folding Length = 394

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP S+     + S GA G T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NILFSPVSIAAAFAMLSLGAKGDTHDEILEGLNFNLTEI----PEAQIHEGFQELLHTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|1OO8|A Chain A, Crystal Structure Of A1pi-Pittsburgh In The Native Conformation Length = 394

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP S+     + S GA G T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NILFSPVSIAAAFAMLSLGAKGDTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|1KCT|A Chain A, Alpha1-Antitrypsin Length = 394

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S GA G T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NIFFSPVSIAAAFAMLSLGAKGDTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|1QMB|A Chain A, Cleaved Alpha-1-Antitrypsin Polymer Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 6/187 (3%)
Query: 113 NLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLS 172
            LA     N   SP S+     + S G    T + +++GL    +E      +  I +  
Sbjct: 16  QLAHQSSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAAIHEGF 71
Query: 173 KDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
           ++    ++Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K+
Sbjct: 72  QELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQ 131
Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
           +ND+V   T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   
Sbjct: 132 INDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVT 189
Query: 293 SVQVPLM 299
           +V+VP+M
Sbjct: 190 TVKVPMM 196

>pdb|1HP7|A Chain A, A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-Antitrypsin Shows Variability Of The Reactive Center And Other Loops Length = 394

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G  G T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NIFFSPVSIATAFAMLSLGTKGDTHDEILEGLNFNLTEI----PEAQIHEGFQELLHTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|1OVA|B Chain B, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL---LKDYKGIIDQLSKDYK 176
           EN    P ++   L +   GA  ST   + K +R          ++   G    +    +
Sbjct: 26  ENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHSSLR 85
Query: 177 GIIDQLSKSPEL---KIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            I++Q++K  ++    +A+++Y  +   + P Y     + +   L  ++F      A+E+
Sbjct: 86  DILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQAREL 145
Query: 234 -NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N WV + TN  I+++++  S+D+ T +VL+NAI FKG W   FK E T+  PF + +  
Sbjct: 146 INSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQE 205
Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYG 324
           S  V +M+    F +   A E   K+LELP+ 
Sbjct: 206 SKPVQMMYQIGLFRVASMASEK-MKILELPFA 236

>pdb|1OVA|C Chain C, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL---LKDYKGIIDQLSKDYK 176
           EN    P ++   L +   GA  ST   + K +R          ++   G    +    +
Sbjct: 26  ENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHSSLR 85
Query: 177 GIIDQLSKSPEL---KIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            I++Q++K  ++    +A+++Y  +   + P Y     + +   L  ++F      A+E+
Sbjct: 86  DILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQAREL 145
Query: 234 -NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N WV + TN  I+++++  S+D+ T +VL+NAI FKG W   FK E T+  PF + +  
Sbjct: 146 INSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQE 205
Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYG 324
           S  V +M+    F +   A E   K+LELP+ 
Sbjct: 206 SKPVQMMYQIGLFRVASMASEK-MKILELPFA 236

>pdb|1OVA|A Chain A, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL---LKDYKGIIDQLSKDYK 176
           EN    P ++   L +   GA  ST   + K +R          ++   G    +    +
Sbjct: 26  ENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDXIEAQCGTSVNVHSSLR 85
Query: 177 GIIDQLSKSPEL---KIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            I++Q++K  ++    +A+++Y  +   + P Y     + +   L  ++F      A+E+
Sbjct: 86  DILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQAREL 145
Query: 234 -NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N WV + TN  I+++++  S+D+ T +VL+NAI FKG W   FK E T+  PF + +  
Sbjct: 146 INSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQE 205
Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYG 324
           S  V +M+    F +   A E   K+LELP+ 
Sbjct: 206 SKPVQMMYQIGLFRVASMASEK-MKILELPFA 236

>pdb|2V95|A Chain A, Struture Of Corticosteroid-Binding Globulin In Complex With Cortisol Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 97/186 (52%), Gaps = 9/186 (4%)
Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           +A N  +N +ISP S+ + L + S G+A + +   ++ L    +ET     +  I Q  +
Sbjct: 25  VALNPDKNTLISPVSISMALAMVSLGSAQTQS---LQSLGFNLTET----SEAEIHQSFQ 77
Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
               ++ Q     E+ + N ++  + ++L  ++       + SE   +DF     A++++
Sbjct: 78  YLNYLLKQSDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFEDWTKASQQI 137
Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N  V + T  KI+ +     LD+    +L+N I  +G W +PF PE T++  FY+++T++
Sbjct: 138 NQHVKDKTQGKIEHVFS--DLDSPASFILVNYIFLRGIWELPFSPENTREEDFYVNETST 195
Query: 294 VQVPLM 299
           V+VP+M
Sbjct: 196 VKVPMM 201

>pdb|1JTI|A Chain A, Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin Mutant R339t Length = 385

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL---LKDYKGIIDQLSKDYK 176
           EN    P ++   L +   GA  ST   + K +R          ++   G    +    +
Sbjct: 25  ENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHSSLR 84
Query: 177 GIIDQLSKSPEL---KIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            I++Q++K  ++    +A+++Y  +   + P Y     + +   L  ++F      A+E+
Sbjct: 85  DILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQAREL 144
Query: 234 -NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N WV + TN  I+++++  S+D+ T +VL+NAI FKG W   FK E T+  PF + +  
Sbjct: 145 INSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKTFKDEDTQAMPFRVTEQE 204
Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYG 324
           S  V +M+    F +   A E   K+LELP+ 
Sbjct: 205 SKPVQMMYQIGLFRVASMASEK-MKILELPFA 235

>pdb|1UHG|A Chain A, Crystal Structure Of S-ovalbumin At 1.9 Angstrom Resolution Length = 385

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL---LKDYKGIIDQLSKDYK 176
           EN    P ++   L +   GA  ST   + K +R          ++   G    +    +
Sbjct: 25  ENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDXIEAQCGTSVNVHSSLR 84
Query: 177 GIIDQLSKSPEL---KIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
            I++Q++K  ++    +A+++Y  +   + P Y     + +   L  ++F      A+E+
Sbjct: 85  DILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQAREL 144
Query: 234 -NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N WV + TN  I+++++  S+D+ T +VL+NAI FKG W   FK E T+  PF + +  
Sbjct: 145 INSWVESQTNGIIRNVLQPXSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQE 204
Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYG 324
           S  V +M+    F +   A E   K+LELP+ 
Sbjct: 205 SKPVQMMYQIGLFRVASMASEK-MKILELPFA 235

>pdb|1D5S|A Chain A, Crystal Structure Of Cleaved Antitrypsin Polymer Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 30  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 85
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 86  QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 145
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 146 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 202

>pdb|1EZX|A Chain A, Crystal Structure Of A Serpin:protease Complex Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 26  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 81
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 82  QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 141
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 142 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 198

>pdb|7API|A Chain A, The S Variant Of Human Alpha1-Antitrypsin, Structure And Implications For Function And Metabolism Length = 347

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 38  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 93
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 94  QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 153
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 154 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 210

>pdb|2HI9|A Chain A, Crystal Structure Of Human Native Protein C Inhibitor Length = 363

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRI---KHSET-LLKDYKGIIDQ 170
           +A   +N   SP S+ + L + S GA  ST   +++GL +   K SE  L + ++ ++ +
Sbjct: 15  SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQE 74
Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++   G         +L + N ++    ++L   + +     + ++    +F     A 
Sbjct: 75  LNQPRDGF--------QLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAM 126
Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++ND+V+  T  KI DL+K  +LD++  ++++N I FK KW   F  + T++  FY+  
Sbjct: 127 KQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTS 184
Query: 291 TNSVQVPLMFVKDSFY 306
              V+VP+M  +D ++
Sbjct: 185 ETVVRVPMMSREDQYH 200

>pdb|3DY0|A Chain A, Crystal Structure Of Cleaved Pci Bound To Heparin Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRI---KHSE-TLLKDYKGIIDQ 170
           +A   +N   SP S+ + L + S GA  ST   +++GL +   K SE  L + ++ ++ +
Sbjct: 22  SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQE 81
Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++   G         +L + N ++    ++L   + +     + ++    +F     A 
Sbjct: 82  LNQPRDGF--------QLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAM 133
Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++ND+V+  T  KI DL+K  +LD++  ++++N I FK KW   F  + T++  FY+  
Sbjct: 134 KQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTS 191
Query: 291 TNSVQVPLMFVKDSFY 306
              V+VP+M  +D ++
Sbjct: 192 ETVVRVPMMSREDQYH 207

>pdb|1LQ8|A Chain A, Crystal Structure Of Cleaved Protein C Inhibitor Length = 346

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRI---KHSE-TLLKDYKGIIDQ 170
           +A   +N   SP S+ + L + S GA  ST   +++GL +   K SE  L + ++ ++ +
Sbjct: 29  SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQE 88
Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++   G         +L + N ++    ++L   + +     + ++    +F     A 
Sbjct: 89  LNQPRDGF--------QLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAM 140
Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++ND+V+  T  KI DL+K  +LD++  ++++N I FK KW   F  + T++  FY+  
Sbjct: 141 KQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTS 198
Query: 291 TNSVQVPLMFVKDSFY 306
              V+VP+M  +D ++
Sbjct: 199 ETVVRVPMMSREDQYH 214

>pdb|3NDF|A Chain A, Cleaved Antitrypsin With P8-P6 Asp Length = 343

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 34  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 89
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 90  QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 149
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 150 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 206

>pdb|2OL2|A Chain A, High Resolution Structure Of Native Pci In Space Group P21 Length = 395

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRI---KHSE-TLLKDYKGIIDQ 170
           +A   +N   SP S+ + L + S GA  ST   +++GL +   K SE  L + ++ ++ +
Sbjct: 47  SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQE 106
Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++   G         +L + N ++    ++L   + +     + ++    +F     A 
Sbjct: 107 LNQPRDGF--------QLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAM 158
Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++ND+V+  T  KI DL+K  +LD++  ++++N I FK KW   F  + T++  FY+  
Sbjct: 159 KQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTS 216
Query: 291 TNSVQVPLMFVKDSFY 306
              V+VP+M  +D ++
Sbjct: 217 ETVVRVPMMSREDQYH 232

>pdb|3T1P|A Chain A, Crystal Structure Of An Alpha-1-Antitrypsin Trimer Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 26  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 81
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 82  QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 141
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 142 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 198

>pdb|3NDD|A Chain A, Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Length = 343

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 34  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 89
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 90  QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 149
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 150 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 206

>pdb|1PSI|A Chain A, Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 To Leu Length = 394

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NILFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|3DRM|A Chain A, 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- Antitrypsin Length = 404

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 59  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 114
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 115 QPDSQLQLTFGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 174
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 175 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 231

>pdb|3NE4|A Chain A, 1.8 Angstrom Structure Of Intact Native Wild-Type Alpha-1-Antitrypsin Length = 424

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 79  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 134
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 135 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 194
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 195 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 251

>pdb|1QLP|A Chain A, 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsin: A Canonical Template For Active Serpins Length = 394

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|2QUG|A Chain A, Crystal Structure Of Alpha-1-Antitrypsin, Crystal Form A Length = 394

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 49  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 104
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 105 QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 164
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 165 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 221

>pdb|3DRU|A Chain A, Crystal Structure Of Gly117phe Alpha1-Antitrypsin Length = 404

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 6/179 (3%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N   SP S+     + S G    T + +++GL    +E      +  I +  ++    ++
Sbjct: 59  NIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEI----PEAQIHEGFQELLRTLN 114
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
           Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++ND+V   
Sbjct: 115 QPDSQLQLTTGNFLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKG 174
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
           T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V+VP+M
Sbjct: 175 TQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMM 231

>pdb|1XU8|A Chain A, The 2.8 A Structure Of A Tumour Suppressing Serpin Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP  L   L LA  GA G TA  + + L  ++    +KD       ++ D    ++
Sbjct: 32  NVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFEN----VKDVPFGFQTVTSD----VN 83
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK-EMNDWVSN 239
           +LS    LK+  ++Y  K + L+  + +     +  EL  VDF       K ++N+ + +
Sbjct: 84  KLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKD 143
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T+   ++++  +S++  TK++++NA +F GKW   F    TK+ PF L+ T++  V +M
Sbjct: 144 LTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFPESETKECPFRLNKTDTKPVQMM 203
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY 323
            ++ +F M         K++ELP+
Sbjct: 204 NMEATFCMG-NIDSINCKIIELPF 226

>pdb|1WZ9|A Chain A, The 2.1 A Structure Of A Tumour Suppressing Serpin Length = 375

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP  L   L LA  GA G TA  + + L  ++    +KD       ++ D    ++
Sbjct: 27  NVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFEN----VKDVPFGFQTVTSD----VN 78
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK-EMNDWVSN 239
           +LS    LK+  ++Y  K + L+  + +     +  EL  VDF       K ++N+ + +
Sbjct: 79  KLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKD 138
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T+   ++++  +S++  TK++++NA +F GKW   F    TK+ PF L+ T++  V +M
Sbjct: 139 LTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFPESETKEXPFRLNKTDTKPVQMM 198
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY 323
            ++ +F M         K++ELP+
Sbjct: 199 NMEATFXMG-NIDSINXKIIELPF 221

>pdb|1XQG|A Chain A, 3.10 A Crystal Structure Of Maspin, Space Group P 4 21 2 Length = 389

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 105/204 (51%), Gaps = 10/204 (4%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N + SP +L   L LA  GA G TA  + + L  ++    +KD       ++ D    ++
Sbjct: 41  NVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFEN----VKDVPFGFQTVTSD----VN 92
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK-EMNDWVSN 239
           +LS    LK+  ++Y  K + L+  + +     +  EL  VDF       K ++N+ + +
Sbjct: 93  KLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKD 152
Query: 240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM 299
            T+   ++++  +S++  TK++++NA +F GKW   F    TK+ PF ++ T++  V +M
Sbjct: 153 LTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFSESETKESPFRVNKTDTKPVQMM 212
Query: 300 FVKDSFYMYEEAGEDGFKMLELPY 323
            ++ +F M      +  K++ELP+
Sbjct: 213 NMEATFSMGNIDSINS-KIIELPF 235

>pdb|1F0C|A Chain A, Structure Of The Viral Serpin Crma Length = 305

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 118 KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKG 177
           K EN  ISP S+  VL +  +GA GSTAE                       QLSK  + 
Sbjct: 12  KGENVFISPPSISSVLTILYYGANGSTAE-----------------------QLSKYVEK 48
Query: 178 IIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWV 237
             D+       K  NK+Y         ++  +  DNF +    VDF+        +N  V
Sbjct: 49  EADKNKDDISFKSMNKVYGRYSAVFKDSFLRKIGDNFQT----VDFTDC-RTVDAINKCV 103
Query: 238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVP 297
              T  KI  L+  + L   T L+ I+A++FK KW +PF+ E T D PFY+  T  V V 
Sbjct: 104 DIFTEGKINPLLD-EPLSPDTCLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVS 162
Query: 298 LMFVKDSFYMYEEAGED--GFKMLELPYGVSISFII 331
           +M +    + +    E    F ++ELPY    S ++
Sbjct: 163 MMSMYGEAFNHASVKESFGNFSIIELPYVGDTSMVV 198

>pdb|4AJT|A Chain A, The Cystal Structure Of Mouse Protein-Z Dependent Protease Inhibitor(Mzpi) Length = 427

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N I SPF L V +     G  G T   +  GL ++     L     +I  L   +K + +
Sbjct: 80  NVIFSPFGLSVAMVNLMLGTKGETKVQIENGLNLQA----LSQAGPLI--LPALFKKVKE 133
Query: 181 QLSKSPELKIANK--IYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS 238
             S + +L ++     +  KD ++   Y   +   F+ E   ++F     A   +N  + 
Sbjct: 134 TFSSNRDLGLSQGSFAFIHKDFDIKETYFNLSKKYFDIEYVSINFQNSSQARGLINHCIV 193
Query: 239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPL 298
             T  KI  L   D ++  TKL+L++ + FKGKW  PF P  T+   F+LD   +++VP+
Sbjct: 194 KETEGKIPKLF--DEINPETKLILVDYVLFKGKWLTPFDPSFTEADTFHLDKYRAIKVPM 251
Query: 299 MFVKDSFYMYEEAGEDGFK--MLELPYGVSISFII 331
           M+ + +F       +  F+  +L+LPY  + + ++
Sbjct: 252 MYREGNF---TSTFDKKFRCHILKLPYQGNATMLV 283

>pdb|1C8O|A Chain A, 2.9 A Structure Of Cleaved Viral Serpin Crma Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 118 KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKG 177
           K EN  ISP S+  VL +  +GA GSTAE                       QLSK  + 
Sbjct: 12  KGENVFISPPSISSVLTILYYGANGSTAE-----------------------QLSKYVEK 48
Query: 178 IIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWV 237
             D+       K  NK+Y         ++  +  DNF +    VDF+        +N  V
Sbjct: 49  EADKNKDDISFKSMNKVYGRYSAVFKDSFLRKIGDNFQT----VDFTDS-RTVDAINKSV 103
Query: 238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVP 297
              T  KI  L+  + L   T L+ I+A++FK KW +PF+ E T D PFY+  T  V V 
Sbjct: 104 DIFTEGKINPLLD-EPLSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVS 162
Query: 298 LMFVKDSFYMYEEAGED--GFKMLELPYGVSISFII 331
           +M +    + +    E    F ++ELPY    S ++
Sbjct: 163 MMSMYGEAFNHASVKESFGNFSIIELPYVGDTSMVV 198

>pdb|1JMO|A Chain A, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin Complex Length = 480

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 16/227 (7%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            N  +N  I+P  +   +G+ S G  G T E +   L  K        Y+  I  +   +
Sbjct: 126 VNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYE--ITTIHNLF 183
Query: 176 KGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
           + +  +L +      L+  N +Y  K   +   ++T+  + + +E    DFS P   +K 
Sbjct: 184 RKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPAFISK- 242
Query: 233 MNDWVSNHTNDKIKDLIK--ADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
                +NH     K LIK   +++D +T+++++N I+FKG W   F  E T +  F L++
Sbjct: 243 ----TNNHIMKLTKGLIKDALENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNE 298
Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVP 337
              V+V +M  K +F    +   D   +L+L Y   IS +I   VVP
Sbjct: 299 REVVKVSMMQTKGNFLAANDQELDC-DILQLEYVGGISMLI---VVP 341

>pdb|1JMJ|A Chain A, Crystal Structure Of Native Heparin Cofactor Ii Length = 480

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 16/227 (7%)
Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            N  +N  I+P  +   +G+ S G  G T E +   L  K        Y+  I  +   +
Sbjct: 126 VNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYE--ITTIHNLF 183
Query: 176 KGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
           + +  +L +      L+  N +Y  K   +   ++T+  + + +E    DFS P   +K 
Sbjct: 184 RKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPAFISK- 242
Query: 233 MNDWVSNHTNDKIKDLIK--ADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
                +NH     K LIK   +++D +T+++++N I+FKG W   F  E T +  F L++
Sbjct: 243 ----TNNHIMKLTKGLIKDALENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNE 298
Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVP 337
              V+V +M  K +F    +   D   +L+L Y   IS +I   VVP
Sbjct: 299 REVVKVSMMQTKGNFLAANDQELDC-DILQLEYVGGISMLI---VVP 341

>pdb|3STO|A Chain A, Serpin From The Trematode Schistosoma Haematobium Length = 406

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 100/223 (44%), Gaps = 13/223 (5%)
Query: 120 ENAIISPFSLHVVLG--LASFGAAGSTAEAMMKGLRIKHSETLL------KDYKGIIDQL 171
           +N +  P  +   LG  L S GA G T   + K  R+K + +        ++ K +  +L
Sbjct: 37  DNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTXRLKSTSSSWNSSEAQQEXKSLYQEL 96
Query: 172 SKDYKGIIDQLSKSPE--LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAA 229
           +         L++  E  ++I+  I+  K  E+   +     ++   EL +VDFS   +A
Sbjct: 97  NNSLTSEKTFLNEKEENVVRISTGIFVEKTYEVERRFNESIANDSEGELKQVDFSNRTSA 156
Query: 230 AKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLD 289
             ++NDWV   +N  ++     D +   T  +L+N  +F+  W  PF+P  T+   FY+ 
Sbjct: 157 TVDINDWVDQQSNGLLEKFF-TDDIPDDTAXILVNVFYFRDFWQSPFEPHYTRKEDFYIS 215
Query: 290 DTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               + V     ++    Y +  ++GF+++  P      +F+I
Sbjct: 216 PDRQITVDXX-TQEGVXKYGKFEDEGFEIVSKPLNNTRFTFVI 257

>pdb|1IMV|A Chain A, 2.85 A Crystal Structure Of Pedf Length = 398

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 15/212 (7%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGL--RIKHSETLLKDYKGIIDQLSKDYKGI 178
           N ++SP S+   L   S GA   T   + + L   +  S  +   YK ++D ++   K  
Sbjct: 57  NVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDIHGTYKELLDTVTAPQKN- 115
Query: 179 IDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS 238
                    LK A++I F K + +  ++      ++ +   +V    P    +E+N+WV 
Sbjct: 116 ---------LKSASRIVFEKKLRIKSSFVAPLEKSYGTR-PRVLTGNPRLDLQEINNWVQ 165
Query: 239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPL 298
                K+    K   +     ++L+   HFKG+W   F    T    FYLD+  +V+VP+
Sbjct: 166 AQMKGKLARSTK--EIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPM 223
Query: 299 MFVKDSFYMYEEAGEDGFKMLELPYGVSISFI 330
           M    +   Y    +   K+ +LP   S+S I
Sbjct: 224 MSDPKAVLRYGLDSDLSCKIAQLPLTGSMSII 255

>pdb|2R9Y|A Chain A, Structure Of Antiplasmin Length = 430

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIID 180
           N ++SP S+ + L   + GA   T  ++ + L +     L          LS  Y+ +  
Sbjct: 44  NLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTGSCL-------PHLLSHFYQNL-- 94
Query: 181 QLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNH 240
                  +++A +IY  K   +   +  Q+   F ++  K+   Q    A  +N WV   
Sbjct: 95  ---GPGTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTGKQEEDLAN-INQWVKEA 150
Query: 241 TNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMF 300
           T  KI+D +    L  ST L+L+NAIHF G W   F P  T+   F+LD+  +V V +M 
Sbjct: 151 TEGKIEDFLS--ELPDSTVLLLLNAIHFHGFWRTKFDPSLTQKDFFHLDERFTVSVDMMH 208
Query: 301 VKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
                  +    +   ++   P+  ++SF++
Sbjct: 209 AVSYPLRWFLLEQPEIQVAHFPFKNNMSFVV 239

>pdb|4AU2|A Chain A, Crystal Structure Of A Hsp47-Collagen Complex Length = 392

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/215 (20%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGST---AEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           EN ++SP  +   LGL S G   +T   A+A++   +++  E     + G+ + L    +
Sbjct: 31  ENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLRDEEV----HAGLGELL----R 82
Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
            + +  +++   K+ +++Y    +     +   +  ++N E  K++F    +A + +N+W
Sbjct: 83  SLSNSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRDKRSALQSINEW 142
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
            +  T+ K+ ++ K   ++ +   +L+NA+ FK  W   F  +   +  F +  + +V V
Sbjct: 143 AAQTTDGKLPEVTK--DVERTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGV 200
Query: 297 PLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            +M  +   Y Y +  ++  +++E+P    +S +I
Sbjct: 201 TMMH-RTGLYNYYDDEKEKLQIVEMPLAHKLSSLI 234

>pdb|2OAY|A Chain A, Crystal Structure Of Latent Human C1-Inhibitor Length = 390

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 31/185 (16%)
Query: 121 NAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL---KDYKGIIDQLSK-DYK 176
           N   SPFS+  +L     GA  +T   +         E++L   KD+  +   L     K
Sbjct: 56  NMAFSPFSIASLLTQVLLGAGENTKTNL---------ESILSYPKDFTCVHQALKGFTTK 106
Query: 177 GI--IDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           G+  + Q+  SP+L I       +D  +N      A     S   +V  +   A  + +N
Sbjct: 107 GVTSVSQIFHSPDLAI-------RDTFVN------ASRTLYSSSPRVLSNNSDANLELIN 153
Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV+ +TN+KI  L+  DSL + T+LVL+NAI+   KW   F P+ T+  PF+  ++  +
Sbjct: 154 TWVAKNTNNKISRLL--DSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFKNS-VI 210
Query: 295 QVPLM 299
           +VP+M
Sbjct: 211 KVPMM 215

>pdb|4AU3|A Chain A, Crystal Structure Of A Hsp47-Collagen Complex Length = 392

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/215 (20%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGST---AEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           EN ++SP  +   LGL S G   +T   A+A++   +++  E     + G+ + L    +
Sbjct: 31  ENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLRDEEV----HAGLGELL----R 82
Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
            + +  +++   K+ +++Y    +     +   +  ++N E  K++F    +A + +N+W
Sbjct: 83  SLSNSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRDKRSALQSINEW 142
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
            +  T+ K+ ++ K   ++ +   +L+NA  FK  W   F  +   +  F +  + +V V
Sbjct: 143 AAQTTDGKLPEVTK--DVERTDGALLVNAXFFKPHWDEKFHHKXVDNRGFXVTRSYTVGV 200
Query: 297 PLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
                +   Y Y +  ++  +++E P    +S +I
Sbjct: 201 TXXH-RTGLYNYYDDEKEKLQIVEXPLAHKLSSLI 234

>pdb|4AU3|B Chain B, Crystal Structure Of A Hsp47-Collagen Complex Length = 392

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/215 (20%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 120 ENAIISPFSLHVVLGLASFGAAGST---AEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
           EN ++SP  +   LGL S G   +T   A+A++   +++  E     + G+ + L    +
Sbjct: 31  ENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLRDEEV----HAGLGELL----R 82
Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
            + +  +++   K+ +++Y    +     +   +  ++N E  K++F    +A + +N+W
Sbjct: 83  SLSNSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRDKRSALQSINEW 142
Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
            +  T+ K+ ++ K   ++ +   +L+NA  FK  W   F  +   +  F +  + +V V
Sbjct: 143 AAQTTDGKLPEVTK--DVERTDGALLVNAXFFKPHWDEKFHHKXVDNRGFXVTRSYTVGV 200
Query: 297 PLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
                +   Y Y +  ++  +++E P    +S +I
Sbjct: 201 TXXH-RTGLYNYYDDEKEKLQIVEXPLAHKLSSLI 234

>pdb|1M93|B Chain B, 1.65 A Structure Of Cleaved Viral Serpin Crma Length = 245

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 188 LKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKD 247
            K  NK+Y         ++  +  DNF +    VDF+        +N  V   T  KI  
Sbjct: 4   FKSMNKVYGRYSAVFKDSFLRKIGDNFQT----VDFTDS-RTVDAINKSVDIFTEGKINP 58
Query: 248 LIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYM 307
           L+  + L   T L+ I+A++FK KW +PF+ E T D PFY+  T  V V +M +    + 
Sbjct: 59  LLD-EPLSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFN 117
Query: 308 YEEAGED--GFKMLELPYGVSISFII 331
           +    E    F ++ELPY    S ++
Sbjct: 118 HASVKESFGNFSIIELPYVGDTSMVV 143

>pdb|2PEF|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Latent State Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           FSI+L     +  + + KEN++ISP S  + L + + GA   T   M K L         
Sbjct: 16  FSIEL-----FKNSIDDKENSLISPLSAMLALAMTANGADNETLAQMEKALG-------- 62
Query: 162 KDYKGIIDQLSKDYKGIIDQL--SKSPELKIANKIYFAKDIELNPA--YQTQAVDNFNSE 217
           KD    I+ L+K     + +L   +  +L IAN I+F K+ +  P+  +     D + ++
Sbjct: 63  KDIS--IEDLNKYLYTYMKKLPNEEKSKLTIANSIWF-KENDFMPSKDFLQIIADYYKAD 119
Query: 218 LGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFK 277
           + K  F    +   ++N+WV + TN  I  ++  + +D    + LINA+ F  +W   ++
Sbjct: 120 IFKAAFDS--STVSDINNWVKSKTNGMIDKIL--NKIDPEDVMYLINAVAFDAEWETVYE 175
Query: 278 PEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEE 310
             +  +  F     N  +V  M  +++ Y+ EE
Sbjct: 176 KASVHEDIFTDVYGNRQKVEFMNSEENLYIEEE 208

>pdb|2PEE|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Native State Length = 387

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           FSI+L     +  + + KEN++ISP S  + L + + GA   T   M K L         
Sbjct: 31  FSIEL-----FKNSIDDKENSLISPLSAMLALAMTANGADNETLAQMEKALG-------- 77
Query: 162 KDYKGIIDQLSKDYKGIIDQL--SKSPELKIANKIYFAKDIELNPA--YQTQAVDNFNSE 217
           KD    I+ L+K     + +L   +  +L IAN I+F K+ +  P+  +     D + ++
Sbjct: 78  KDIS--IEDLNKYLYTYMKKLPNEEKSKLTIANSIWF-KENDFMPSKDFLQIIADYYKAD 134
Query: 218 LGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFK 277
           + K  F    +   ++N+WV + TN  I  ++  + +D    + LINA+ F  +W   ++
Sbjct: 135 IFKAAFDS--STVSDINNWVKSKTNGMIDKIL--NKIDPEDVMYLINAVAFDAEWETVYE 190
Query: 278 PEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEE 310
             +  +  F     N  +V  M  +++ Y+ EE
Sbjct: 191 KASVHEDIFTDVYGNRQKVEFMNSEENLYIEEE 223

>pdb|2VH4|A Chain A, Structure Of A Loop C-sheet Serpin Polymer Length = 381

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           FSI+L     +  + + KEN++ISP S  + L + + GA   T   M K L         
Sbjct: 24  FSIEL-----FKNSIDDKENSLISPLSAMLALAMTANGADNETLAQMEKALG-------- 70
Query: 162 KDYKGIIDQLSKDYKGIIDQL--SKSPELKIANKIYFAKDIELNPA--YQTQAVDNFNSE 217
           KD    I+ L+K     + +L   +  +L IAN I+F K+ +  P+  +     D + ++
Sbjct: 71  KDIS--IEDLNKYLYTYMKKLPNEEKSKLTIANSIWF-KENDFMPSKDFLQIIADYYKAD 127
Query: 218 LGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFK 277
           + K  F    +   ++N+WV + TN  I  ++  + +D    + LINA+ F  +W   ++
Sbjct: 128 IFKAAFDS--STVSDINNWVKSKTNGMIDKIL--NKIDPEDVMYLINAVAFDAEWETVYE 183
Query: 278 PEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEE 310
             +  +  F     N  +V  M  +++ Y+ EE
Sbjct: 184 KASVHEDIFTDVYGNRQKVEFMNSEENLYIEEE 216

>pdb|1MTP|A Chain A, The X-Ray Crystal Structure Of A Serpin From A Thermophilic Prokaryote Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/200 (21%), Positives = 86/200 (43%), Gaps = 20/200 (10%)
Query: 123 IISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQL 182
           I SP+S+   LG+ + GA  +T   +   L    +  L    + + D             
Sbjct: 31  IWSPYSVACALGVLAAGARATTRTELTTLLGTDPAPLLAALDRAVTD------------- 77
Query: 183 SKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-MNDWVSNHT 241
             SP+L     ++ + D+ +  +++    D  +S++   DF   P   +  +N  +++ T
Sbjct: 78  --SPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADAT 135
Query: 242 NDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFV 301
              I++L+   ++    + +L NA+  K +WT PF+   T++G F        +VP M  
Sbjct: 136 RGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTREGTFR-TPRGPKRVPFMHR 194
Query: 302 KDSFYMYEEAGEDGFKMLEL 321
             +      A   G++M+ L
Sbjct: 195 TKTM---PYATARGWRMVTL 211

>pdb|1SNG|A Chain A, Structure Of A Thermophilic Serpin In The Native State Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/200 (21%), Positives = 85/200 (42%), Gaps = 20/200 (10%)
Query: 123 IISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQL 182
           I SP+S+   LG+ + GA  +T   +   L    +  L    + + D             
Sbjct: 35  IWSPYSVAXALGVLAAGARATTRTELTTLLGTDPAPLLAALDRAVTD------------- 81
Query: 183 SKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE-MNDWVSNHT 241
             SP+L     ++ + D+ +  +++    D  +S++   DF   P   +  +N  +++ T
Sbjct: 82  --SPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADAT 139
Query: 242 NDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFV 301
              I++L+   ++    + +L NA+  K +WT PF+   T+ G F        +VP M  
Sbjct: 140 RGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTRAGTFR-TPRGPKRVPFMHR 198
Query: 302 KDSFYMYEEAGEDGFKMLEL 321
             +      A   G++M+ L
Sbjct: 199 TKTM---PYATARGWRMVTL 215

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	342
3ozq_A	376	Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito	2e-76
1sek_A	378	Serpin K; serine protease inhibitor, protease; 2.1	1e-75
1wz9_A	375	Maspin precursor; serpin, tumor suppressor, serpin	2e-74
1lj5_A	379	Plasminogen activator inhibitor-1; beta-barrell, b	2e-74
3f5n_A	407	Neuroserpin; cleaved form, fenib, human, tissue PL	7e-73
3le2_A	393	Serpin-ZX; apoplast, glycoprotein, protease inhibi	9e-73
1hle_A	345	Horse leukocyte elastase inhibitor; hydrolase inhi	1e-72
3kcg_I	432	Antithrombin-III, ATIII; michaelis complex, blood	2e-72
3f02_A	359	Neuroserpin; cleaved form, fenib, human, disease M	7e-72
3pzf_A	397	Serpin 2; protease inhibitor, melanization, hydrol	2e-71
3nda_A	377	Serpin-2; vaccination target, TICK, hydrolase inhi	2e-71
3f1s_A	385	Protein Z-dependent protease inhibitor; PZ, ZPI, c	5e-71
1mtp_A	323	Serine proteinase inhibitor (serpin), chain A; str	7e-71
2arr_A	382	Plasminogen activator inhibitor-2; serpin, peptide	2e-70
1sng_A	370	COG4826: serine protease inhibitor; serine proteas	2e-70
2pef_A	373	Serine protease inhibitor; serpin; 1.60A {Thermoan	4e-70
4dy0_A	379	GLIA-derived nexin; serpin, protease inhibitor, th	5e-70
2h4r_A	415	MENT, heterochromatin-associated protein MENT; ser	1e-69
1yxa_A	398	Serine (OR cysteine) proteinase inhibitor, clade 3	2e-69
2h4p_A	394	MENT, heterochromatin-associated protein MENT; ser	3e-69
1uhg_A	385	Ovalbumin, S-ovalbumin; allergen, egg white protei	3e-69
3sto_A	406	Serine protease inhibitor; serpin fold, hydrolase	3e-69
4au2_A	392	HSP47, serpin peptidase inhibitor, clade H (heat s	3e-69
2zv6_A	401	Serpin B3; serine proteinase inhibitor, reactive s	3e-69
3b9f_I	395	Protein C inhibitor; michaelis complex, acute phas	1e-68
1as4_A	341	Antichymotrypsin, ACT; serpin, serine protease inh	1e-68
2vdx_A	373	Corticosteroid-binding globulin; transport protein	2e-68
3dy0_A	336	N-terminus plasma serine protease inhibitor; serpi	6e-68
1qmn_A	401	AACT, alpha-1-antichymotrypsin; serpin, serine pro	1e-67
3ndd_A	343	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	4e-67
1jmo_A	480	HC-II, heparin cofactor II, HLS2, serin; serpin, t	4e-67
3ne4_A	424	Alpha-1-antitrypsin; serpin, LUNG disease, liver d	5e-67
2ceo_A	379	Thyroxine-binding globulin; transport, serpin, hor	7e-67
1imv_A	398	PEDF, pigment epithelium-derived factor; serpin, a	9e-67
2r9y_A	430	Alpha-2-antiplasmin; inhibitory serpin, plasmin in	3e-66
2xn6_A	350	Thyroxine-binding globulin; transport, cleaved pro	5e-66
2oay_A	390	C1-inhibitor, plasma protease C1 inhibitor, C1 INH	2e-65
2v95_A	371	Corticosteroid-binding globulin; transport protein	2e-64
1f0c_A	305	ICE inhibitor; apoptosis, caspase inhibitor, prote	2e-61
2wxw_A	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	6e-61
2wxy_C	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	3e-60
1m93_B	245	Serine proteinase inhibitor 2; serpin, CRMA, apopt	7e-52
1m93_A	55	Serine proteinase inhibitor 2; serpin, CRMA, apopt	8e-08

>3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} Length = 376

 Score =  238 bits (610), Expect = 2e-76
 Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 11/219 (5%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           +   +K N ++SPFS   +L LA  G  G TAE + + L           + G  ++   
Sbjct: 26  VLKTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLH----------FVGDREKAEG 75

Query: 174 DYKGIIDQLSKS-PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
             K ++ +L+     L  ANKIY   +  +   +Q  AV+ + ++   VDFS+   AAK 
Sbjct: 76  AVKEVLSKLTNEEYTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFSEKNDAAKL 135

Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
           MN WV   T  KI++L+  + L+  T++VLINA++F  KW VPF P  T+   F+     
Sbjct: 136 MNAWVEEQTQHKIQNLVDPEILNNLTRVVLINALYFNAKWLVPFPPFHTRKSDFHKSAKE 195

Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            VQV  M++ + ++ Y E      K+LELP+    S  I
Sbjct: 196 VVQVDTMYLDEQYFNYYECHHLDAKLLELPFKGGASLTI 234

>1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I Length = 378

 Score =  236 bits (605), Expect = 1e-75
 Identities = 70/218 (32%), Positives = 113/218 (51%), Gaps = 11/218 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            AN  +N ++S FS+   LG  +  + G + + +++ L + +       +  +   +   
Sbjct: 28  KANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVRAV 87

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
                    K  +LK+A+KIY AK +ELN  +   + D F SE+  VDF +   AA  +N
Sbjct: 88  ---------KGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSVEAAGAIN 138

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV + TN++IK+L+  D+LD +T+ VL+NAI+FKG W   F  E T D  F++    ++
Sbjct: 139 KWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFNKERTMDRDFHVSKDKTI 198

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           +VP M  K      +   E   KM+E+ Y G   S II
Sbjct: 199 KVPTMIGKKDVRYADVP-ELDAKMIEMSYEGDQASMII 235

>1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A Length = 375

 Score =  233 bits (597), Expect = 2e-74
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 11/219 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
                 N + SP  L   L LA  GA G TA  + + L  ++ + +   ++ +   ++K 
Sbjct: 21  EKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVNK- 79

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-AAAKEM 233
                  LS    LK+  ++Y  K + L+  + +     +  EL  VDF         ++
Sbjct: 80  -------LSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQI 132

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N+ + + T+   ++++  +S++  TK++++NA +F GKW   F    TK+ PF L+ T++
Sbjct: 133 NNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFPESETKECPFRLNKTDT 192

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
             V +M ++ +F M         K++ELP+    +S  I
Sbjct: 193 KPVQMMNMEATFCMGNID-SINCKIIELPFQNKHLSMFI 230

>1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B Length = 379

 Score =  233 bits (596), Expect = 2e-74
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 12/221 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET-LLKDYKGIIDQLSK 173
            A+K  N + SP+ +  VL +      G T + +   +  K  +  +    + +  +L  
Sbjct: 25  QASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMG 84

Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
                        E+   + I+  +D++L   +       F S + +VDFS+   A   +
Sbjct: 85  P--------WNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFII 136

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           NDWV  HT   I +L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++
Sbjct: 137 NDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGST 196

Query: 294 VQVPLMFVKDSFYMYE--EAGEDGFKMLELPY-GVSISFII 331
           V VP+M   + F   E        + +LELPY G ++S  I
Sbjct: 197 VSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFI 237

>3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} Length = 407

 Score =  230 bits (588), Expect = 7e-73
 Identities = 70/223 (31%), Positives = 112/223 (50%), Gaps = 12/223 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A  + EN + SP S+ + +G+   GA GST + +   +     +       G      K+
Sbjct: 36  ATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKN------GEEFSFLKE 89

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           +  ++        +KIAN ++      +N  +       FN+ +  VDFSQ  A A  +N
Sbjct: 90  FSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYIN 149

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV N+TN+ +KDL+     DA+T L LINA++FKG W   F+PE T+   F  DD + V
Sbjct: 150 KWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEV 209

Query: 295 QVPLMFVKDSFYMYE-----EAGEDGFKMLELPY-GVSISFII 331
           Q+P+M+ +  FY  E           +++LE+PY G  IS ++
Sbjct: 210 QIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMML 252

>3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} Length = 393

 Score =  229 bits (587), Expect = 9e-73
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 14/222 (6%)

Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            ++  N I SP S++VVL + + G+AG+T + ++  L+   ++ L      I+  +  D 
Sbjct: 27  VSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFSSTDQLNSFSSEIVSAVLADG 86

Query: 176 KGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-AAAKEMN 234
                  +  P+L +AN  +  K +   P+++    D++ +   + DF         E+N
Sbjct: 87  SA-----NGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAASNQADFQSKAVEVIAEVN 141

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            W    TN  I +++   S D+ TKL+  NA++FKG W   F    T++G F+L D N V
Sbjct: 142 SWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEKFDESLTQEGEFHLLDGNKV 201

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPY-----GVSISFII 331
             P M  K   Y+      DGFK+L LPY         S   
Sbjct: 202 TAPFMTSKKKQYVSA---YDGFKVLGLPYLQGQDKRQFSMYF 240

>1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 345

 Score =  227 bits (581), Expect = 1e-72
 Identities = 71/219 (32%), Positives = 106/219 (48%), Gaps = 11/219 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            ++   N  ISP S+   L +   G  G+TA  + K L     E +   ++ +   ++K 
Sbjct: 22  ESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTVEDIHSRFQSLNADINKP 81

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-AAAKEM 233
                        LK+AN++Y  K       +       + +EL  VDF Q P  A KE+
Sbjct: 82  --------GAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEI 133

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N+WV   T  KI +L+    +D  TKLVL+NAI+FKG W   F  EAT+D PF L+  ++
Sbjct: 134 NEWVKGQTEGKIPELLVKGMVDNMTKLVLVNAIYFKGNWQQKFMKEATRDAPFRLNKKDT 193

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
             V +M+ K  F       +   ++LELPY G  +S II
Sbjct: 194 KTVKMMYQKKKFPYN-YIEDLKCRVLELPYQGKELSMII 231

>3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... Length = 432

 Score =  230 bits (588), Expect = 2e-72
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 6/219 (2%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + N  +N  +SP S+     +   GA   T + +M+  +         D   I    +K 
Sbjct: 69  SKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSD--QIHFFFAKL 126

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-AAAKEM 233
              +  + +K+ +L  AN+++  K +  N  YQ  +   + ++L  +DF +    +   +
Sbjct: 127 NCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI 186

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE T+   FY  D  S
Sbjct: 187 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGES 246

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
               +M+ +  F        +G ++LELP+ G  I+ ++
Sbjct: 247 CSASMMYQEGKFRYRRV--AEGTQVLELPFKGDDITMVL 283

>3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A Length = 359

 Score =  226 bits (578), Expect = 7e-72
 Identities = 70/223 (31%), Positives = 112/223 (50%), Gaps = 12/223 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A  + EN + SP S+ + +G+   GA GST + +   +     +       G      K+
Sbjct: 36  ATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKN------GEEFSFLKE 89

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           +  ++        +KIAN ++      +N  +       FN+ +  VDFSQ  A A  +N
Sbjct: 90  FSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYIN 149

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV N+TN+ +KDL+     DA+T L LINA++FKG W   F+PE T+   F  DD + V
Sbjct: 150 KWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEV 209

Query: 295 QVPLMFVKDSFYMYE-----EAGEDGFKMLELPY-GVSISFII 331
           Q+P+M+ +  FY  E           +++LE+PY G  IS ++
Sbjct: 210 QIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDEISMML 252

>3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} Length = 397

 Score =  226 bits (579), Expect = 2e-71
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 18/226 (7%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGA-------AGSTAEAMMKGLRIKHSETLLKDYKG 166
           +  N   N ++SPFS+ ++L L    +         +T   +   ++  + +     YK 
Sbjct: 33  IFKNHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQNDNIDHTRSYYKQ 92

Query: 167 IIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP 226
           +++   +D        +K  +L IA   +    IE+   YQ  A  ++++ L KV +S P
Sbjct: 93  LLESAQQD--------NKDYDLNIATNFFVDDFIEVINKYQQIANTHYHAMLEKVSYSNP 144

Query: 227 PAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPF 286
              A  +N+WVS HTN ++++++  DSL+    + L+N I+FKG WT PF   A    PF
Sbjct: 145 TQTAATINNWVSEHTNGRLREIVTPDSLE-GAVITLVNVIYFKGLWTYPFPEVANNVKPF 203

Query: 287 YLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           Y           M     FY    A + G ++L LPY G  ++   
Sbjct: 204 YGTRGKPTNAQYMEQNGQFYYDNSA-DLGAQILRLPYRGNKLAMYF 248

>3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} Length = 377

 Score =  225 bits (576), Expect = 2e-71
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 16/224 (7%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIID 169
           L +  ++N   SP+S+   +G+A  GA G T + + +GL     +     +L  Y    +
Sbjct: 22  LPSGPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGFSDVDLTDAGVLDAYTHHTE 81

Query: 170 QLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-A 228
           +L             +  L +AN     + + L  +Y++    +F +EL KVDF+  P A
Sbjct: 82  RLKST--------PSNSTLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFAGEPQA 133

Query: 229 AAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYL 288
           A   +N+WV   T+DKI+ L   + LD  T LVL+NAI+FKG+W   F  E T+   F+ 
Sbjct: 134 AVDFVNNWVKRKTHDKIEKLFN-EPLDPDTLLVLLNAIYFKGEWNTAFVKEHTEKRQFFN 192

Query: 289 DDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
                V+V  M ++          +   +++ELPY G+  +  I
Sbjct: 193 GGVTPVEVDTMRLEARIKYRFFD-DLQVEVVELPYRGLDYTMAI 235

>3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* Length = 385

 Score =  225 bits (575), Expect = 5e-71
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 12/221 (5%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSK 173
           ++     N + SPF + + +     GA G T   + +GL ++  +            L  
Sbjct: 31  ISMRHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALK------PTKPGLLPS 84

Query: 174 DYKGIIDQLSKSP--ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK 231
            +KG+ + LS++    L   +  +  KD ++   +   +   F++E   ++F     A +
Sbjct: 85  LFKGLRETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKR 144

Query: 232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
            MN +++  T  KI  L   D ++  TKL+L++ I FKGKW  PF P  T+   F+LD  
Sbjct: 145 LMNHYINKETRGKIPKLF--DEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKY 202

Query: 292 NSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
            +++VP+M+    F    +       +L+LPY G +   ++
Sbjct: 203 KTIKVPMMYGAGKFASTFDK-NFRCHVLKLPYQGNATMLVV 242

>1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 Length = 323

 Score =  222 bits (568), Expect = 7e-71
 Identities = 42/218 (19%), Positives = 89/218 (40%), Gaps = 20/218 (9%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            A      I SP+S+   LG+ + GA  +T   +   L    +  L              
Sbjct: 23  EAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLGTDPAPLL-------------- 68

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEM 233
              +   ++ SP+L     ++ + D+ +  +++    D  +S++   DF + P      +
Sbjct: 69  -AALDRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATV 127

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N  +++ T   I++L+   ++    + +L NA+  K +WT PF+   T++G F       
Sbjct: 128 NADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTREGTFRTPR-GP 186

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            +VP M    +          G++M+ L     ++  +
Sbjct: 187 KRVPFMHRTKTMPYAT---ARGWRMVTLHAHDELAVDV 221

>2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A Length = 382

 Score =  223 bits (571), Expect = 2e-70
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 12/221 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            A+  +N  +SP+S+   + +   G+ GST + M   L+               D++   
Sbjct: 21  KASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFNEVGAAA-------DKIHSS 73

Query: 175 YKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-AAA 230
           ++ +   ++ S     L+  NK++  K       Y       ++SE   VDF +    A 
Sbjct: 74  FRSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEAR 133

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++N WV   T  KI +L+   S+D  T++VL+NA++FKGKW  PF+ +     PF ++ 
Sbjct: 134 KKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLFPFRVNS 193

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
                V +M++++         +   ++LELPY   +S  +
Sbjct: 194 AQRTPVQMMYLREKLN-IGYIEDLKAQILELPYAGDVSMFL 233

>1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 Length = 370

 Score =  222 bits (569), Expect = 2e-70
 Identities = 42/218 (19%), Positives = 88/218 (40%), Gaps = 20/218 (9%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            A      I SP+S+   LG+ + GA  +T   +   L    +  L              
Sbjct: 27  EAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLGTDPAPLL-------------- 72

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEM 233
              +   ++ SP+L     ++ + D+ +  +++    D  +S++   DF + P      +
Sbjct: 73  -AALDRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATV 131

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N  +++ T   I++L+   ++    + +L NA+  K +WT PF+   T+ G F       
Sbjct: 132 NADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTRAGTFRTPR-GP 190

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            +VP M    +          G++M+ L     ++  +
Sbjct: 191 KRVPFMHRTKTMPYAT---ARGWRMVTLHAHDELAVDV 225

>2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A Length = 373

 Score =  222 bits (568), Expect = 4e-70
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 22/220 (10%)

Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            + KEN++ISP S  + L + + GA   T   M K L    S           + L+K  
Sbjct: 25  IDDKENSLISPLSAMLALAMTANGADNETLAQMEKALGKDISI----------EDLNKYL 74

Query: 176 KGIIDQLSKSP--ELKIANKIYFA-KDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
              + +L      +L IAN I+F   D   +  +     D + +++ K  F    +   +
Sbjct: 75  YTYMKKLPNEEKSKLTIANSIWFKENDFMPSKDFLQIIADYYKADIFKAAFDS--STVSD 132

Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
           +N+WV + TN  I  ++  + +D    + LINA+ F  +W   ++  +  +  F     N
Sbjct: 133 INNWVKSKTNGMIDKIL--NKIDPEDVMYLINAVAFDAEWETVYEKASVHEDIFTDVYGN 190

Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
             +V  M  +++ Y+     E+       PY     SF+ 
Sbjct: 191 RQKVEFMNSEENLYI----EEENAVGFVKPYAKNHYSFVA 226

>4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C Length = 379

 Score =  222 bits (567), Expect = 5e-70
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 13/221 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            +   +N +ISP  +  VLG+   GA G T + +   +R   +          + ++ K 
Sbjct: 25  KSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVNG---------VGKILKK 75

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
               I        + +AN ++     E+   + T+  D F  E+  V+F  P +A   +N
Sbjct: 76  INKAIVSKKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFEDPASACDSIN 135

Query: 235 DWVSNHTNDKIKDLIKADSLDAS-TKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
            WV N T D I +L+  D +D   T+LVL+NA++FKG W   F+PE TK   F   D  S
Sbjct: 136 AWVKNETRDMIDNLLSPDLIDGVLTRLVLVNAVYFKGLWKSRFQPENTKKRTFVAADGKS 195

Query: 294 VQVPLMFVKDSFYMYE--EAGEDGFKMLELPY-GVSISFII 331
            QVP++     F         +  +  +ELPY G SIS +I
Sbjct: 196 YQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGESISMLI 236

>2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A Length = 415

 Score =  222 bits (567), Expect = 1e-69
 Identities = 72/239 (30%), Positives = 112/239 (46%), Gaps = 23/239 (9%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDY---------- 164
             N+ +N   SP+S+   L L    A GSTA  M + L    +                 
Sbjct: 26  ETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRPK 85

Query: 165 -------KGIIDQLSKDYKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNF 214
                      + +   +K ++   +K      L+ AN+IY  K   L P Y   +   +
Sbjct: 86  RRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYY 145

Query: 215 NSELGKVDFSQ-PPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWT 273
            +E  KV+F   P  + KE+N WV   T  KIK+L+ +D + A+T+L+L+NAI+FK +W 
Sbjct: 146 KAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWE 205

Query: 274 VPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           V F+ E T   PF L    S  V +M+++D+F +     +  FKM+ELPY    +S  I
Sbjct: 206 VKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIME-KMNFKMIELPYVKRELSMFI 263

>1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} Length = 398

 Score =  221 bits (565), Expect = 2e-69
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 17/232 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIIDQ 170
             N   N + SP S+   L L S GA G+T E +++GL+   +ET    + + +  ++ +
Sbjct: 44  LKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTETSEADIHQGFGHLLQR 103

Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++             ++   + ++  K  ++   +Q +A   + +E    DF QP  A 
Sbjct: 104 LNQP--------KDQVQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADFQQPRQAK 155

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K +ND+V   T   IK+L+    LD  T +VL+N I+FK KW VPF P  T    FY   
Sbjct: 156 KLINDYVRKQTQGMIKELVS--DLDKRTLMVLVNYIYFKAKWKVPFDPLDTFKSEFYCGK 213

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
              V VP+M ++D    Y    E    ++EL Y  + S +    ++P+ GR+
Sbjct: 214 RRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYTGNASALF---ILPDQGRM 262

>2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A Length = 394

 Score =  220 bits (563), Expect = 3e-69
 Identities = 72/239 (30%), Positives = 112/239 (46%), Gaps = 23/239 (9%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDY---------- 164
             N+ +N   SP+S+   L L    A GSTA  M + L    +                 
Sbjct: 46  ETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRPK 105

Query: 165 -------KGIIDQLSKDYKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNF 214
                      + +   +K ++   +K      L+ AN+IY  K   L P Y   +   +
Sbjct: 106 RRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYY 165

Query: 215 NSELGKVDFSQ-PPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWT 273
            +E  KV+F   P  + KE+N WV   T  KIK+L+ +D + A+T+L+L+NAI+FK +W 
Sbjct: 166 KAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWE 225

Query: 274 VPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           V F+ E T   PF L    S  V +M+++D+F +     +  FKM+ELPY    +S  I
Sbjct: 226 VKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLIME-KMNFKMIELPYVKRELSMFI 283

>1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A Length = 385

 Score =  220 bits (562), Expect = 3e-69
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 9/225 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLR---IKHSETLLKDYKGIIDQL 171
             +  EN    P ++   L +   GA  ST   + K +R   +      ++   G    +
Sbjct: 20  VHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNV 79

Query: 172 SKDYKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP- 227
               + I++Q++K        +A+++Y  +   + P Y     + +   L  ++F     
Sbjct: 80  HSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAAD 139

Query: 228 AAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFY 287
            A + +N WV + TN  I+++++  S+D+ T +VL+NAI FKG W   FK E T+  PF 
Sbjct: 140 QARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFR 199

Query: 288 LDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           + +  S  V +M+    F +   A  +  K+LELP+   ++S ++
Sbjct: 200 VTEQESKPVQMMYQIGLFRVASMA-SEKMKILELPFASGTMSMLV 243

>3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} Length = 406

 Score =  221 bits (564), Expect = 3e-69
 Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 13/228 (5%)

Query: 115 AANKKENAIISPFSLHVVLG--LASFGAAGSTAEAMMKGLRIKHSETLL------KDYKG 166
           A    +N +  P  +   LG  L S GA G T   + K +R+K + +        ++ K 
Sbjct: 32  ADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKSTSSSWNSSEAQQEMKS 91

Query: 167 IIDQLSKDYKGIIDQL--SKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFS 224
           +  +L+         L   +   ++I+  I+  K  E+   +     ++   EL +VDFS
Sbjct: 92  LYQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYEVERRFNESIANDSEGELKQVDFS 151

Query: 225 QPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDG 284
              +A  ++NDWV   +N  ++     D +   T ++L+N  +F+  W  PF+P  T+  
Sbjct: 152 NRTSATVDINDWVDQQSNGLLEKFFT-DDIPDDTAMILVNVFYFRDFWQSPFEPHYTRKE 210

Query: 285 PFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
            FY+     + V +M  +      +   ++GF+++  P      +F+I
Sbjct: 211 DFYISPDRQITVDMMTQEGVMKYGKFE-DEGFEIVSKPLNNTRFTFVI 257

>4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B Length = 392

 Score =  220 bits (563), Expect = 3e-69
 Identities = 44/220 (20%), Positives = 96/220 (43%), Gaps = 13/220 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH--SETLLKDYKGIIDQLS 172
                EN ++SP  +   LGL S G   +TA      L  +    E +      ++  LS
Sbjct: 26  KDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLS 85

Query: 173 KDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
                     +++   K+ +++Y    +     +   +  ++N E  K++F    +A + 
Sbjct: 86  N-------STARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRDKRSALQS 138

Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
           +N+W +  T+ K+ ++ K   ++ +   +L+NA+ FK  W   F  +   +  F +  + 
Sbjct: 139 INEWAAQTTDGKLPEVTK--DVERTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSY 196

Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           +V V +M     +  Y++  ++  +++E+P      S II
Sbjct: 197 TVGVTMMHRTGLYNYYDDE-KEKLQIVEMPLAHKLSSLII 235

>2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} Length = 401

 Score =  220 bits (563), Expect = 3e-69
 Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 11/228 (4%)

Query: 114 LAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLR-----IKHSETLLKDYKGII 168
              +K+ N   SP S+   LG+   GA  +TA+ + K L         +      +    
Sbjct: 30  FRKSKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTGKAATYHVDRS 89

Query: 169 DQLSKDYKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQ 225
             +   ++ ++ + +KS    ELKIANK++  K       Y       + + +  VDF+ 
Sbjct: 90  GNVHHQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFAN 149

Query: 226 PP-AAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDG 284
            P  + K++N WV + TN+KIK+LI   ++ ++T LVL+NAI+FKG+W   F  E TK+ 
Sbjct: 150 APEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEE 209

Query: 285 PFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
            F+ +      + +M    SF+      +   K+LE+PY G  +S I+
Sbjct: 210 KFWPNKNTYKSIQMMRQYTSFHFASLE-DVQAKVLEIPYKGKDLSMIV 256

>3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* Length = 395

 Score =  219 bits (559), Expect = 1e-68
 Identities = 51/222 (22%), Positives = 110/222 (49%), Gaps = 16/222 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIIDQ 170
           +A   +N   SP S+ + L + S GA  ST   +++GL +   ++    L + ++ ++ +
Sbjct: 47  SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQE 106

Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++             +L + N ++    ++L   + +     + ++    +F     A 
Sbjct: 107 LNQP--------RDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAM 158

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++ND+V+  T  KI DL+K  +LD++  ++++N I FK KW   F  + T++  FY+  
Sbjct: 159 KQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTS 216

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
              V+VP+M  +D ++   +      +++ +PY G + +  I
Sbjct: 217 ETVVRVPMMSREDQYHYLLDR-NLSCRVVGVPYQGNATALFI 257

>1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A Length = 341

 Score =  217 bits (555), Expect = 1e-68
 Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 17/232 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIIDQ 170
                +N I SP S+   L   S GA  +T   ++KGL+   +ET    + + ++ ++  
Sbjct: 24  LKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRT 83

Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++         S   +L + N ++  + + L   +   A   + SE    DF    AA 
Sbjct: 84  LNQS--------SDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAK 135

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K +ND+V N T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL  
Sbjct: 136 KLINDYVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSK 193

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
              V VP+M +      Y    E    ++EL Y  + S +    ++P+  ++
Sbjct: 194 KKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALF---ILPDQDKM 242

>2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* Length = 373

 Score =  218 bits (557), Expect = 2e-68
 Identities = 60/232 (25%), Positives = 115/232 (49%), Gaps = 18/232 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIIDQ 170
           A + K+N  ISP S+ + L + S G  G T   +++GL    +E     + + ++ +   
Sbjct: 24  ALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQL 83

Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
            +K           S E+ + N ++    +EL  ++       + SE+  ++F     A+
Sbjct: 84  FAKS--------DTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATAS 135

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           +++N +V N T  KI DL     LD+   LVL+N I FKG WT PF   +T++  FY+D+
Sbjct: 136 RQINSYVKNKTQGKIVDLF--SGLDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDE 193

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
           T  V+VP+M    +     ++ E   +++++ Y  + +      ++P+ G++
Sbjct: 194 TTVVKVPMMLQSSTISYLHDS-ELPCQLVQMNYVGNGTVFF---ILPDKGKM 241

>3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* Length = 336

 Score =  215 bits (550), Expect = 6e-68
 Identities = 52/221 (23%), Positives = 112/221 (50%), Gaps = 14/221 (6%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           +A   +N   SP S+ + L + S GA  ST   +++GL +   ++  K+       L + 
Sbjct: 22  SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKE-------LHRG 74

Query: 175 YKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAK 231
           ++ ++ +L++     +L + N ++    ++L   + +     + ++    +F     A K
Sbjct: 75  FQQLLQELNQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMK 134

Query: 232 EMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDT 291
           ++ND+V+  T  KI DL+K  +LD++  ++++N I FK KW   F  + T++  FY+   
Sbjct: 135 QINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSE 192

Query: 292 NSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
             V+VP+M  +D ++   +      +++ +PY G + +  I
Sbjct: 193 TVVRVPMMSREDQYHYLLDR-NLSCRVVGVPYQGNATALFI 232

>1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A Length = 401

 Score =  216 bits (553), Expect = 1e-67
 Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 17/232 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIIDQ 170
                +N I SP S+   L   S GA  +T   ++KGL+   +ET    + + ++ ++  
Sbjct: 44  LKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRT 103

Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++         S   +L + N ++  + + L   +   A   + SE    DF    AA 
Sbjct: 104 LNQS--------SDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAK 155

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K +ND+V N T  KI DLIK   LD+ T +VL+N I FK KW +PF P+ T    FYL  
Sbjct: 156 KLINDYVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSK 213

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
              V VP+M +      Y    E    ++EL Y  + S +    ++P+  ++
Sbjct: 214 KKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALF---ILPDQDKM 262

>3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A Length = 343

 Score =  213 bits (545), Expect = 4e-67
 Identities = 56/232 (24%), Positives = 106/232 (45%), Gaps = 18/232 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIIDQ 170
             +   N   SP S+     + S G    T + +++GL    +E     + + ++ ++  
Sbjct: 28  HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRT 87

Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++             +L   N ++ ++ ++L   +       ++SE   V+F     A 
Sbjct: 88  LNQ--------PDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAK 139

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++ND+V   T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D 
Sbjct: 140 KQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQ 197

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
             +V+VP+M     F +     +    +L + Y  + + I     +P+ G+L
Sbjct: 198 VTTVKVPMMKRLGMFNIQHAK-KLSSWVLLMKYLGNATAIF---FLPDEGKL 245

>1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* Length = 480

 Score =  217 bits (555), Expect = 4e-67
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 9/219 (4%)

Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            N  +N  I+P  +   +G+ S G  G T E +   L  K        Y+  I  +   +
Sbjct: 126 VNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYE--ITTIHNLF 183

Query: 176 KGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
           + +  +L +      L+  N +Y  K   +   ++T+  + + +E    DFS P   +K 
Sbjct: 184 RKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPAFISK- 242

Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N+ +   T   IKD +  +++D +T+++++N I+FKG W   F  E T +  F L++  
Sbjct: 243 TNNHIMKLTKGLIKDAL--ENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNERE 300

Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            V+V +M  K +F    +  E    +L+L Y   IS +I
Sbjct: 301 VVKVSMMQTKGNFLAANDQ-ELDCDILQLEYVGGISMLI 338

>3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B Length = 424

 Score =  215 bits (550), Expect = 5e-67
 Identities = 56/232 (24%), Positives = 106/232 (45%), Gaps = 18/232 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET----LLKDYKGIIDQ 170
             +   N   SP S+     + S G    T + +++GL    +E     + + ++ ++  
Sbjct: 73  HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRT 132

Query: 171 LSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA 230
           L++             +L   N ++ ++ ++L   +       ++SE   V+F     A 
Sbjct: 133 LNQ--------PDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAK 184

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++ND+V   T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D 
Sbjct: 185 KQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQ 242

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFIIKSQVVPEMGRL 342
             +V+VP+M     F +     +    +L + Y  + + I     +P+ G+L
Sbjct: 243 VTTVKVPMMKRLGMFNIQHCK-KLSSWVLLMKYLGNATAIF---FLPDEGKL 290

>2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} Length = 379

 Score =  214 bits (546), Expect = 7e-67
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 9/219 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
                +N   SP S+   L + SFGA  ST   +++ L    ++T + +    I    + 
Sbjct: 23  VETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE----IQHGFQH 78

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
               ++   K  EL+I N ++  K ++    +       + +E+   DFS   AA +E+N
Sbjct: 79  LICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEIN 138

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKD-GPFYLDDTNS 293
             V   T  K+  LI    L  +T +VL+N IHFK +W  PF P  T+D   F +D T +
Sbjct: 139 SHVEMQTKGKVVGLI--QDLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTT 196

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           VQVP+M   + +Y   +  E    +L++ Y   +++  +
Sbjct: 197 VQVPMMHQMEQYYHLVDM-ELNCTVLQMDYSKNALALFV 234

>1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 Length = 398

 Score =  214 bits (547), Expect = 9e-67
 Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 13/218 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + +   N ++SP S+   L   S GA   T   + + L      +           +   
Sbjct: 51  SMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISS---------PDIHGT 101

Query: 175 YKGIIDQLSKS-PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
           YK ++D ++     LK A++I F K + +  ++      ++ +    +  + P    +E+
Sbjct: 102 YKELLDTVTAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGN-PRLDLQEI 160

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N+WV      K+        +     ++L+   HFKG+W   F    T    FYLD+  +
Sbjct: 161 NNWVQAQMKGKLARST--KEIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERT 218

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
           V+VP+M    +   Y    +   K+ +LP   S+S I 
Sbjct: 219 VRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGSMSIIF 256

>2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} Length = 430

 Score =  213 bits (545), Expect = 3e-66
 Identities = 47/217 (21%), Positives = 91/217 (41%), Gaps = 15/217 (6%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
             +   N ++SP S+ + L   + GA   T  ++ + L +            ++    ++
Sbjct: 38  QTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMN----TGSCLPHLLSHFYQN 93

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
                        +++A +IY  K   +   +  Q+   F ++  K+   +       +N
Sbjct: 94  --------LGPGTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTG-KQEEDLANIN 144

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV   T  KI+D +    L  ST L+L+NAIHF G W   F P  T+   F+LD+  +V
Sbjct: 145 QWVKEATEGKIEDFL--SELPDSTVLLLLNAIHFHGFWRTKFDPSLTQKDFFHLDERFTV 202

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            V +M        +    +   ++   P+  ++SF++
Sbjct: 203 SVDMMHAVSYPLRWFLLEQPEIQVAHFPFKNNMSFVV 239

>2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* Length = 350

 Score =  210 bits (538), Expect = 5e-66
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 9/219 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
                +N   SP S+   L + SFGA  ST   +++ L    ++T + +    I    + 
Sbjct: 28  VETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVE----IQHGFQH 83

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
               ++   K  EL+I N ++  K ++    +       + +E+   DFS   AA +E+N
Sbjct: 84  LICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEIN 143

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKD-GPFYLDDTNS 293
             V   T  K+  LI+   L  +T +VL+N IHFK +W  PF P  T+D   F +D T +
Sbjct: 144 SHVEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTT 201

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           VQVP+M   D +Y   +  E    +L++ Y   +++  +
Sbjct: 202 VQVPMMHQMDQYYHLVDM-ELNCTVLQMDYSKNALALFV 239

>2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} Length = 390

 Score =  210 bits (537), Expect = 2e-65
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 19/215 (8%)

Query: 117 NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYK 176
             + N   SPFS+  +L     GA  +T   +   L      T           + +  K
Sbjct: 52  KVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFT----------CVHQALK 101

Query: 177 GIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW 236
           G   +      +   ++I+ + D+ +   +   +   ++S    +      A  + +N W
Sbjct: 102 GFTTK-----GVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSN-NSDANLELINTW 155

Query: 237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQV 296
           V+ +TN+KI  L+  DSL + T+LVL+NAI+   KW   F P+ T+  PF+  ++  ++V
Sbjct: 156 VAKNTNNKISRLL--DSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFKNS-VIKV 212

Query: 297 PLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
           P+M  K     +        K+ +L    ++S +I
Sbjct: 213 PMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVI 247

>2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} Length = 371

 Score =  207 bits (529), Expect = 2e-64
 Identities = 50/219 (22%), Positives = 106/219 (48%), Gaps = 13/219 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMK-GLRIKHSETLLKDYKGIIDQLSK 173
           A N  +N +ISP S+ + L + S G+A + +   +   L       + + ++ +   L +
Sbjct: 26  ALNPDKNTLISPVSISMALAMVSLGSAQTQSLQSLGFNLTETSEAEIHQSFQYLNYLLKQ 85

Query: 174 DYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
                        E+ + N ++  + ++L  ++       + SE   +DF     A++++
Sbjct: 86  --------SDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFEDWTKASQQI 137

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N  V + T  KI+ +     LD+    +L+N I  +G W +PF PE T++  FY+++T++
Sbjct: 138 NQHVKDKTQGKIEHVFS--DLDSPASFILVNYIFLRGIWELPFSPENTREEDFYVNETST 195

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           V+VP+M    S   + ++     +++++ Y G   +F I
Sbjct: 196 VKVPMMVQSGSIGYFRDS-VFPCQLIQMDYVGNGTAFFI 233

>1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A Length = 305

 Score =  197 bits (504), Expect = 2e-61
 Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 31/219 (14%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           ++ K EN  ISP S+  VL +  +GA GSTAE + K +  +                   
Sbjct: 9   SSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKE------------------- 49

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
                D+       K  NK+Y         ++              VDF+        +N
Sbjct: 50  ----ADKNKDDISFKSMNKVYGRYSAVFKDSFL----RKIGDNFQTVDFTDC-RTVDAIN 100

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
             V   T  KI  L+  + L   T L+ I+A++FK KW +PF+ E T D PFY+  T  V
Sbjct: 101 KCVDIFTEGKINPLLD-EPLSPDTCLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMV 159

Query: 295 QVPLMFVKDSFYMYEEAGE--DGFKMLELPYGVSISFII 331
            V +M +    + +    E    F ++ELPY    S ++
Sbjct: 160 DVSMMSMYGEAFNHASVKESFGNFSIIELPYVGDTSMVV 198

>2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B Length = 453

 Score =  200 bits (511), Expect = 6e-61
 Identities = 38/227 (16%), Positives = 87/227 (38%), Gaps = 13/227 (5%)

Query: 113 NLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLS 172
            L        ++SP ++   L     GA   TA+ +   L +   +            LS
Sbjct: 91  ELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKVLS 150

Query: 173 --KDYKGIIDQLSKS-----PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGK-VDFS 224
             +  +G++    ++       L     ++ A  + L   +           L + +DF+
Sbjct: 151 ALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFT 210

Query: 225 QPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDG 284
           +   AA++++ ++   T  K    +        + L     +HF+GK          +  
Sbjct: 211 ELDVAAEKIDRFMQAVTGWKTGCSLM--GASVDSTLAFNTYVHFQGKM--KGFSLLAEPQ 266

Query: 285 PFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            F++D++ SV VP++    +F  + +  +D F + ++P+  S   ++
Sbjct: 267 EFWVDNSTSVSVPMLSGMGTFQHWSDI-QDNFSVTQVPFTESACLLL 312

>2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A Length = 453

 Score =  198 bits (506), Expect = 3e-60
 Identities = 38/227 (16%), Positives = 87/227 (38%), Gaps = 16/227 (7%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           A +    AI+SP +L   L     G+   TA  +   L +   E      +    ++   
Sbjct: 91  AGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKEGDCTS-RLDGHKVLAA 149

Query: 175 YKGIIDQLSK--------SPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGK-VDFSQ 225
            + +   L               I   ++ A    L  ++         +   + +D S 
Sbjct: 150 LRAVQGLLVTQGGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQSLALFTPALFPRSLDLST 209

Query: 226 -PPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDG 284
            P  A +++N ++   T  K+   +  + +   + L+    +HF+G      +     + 
Sbjct: 210 DPVLATEKINRFIKAVTGWKMNLPL--EGVSTDSTLLFNTYVHFQGTMRGFSQLPGVHE- 266

Query: 285 PFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            F++D++ SV VP++    +F  + +A ++ F +  +P G   + ++
Sbjct: 267 -FWVDNSISVSVPMISGTGNFQHWSDA-QNNFSVTCVPLGERATLLL 311

>1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 245

 Score =  171 bits (435), Expect = 7e-52
 Identities = 41/147 (27%), Positives = 63/147 (42%), Gaps = 8/147 (5%)

Query: 187 ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIK 246
             K  NK+Y         ++              VDF+        +N  V   T  KI 
Sbjct: 3   SFKSMNKVYGRYSAVFKDSFL----RKIGDNFQTVDFTDS-RTVDAINKSVDIFTEGKIN 57

Query: 247 DLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFY 306
            L+  + L   T L+ I+A++FK KW +PF+ E T D PFY+  T  V V +M +    +
Sbjct: 58  PLLD-EPLSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAF 116

Query: 307 MYEEAGE--DGFKMLELPYGVSISFII 331
            +    E    F ++ELPY    S ++
Sbjct: 117 NHASVKESFGNFSIIELPYVGDTSMVV 143

>1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 55

 Score = 47.3 bits (113), Expect = 8e-08
 Identities = 17/45 (37%), Positives = 26/45 (57%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET 159
           ++ K EN  ISP S+  VL +  +GA GSTAE + K +  +  + 
Sbjct: 9   SSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKN 53

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	342
3f02_A	359	Neuroserpin; cleaved form, fenib, human, disease M	100.0
1hle_A	345	Horse leukocyte elastase inhibitor; hydrolase inhi	100.0
3ndd_A	343	Alpha-1-antitrypsin; serpin, hydrolase inhibitor;	100.0
3dy0_A	336	N-terminus plasma serine protease inhibitor; serpi	100.0
3f5n_A	407	Neuroserpin; cleaved form, fenib, human, tissue PL	100.0
3ne4_A	424	Alpha-1-antitrypsin; serpin, LUNG disease, liver d	100.0
2h4p_A	394	MENT, heterochromatin-associated protein MENT; ser	100.0
3nda_A	377	Serpin-2; vaccination target, TICK, hydrolase inhi	100.0
4ga7_A	389	Leukocyte elastase inhibitor; serpin, conformation	100.0
1uhg_A	385	Ovalbumin, S-ovalbumin; allergen, egg white protei	100.0
2xn6_A	350	Thyroxine-binding globulin; transport, cleaved pro	100.0
3ozq_A	376	Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito	100.0
4au2_A	392	HSP47, serpin peptidase inhibitor, clade H (heat s	100.0
2zv6_A	401	Serpin B3; serine proteinase inhibitor, reactive s	100.0
1as4_A	341	Antichymotrypsin, ACT; serpin, serine protease inh	100.0
3sto_A	406	Serine protease inhibitor; serpin fold, hydrolase	100.0
2h4r_A	415	MENT, heterochromatin-associated protein MENT; ser	100.0
1lj5_A	379	Plasminogen activator inhibitor-1; beta-barrell, b	100.0
2ceo_A	379	Thyroxine-binding globulin; transport, serpin, hor	100.0
2arr_A	382	Plasminogen activator inhibitor-2; serpin, peptide	100.0
3b9f_I	395	Protein C inhibitor; michaelis complex, acute phas	100.0
4afx_A	387	Protein Z dependent protease inhibitor; hydrolase	100.0
2vdx_A	373	Corticosteroid-binding globulin; transport protein	100.0
1sek_A	378	Serpin K; serine protease inhibitor, protease; 2.1	100.0
4dy0_A	379	GLIA-derived nexin; serpin, protease inhibitor, th	100.0
1wz9_A	375	Maspin precursor; serpin, tumor suppressor, serpin	100.0
1yxa_A	398	Serine (OR cysteine) proteinase inhibitor, clade 3	100.0
3f1s_A	385	Protein Z-dependent protease inhibitor; PZ, ZPI, c	100.0
4ajt_A	427	Protein Z-dependent protease inhibitor; blood clot	100.0
3pzf_A	397	Serpin 2; protease inhibitor, melanization, hydrol	100.0
1qmn_A	401	AACT, alpha-1-antichymotrypsin; serpin, serine pro	100.0
3kcg_I	432	Antithrombin-III, ATIII; michaelis complex, blood	100.0
1imv_A	398	PEDF, pigment epithelium-derived factor; serpin, a	100.0
2v95_A	371	Corticosteroid-binding globulin; transport protein	100.0
3le2_A	393	Serpin-ZX; apoplast, glycoprotein, protease inhibi	100.0
1mtp_A	323	Serine proteinase inhibitor (serpin), chain A; str	100.0
1jmo_A	480	HC-II, heparin cofactor II, HLS2, serin; serpin, t	100.0
1sng_A	370	COG4826: serine protease inhibitor; serine proteas	100.0
2wxy_C	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	100.0
2pef_A	373	Serine protease inhibitor; serpin; 1.60A {Thermoan	100.0
2wxw_A	453	Angiotensinogen, serpin A8; glycoprotein, hyperten	100.0
2r9y_A	430	Alpha-2-antiplasmin; inhibitory serpin, plasmin in	100.0
1f0c_A	305	ICE inhibitor; apoptosis, caspase inhibitor, prote	100.0
2oay_A	390	C1-inhibitor, plasma protease C1 inhibitor, C1 INH	100.0
1m93_B	245	Serine proteinase inhibitor 2; serpin, CRMA, apopt	100.0
1m93_A	55	Serine proteinase inhibitor 2; serpin, CRMA, apopt	99.38

>3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A

Probab=100.00  E-value=2.2e-54  Score=421.35  Aligned_cols=230  Identities=30%  Similarity=0.531  Sum_probs=205.3

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      .++++.+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        18 ~l~~~~~-~Fa~~L~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~   79 (359)
T 3f02_A           18 FPEEAIA-DLSVNMYN-----------------RLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLK   79 (359)
T ss_dssp             ---CHHH-HHHHHHHH-----------------HHHHHSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTCCC--
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhhcCCCCCEEEcHHHHHHHHHHHHhhcCChHHHHHHHHhCCCCCC
Confidence            4556667 99999999                 88776 78999999999999999999999999999999999998654


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      ..+         ++..|+.++..+.+.+   .+.+||+||+++++++.++|++.++++|+++++.+||.+++.+++.||+
T Consensus        80 ~~~---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  150 (359)
T 3f02_A           80 NGE---------EFSFLKEFSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYINK  150 (359)
T ss_dssp             --C---------HHHHHHCC----------CEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHH
T ss_pred             HHH---------HHHHHHHHHHHHhcCCCCcEEEEEEEEEEeCCCccchHHHHHHHHHhcCceEEcCCCCHHHHHHHHHH
Confidence            334         8888998888776433   8999999999999999999999999999999999999988889999999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|++++++++++++|+++|+||+||||.|+++|++.+|++++|+..+|++++||||++.+. |+|+++++++
T Consensus       151 WV~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~-~~y~~~~~l~  229 (359)
T 3f02_A          151 WVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGE-FYYGEFSDGS  229 (359)
T ss_dssp             HHHHTTTTCSCCSSCGGGCSTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEE-EEEEEEECCC
T ss_pred             HHHhhhCCcccccCCcccCCCCceEEEEeHHHHhHHhhccCCcccceeeeeEecCCcEEEccceEeece-EeEEEccCcC
Confidence            999999999999999999999999999999999999999999999999999999999999999999998 9999999998


Q ss_pred             e------EEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         316 F------KMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       316 ~------~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      +      +|||||| ++++||+|   |||+++
T Consensus       230 a~~~~~~~vleLPY~~~~~sm~i---iLP~~~  258 (359)
T 3f02_A          230 NEAGGIYQVLEIPYEGDEISMML---VLSRQE  258 (359)
T ss_dssp             ---CCEEEEEEEEBTTSSEEEEE---EECCTT
T ss_pred             cccccccEEEEeEcCCCcEEEEE---EEcCCC
Confidence            8      9999999 99999999   899986

>1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1

Probab=100.00  E-value=1.1e-53  Score=414.25  Aligned_cols=225  Identities=33%  Similarity=0.566  Sum_probs=211.0

Q ss_pred             ccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccch
Q psy2651          83 SILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL  161 (342)
Q Consensus        83 ~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~  161 (342)
                      ++.+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++...  +
T Consensus         7 ~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~--~   66 (345)
T 1hle_A            7 TANT-HFAVDLFR-----------------ALNESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTVE--D   66 (345)
T ss_dssp             HHHH-HHHHHHHH-----------------HHHHHCSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTGGGST--T
T ss_pred             HHHH-HHHHHHHH-----------------HHhhcCCCCCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCCHH--H
Confidence            4445 99999999                 88776 78999999999999999999999999999999999997532  4


Q ss_pred             hcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecC-CCcHHHHHhhchhh
Q psy2651         162 KDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEMNDWV  237 (342)
Q Consensus       162 ~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF-~~~~~a~~~IN~WV  237 (342)
                               ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+|| .+++.+++.||+||
T Consensus        67 ---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV  137 (345)
T 1hle_A           67 ---------IHSRFQSLNADINKPGAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWV  137 (345)
T ss_dssp             ---------HHHHHHHHHHHHTCSSCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHH
T ss_pred             ---------HHHHHHHHHHHHhCCCCCcEEEEEEEeeecCCCchhHHHHHHHHHHhCCeEEEecCCCCHHHHHHHHHHHH
Confidence                     8899999999987643   8999999999999999999999999999999999999 56777899999999


Q ss_pred             hcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeE
Q psy2651         238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFK  317 (342)
Q Consensus       238 ~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~  317 (342)
                      +++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|+.++||||++.+. |+|+++++++++
T Consensus       138 ~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~  216 (345)
T 1hle_A          138 KGQTEGKIPELLVKGMVDNMTKLVLVNAIYFKGNWQQKFMKEATRDAPFRLNKKDTKTVKMMYQKKK-FPYNYIEDLKCR  216 (345)
T ss_dssp             HHHTTTSSSCSSCTTSSCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEE-EEEEEEGGGTEE
T ss_pred             HHHhcCchhhhcCCcCCCCcceEEEEEeeEecccccCCCCcccCcceeEEeCCCeEEEEEEEEeece-EeeEEeCCCCeE
Confidence            9999999999999999999999999999999999999999999999999999999999999999998 999999999999


Q ss_pred             EEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         318 MLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       318 vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      |||||| ++++||+|   |||+++
T Consensus       217 vleLPy~~~~~sm~i---iLP~~~  237 (345)
T 1hle_A          217 VLELPYQGKELSMII---LLPDDI  237 (345)
T ss_dssp             EEEEEBTTSSEEEEE---EEESSC
T ss_pred             EEEecCCCCeEEEEE---EecCCC
Confidence            999999 99999999   899986

>3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A

Probab=100.00  E-value=1.6e-53  Score=412.78  Aligned_cols=231  Identities=26%  Similarity=0.463  Sum_probs=211.8

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      .++.+.+ +||++||+                 ++++. +++|+||||+||+.+|+|+++||+|+|++||.++||++..+
T Consensus        10 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~   71 (343)
T 3ndd_A           10 KITPNLA-EFAFSLYR-----------------QLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTE   71 (343)
T ss_dssp             TTHHHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTT
T ss_pred             HHHHHHh-HHHHHHHH-----------------HHhhcCCCCCEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCCCC
Confidence            4555666 99999999                 88776 78899999999999999999999999999999999998643


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      .++.+       ++..|+.++..+.+++   .+.+||+||+++++++.++|++.++++|+++++.+||.+++.+++.||+
T Consensus        72 ~~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  144 (343)
T 3ndd_A           72 IPEAQ-------IHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQIND  144 (343)
T ss_dssp             SCHHH-------HHHHHHHHHHHHTSCCTTCEEEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTSHHHHHHHHHH
T ss_pred             CCHHH-------HHHHHHHHHHHHhCCCCCceEEeehhhHhhCCCChhHHHHHHHHHHhccccEeecCCCHHHHHHHHHH
Confidence            22222       8899999999887643   8999999999999999999999999999999999999988889999999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. |+|+++++++
T Consensus       145 wV~~~T~g~I~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-~~~~~~~~l~  221 (343)
T 3ndd_A          145 YVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGM-FNIQHAKKLS  221 (343)
T ss_dssp             HHHHHTTTSSCSCCS--CCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEE-EEEEEEGGGT
T ss_pred             HHHHhhcCchhhhhh--cCCCCceEEEEeHHHHhHHHhcccCCccccCcceecCCCcEEEEEEEEEEee-EEEEEeccCC
Confidence            999999999999997  7999999999999999999999999999999999999999999999999998 9999999999


Q ss_pred             eEEEEEeCCCcEEEEEeecCCCCCCC
Q psy2651         316 FKMLELPYGVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       316 ~~vLELPY~~~~SMlI~~~ILP~~g~  341 (342)
                      ++||||||.+++||+|   |||++|.
T Consensus       222 ~~vleLPY~~~~sm~i---iLP~~~~  244 (343)
T 3ndd_A          222 SWVLLMKYLGNATAIF---FLPDEGK  244 (343)
T ss_dssp             EEEEEEEBSSSEEEEE---EEECTTC
T ss_pred             eEEEEEecCCCeEEEE---EEeCccC
Confidence            9999999933589999   8999865

>3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A*

Probab=100.00  E-value=2e-53  Score=411.10  Aligned_cols=223  Identities=26%  Similarity=0.532  Sum_probs=207.6

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 +++.. +++|+||||+||+.+|+|+++||+|+|++||.++||++.....+.+   
T Consensus        11 ~Fa~~l~~-----------------~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~---   70 (336)
T 3dy0_A           11 DFTFDLYR-----------------ALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKE---   70 (336)
T ss_dssp             CHHHHHHH-----------------HHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHH---
T ss_pred             HHHHHHHH-----------------HHhhhCCCCCEEEchHHHHHHHHHHHhHCcHHHHHHHHHHhCCCCCcCCHHH---
Confidence            99999999                 88876 7899999999999999999999999999999999999875322212   


Q ss_pred             hhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccCC
Q psy2651         167 IIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTND  243 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~g  243 (342)
                          ++..|+.++..+...+   .+.+||+||+++++++.++|++.++++|+++++.+||.+++.+++.||+||+++|+|
T Consensus        71 ----~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~~~T~g  146 (336)
T 3dy0_A           71 ----LHRGFQQLLQELNQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMKQINDYVAKQTKG  146 (336)
T ss_dssp             ----HHHHHHHHHHHTTSCCSSSEEEEEEEEEECTTCCBCHHHHHHHHHHHCCEEEECCTTSHHHHHHHHHHHHHHHTTT
T ss_pred             ----HHHHHHHHHHHHhCCCCCcEEEEeehhhhCCCCCccHHHHHHHHHHhCCeeEEECCCChHHHHHHHHHHHHHhhcC
Confidence                8899999999887643   899999999999999999999999999999999999998888999999999999999


Q ss_pred             ccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEeC
Q psy2651         244 KIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY  323 (342)
Q Consensus       244 ~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELPY  323 (342)
                      +|+++++  +++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. |+|+++++++++||||||
T Consensus       147 ~I~~l~~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-f~~~~~~~l~~~vleLPy  223 (336)
T 3dy0_A          147 KIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQ-YHYLLDRNLSCRVVGVPY  223 (336)
T ss_dssp             SSCCCCC--SCCSCEEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEE-EEEEEETTTTEEEEEEEB
T ss_pred             cHhHhhc--CCCCCCeEEeEehheeeeeccCCCCcccccccceeccCCcEEEEeeEEEEeE-EEEEEecCCCeEEEEeec
Confidence            9999998  7999999999999999999999999999999999999999999999999998 999999999999999999


Q ss_pred             -CCcEEEEEeecCCCCCCC
Q psy2651         324 -GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       324 -~~~~SMlI~~~ILP~~g~  341 (342)
                       | ++||+|   |||+++.
T Consensus       224 ~~-~~sm~i---iLP~~~~  238 (336)
T 3dy0_A          224 QG-NATALF---ILPSEGK  238 (336)
T ss_dssp             SS-SCEEEE---EEECTTC
T ss_pred             CC-CeEEEE---EecCCCC
Confidence             6 589999   8999864

>3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=420.93  Aligned_cols=230  Identities=30%  Similarity=0.543  Sum_probs=211.3

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      .++++.+ +||++||+                 ++++. +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        18 ~l~~~~~-~Fa~~L~~-----------------~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~   79 (407)
T 3f5n_A           18 FPEEAIA-DLSVNMYN-----------------RLRATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLK   79 (407)
T ss_dssp             -CTHHHH-HHHHHHHH-----------------HHHHTTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHCCC---
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHHhhCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCCCC
Confidence            4556666 99999999                 98877 78999999999999999999999999999999999998654


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      ..+         ++..++.++..+.+.+   .+.+||+||+++++++.++|++.++++|+++++.+||.+++.+++.||+
T Consensus        80 ~~~---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  150 (407)
T 3f5n_A           80 NGE---------EFSFLKEFSNMVTAKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQNVAVANYINK  150 (407)
T ss_dssp             -CC---------CHHHHHHHHHHTTC-CCSCEEEEEEEEEEETTCCBCTTHHHHHHHTSCCEEEEECTTSHHHHHHHHHH
T ss_pred             HHH---------HHHHHHHHHHHHhccCCCcEEEEEEEEEEeCCCccCHHHHHHHHHhhcCceEEcCCCChHHHHHHHHH
Confidence            333         7889999999887543   8999999999999999999999999999999999999988889999999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|++++++++++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. |+|+++++++
T Consensus       151 WV~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~-f~y~~~~~l~  229 (407)
T 3f5n_A          151 WVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGE-FYYGEFSDGS  229 (407)
T ss_dssp             HHHHTTTTCSCCCCCGGGCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEE-EEEEEEECC-
T ss_pred             HHHHhhCCchhhcCCcccCCCCceEEEEEeeeeecccccCCCccCceeeeEEcCCCeEEEEeEEEEeee-eeeEEccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999998 9999999988


Q ss_pred             ------eEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         316 ------FKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       316 ------~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                            ++|||||| ++++||+|   |||+++
T Consensus       230 ~~~~~~~~vleLPY~~~~~sm~i---iLP~~~  258 (407)
T 3f5n_A          230 NEAGGIYQVLEIPYEGDEISMML---VLSRQE  258 (407)
T ss_dssp             ----CEEEEEEEEBTTSSEEEEE---EECCTT
T ss_pred             cccCcceEEEEEECCCCcEEEEE---EECCCC
Confidence                  99999999 99999999   899986

>3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B

Probab=100.00  E-value=3.8e-53  Score=420.61  Aligned_cols=232  Identities=25%  Similarity=0.455  Sum_probs=213.3

Q ss_pred             ccccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCc
Q psy2651          79 VSFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHS  157 (342)
Q Consensus        79 ~~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~  157 (342)
                      ..++.+.+ +||++||+                 +++.. +++|+||||+||+.+|+|+++||+|+|++||.++||++..
T Consensus        54 ~~l~~~~~-~Fa~~L~~-----------------~l~~~~~~~Ni~~SP~SI~~aLaml~~GA~g~T~~ql~~~L~~~~~  115 (424)
T 3ne4_A           54 NKITPNLA-EFAFSLYR-----------------QLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLT  115 (424)
T ss_dssp             CTTHHHHH-HHHHHHHH-----------------HHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTT
T ss_pred             HHHHHHHH-HHHHHHHH-----------------HHHhhCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCC
Confidence            35666777 99999999                 88876 7899999999999999999999999999999999999864


Q ss_pred             ccchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhc
Q psy2651         158 ETLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN  234 (342)
Q Consensus       158 ~~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN  234 (342)
                      +.++.+       ++..|+.++..+..++   .+.+||+||+++++++.++|++.++++|+++++.+||.+++.+++.||
T Consensus       116 ~~~~~~-------i~~~f~~ll~~l~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN  188 (424)
T 3ne4_A          116 EIPEAQ-------IHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQIN  188 (424)
T ss_dssp             TSCHHH-------HHHHHHHHHHHHTCSSCSSCCEEEEEEEEETTSCBCHHHHHHHHTTTCCEEEEECTTSHHHHHHHHH
T ss_pred             CCCHHH-------HHHHHHHHHHHhcCCCCCcEEEEEEEEEEcCCCCcCHHHHHHHHHhhcceEEEecCCChHHHHHHHH
Confidence            322222       8899999999987643   899999999999999999999999999999999999998888999999


Q ss_pred             hhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCC
Q psy2651         235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGED  314 (342)
Q Consensus       235 ~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l  314 (342)
                      +||+++|+|+|+++++  +++++|+++|+|||||||.|+++|++.+|++++|+..+|++++||||++.+. |+|++++++
T Consensus       189 ~wV~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-f~y~~~~~l  265 (424)
T 3ne4_A          189 DYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGM-FNIQHCKKL  265 (424)
T ss_dssp             HHHHHHTTTSSCSCCC--CCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEE-EEEEEETTT
T ss_pred             HHHHHhhCCCcccccc--CCCCcchhhhhhHHhhehhhhcCCCcccceeEeeeccCCcEEEEEEEEeecc-eeEEEecCC
Confidence            9999999999999998  7999999999999999999999999999999999999999999999999998 999999999


Q ss_pred             CeEEEEEeCCCcEEEEEeecCCCCCCC
Q psy2651         315 GFKMLELPYGVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       315 ~~~vLELPY~~~~SMlI~~~ILP~~g~  341 (342)
                      +++||||||.+++||+|   |||++|.
T Consensus       266 ~~~vleLPY~~~~sm~i---iLP~~~~  289 (424)
T 3ne4_A          266 SSWVLLMKYLGNATAIF---FLPDEGK  289 (424)
T ss_dssp             TEEEEEEEETTTEEEEE---EEECTTC
T ss_pred             CeEEEEEecCCCeEEEE---EEcCcCC
Confidence            99999999933589999   8999875

>2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A

Probab=100.00  E-value=4.2e-53  Score=417.01  Aligned_cols=239  Identities=31%  Similarity=0.558  Sum_probs=211.8

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++.++.+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        28 ~l~~~~~-~Fa~~L~k-----------------~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~   89 (394)
T 2h4p_A           28 QVSASIG-NFTVDLFN-----------------KLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAV   89 (394)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSSCC-
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhccCCCCCEEEChHHHHHHHHHHHHhccChHHHHHHHHhCCCccc
Confidence            3455566 99999999                 88776 78999999999999999999999999999999999998632


Q ss_pred             cc---h-----------hccc---chhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhccccc
Q psy2651         159 TL---L-----------KDYK---GIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSEL  218 (342)
Q Consensus       159 ~~---~-----------~~~~---~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v  218 (342)
                      ..   .           .+++   ...+.++..|+.++..+...+   .+.+||+||+++++++.++|++.++++|++++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~  169 (394)
T 2h4p_A           90 RAESSSVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEP  169 (394)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHTCCCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHCCEE
T ss_pred             ccccccccccccccccccccccccccHHHHHHHHHHHHHHhhcCCCCcEEEEEEEEEEeCCCCccHHHHHHHHHHhCCee
Confidence            00   0           0000   000128899999999887643   89999999999999999999999999999999


Q ss_pred             EEecC-CCcHHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEe
Q psy2651         219 GKVDF-SQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVP  297 (342)
Q Consensus       219 ~~vdF-~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~Vp  297 (342)
                      +.+|| .+++++++.||+||+++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++|+..+|+.++||
T Consensus       170 ~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~T~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~  249 (394)
T 2h4p_A          170 QKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVK  249 (394)
T ss_dssp             EEECTTTCHHHHHHHHHHHHHHHTTTCC-CCSCTTTSCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEE
T ss_pred             EEecCcCCHHHHHHHHHHHHHHhhCCchhhccCccccCCccceeeeeeeeEEceeCCCCCcccccceEEEecCCeEEECc
Confidence            99999 56778999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeeecceeeeEEEeCCCCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         298 LMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       298 MM~~~~~~f~y~~~~~l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ||++.+. |+|+++++++++|||||| ++++||+|   |||+++
T Consensus       250 mM~~~~~-f~~~~~~~l~~~vleLPY~~~~~sM~i---iLP~~~  289 (394)
T 2h4p_A          250 MMYMRDT-FPVLIMEKMNFKMIELPYVKRELSMFI---LLPDDI  289 (394)
T ss_dssp             EEEEEEE-EEEEEETTTTEEEEEEEBGGGSEEEEE---EEESSC
T ss_pred             eEeccCc-eeeEEeCCCCEEEEEeecCCCcEEEEE---EecCCC
Confidence            9999998 999999999999999999 99999999   899986

>3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus}

Probab=100.00  E-value=3.7e-53  Score=415.18  Aligned_cols=229  Identities=31%  Similarity=0.547  Sum_probs=209.2

Q ss_pred             cccccccccccccccccCCcchhhhhhhhhhhhhccCCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccch
Q psy2651          82 SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL  161 (342)
Q Consensus        82 ~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~  161 (342)
                      +++.+ +||++||+                 ++++..++|+||||+||+.+|+|+++||+|+|++||.++||++..+..+
T Consensus         8 ~~~~~-~Fa~~l~~-----------------~l~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~   69 (377)
T 3nda_A            8 TKANN-RFGLRLLR-----------------ALPSGPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGFSDVDLTD   69 (377)
T ss_dssp             HHHHH-HHHHHHHH-----------------HSCCBTTBCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTTGGGTCCH
T ss_pred             HHHHH-HHHHHHHH-----------------HHhhcCCCCEEEecHHHHHHHHHHHhhccchhHHHHHHHhCCCCcCCCH
Confidence            34445 99999999                 8865457899999999999999999999999999999999998543222


Q ss_pred             hcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecC-CCcHHHHHhhchhh
Q psy2651         162 KDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEMNDWV  237 (342)
Q Consensus       162 ~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF-~~~~~a~~~IN~WV  237 (342)
                      ++       ++..|+.++..+.+.+   .+.+||+||+++++++.++|++.++++|+++++.+|| .+++.+++.||+||
T Consensus        70 ~~-------i~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV  142 (377)
T 3nda_A           70 AG-------VLDAYTHHTERLKSTPSNSTLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFAGEPQAAVDFVNNWV  142 (377)
T ss_dssp             HH-------HHHHHHHHHHHHHHCCCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHH
T ss_pred             HH-------HHHHHHHHHHHhcCCCCCcEEEEEeEEEEeCCCCchHHHHHHHHHhccCceEEecCCCCHHHHHHHHHHHH
Confidence            22       8889999988875432   8999999999999999999999999999999999999 67777999999999


Q ss_pred             hcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeE
Q psy2651         238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFK  317 (342)
Q Consensus       238 ~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~  317 (342)
                      +++|+|+|++++ +++++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. |+|+++++++++
T Consensus       143 ~~~T~g~I~~ll-~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~~~~~  220 (377)
T 3nda_A          143 KRKTHDKIEKLF-NEPLDPDTLLVLLNAIYFKGEWNTAFVKEHTEKRQFFNGGVTPVEVDTMRLEAR-IKYRFFDDLQVE  220 (377)
T ss_dssp             HHHTTTSCCCSC-SSCCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEETTTEEEEEEEEEEEEE-EEEEEETTTTEE
T ss_pred             HHHhcCchhhhc-CCCCCCCceEEEEehheeccccccCCCCccccccceecCCCeEEEEeeEeeECe-EEEEEEcCCCeE
Confidence            999999999999 889999999999999999999999999999999999999999999999999998 999999999999


Q ss_pred             EEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         318 MLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       318 vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      |||||| ++++||+|   |||+++
T Consensus       221 vleLPy~~~~~sm~i---iLP~~~  241 (377)
T 3nda_A          221 VVELPYRGLDYTMAI---LLPKEN  241 (377)
T ss_dssp             EEEEEBTTSSEEEEE---EEESST
T ss_pred             EEEEecCCCcEEEEE---EEcCCC
Confidence            999999 88999999   899964

>4ga7_A Leukocyte elastase inhibitor; serpin, conformational change, serine protease inhibitor, Ca inhibitor, chymase inhibitor, chymotrypsin inhibitor; 2.90A {Homo sapiens}

Probab=100.00  E-value=3.6e-53  Score=416.79  Aligned_cols=221  Identities=32%  Similarity=0.576  Sum_probs=209.4

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++..+  +     
T Consensus        20 ~Fa~~L~~-----------------~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~--~-----   75 (389)
T 4ga7_A           20 RFALDLFL-----------------ALSENNPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVE--E-----   75 (389)
T ss_dssp             HHHHHHHH-----------------HHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGCT--T-----
T ss_pred             HHHHHHHH-----------------HHhhcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHH--H-----
Confidence            99999999                 98876 78999999999999999999999999999999999997543  3     


Q ss_pred             hhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCC-cHHHHHhhchhhhcccC
Q psy2651         167 IIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQ-PPAAAKEMNDWVSNHTN  242 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~-~~~a~~~IN~WV~~~T~  242 (342)
                          ++..|+.++..+.+.+   .+.+||+||++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+
T Consensus        76 ----~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~  151 (389)
T 4ga7_A           76 ----VHSRFQSLNADINKRGASYILKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTE  151 (389)
T ss_dssp             ----HHHHHHHHHHHHTCTTCSSEEEEEEEEEEETTSCBCHHHHHHHHHHTSCCEEEECHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ----HHHHHHHHHHHHhCCCCCcEEEEeeeeeecCCCccCHHHHHHHHHHhCCeeEecccccCHHHHHHHHHHHHHHhhC
Confidence                8899999999887543   899999999999999999999999999999999999987 56788999999999999


Q ss_pred             CccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEe
Q psy2651         243 DKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELP  322 (342)
Q Consensus       243 g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELP  322 (342)
                      |+|++++++++++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. |+|+++++++++|||||
T Consensus       152 g~I~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~vleLP  230 (389)
T 4ga7_A          152 GKIPELLASGMVDNMTKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKK-FAYGYIEDLKCRVLELP  230 (389)
T ss_dssp             TSSTTSSCTTSSCTTCCEEEEEEEEEECCBSSCCCTTTCEEEEEEEETTEEEEEEEEEEEEE-EEEEEETTTTEEEEEEE
T ss_pred             CchhhccCCCCCCCCceEEEEEEEEEEeeecCCCCccCccccceEeCCCcEEEEEEEEEeee-EEEEEECCCCEEEEEEE
Confidence            99999999999999999999999999999999999999999999999999999999999998 99999999999999999


Q ss_pred             C-CCcEEEEEeecCCCCCC
Q psy2651         323 Y-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       323 Y-~~~~SMlI~~~ILP~~g  340 (342)
                      | ++++||+|   |||+++
T Consensus       231 y~~~~~sm~i---iLP~~~  246 (389)
T 4ga7_A          231 YQGEELSMVI---LLPDDI  246 (389)
T ss_dssp             BTTSSEEEEE---EEESSC
T ss_pred             CCCCCEEEEE---EecCCC
Confidence            9 99999999   899985

>1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A

Probab=100.00  E-value=6e-53  Score=414.63  Aligned_cols=228  Identities=25%  Similarity=0.468  Sum_probs=209.8

Q ss_pred             cccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCccc-
Q psy2651          82 SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET-  159 (342)
Q Consensus        82 ~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~-  159 (342)
                      .++.+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++.... 
T Consensus         4 ~~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~   65 (385)
T 1uhg_A            4 GAASM-EFCFDVFK-----------------ELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGF   65 (385)
T ss_dssp             HHHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTC
T ss_pred             hhHHH-HHHHHHHH-----------------HHHhcCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCccccc
Confidence            34455 99999999                 88776 789999999999999999999999999999999999986531 


Q ss_pred             --------c---hhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecC-C
Q psy2651         160 --------L---LKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-S  224 (342)
Q Consensus       160 --------~---~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF-~  224 (342)
                              .   +         ++..|+.++..+.+.+   .+.+||+||+++++++.++|++.++++|+++++.+|| .
T Consensus        66 ~~~~~~~~~~~~~---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~  136 (385)
T 1uhg_A           66 GDSIEAQCGTSVN---------VHSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQT  136 (385)
T ss_dssp             SHHHHTTTTSCTT---------TTHHHHHHHHHHTSCCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTT
T ss_pred             ccccccccchHHH---------HHHHHHHHHHHHhCCCCCcEEEEEEEeeccCCCCccHHHHHHHHHHhCCEEEEecCCC
Confidence                    1   3         7888999999887643   8999999999999999999999999999999999999 6


Q ss_pred             CcHHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecce
Q psy2651         225 QPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDS  304 (342)
Q Consensus       225 ~~~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~  304 (342)
                      +++++++.||+||+++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+.
T Consensus       137 ~~~~a~~~IN~wV~~~T~gkI~~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~  216 (385)
T 1uhg_A          137 AADQARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGL  216 (385)
T ss_dssp             THHHHHHHHHHHHHHHTTTCSCCCSCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEE
T ss_pred             CHHHHHHHHHHHHHHHhcCchhhhCCcccCCCccceEeeeeeEEeeeecCCCCcCCCcCcEEEECCCeEEEEEEEEeece
Confidence            67789999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             eeeEEEeCCCCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         305 FYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       305 ~f~y~~~~~l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                       |+|+++++++++|||||| ++++||+|   |||+++
T Consensus       217 -~~~~~~~~~~~~vleLPy~~~~~sm~i---iLP~~~  249 (385)
T 1uhg_A          217 -FRVASMASEKMKILELPFASGTMSMLV---LLPDEV  249 (385)
T ss_dssp             -EEEEEEGGGTEEEEEEEBTTSSEEEEE---EEESST
T ss_pred             -EEEEEeCCCCeEEEEeccCCCcEEEEE---EeCCCC
Confidence             999999999999999999 99999999   899986

>2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A*

Probab=100.00  E-value=7.2e-53  Score=409.33  Aligned_cols=229  Identities=30%  Similarity=0.496  Sum_probs=209.1

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCccc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET  159 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~  159 (342)
                      +.+..+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++..+.
T Consensus        11 l~~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~   72 (350)
T 2xn6_A           11 MSSINA-DFAFNLYR-----------------RFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDT   72 (350)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTS
T ss_pred             HHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCccCC
Confidence            444556 99999999                 88766 788999999999999999999999999999999999976432


Q ss_pred             chhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchh
Q psy2651         160 LLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW  236 (342)
Q Consensus       160 ~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~W  236 (342)
                      +..+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.||+|
T Consensus        73 ~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~W  145 (350)
T 2xn6_A           73 PMVE-------IQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSH  145 (350)
T ss_dssp             CHHH-------HHHHHHHHHHHHHSCBTTEEEEEEEEEEEETTCCBCHHHHHHHHHHSCEEEEEECTTSHHHHHHHHHHH
T ss_pred             CHHH-------HHHHHHHHHHHhhCCCCCcEEEEEEeehhhCCCcHHHHHHHHHHHHhCCEEEeeCCCCHHHHHHHHHHH
Confidence            2212       8899999998886543   89999999999999999999999999999999999999888899999999


Q ss_pred             hhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccC-eeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGP-FYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       237 V~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~-F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      |+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++ ||..+|+.++||||++.+. |+|+++++++
T Consensus       146 V~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~l~  222 (350)
T 2xn6_A          146 VEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMDQ-YYHLVDMELN  222 (350)
T ss_dssp             HHHHTTTCSCCCCS--CCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEEETTEEEEEEEEEEEEE-EEEEEETTTT
T ss_pred             HHHhhCCchhhhhc--ccCCCceeeeeeHHHHhhHhhccCChhhCccCCceEeCCCcEEEEEEEEEeee-EeEEEeCCCC
Confidence            99999999999996  599999999999999999999999999999999 9999999999999999998 9999999999


Q ss_pred             eEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         316 FKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       316 ~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++|||||| |+. ||+|   |||++|.
T Consensus       223 ~~vleLPy~~~~-sm~i---iLP~~~~  245 (350)
T 2xn6_A          223 CTVLQMDYSKNA-LALF---VLPKEGQ  245 (350)
T ss_dssp             EEEEEEEBSSSE-EEEE---EEECTTC
T ss_pred             eEEEEeecCCCe-EEEE---EecCCCC
Confidence            99999999 664 9999   7999864

>3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor}

Probab=100.00  E-value=1.1e-52  Score=411.72  Aligned_cols=228  Identities=33%  Similarity=0.523  Sum_probs=210.3

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhccCCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCccc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET  159 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~  159 (342)
                      +++++.+ +||++||+                 ++...+++|+||||+||+.+|+|+++||+|+|++||.++||++... 
T Consensus        10 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~-   70 (376)
T 3ozq_A           10 EFPNAVN-SFTPSVYK-----------------EVLKTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLHFVGDR-   70 (376)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCCSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCH-
T ss_pred             HHHHHHh-HHHHHHHH-----------------HHhhCCCCCEEEcHHHHHHHHHHHHhHCchHHHHHHHHHHCCCCcH-
Confidence            3444555 99999999                 8873388999999999999999999999999999999999995433 


Q ss_pred             chhcccchhHHHHHHHHHHHHHhCCCc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhh
Q psy2651         160 LLKDYKGIIDQLSKDYKGIIDQLSKSP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS  238 (342)
Q Consensus       160 ~~~~~~~~~~~v~~~~~~l~~~l~~~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~  238 (342)
                      .+         ++..++.++..+...+ .+.+||+||+++++++.++|++.++++|+++++.+||.+++++++.||+||+
T Consensus        71 ~~---------~~~~~~~~l~~l~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~  141 (376)
T 3ozq_A           71 EK---------AEGAVKEVLSKLTNEEYTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFSEKNDAAKLMNAWVE  141 (376)
T ss_dssp             HH---------HHHHHHHHHHHTBCSSCEEEEEEEEEEETTSCCCHHHHHHHHHTTSCEEEEECCSSHHHHHHHHHHHHH
T ss_pred             HH---------HHHHHHHHHHHhcCCCcEEeeehhHHHhCCCcchHHHHHHHHHhhCCeeEEecCCChHHHHHHHHHHHH
Confidence            22         7888888888876444 8999999999999999999999999999999999999998889999999999


Q ss_pred             cccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeee-ecceeeeEEEeCCCCeE
Q psy2651         239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMF-VKDSFYMYEEAGEDGFK  317 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~-~~~~~f~y~~~~~l~~~  317 (342)
                      ++|+|+|++++++++++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||+ +.+. |+|+++++++++
T Consensus       142 ~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-~~y~~~~~~~~~  220 (376)
T 3ozq_A          142 EQTQHKIQNLVDPEILNNLTRVVLINALYFNAKWLVPFPPFHTRKSDFHKSAKEVVQVDTMYLDEQY-FNYYECHHLDAK  220 (376)
T ss_dssp             HHTTTCSCCCSCGGGCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEE-EEEEEETTTTEE
T ss_pred             hhhcCchhhccCcccCCCcceEEEEehhhhhhhhccCCCcccceeeeeEecCCcEEEEeehhhccCc-eeEEEecCCCeE
Confidence            99999999999988999999999999999999999999999999999999999999999999 9998 999999999999


Q ss_pred             EEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         318 MLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       318 vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      |||||| ++ +||+|   |||+++
T Consensus       221 vleLPy~~~-~sm~i---iLP~~~  240 (376)
T 3ozq_A          221 LLELPFKGG-ASLTI---VLSNQI  240 (376)
T ss_dssp             EEEEEBTTS-CEEEE---EEESST
T ss_pred             EEEEeCCCC-EEEEE---EeCCCC
Confidence            999999 77 99999   899975

>4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B

Probab=100.00  E-value=1.4e-52  Score=413.03  Aligned_cols=229  Identities=21%  Similarity=0.404  Sum_probs=212.0

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      +++++.+ +||++||+                 ++++. +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus         8 ~l~~~~~-~Fa~~L~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   69 (392)
T 4au2_A            8 TLAERSA-GLAFSLYQ-----------------AMAKDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLR   69 (392)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHCTTCCSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTSC
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhhcCCCCeEEECHHHHHHHHHHHHhhcCcHHHHHHHHhcCCCCCC
Confidence            3445556 99999999                 99887 88999999999999999999999999999999999998655


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc----chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhc
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP----ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN  234 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~----~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN  234 (342)
                      ..+         ++..+++++..+....    .+.+||+||+++++++.++|++.++++|+++++.+||.+++.+++.||
T Consensus        70 ~~~---------~~~~~~~l~~~l~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN  140 (392)
T 4au2_A           70 DEE---------VHAGLGELLRSLSNSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRDKRSALQSIN  140 (392)
T ss_dssp             HHH---------HHHHHHHHHHHTTC-----CCCEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTSHHHHHHHHH
T ss_pred             HHH---------HHHHHHHHHHHHhcCCCCCceEEEEEEEEeecCCchhHHHHHHHHHhhCCeeEEecCCChHHHHHHHH
Confidence            333         8899999998885432    789999999999999999999999999999999999999888999999


Q ss_pred             hhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCC
Q psy2651         235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGED  314 (342)
Q Consensus       235 ~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l  314 (342)
                      +||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. ++|++++++
T Consensus       141 ~WV~~~T~gkI~~l~~--~~~~~t~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-~~~~~~~~~  217 (392)
T 4au2_A          141 EWAAQTTDGKLPEVTK--DVERTDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGL-YNYYDDEKE  217 (392)
T ss_dssp             HHHHHHTTTSSCCSCS--CCCCSSSEEEEEEEEECCCBSSCCCTTSEEEEEEESSSSCEEEEEEEEEEEE-EEEEEETTT
T ss_pred             HHHHHhcCCCccchhc--ccCCcchhhheehhheeccccCCCCccccccCceecCCCceeEEeeeeecce-eeEEeeccC
Confidence            9999999999999996  6999999999999999999999999999999999999999999999999998 999999999


Q ss_pred             CeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         315 GFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       315 ~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++++||||| ++.+||+|   |||+++.
T Consensus       218 ~~~vleLPy~~~~~sm~i---llP~~~~  242 (392)
T 4au2_A          218 KLQIVEMPLAHKLSSLII---LMPHHVE  242 (392)
T ss_dssp             TEEEEEEEBGGGSEEEEE---EEESSSC
T ss_pred             ceeEEEeecCCCcEEEEE---EeCCCCC
Confidence            999999999 99999999   7999864

>2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=414.89  Aligned_cols=229  Identities=30%  Similarity=0.523  Sum_probs=209.0

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++.+..+ +||++||+                 ++.+. + +|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        14 ~~~~~~~-~Fa~~l~~-----------------~l~~~~~-~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   74 (401)
T 2zv6_A           14 SLSEANT-KFMFDLFQ-----------------QFRKSKE-NNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVT   74 (401)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCC-SCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHTTC----
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhhCCC-CCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCccc
Confidence            4445556 99999999                 88766 6 999999999999999999999999999999999997642


Q ss_pred             --------------cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEe
Q psy2651         159 --------------TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKV  221 (342)
Q Consensus       159 --------------~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~v  221 (342)
                                    ..+         ++..|+.++..+.+.+   .+.+||+||+++++++.++|++.++++|+++++.+
T Consensus        75 ~~~~~~~~~~~~~~~~~---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~v  145 (401)
T 2zv6_A           75 ENTTGKAATYHVDRSGN---------VHHQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESV  145 (401)
T ss_dssp             ----------------C---------THHHHHHHHHHHHSCCSSCCEEEECCEEEETTSCCCHHHHHHHHHHHSCCEEEE
T ss_pred             ccccccccccccccHHH---------HHHHHHHHHHHhhCCCCCcEEEEEEEEEecCCCChhHHHHHHHHHHhCCEEEEc
Confidence                          122         7888999988886543   89999999999999999999999999999999999


Q ss_pred             cC-CCcHHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeee
Q psy2651         222 DF-SQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMF  300 (342)
Q Consensus       222 dF-~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~  300 (342)
                      || .+++++++.||+||+++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++|+..+|+.++||||+
T Consensus       146 dF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~  225 (401)
T 2zv6_A          146 DFANAPEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWPNKNTYKSIQMMR  225 (401)
T ss_dssp             CTTTCHHHHHHHHHHHHHHHTTTCSCCSSCTTTSCTTCCEEEEEEEEECCCBSSCCCTTSEEEEEECSSSSCCEEEEEEE
T ss_pred             cCCCCHHHHHHHHHHHHHHhhCCccccccCcccCCCcceEEEEEhheeccccCCCCCCCCceeeEEEecCCceEEeEEEe
Confidence            99 56778999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecceeeeEEEeCCCCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         301 VKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       301 ~~~~~f~y~~~~~l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      +.+. |+|+++++++++|||||| ++++||+|   |||+++
T Consensus       226 ~~~~-f~~~~~~~l~~~vleLPY~~~~~sm~i---iLP~~~  262 (401)
T 2zv6_A          226 QYTS-FHFASLEDVQAKVLEIPYKGKDLSMIV---LLPNEI  262 (401)
T ss_dssp             EEEE-EEECEETTTTEEEEEEEBTTSSSEEEE---EEESST
T ss_pred             ccCc-eeEEEeCCCCEEEEEeecCCCcEEEEE---EecCCC
Confidence            9998 999999999999999999 99999999   899975

>1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A

Probab=100.00  E-value=1.2e-52  Score=406.44  Aligned_cols=231  Identities=32%  Similarity=0.535  Sum_probs=208.9

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++++..+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus         6 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   67 (341)
T 1as4_A            6 GLASANV-DFAFSLYK-----------------QLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTE   67 (341)
T ss_dssp             CHHHHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTT
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhccCCCCcEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCcC
Confidence            3445556 99999999                 88766 78899999999999999999999999999999999997643


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      .+..+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.||+
T Consensus        68 ~~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  140 (341)
T 1as4_A           68 TSEAE-------IHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLIND  140 (341)
T ss_dssp             SCHHH-------HHHHHHHHHHHHCEECSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHH
T ss_pred             CCHHH-------HHHHHHHHHHHHhccCCCcEEEeeehhHHhCCCchhHHHHHHHHHHhCCceEecCCCCHHHHHHHHHH
Confidence            22212       8899999999886533   8999999999999999999999999999999999999988889999999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+..|+|+++++++
T Consensus       141 WV~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~  218 (341)
T 1as4_A          141 YVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELS  218 (341)
T ss_dssp             HHHHHTTTSCCCSCC--CCCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEETTTT
T ss_pred             HHHHhhcCchhhHhh--ccCCCceEEEEEhHhhcchhcCCCCccccccceeEeCCCeEEEEEEEEecCceEEEEEecCCC
Confidence            999999999999996  599999999999999999999999999999999999999999999999998438999999999


Q ss_pred             eEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         316 FKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       316 ~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++|||||| ++. ||+|   |||++|.
T Consensus       219 ~~vleLPY~~~~-sm~i---iLP~~~~  241 (341)
T 1as4_A          219 CTVVELKYTGNA-SALF---ILPDQDK  241 (341)
T ss_dssp             EEEEEEEBSSSE-EEEE---EEECTTC
T ss_pred             eEEEEecCCCCc-EEEE---EeeCCCC
Confidence            99999999 664 9999   7999864

>3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium}

Probab=100.00  E-value=2.3e-52  Score=413.19  Aligned_cols=230  Identities=23%  Similarity=0.482  Sum_probs=203.5

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHc--cCChhHHHHHHHHcCCCCc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASF--GAAGSTAEAMMKGLRIKHS  157 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~--GA~G~T~~qL~~~Lgl~~~  157 (342)
                      .+.+.+ +||++||+                 +++.. +++|+||||+||+.+|+|+++  ||+|+|++||.++||++..
T Consensus        15 ~~~~~~-~Fa~~l~~-----------------~l~~~~~~~Ni~~SP~Si~~aLaml~~~~GA~g~T~~ql~~~L~~~~~   76 (406)
T 3sto_A           15 NISSHK-AFTHAYLS-----------------TVTADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKST   76 (406)
T ss_dssp             -CCHHH-HHHHHHHH-----------------HHTGGGTTSCEEECHHHHHHHHHHHHHTSCSCHHHHHHHHHHTTCSTT
T ss_pred             ccchhh-HHHHHHHH-----------------HHhhcCCCCCEEEccHHHHHHHHHHHhccccCchHHHHHHHHhCCCcc
Confidence            344555 99999999                 98876 889999999999999999999  9999999999999999865


Q ss_pred             cc------chhcccchhHHHHHHHHHHHHHhCCC--------c-chhhhhhhhhccCcccchHHHHHhhhhcccccEEec
Q psy2651         158 ET------LLKDYKGIIDQLSKDYKGIIDQLSKS--------P-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVD  222 (342)
Q Consensus       158 ~~------~~~~~~~~~~~v~~~~~~l~~~l~~~--------~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vd  222 (342)
                      +.      .+       +.++..|+.++..+.+.        + .+.+||+||+++++++.++|++.++++|+++++.+|
T Consensus        77 ~~~~~~~~~~-------~~~~~~~~~l~~~l~~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vd  149 (406)
T 3sto_A           77 SSSWNSSEAQ-------QEMKSLYQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYEVERRFNESIANDSEGELKQVD  149 (406)
T ss_dssp             SSSCCHHHHH-------HHHHHHHHHHHHHHHTCEECC---CEESEEEEEEEEEETTSCCCHHHHHHHHTCSSEEEEEEC
T ss_pred             cccccccCCH-------HHHHHHHHHHHHHHhccCcccccCCCcEEEEEeeeeecCCCccCHHHHHHHHHHhCCeEEEeC
Confidence            32      11       12889999998887553        3 799999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeec
Q psy2651         223 FSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVK  302 (342)
Q Consensus       223 F~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~  302 (342)
                      |.+++++++.||+||+++|+|+|+++++++ ++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.
T Consensus       150 F~~~~~a~~~IN~WV~~~T~gkI~~ll~~~-l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~  228 (406)
T 3sto_A          150 FSNRTSATVDINDWVDQQSNGLLEKFFTDD-IPDDTAMILVNVFYFRDFWQSPFEPHYTRKEDFYISPDRQITVDMMTQE  228 (406)
T ss_dssp             TTSHHHHHHHHHHHHHHHTTTCC---------CCSCCEEEEEEEEECEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEE
T ss_pred             CCChHHHHHHHHHHHHHHhcCcchhhccCC-CCCCceEEEEEeeEEEeecccCCCccCCcCceEECCCCeEEEEeEEEee
Confidence            988888999999999999999999999977 9999999999999999999999999999999999999999999999999


Q ss_pred             ceeeeEEEeCCCCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         303 DSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       303 ~~~f~y~~~~~l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      +. |+|+++++++++|||||| ++++||+|   |||+++
T Consensus       229 ~~-~~y~~~~~~~~~vleLPy~~~~~sm~i---iLP~~~  263 (406)
T 3sto_A          229 GV-MKYGKFEDEGFEIVSKPLNNTRFTFVI---VLPLEK  263 (406)
T ss_dssp             EE-EEEEEETTTTEEEEEEEBSSTTEEEEE---EEESSS
T ss_pred             Cc-eEEEEEcCCCeEEEEEecCCCcEEEEE---EecCCC
Confidence            98 999999999999999999 99999999   899953

>2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A

Probab=100.00  E-value=2.4e-52  Score=414.15  Aligned_cols=237  Identities=32%  Similarity=0.563  Sum_probs=211.4

Q ss_pred             cccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          82 SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        82 ~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      +++.+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++.....
T Consensus        10 ~~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~   71 (415)
T 2h4r_A           10 SASIG-NFTVDLFN-----------------KLNETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRA   71 (415)
T ss_dssp             HHHHH-HHHHHHHH-----------------HHHTTCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSCCC---
T ss_pred             HHHHH-HHHHHHHH-----------------HHhccCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCccccc
Confidence            34445 99999999                 88776 7899999999999999999999999999999999999864200


Q ss_pred             ---h-----------hccc---chhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEE
Q psy2651         161 ---L-----------KDYK---GIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGK  220 (342)
Q Consensus       161 ---~-----------~~~~---~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~  220 (342)
                         .           .+++   ...+.++..|+.++..+.+.+   .+.+||+||+++++++.++|.+.++++|+++++.
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~  151 (415)
T 2h4r_A           72 ESSSVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQK  151 (415)
T ss_dssp             ------------------------CHHHHHHHHHHHHHHTCSSCSSEEEEEEEEEEETTSCBCHHHHHHHHHHHSCCCEE
T ss_pred             ccccccccccccccccccccccccHHHHHHHHHHHHHHHhCCCCCcEEEEEEeehhhCCCCcCHHHHHHHHHHhCCeEEE
Confidence               0           0000   000128899999999887643   8999999999999999999999999999999999


Q ss_pred             ecC-CCcHHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeee
Q psy2651         221 VDF-SQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLM  299 (342)
Q Consensus       221 vdF-~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM  299 (342)
                      +|| .+++++++.||+||+++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|+.++||||
T Consensus       152 vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM  231 (415)
T 2h4r_A          152 VNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMM  231 (415)
T ss_dssp             ECTTTCHHHHHHHHHHHHHHHTTTSCCCCSCGGGCCSSCCEEEEEEEEEECBBSSCCCGGGCEEEEEESSSSCEEEEEEE
T ss_pred             ecCCCCHHHHHHHHHHHHHHHhcCchhhhcCccccCCcceEEEEEhheEeceecCCCCcccCeeeEEEecCCcEEEeeEE
Confidence            999 5677799999999999999999999998899999999999999999999999999999999999999999999999


Q ss_pred             eecceeeeEEEeCCCCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         300 FVKDSFYMYEEAGEDGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       300 ~~~~~~f~y~~~~~l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ++.+. |+|+++++++++|||||| ++++||+|   |||+++
T Consensus       232 ~~~~~-~~~~~~~~l~~~vleLPY~~~~~sm~i---iLP~~~  269 (415)
T 2h4r_A          232 YMRDT-FPVLIMEKMNFKMIELPYVKRELSMFI---LLPDDI  269 (415)
T ss_dssp             EEEEE-EEEEEETTTTEEEEEEEBGGGSEEEEE---EEESSC
T ss_pred             eecCc-EeEEEeCCCCEEEEEeeCCCCcEEEEE---EecCCC
Confidence            99998 999999999999999999 99999999   899986

>1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B

Probab=100.00  E-value=3.7e-52  Score=408.26  Aligned_cols=227  Identities=27%  Similarity=0.519  Sum_probs=209.9

Q ss_pred             cccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          82 SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        82 ~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      .+..+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++... .
T Consensus         9 ~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~-~   69 (379)
T 1lj5_A            9 AHLAS-DFGVRVFQ-----------------QVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDD-K   69 (379)
T ss_dssp             HHHHH-HHHHHHHH-----------------HHHHHSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTS-T
T ss_pred             HHHHH-HHHHHHHH-----------------HHhhcCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCCH-H
Confidence            34445 99999999                 88733 78899999999999999999999999999999999998653 2


Q ss_pred             hhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhh
Q psy2651         161 LKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWV  237 (342)
Q Consensus       161 ~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV  237 (342)
                      +         ++..|+.++..+...+   .+++||+||+++++++.++|.+.++++|+++++.+||.++.++++.||+||
T Consensus        70 ~---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~Wv  140 (379)
T 1lj5_A           70 G---------MAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWV  140 (379)
T ss_dssp             T---------HHHHHHHHHHHHHCGGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTSHHHHHHHHHHHH
T ss_pred             H---------HHHHHHHHHHHHhCCCCCcEEEEEEeeeeeCCcchhHHHHHHHHHHhCCEEEEECCCChHHHHHHHHHHH
Confidence            3         8888999988886543   899999999999999999999999999999999999999888899999999


Q ss_pred             hcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEE--EeCC-C
Q psy2651         238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYE--EAGE-D  314 (342)
Q Consensus       238 ~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~--~~~~-l  314 (342)
                      +++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. |+|+  ++++ +
T Consensus       141 ~~~T~g~I~~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~gl  219 (379)
T 1lj5_A          141 KTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNK-FNYTEFTTPDGH  219 (379)
T ss_dssp             HHTTTTSCCCSSCTTSSCTTCCEEEEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEE-EEEEEEECTTSC
T ss_pred             HhhcCCccccccCcccCCCccceeeeeeeeecccccCCCCcccccceeEEeCCCeEEEEeEEeeEee-eceeeeEcCCCC
Confidence            9999999999999989999999999999999999999999999999999999999999999999998 9996  7778 8


Q ss_pred             CeEEEEEeC-CCcEEEEEeecCCC-CCC
Q psy2651         315 GFKMLELPY-GVSISFIIKSQVVP-EMG  340 (342)
Q Consensus       315 ~~~vLELPY-~~~~SMlI~~~ILP-~~g  340 (342)
                      +++|||||| ++++||+|   ||| +++
T Consensus       220 ~~~vleLPy~~~~~sm~i---iLP~~~~  244 (379)
T 1lj5_A          220 YYDILELPYHGDTLSMFI---AAPYEKE  244 (379)
T ss_dssp             EEEEEEEEBTTSSEEEEE---EEESSTT
T ss_pred             ceEEEEEecCCCcEEEEE---EEecCCC
Confidence            999999999 99999999   899 764

>2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-52  Score=408.52  Aligned_cols=229  Identities=30%  Similarity=0.493  Sum_probs=209.4

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCccc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET  159 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~  159 (342)
                      +++..+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++..+.
T Consensus         6 l~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~   67 (379)
T 2ceo_A            6 MSSINA-DFAFNLYR-----------------RFTVETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDT   67 (379)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHHHHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTS
T ss_pred             HHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCCcCC
Confidence            344555 99999999                 88766 788999999999999999999999999999999999986432


Q ss_pred             chhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchh
Q psy2651         160 LLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW  236 (342)
Q Consensus       160 ~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~W  236 (342)
                      +..+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.||+|
T Consensus        68 ~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~W  140 (379)
T 2ceo_A           68 PMVE-------IQHGFQHLICSLNFPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSNISAAKQEINSH  140 (379)
T ss_dssp             CHHH-------HHHHHHHHHHHHSSCCTTEEEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECTTCHHHHHHHHHHH
T ss_pred             CHHH-------HHHHHHHHHHHhhCCCCCcEEEEeEhhhhhCCCChhHHHHHHHHHHhCCeeeecCCCCHHHHHHHHHHH
Confidence            2212       8899999999987643   89999999999999999999999999999999999999888899999999


Q ss_pred             hhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccC-eeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGP-FYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       237 V~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~-F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      |+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++ ||..+|++++||||++.+. |+|+++++++
T Consensus       141 V~~~T~gkI~~l~~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~l~  217 (379)
T 2ceo_A          141 VEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQ-YYHLVDMELN  217 (379)
T ss_dssp             HHHHTTTSSCCCCC--CCCSSCCEEEEEEEEEEEBBSSCCCGGGCEEEEEEESSSSCEEEEEEEEEEEE-EEEEEETTTT
T ss_pred             HHHHhCCcchhhcc--CCCCCCEEEEEEHhhhhchhcCCCChhhCccCCceEeCCCcEEEEEEEEeeee-EeEEEeCCCC
Confidence            99999999999996  599999999999999999999999999999999 9999999999999999998 9999999999


Q ss_pred             eEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         316 FKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       316 ~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++|||||| ++. ||+|   |||++|.
T Consensus       218 ~~vleLPy~~~~-sm~i---iLP~~~~  240 (379)
T 2ceo_A          218 CTVLQMDYSKNA-LALF---VLPKEGQ  240 (379)
T ss_dssp             EEEEEEEBSSSE-EEEE---EEECTTC
T ss_pred             eEEEEeecCCCe-eEEE---EeeCCCc
Confidence            99999999 765 9999   7999864

>2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A

Probab=100.00  E-value=1.5e-52  Score=411.40  Aligned_cols=228  Identities=27%  Similarity=0.486  Sum_probs=206.2

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc-
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE-  158 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~-  158 (342)
                      ++++.+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++... 
T Consensus         4 l~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~   65 (382)
T 2arr_A            4 LCVANT-LFALNLFK-----------------HLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFNEVGA   65 (382)
T ss_dssp             TTHHHH-HHHHHHHH-----------------HHHHHCSSSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTTTTC--
T ss_pred             HHHHHH-HHHHHHHH-----------------HHhhcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCccc
Confidence            345556 99999999                 88776 78999999999999999999999999999999999998632 


Q ss_pred             -cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecC-CCcHHHHHhh
Q psy2651         159 -TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEM  233 (342)
Q Consensus       159 -~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF-~~~~~a~~~I  233 (342)
                       ..+         ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+|| .+++++++.|
T Consensus        66 ~~~~---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~I  136 (382)
T 2arr_A           66 AADK---------IHSSFRSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKI  136 (382)
T ss_dssp             ---C---------HHHHHHHHHHHHHCCCSSEEEEEEEEEEEETTCCCCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHH
T ss_pred             cHHH---------HHHHHHHHHHHHhCCCCCcEEEeeeehHHhCCCCccHHHHHHHHHHhCCEEEEecCcCcHHHHHHHH
Confidence             123         8899999998886543   8999999999999999999999999999999999999 5667789999


Q ss_pred             chhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC
Q psy2651         234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE  313 (342)
Q Consensus       234 N~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~  313 (342)
                      |+||+++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|+.++||||++.+. |+|+++++
T Consensus       137 N~wV~~~T~g~I~~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~  215 (382)
T 2arr_A          137 NSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLFPFRVNSAQRTPVQMMYLREK-LNIGYIED  215 (382)
T ss_dssp             HHHHHHHTTTSSCCCSCTTSSCTTEEEEEEEEEEEEECBSSCCEECC---EEEEEETTEEEEECEEEEEEE-EEEEEEGG
T ss_pred             HHHHHHHhcCchhhhCCCcCCCCcceEEEEEeeEecccccCCCChhhcccceEecCCCceeeeeEEeccCc-EeEEEECC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998 99999999


Q ss_pred             CCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         314 DGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       314 l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ++++|||||| + ++||+|   |||+++
T Consensus       216 ~~~~vleLPy~~-~~sm~i---iLP~~~  239 (382)
T 2arr_A          216 LKAQILELPYAG-DVSMFL---LLPDEI  239 (382)
T ss_dssp             GTEEEEEEEBSS-SEEEEE---EEEC--
T ss_pred             CCeEEEEecCCC-cEEEEE---EecCCC
Confidence            9999999999 8 999999   899986

>3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A*

Probab=100.00  E-value=5.7e-52  Score=409.05  Aligned_cols=230  Identities=25%  Similarity=0.513  Sum_probs=204.2

Q ss_pred             cccccc-cccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCc
Q psy2651          80 SFSSIL-DQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHS  157 (342)
Q Consensus        80 ~~~~~~-~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~  157 (342)
                      ++.++. + +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++..
T Consensus        28 ~l~~~~~~-~Fa~~L~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~   89 (395)
T 3b9f_I           28 TVAPSSRR-DFTFDLYR-----------------ALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQ   89 (395)
T ss_dssp             ---------CHHHHHHH-----------------HHHHHSTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTC---
T ss_pred             HHHHhhHH-HHHHHHHH-----------------HHhccCCCCCEEEcHHHHHHHHHHHHHHcccHHHHHHHHHhCCCCC
Confidence            556677 7 99999999                 88766 7889999999999999999999999999999999999754


Q ss_pred             ccchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhc
Q psy2651         158 ETLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN  234 (342)
Q Consensus       158 ~~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN  234 (342)
                      +.++.+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.||
T Consensus        90 ~~~~~~-------i~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN  162 (395)
T 3b9f_I           90 KSSEKE-------LHRGFQQLLQELNQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMKQIN  162 (395)
T ss_dssp             -CCHHH-------HHHHHHHHHHHTTSCCTTCCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHH
T ss_pred             CCCHHH-------HHHHHHHHHHHHhCCCCCceeEEEEEEEEECCCccchHHHHHHHHHhCCEeEEcCCCCHHHHHHHHH
Confidence            322112       8899999999887643   899999999999999999999999999999999999998888999999


Q ss_pred             hhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCC
Q psy2651         235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGED  314 (342)
Q Consensus       235 ~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l  314 (342)
                      +||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++|+..+|++++||||++.+. |+|++++++
T Consensus       163 ~WV~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-f~y~~~~~l  239 (395)
T 3b9f_I          163 DYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQ-YHYLLDRNL  239 (395)
T ss_dssp             HHHHHHTTTSSCCCCS--CCCTTCSEEEEEEEEECCCEEECCCTTTCEEEEEESSSSCEEEEEEEEEEEE-EEEEEETTT
T ss_pred             HHHHHHhCCchhhhcc--CCCCCceEEEEEhheeeccccCCCChhhCeeeEEEeCCCeEEEEEEEEeeee-EeEEEECCC
Confidence            9999999999999996  5999999999999999999999999999999999999999999999999998 999999999


Q ss_pred             CeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         315 GFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       315 ~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      +++|||||| |+. ||+|   |||+++.
T Consensus       240 ~~~vleLPY~~~~-sm~i---iLP~~~~  263 (395)
T 3b9f_I          240 SCRVVGVPYQGNA-TALF---ILPSEGK  263 (395)
T ss_dssp             TEEEEEEEBSSSC-EEEE---EEECTTC
T ss_pred             CeEEEEEecCCCe-eEEE---EEeCCCC
Confidence            999999999 765 9999   7999864

>4afx_A Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_A 3h5c_A* 3f1s_A*

Probab=100.00  E-value=3e-52  Score=409.77  Aligned_cols=226  Identities=26%  Similarity=0.494  Sum_probs=208.3

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCC--
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH--  156 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~--  156 (342)
                      .++.+.+ +||++||+                 ++... ++ |+||||+||+.+|+|+++||+|+|++||.++||++.  
T Consensus        53 ~l~~~~~-~Fa~~L~~-----------------~l~~~~~~-Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~  113 (387)
T 4afx_A           53 QLAKETS-NFGFSLLR-----------------KISMRHDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALK  113 (387)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCCS-CEEECHHHHHHHHHHHHTTCCTHHHHHHHHHTTCTTCS
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhhcCCC-CEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCccc
Confidence            4555666 99999999                 88776 55 999999999999999999999999999999999986  


Q ss_pred             -cccchhcccchhHHHHHHHHHHHHHhCCCc--chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhh
Q psy2651         157 -SETLLKDYKGIIDQLSKDYKGIIDQLSKSP--ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM  233 (342)
Q Consensus       157 -~~~~~~~~~~~~~~v~~~~~~l~~~l~~~~--~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~I  233 (342)
                       .+..+         ++..|+.++..+...+  .+.+||+||+++++++.++|++.++++|+++++.+||.++.++++.|
T Consensus       114 ~~~~~~---------~~~~~~~l~~~l~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~I  184 (387)
T 4afx_A          114 PTKPGL---------LPSLFKGLRETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLM  184 (387)
T ss_dssp             CCCTTH---------HHHHHHHHHHHHHHCGGGCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTSHHHHHHHH
T ss_pred             cCCHHH---------HHHHHHHHHHHhccCCCceEEEEEEEeecCCCchhHHHHHHHHHHhccceEecCCCChHHHHHHH
Confidence             22123         8889999888876222  79999999999999999999999999999999999999988899999


Q ss_pred             chhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC
Q psy2651         234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE  313 (342)
Q Consensus       234 N~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~  313 (342)
                      |+||+++|+|+|++++  ++++++|+++|+|||||||.|+++|++..|++++||..+|++++||||++.+. |+|+++++
T Consensus       185 N~WV~~~T~gkI~~ll--~~l~~~t~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~-f~y~~~~~  261 (387)
T 4afx_A          185 NHYINKETRGKIPKLF--DEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGK-FASTFDKN  261 (387)
T ss_dssp             HHHHHHHTTTSSSCSC--CCCCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEE-EEEEEETT
T ss_pred             HHHHHHhcCCCccccc--cCCCCCceEEEEeeeEEEeecccCCCcccceeeeeecCCCcEEEEEEEEeeee-EeEEEecC
Confidence            9999999999999999  58999999999999999999999999999999999999999999999999998 99999999


Q ss_pred             CCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         314 DGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       314 l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ++++|||||| + ++||+|   |||+++
T Consensus       262 l~~~vleLPY~~-~~sM~i---iLP~~~  285 (387)
T 4afx_A          262 FRCHVLKLPYQG-NATMLV---VLMEKM  285 (387)
T ss_dssp             TTEEEEEEEBTT-SEEEEE---EEESCC
T ss_pred             CceEEEEEEcCC-cEEEEE---EecCCC
Confidence            9999999999 8 999999   899984

>2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A*

Probab=100.00  E-value=3.6e-52  Score=407.54  Aligned_cols=230  Identities=29%  Similarity=0.542  Sum_probs=208.6

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++++..+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus         6 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   67 (373)
T 2vdx_A            6 GLASANV-DFAFSLYK-----------------HLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTE   67 (373)
T ss_dssp             CHHHHHH-HHHHHHHH-----------------HHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTT
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHhCCCCCC
Confidence            3445556 99999999                 88765 78899999999999999999999999999999999997543


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      .+..+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.||+
T Consensus        68 ~~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  140 (373)
T 2vdx_A           68 RSETE-------IHQGFQHLHQLFAKSDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQDWATASRQINS  140 (373)
T ss_dssp             SCHHH-------HHHHHHHHHHHHHSCCSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTSHHHHHHHHHH
T ss_pred             CCHHH-------HHHHHHHHHHHhhccCCcccceeEEEEEEECCCChHHHHHHHHHHHhCCeeEeecCcchHHHHHHHHH
Confidence            21212       8899999998886543   8999999999999999999999999999999999999988889999999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. |+|+++++++
T Consensus       141 WV~~~T~gkI~~l~~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~l~  217 (373)
T 2vdx_A          141 YVKNKTQGKIVDLFS--GLDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSST-ISYLHDSELP  217 (373)
T ss_dssp             HHHHHTTTCSCCSSC--C-CCCCSEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEE-EEEEECSSSS
T ss_pred             HHHHHhcCchhhhcc--CCCCCCeEEEEEHHhhhhhhhCcCCccccccceEEeCCCcEEEEEEEEeeee-EeeEEeCCCC
Confidence            999999999999996  5999999999999999999999999999999999999999999999999998 9999999999


Q ss_pred             eEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         316 FKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       316 ~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++|||||| ++ .||+|   |||++|.
T Consensus       218 ~~vleLPy~~~-~sm~i---iLP~~~~  240 (373)
T 2vdx_A          218 CQLVQMNYVGN-GTVFF---ILPDKGK  240 (373)
T ss_dssp             EEEEEEEBSSS-EEEEE---EEECTTC
T ss_pred             eEEEEEecCCC-eEEEE---EecCCCC
Confidence            99999999 64 79999   7999874

>1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I

Probab=100.00  E-value=1.6e-52  Score=410.68  Aligned_cols=226  Identities=31%  Similarity=0.564  Sum_probs=207.9

Q ss_pred             cccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          82 SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        82 ~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      .+..+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++..+  
T Consensus        12 ~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~--   71 (378)
T 1sek_A           12 RESND-QFTAQMFS-----------------EVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDN--   71 (378)
T ss_dssp             HHHHH-HHHHHHHH-----------------HHHHTSTTSCEEECSTTTHHHHHHHHHHCCHHHHHHHHHHHTCCCHH--
T ss_pred             HHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEcHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCCCc--
Confidence            34455 99999999                 88876 78899999999999999999999999999999999998643  


Q ss_pred             hhcccchhHHHHHHHHHHHHHhCCCc--chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhh
Q psy2651         161 LKDYKGIIDQLSKDYKGIIDQLSKSP--ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS  238 (342)
Q Consensus       161 ~~~~~~~~~~v~~~~~~l~~~l~~~~--~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~  238 (342)
                      .         ....++.+...+...+  .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.||+||+
T Consensus        72 ~---------~~~~~~~l~~~l~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~WV~  142 (378)
T 1sek_A           72 V---------TKDVFADLNRGVRAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSVEAAGAINKWVE  142 (378)
T ss_dssp             H---------HHHHHHHHHHTCSCCTTEEEEEEEEEEEETTSCBCHHHHHHHHHTTCCEEEEECGGGHHHHHHHHHHHHH
T ss_pred             h---------HHHHHHHHHHHHhccCCCeEEeeeehhhhCCCCHhHHHHHHHHHHhCCeeEeeCCcCHHHHHHHHHHHHH
Confidence            1         1145677777776543  7999999999999999999999999999999999999888889999999999


Q ss_pred             cccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEE
Q psy2651         239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKM  318 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~v  318 (342)
                      ++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. |+|+++++++++|
T Consensus       143 ~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~l~~~v  221 (378)
T 1sek_A          143 DQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFNKERTMDRDFHVSKDKTIKVPTMIGKKD-VRYADVPELDAKM  221 (378)
T ss_dssp             HHTTTSSCCCSCGGGCCTTCCEEEEEEEEEEECBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEE-EEEEEEGGGTEEE
T ss_pred             HHhCCcccccCCcccCCCCCeEEEEEeeEEeccccCCCCCCCcccceEEeCCCEEEEeeEEEeece-EeEEEeCCCCeEE
Confidence            999999999999999999999999999999999999999999999999999999999999999998 9999999999999


Q ss_pred             EEEeC-CCcEEEEEeecCCCCCC
Q psy2651         319 LELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       319 LELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ||||| |+++||+|   |||+++
T Consensus       222 leLPy~~~~~sm~i---iLP~~~  241 (378)
T 1sek_A          222 IEMSYEGDQASMII---ILPNQV  241 (378)
T ss_dssp             EEEEBGGGSEEEEE---EEESST
T ss_pred             EEEECCCCcEEEEE---EEeCCC
Confidence            99999 99999999   899974

>4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C

Probab=100.00  E-value=3.8e-52  Score=408.18  Aligned_cols=225  Identities=30%  Similarity=0.528  Sum_probs=205.7

Q ss_pred             ccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccch
Q psy2651          83 SILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL  161 (342)
Q Consensus        83 ~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~  161 (342)
                      +..+ +||++||+                 ++++. +++|+||||+||+.+|+|+++||+|+|++||.++||++..+   
T Consensus        10 ~~~~-~f~~~L~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~---   68 (379)
T 4dy0_A           10 ELGS-NTGIQVFN-----------------QIVKSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVNG---   68 (379)
T ss_dssp             HHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTSCSTT---
T ss_pred             HHhh-HHHHHHHH-----------------HHHhhCcCCcEEECHHHHHHHHHHHHHHcChHHHHHHHHHhCCChhH---
Confidence            3334 99999999                 99877 89999999999999999999999999999999999997655   


Q ss_pred             hcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhh
Q psy2651         162 KDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS  238 (342)
Q Consensus       162 ~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~  238 (342)
                               ++..++.+...+....   .+.+||+||+++++++.++|++.++++|+++++.+||.++.++++.||+||+
T Consensus        69 ---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~wV~  139 (379)
T 4dy0_A           69 ---------VGKILKKINKAIVSKKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFEDPASACDSINAWVK  139 (379)
T ss_dssp             ---------THHHHHHHHHHHHCGGGSSCCEEEEEEEESCTTSSCHHHHHHHHHHHCEEEEECCTTSHHHHHHHHHHHHH
T ss_pred             ---------HHHHHHHHHHHHhccCCCceeeeeeeeeeEccccccchhhhhhhhcCCcEEEEeccCChHHHHHHHHHHHH
Confidence                     5666777776665433   7999999999999999999999999999999999999999889999999999


Q ss_pred             cccCCccccCCCCCCCCcc-cceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeC---CC
Q psy2651         239 NHTNDKIKDLIKADSLDAS-TKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAG---ED  314 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~-t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~---~l  314 (342)
                      ++|+|+|+++++++++++. |+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. ++|+++.   ++
T Consensus       140 ~~T~g~I~~ll~~~~~~~~~T~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~-~~~~~~~~~~~l  218 (379)
T 4dy0_A          140 NETRDMIDNLLSPDLIDGVLTRLVLVNAVYFKGLWKSRFQPENTKKRTFVAADGKSYQVPMLAQLSV-FRCGSTSAPNDL  218 (379)
T ss_dssp             HHTTTCCCCCCCGGGCCTTTCCEEEEEEEEECCCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEE-EEEEEEECTTSC
T ss_pred             HhcCCcccccCCcccCCcccceEEEEEEEEEEeeecCCCchhhCeeeeEEeCCCceEEeeeeEeeee-eccccccccccc
Confidence            9999999999999888764 99999999999999999999999999999999999999999999998 9998764   67


Q ss_pred             CeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         315 GFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       315 ~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++++||||| |+++||+|   |||++++
T Consensus       219 ~~~vl~LPy~~~~~sm~i---iLP~~~~  243 (379)
T 4dy0_A          219 WYNFIELPYHGESISMLI---ALPTESS  243 (379)
T ss_dssp             EEEEEEEEBTTSSEEEEE---EEESSTT
T ss_pred             ceEEEEeccCCCceEEEE---EecCccc
Confidence            899999999 99999999   7987653

>1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A

Probab=100.00  E-value=2.1e-52  Score=409.46  Aligned_cols=222  Identities=25%  Similarity=0.466  Sum_probs=207.2

Q ss_pred             ccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccch
Q psy2651          83 SILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL  161 (342)
Q Consensus        83 ~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~  161 (342)
                      ++.+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++...  +
T Consensus         6 ~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~--~   65 (375)
T 1wz9_A            6 LANS-AFAVDLFK-----------------QLCEKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFENVK--D   65 (375)
T ss_dssp             HHHH-HHHHHHHH-----------------HHHHHCTTSCCEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS--C
T ss_pred             HHHH-HHHHHHHH-----------------HHhccCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHH--H
Confidence            3445 99999999                 88775 78999999999999999999999999999999999997543  3


Q ss_pred             hcccchhHHHHHHHHHHHHHhCCC--c-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecC-CCcHHHHHhhchhh
Q psy2651         162 KDYKGIIDQLSKDYKGIIDQLSKS--P-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDF-SQPPAAAKEMNDWV  237 (342)
Q Consensus       162 ~~~~~~~~~v~~~~~~l~~~l~~~--~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF-~~~~~a~~~IN~WV  237 (342)
                               ++..|+.++..+...  + .+++||+||+++++++.++|.+.++++|+++++.+|| .+++++++.||+||
T Consensus        66 ---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV  136 (375)
T 1wz9_A           66 ---------VPFGFQTVTSDVNKLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSI  136 (375)
T ss_dssp             ---------HHHHHHHHHHHHHHHTTTSEEEEEEEEEEEGGGCCCHHHHHHHTTTTTTTEEEECTTTCHHHHHHHHHHHH
T ss_pred             ---------HHHHHHHHHHHhhcCCCCcEEEEeeeeeeeCCcchhHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHH
Confidence                     888899888877543  2 8999999999999999999999999999999999999 57778999999999


Q ss_pred             hcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeE
Q psy2651         238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFK  317 (342)
Q Consensus       238 ~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~  317 (342)
                      +++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++||..+|+.++||||++.+. |+|+++++++++
T Consensus       137 ~~~T~g~I~~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~~~~~  215 (375)
T 1wz9_A          137 KDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFPESETKECPFRLNKTDTKPVQMMNMEAT-FCMGNIDSINCK  215 (375)
T ss_dssp             HHHTTTSCSCTTTTSCCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEE-EEEEEETTTTEE
T ss_pred             HHHhcCchhhccCcccCCccchhhheeheeeecccCCCCCccCceeeeEEeCCCeEEEEEEEEeeee-EeeEEeCCcceE
Confidence            9999999999999999999999999999999999999999999999999999999999999999998 999999999999


Q ss_pred             EEEEeC-CCcEEEEEeecCCC
Q psy2651         318 MLELPY-GVSISFIIKSQVVP  337 (342)
Q Consensus       318 vLELPY-~~~~SMlI~~~ILP  337 (342)
                      |||||| ++++||+|   |||
T Consensus       216 vleLPy~~~~~sm~i---iLP  233 (375)
T 1wz9_A          216 IIELPFQNKHLSMFI---LLP  233 (375)
T ss_dssp             EEEEEBGGGSEEEEE---EEE
T ss_pred             EEEeecCCCeEEEEE---Eec
Confidence            999999 99999999   899

>1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus}

Probab=100.00  E-value=8.7e-52  Score=408.11  Aligned_cols=230  Identities=32%  Similarity=0.552  Sum_probs=210.0

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++.+..+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        26 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   87 (398)
T 1yxa_A           26 TLASINT-DFAFSLYK-----------------ELVLKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTE   87 (398)
T ss_dssp             -CHHHHH-HHHHHHHH-----------------HHHHHSTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTT
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEchHHHHHHHHHHHhhcccHHHHHHHHHhCCCccc
Confidence            4555666 99999999                 88766 78899999999999999999999999999999999997543


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      .++.+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.+++++++.||+
T Consensus        88 ~~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  160 (398)
T 1yxa_A           88 TSEAD-------IHQGFGHLLQRLNQPKDQVQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADFQQPRQAKKLIND  160 (398)
T ss_dssp             SCHHH-------HHHHHHHHHHHHSSCBTTBEEEEEEEEEEETTSCCCHHHHHHHHHHHSCEEEEECTTSHHHHHHHHHH
T ss_pred             CCHHH-------HHHHHHHHHHHHhCCCCCceeeeeeEEEEeCCCchhHHHHHHHHHHhCCceeecCCCCHHHHHHHHHH
Confidence            21212       8899999999887643   8999999999999999999999999999999999999988888999999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecc-eeeeEEEeCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKD-SFYMYEEAGED  314 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~-~~f~y~~~~~l  314 (342)
                      ||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+ . |+|++++++
T Consensus       161 WV~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-~~y~~~~~l  237 (398)
T 1yxa_A          161 YVRKQTQGMIKELVS--DLDKRTLMVLVNYIYFKAKWKVPFDPLDTFKSEFYCGKRRPVIVPMMSMEDLT-TPYFRDEEL  237 (398)
T ss_dssp             HHHHHTTTSSSCCCC--CCCTTCCEEEEEEEEEECBBSSCCCGGGCEEEEECCCCSSCEEEEEEEEEEEE-EEEEEETTT
T ss_pred             HHHHHhcCchhhhhh--ccCCCcEEEEEEHHhhhhhhhCCCCcccCeeeEEEeCCCeEEEEEEEEEcCce-EEEEEeCCC
Confidence            999999999999996  599999999999999999999999999999999999999999999999999 8 999999999


Q ss_pred             CeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         315 GFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       315 ~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      +++|||||| ++ .||+|   |||++|+
T Consensus       238 ~~~vleLPY~~~-~sm~i---iLP~~~~  261 (398)
T 1yxa_A          238 SCTVVELKYTGN-ASALF---ILPDQGR  261 (398)
T ss_dssp             TEEEEEEEBSSS-EEEEE---EEECTTC
T ss_pred             CeEEEEEecCCC-eeEEE---EecCcCc
Confidence            999999999 76 49999   7999875

>3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A*

Probab=100.00  E-value=9.3e-52  Score=406.23  Aligned_cols=227  Identities=23%  Similarity=0.411  Sum_probs=208.7

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCc-
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHS-  157 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~-  157 (342)
                      ++.+..+ +||++||+                 ++.+. ++ |+||||+||+.+|+|+++||+|+|++||.++||++.. 
T Consensus        15 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~-Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   75 (385)
T 3f1s_A           15 QLAKETS-NFGFSLLR-----------------KISMRHDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALK   75 (385)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCCS-CEEECHHHHHHHHHHHTTTCCTHHHHHHHHHTTCTTCC
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhhCCCC-cEEEchHHHHHHHHHHHHhcchHHHHHHHHhcCCCCCc
Confidence            3445556 99999999                 88766 56 9999999999999999999999999999999999863 


Q ss_pred             -ccchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhh
Q psy2651         158 -ETLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM  233 (342)
Q Consensus       158 -~~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~I  233 (342)
                       +..+         ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.|
T Consensus        76 ~~~~~---------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~I  146 (385)
T 3f1s_A           76 PTKPG---------LLPSLFKGLRETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLM  146 (385)
T ss_dssp             CSSTT---------HHHHHHHHHHHHHHHCSSSCEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECCSSHHHHHHHH
T ss_pred             CCHHH---------HHHHHHHHHHHhhcCCCCcEEEEEEEEEEECCCchhHHHHHHHHHHhCCeeEEeCCCChHHHHHHH
Confidence             2123         8899999888875432   89999999999999999999999999999999999999888899999


Q ss_pred             chhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC
Q psy2651         234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE  313 (342)
Q Consensus       234 N~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~  313 (342)
                      |+||+++|+|+|++++  ++++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. |+|+++++
T Consensus       147 N~WV~~~T~gkI~~l~--~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~  223 (385)
T 3f1s_A          147 NHYINKETRGKIPKLF--DEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGK-FASTFDKN  223 (385)
T ss_dssp             HHHHHHHTTTSSSCCC--SCCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEE-EEEEEETT
T ss_pred             HHHHHHHhcCchhhHh--hccCCCCeEEEEEhhhccchhcCCCCccCccceEEEECCCEEEEEEEEeccCc-ccEEEeCC
Confidence            9999999999999999  58999999999999999999999999999999999999999999999999998 99999999


Q ss_pred             CCeEEEEEeCCCcEEEEEeecCCCCCC
Q psy2651         314 DGFKMLELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       314 l~~~vLELPY~~~~SMlI~~~ILP~~g  340 (342)
                      ++++||||||++++||+|   |||+++
T Consensus       224 l~~~vleLPy~~~~sm~i---iLP~~~  247 (385)
T 3f1s_A          224 FRCHVLKLPYQGNATMLV---VLMEKM  247 (385)
T ss_dssp             TTEEEEEEEETTTEEEEE---EEECTT
T ss_pred             CCeEEEEecCCCcEEEEE---EeCCCC
Confidence            999999999988899999   899974

>4ajt_A Protein Z-dependent protease inhibitor; blood clotting, ZPI; 2.50A {Mus musculus}

Probab=100.00  E-value=1.5e-51  Score=409.28  Aligned_cols=226  Identities=26%  Similarity=0.490  Sum_probs=207.8

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhccCCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCC---
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH---  156 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~---  156 (342)
                      .++++.+ +||++||+                 +++....+|+||||+||+.+|+|+++||+|+|++||.++||++.   
T Consensus        57 ~l~~~~~-~Fa~~L~~-----------------~l~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~  118 (427)
T 4ajt_A           57 QLSNETS-SFGFNLLR-----------------KISMRHDGNVIFSPFGLSVAMVNLMLGTKGETKVQIENGLNLQALSQ  118 (427)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCCSCEEECHHHHHHHHHHHHHHCCTHHHHHHHHHHTCHHHHT
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHHhcCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCcccc
Confidence            5566667 99999999                 88766334999999999999999999999999999999999973   


Q ss_pred             cccchhcccchhHHHHHHHHHHHHHhCCCc--chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhc
Q psy2651         157 SETLLKDYKGIIDQLSKDYKGIIDQLSKSP--ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN  234 (342)
Q Consensus       157 ~~~~~~~~~~~~~~v~~~~~~l~~~l~~~~--~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN  234 (342)
                      .+..+         ++..|+.++..+...+  .+.+||+||++++++++++|++.++++|+++++.+||.++..+++.||
T Consensus       119 ~~~~~---------i~~~f~~l~~~l~~~~~~~L~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~IN  189 (427)
T 4ajt_A          119 AGPLI---------LPALFKKVKETFSSNRDLGLSQGSFAFIHKDFDIKETYFNLSKKYFDIEYVSINFQNSSQARGLIN  189 (427)
T ss_dssp             SCTTH---------HHHHHHHHHHHHHTCTTSCEEEEEEEEEETTSCCCHHHHHHHHHHSCCCEEEECTTSHHHHHHHHH
T ss_pred             CCHHH---------HHHHHHHHHHHhCCCCCceehhhhHHHHccCCchhHHHHHHHHHhhcceeEEcCCCChHHHHHHHH
Confidence            12123         8899999988876322  899999999999999999999999999999999999988888999999


Q ss_pred             hhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCC
Q psy2651         235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGED  314 (342)
Q Consensus       235 ~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l  314 (342)
                      +||+++|+|+|++++  ++++++|+++|+|||||||.|+++|++.+|++++||..+|++++||||++.+. |+|++++++
T Consensus       190 ~WV~~~T~gkI~~ll--~~l~~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~-f~~~~~~~l  266 (427)
T 4ajt_A          190 HCIVKETEGKIPKLF--DEINPETKLILVDYVLFKGKWLTPFDPSFTEADTFHLDKYRAIKVPMMYREGN-FTSTFDKKF  266 (427)
T ss_dssp             HHHHHHTTTSSCSCC--SCCCTTCCEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEE-EEEEEETTT
T ss_pred             HHHHHhhCCcccccc--cCCCCcceeEEeeeeeeeeeecCCCChhhccccceeccCCCEEEEEEEEecCc-eeEEEecCC
Confidence            999999999999999  58999999999999999999999999999999999999999999999999998 999999999


Q ss_pred             CeEEEEEeC-CCcEEEEEeecCCCCC
Q psy2651         315 GFKMLELPY-GVSISFIIKSQVVPEM  339 (342)
Q Consensus       315 ~~~vLELPY-~~~~SMlI~~~ILP~~  339 (342)
                      +++|||||| + ++||+|   |||++
T Consensus       267 ~~~vleLPY~~-~~sm~i---iLP~~  288 (427)
T 4ajt_A          267 RCHILKLPYQG-NATMLV---VLMEK  288 (427)
T ss_dssp             TEEEEEEEEGG-GEEEEE---EEECT
T ss_pred             ceEEEEEEcCC-CeEEEE---EecCC
Confidence            999999999 8 999999   89998

>3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae}

Probab=100.00  E-value=4.2e-51  Score=402.97  Aligned_cols=225  Identities=27%  Similarity=0.504  Sum_probs=205.1

Q ss_pred             ccccccccccccccccCCcchhhhhhhhhhhhhccCCCCEEEChhhHHHHHHHHHccCChhH------HHHHHHHcCCCC
Q psy2651          83 SILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGST------AEAMMKGLRIKH  156 (342)
Q Consensus        83 ~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~Niv~SP~sI~~aLamL~~GA~G~T------~~qL~~~Lgl~~  156 (342)
                      +..+ +||++||+                 ++++.+++|+||||+||+.+|+|+++||+|+|      .+|+.++|++..
T Consensus        20 ~~~~-~Fa~~L~k-----------------~l~~~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~~~~~~~~~l~~l~~~~   81 (397)
T 3pzf_A           20 QRQN-EFDLMFVK-----------------EIFKNHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQND   81 (397)
T ss_dssp             CCCC-HHHHHHHH-----------------HHHHTCSSCEEECHHHHHHHHHHHHHHSGGGCC-CCCHHHHHGGGGSSTT
T ss_pred             chhh-HHHHHHHH-----------------HHHhCCCCCEEEchHHHHHHHHHHHhhcCCCCccChHHHHHHHHHcCCCC
Confidence            3444 99999999                 88765788999999999999999999999998      777777777654


Q ss_pred             cccchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhh
Q psy2651         157 SETLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM  233 (342)
Q Consensus       157 ~~~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~I  233 (342)
                      .. .+         ++..|++++..+...+   .+.+||+||+++++++.++|++.++++|+++++.+||.+++.+++.|
T Consensus        82 ~~-~~---------~~~~~~~ll~~l~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~a~~~I  151 (397)
T 3pzf_A           82 NI-DH---------TRSYYKQLLESAQQDNKDYDLNIATNFFVDDFIEVINKYQQIANTHYHAMLEKVSYSNPTQTAATI  151 (397)
T ss_dssp             CH-HH---------HHHHHHHHHHHHHCCCSSCEEEEEEEEEEETTCCBCHHHHHHHHHHHCEEEEEECTTSHHHHHHHH
T ss_pred             ch-HH---------HHHHHHHHHHHHhcCCCCcEEEEeeeeeEeCCCccchHHHHHHHHHhCCeEEEeCCCChHHHHHHH
Confidence            32 12         6677888888876543   89999999999999999999999999999999999999988888999


Q ss_pred             chhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC
Q psy2651         234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE  313 (342)
Q Consensus       234 N~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~  313 (342)
                      |+||+++|+|+|+++++++.++ +|+++|+||+||||.|+++|++.+|++++|+..+|++++||||++.+. |+|+++++
T Consensus       152 N~WV~~~T~gkI~~ll~~~~~~-~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~-~~y~~~~~  229 (397)
T 3pzf_A          152 NNWVSEHTNGRLREIVTPDSLE-GAVITLVNVIYFKGLWTYPFPEVANNVKPFYGTRGKPTNAQYMEQNGQ-FYYDNSAD  229 (397)
T ss_dssp             HHHHHHHTTTSCCCCCCGGGGT-TCSEEEEEEEEEEEEBSSCCCCCSCCEEEECCSSSSCEEEEEEEEEEE-EEEEEETT
T ss_pred             HHHHHHHhCCcccccCCCCCcc-cceeEEeeheecccccCccCCcccccccccccCCCcEEEEEEEEecCC-cCeEEccC
Confidence            9999999999999999988888 899999999999999999999999999999999999999999999998 99999999


Q ss_pred             CCeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         314 DGFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       314 l~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ++++|||||| ++.+||+|   |||+++
T Consensus       230 l~~~vleLPy~~~~~sm~i---iLP~~~  254 (397)
T 3pzf_A          230 LGAQILRLPYRGNKLAMYF---ILPNPD  254 (397)
T ss_dssp             TTEEEEEEEBTTSSEEEEE---EEECTT
T ss_pred             CCEEEEEEEcCCCceEEEE---EECCCC
Confidence            9999999999 99999999   899975

>1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A

Probab=100.00  E-value=2.6e-51  Score=405.08  Aligned_cols=231  Identities=32%  Similarity=0.527  Sum_probs=206.2

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      .+.+..+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        26 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   87 (401)
T 1qmn_A           26 GLASANV-DFAFSLYK-----------------QLVLKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTE   87 (401)
T ss_dssp             -CHHHHH-HHHHHHHH-----------------HHHHHCSSSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTCCTTT
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEecHHHHHHHHHHHhhccCHHHHHHHHHhCCCCCC
Confidence            3455566 99999999                 88766 78899999999999999999999999999999999997543


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      .++.+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.++.++++.||+
T Consensus        88 ~~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  160 (401)
T 1qmn_A           88 TSEAE-------IHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLIND  160 (401)
T ss_dssp             CCHHH-------HHHHHHHHHHHHCCCSSSCEEEEEEEEEEESSCCCCHHHHHHHHHHHCCEEEEECGGGHHHHHHHHHH
T ss_pred             CCHHH-------HHHHHHHHHHHHhcCCCCceEEEEEEEEeeCCCchHHHHHHHHHHhcCCeEEecCccCHHHHHHHHHH
Confidence            22212       8899999999987643   8999999999999999999999999999999999999988888899999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++||..+|+.++||||++.+..|+|+++++++
T Consensus       161 WV~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~  238 (401)
T 1qmn_A          161 YVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELS  238 (401)
T ss_dssp             HCSSEEEEEEEECC------CCCCEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTT
T ss_pred             HHHHHhcCchhhhcc--CCCCCceEEEEEeeeeeehhcCCCChhcCccceEEcCCCcEEEeeEEEEcCceEEEEEeCCCc
Confidence            999999999999996  599999999999999999999999999999999999999999999999998438999999999


Q ss_pred             eEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         316 FKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       316 ~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++|||||| |+. ||+|   |||++|.
T Consensus       239 ~~vleLPY~~~~-sm~i---iLP~~~~  261 (401)
T 1qmn_A          239 CTVVELKYTGNA-SALF---ILPDQDK  261 (401)
T ss_dssp             EEEEEEEBSSSE-EEEE---EEECTTC
T ss_pred             eEEEEEecCCCe-EEEE---EEECCCC
Confidence            99999999 765 9999   7999864

>3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} SCOP: e.1.1.1 PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ...

Probab=100.00  E-value=1.6e-51  Score=409.98  Aligned_cols=231  Identities=27%  Similarity=0.533  Sum_probs=207.2

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++.+.+ +||++||+                 +++..  +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        51 l~~~~~-~Fa~~L~k-----------------~l~~~~~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~  112 (432)
T 3kcg_I           51 LSKANS-RFATTFYQ-----------------HLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTIS  112 (432)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHHHHSCTTSCCCBCHHHHHHHHHHHHTTCCHHHHHHHHHHTTCTTSC
T ss_pred             HHHHHh-HHHHHHHH-----------------HHhhccCCCCCEEEcHHHHHHHHHHHHhhcccHHHHHHHHHhCCCccc
Confidence            344556 99999999                 88763  58899999999999999999999999999999999997432


Q ss_pred             -cchhcccchhHHHHHHHHHHHHHhCC---Cc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHh
Q psy2651         159 -TLLKDYKGIIDQLSKDYKGIIDQLSK---SP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKE  232 (342)
Q Consensus       159 -~~~~~~~~~~~~v~~~~~~l~~~l~~---~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~  232 (342)
                       ...++       ++..|+.++..+.+   .+ .+.+||+||+++++++.++|++.++++|+++++.+||.+. +.+++.
T Consensus       113 ~~~~~~-------i~~~f~~l~~~l~~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~~~  185 (432)
T 3kcg_I          113 EKTSDQ-------IHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAA  185 (432)
T ss_dssp             HHHHHT-------HHHHHHHHHHHHHHHHTTTEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECHHHHHHHHHHH
T ss_pred             cccHHH-------HHHHHHHHHHHHhcccCCCcEEEEEEEEEEcCCCccCHHHHHHHHHHhCCeEEeccCCCCHHHHHHH
Confidence             11112       88888888776642   23 8999999999999999999999999999999999999865 445667


Q ss_pred             hchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeC
Q psy2651         233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAG  312 (342)
Q Consensus       233 IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~  312 (342)
                      ||+||+++|+|+|++++++++++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. |+|++++
T Consensus       186 IN~WV~~~T~gkI~~ll~~~~l~~~T~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-f~y~~~~  264 (432)
T 3kcg_I          186 INKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGK-FRYRRVA  264 (432)
T ss_dssp             HHHHHHHHTTTSSCCSSCTTSSCTTCCEEEEEEEEEEECBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEE-EEEEECG
T ss_pred             HHHHHHhhccCchhccCCcccCCCCceEEEEeHHhhhhhhhcCCCcccceeeeEEECCCeEEEEEEEEecce-eeEEEec
Confidence            999999999999999999889999999999999999999999999999999999999999999999999998 9999998


Q ss_pred             CCCeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         313 EDGFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       313 ~l~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      + +++|||||| |+++||+|   |||++++
T Consensus       265 ~-~~~vleLPy~~~~~sm~i---iLP~~~~  290 (432)
T 3kcg_I          265 E-GTQVLELPFKGDDITMVL---ILPKPEK  290 (432)
T ss_dssp             G-GCEEEEEEBTTSSEEEEE---EECCTTS
T ss_pred             C-CcEEEEEEcCCCceEEEE---EecCCCC
Confidence            8 999999999 99999999   8999874

>1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1

Probab=100.00  E-value=9.8e-51  Score=400.57  Aligned_cols=227  Identities=23%  Similarity=0.443  Sum_probs=208.7

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++.+..+ +||++||+                 ++... +++|+||||+||+.+|+|+++||+|+|++||.++||++..+
T Consensus        33 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~   94 (398)
T 1imv_A           33 KLAAAVS-NFGYDLYR-----------------VRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLIS   94 (398)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCC
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHHccCCCCCEEEChHHHHHHHHHHHHhcccHHHHHHHHHhCCCCCC
Confidence            3445556 99999999                 88766 78899999999999999999999999999999999997643


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhh
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWV  237 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV  237 (342)
                      ..+         ++..|+.++..+...+ .+.+||+||+++++++.++|.+.++++|+++++.+| .++.++++.||+||
T Consensus        95 ~~~---------~~~~~~~l~~~l~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vd-~~~~~a~~~IN~WV  164 (398)
T 1imv_A           95 SPD---------IHGTYKELLDTVTAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLT-GNPRLDLQEINNWV  164 (398)
T ss_dssp             CSC---------HHHHHHHHHHHHTSTTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECC-SCHHHHHHHHHHHH
T ss_pred             cHH---------HHHHHHHHHHHhhCCCCCeEEEEEEeecCCCcHHHHHHHHHHHHhCCcceecC-CCHHHHHHHHHHHH
Confidence            234         8999999999887655 778999999999999999999999999999999999 88888999999999


Q ss_pred             hcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeec-ceeeeEEEeCCCCe
Q psy2651         238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVK-DSFYMYEEAGEDGF  316 (342)
Q Consensus       238 ~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~-~~~f~y~~~~~l~~  316 (342)
                      +++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++. +. |+|++++++++
T Consensus       165 ~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~-f~~~~~~~l~~  241 (398)
T 1imv_A          165 QAQMKGKLARSTK--EIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAV-LRYGLDSDLSC  241 (398)
T ss_dssp             HHHTTTCSCCCCS--CCCSSCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEE-EEEEEETTTTE
T ss_pred             HHhhcCchhhhhh--ccCCCceEEEEEhhhhhhhhcCcCChhhCeeeEEEeCCCEEEEEEEEEEecce-eEEEEecCCCe
Confidence            9999999999996  79999999999999999999999999999999999999999999999999 98 99999999999


Q ss_pred             EEEEEeC-CCcEEEEEeecCCC--CCCC
Q psy2651         317 KMLELPY-GVSISFIIKSQVVP--EMGR  341 (342)
Q Consensus       317 ~vLELPY-~~~~SMlI~~~ILP--~~g~  341 (342)
                      +|||||| | ++||+|   |||  +++.
T Consensus       242 ~vleLPY~~-~~sm~i---iLP~~~~~~  265 (398)
T 1imv_A          242 KIAQLPLTG-SMSIIF---FLPLKVTQN  265 (398)
T ss_dssp             EEEEEEETT-TEEEEE---EEESSCCSC
T ss_pred             EEEEEccCC-CeEEEE---EEeCCCCCC
Confidence            9999999 6 599999   799  7654

>2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus}

Probab=100.00  E-value=9.1e-51  Score=397.39  Aligned_cols=227  Identities=24%  Similarity=0.489  Sum_probs=203.3

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      .++++.+ +||++||+                 ++... +++|+||||+||+.+|+|+++||   |++||.++||++...
T Consensus         8 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA---T~~el~~~L~~~~~~   66 (371)
T 2v95_A            8 GLAPTNV-DFAFNLYQ-----------------RLVALNPDKNTLISPVSISMALAMVSLGS---AQTQSLQSLGFNLTE   66 (371)
T ss_dssp             TTHHHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHTTTC-----CHHHHHHTCCTTT
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhccCCCCcEEEchHHHHHHHHHHHHHH---HHHHHHHHhCCCCCC
Confidence            3445556 99999999                 88765 78999999999999999999999   999999999997543


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhch
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMND  235 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~  235 (342)
                      .++.+       ++..|+.++..+...+   .+.+||+||+++++++.++|.+.++++|+++++.+||.+++++++.||+
T Consensus        67 ~~~~~-------~~~~~~~l~~~l~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~a~~~IN~  139 (371)
T 2v95_A           67 TSEAE-------IHQSFQYLNYLLKQSDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFEDWTKASQQINQ  139 (371)
T ss_dssp             SCHHH-------HHHHHHHHHHHHTTGGGSEEEEEEEEEEECTTCCBCHHHHHHHHHHSCCEEEECCCSSHHHHHHHHHH
T ss_pred             CCHHH-------HHHHHHHHHHHHhCCCCCcEEEEEEEEeEeCCCchhHHHHHHHHHHhCCceEEecCccHHHHHHHHHH
Confidence            21212       8899999999887643   8999999999999999999999999999999999999988889999999


Q ss_pred             hhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCC
Q psy2651         236 WVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDG  315 (342)
Q Consensus       236 WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~  315 (342)
                      ||+++|+|+|+++++  +++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. |+|+++++++
T Consensus       140 WV~~~T~gkI~~l~~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~y~~~~~l~  216 (371)
T 2v95_A          140 HVKDKTQGKIEHVFS--DLDSPASFILVNYIFLRGIWELPFSPENTREEDFYVNETSTVKVPMMVQSGS-IGYFRDSVFP  216 (371)
T ss_dssp             HHHHHTTTCCCCSCC--C--CCCSEEEEEEEEEEECBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEE-EEEEEETTTT
T ss_pred             HHHHHhcCchhhhcc--CCCCCceEEEEEHHhhhhhhhCcCCCcccceeEEEECCCeEEEEEEEEeeee-EeeEEeCCCC
Confidence            999999999999996  5999999999999999999999999999999999999999999999999998 9999999999


Q ss_pred             eEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         316 FKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       316 ~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ++|||||| |+ .||+|   |||+++.
T Consensus       217 ~~vleLPy~~~-~sm~i---iLP~~~~  239 (371)
T 2v95_A          217 CQLIQMDYVGN-GTAFF---ILPDQGQ  239 (371)
T ss_dssp             EEEEEEEBSSS-EEEEE---EEECTTC
T ss_pred             EEEEEEecCCC-eEEEE---EecCCCC
Confidence            99999999 64 79999   7999874

>3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} SCOP: e.1.1.0

Probab=100.00  E-value=6.9e-51  Score=401.03  Aligned_cols=220  Identities=29%  Similarity=0.516  Sum_probs=201.3

Q ss_pred             cccccccccccCCcchhhhhhhhhhhh-hcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNL-AAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYK  165 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l-~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~  165 (342)
                      +||++||+                 ++ .+. +++|+||||+||+.+|+|+++||+|+|++||.++||++..+  +    
T Consensus        14 ~Fa~~L~~-----------------~l~~~~~~~~Ni~~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~--~----   70 (393)
T 3le2_A           14 QVSMNLAK-----------------HVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFSSTD--Q----   70 (393)
T ss_dssp             HHHHHHHH-----------------HHHHTSCTTCCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHHTCSSHH--H----
T ss_pred             HHHHHHHH-----------------HHhcccCCCCCEEECHHHHHHHHHHHHhcCCCcHHHHHHHHhCCCCHH--H----
Confidence            99999999                 98 555 78999999999999999999999999999999999998432  3    


Q ss_pred             chhHHHHHHHHHHHHHhCC-----Cc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCC-cHHHHHhhchhhh
Q psy2651         166 GIIDQLSKDYKGIIDQLSK-----SP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQ-PPAAAKEMNDWVS  238 (342)
Q Consensus       166 ~~~~~v~~~~~~l~~~l~~-----~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~-~~~a~~~IN~WV~  238 (342)
                           ++..++.++..+..     .+ .+.+||+||+++++++.++|++.++++|+++++.+||.+ ++.++++||+||+
T Consensus        71 -----~~~~~~~l~~~l~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~  145 (393)
T 3le2_A           71 -----LNSFSSEIVSAVLADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAASNQADFQSKAVEVIAEVNSWAE  145 (393)
T ss_dssp             -----HHHHHHHTHHHHHSCCGGGTSCEEEEEEEEEEETTSCBCHHHHHHHHHHSCCEEEEECHHHHHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHHHHHhhccccCCCCcEEEeeeehhhcCCCCcChHHHHHHHHhhcceEEEecccccHHHHHHHHHHHHH
Confidence                 78888888877642     12 799999999999999999999999999999999999976 5678899999999


Q ss_pred             cccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEE
Q psy2651         239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKM  318 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~v  318 (342)
                      ++|+|+|++++++++++++|+++|+||+||||.|+++|++.+|++++||..+|++++||||++.+. +.|++.  .+++|
T Consensus       146 ~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~-~~~~~~--~~~~v  222 (393)
T 3le2_A          146 KETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEKFDESLTQEGEFHLLDGNKVTAPFMTSKKK-QYVSAY--DGFKV  222 (393)
T ss_dssp             HHTTTSCCCSSCTTCSCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEECCSC-EEEEEE--TTEEE
T ss_pred             HhhcCchhhhCCccCCCCCcEEEEEEeeeEecccccCCChhhccccccEeCCCcEEEEccccccCe-eeeeec--cCcEE
Confidence            999999999999999999999999999999999999999999999999999999999999999998 777764  48999


Q ss_pred             EEEeC-C----CcEEEEEeecCCCCCCC
Q psy2651         319 LELPY-G----VSISFIIKSQVVPEMGR  341 (342)
Q Consensus       319 LELPY-~----~~~SMlI~~~ILP~~g~  341 (342)
                      ||||| +    .++||+|   |||++++
T Consensus       223 leLPy~~~~~~~~~sm~i---iLP~~~~  247 (393)
T 3le2_A          223 LGLPYLQGQDKRQFSMYF---YLPDANN  247 (393)
T ss_dssp             EEEEBCCTTCSCCEEEEE---EEESSTT
T ss_pred             EEeecCCCCCCCcEEEEE---EeCCCCC
Confidence            99999 7    5899999   8999874

>1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1

Probab=100.00  E-value=3e-50  Score=386.95  Aligned_cols=218  Identities=21%  Similarity=0.361  Sum_probs=203.3

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      .+.+..+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||   . 
T Consensus         5 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~---~-   62 (323)
T 1mtp_A            5 FLRDDHL-EFALHLHR-----------------RLAEAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLG---T-   62 (323)
T ss_dssp             SSCHHHH-HHHHHHHH-----------------HHHHHSTTCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHT---S-
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhccCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHHH---H-
Confidence            4455566 99999999                 88776 789999999999999999999999999999999998   2 


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCC-CcHHHHHhhchh
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFS-QPPAAAKEMNDW  236 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~-~~~~a~~~IN~W  236 (342)
                        +         ++..|+.+ ..+...+ .+.+||+||+++++++.++|.+.++++|+++++.+||. +++.+++.||+|
T Consensus        63 --~---------~~~~~~~l-~~l~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~W  130 (323)
T 1mtp_A           63 --D---------PAPLLAAL-DRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNAD  130 (323)
T ss_dssp             --C---------HHHHHHHH-HHHTCSCTTEEEEEEEEECTTSCBCHHHHHHHHHSTTCEEEECCTTTCHHHHHHHHHHH
T ss_pred             --H---------HHHHHHHH-HHHhCCCcEEeeeeeeeeECCcEecHHHHHHHHHHhCCEEEEEcCCCCHHHHHHHHHHH
Confidence              3         78888888 7776333 89999999999999999999999999999999999997 778899999999


Q ss_pred             hhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCe
Q psy2651         237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGF  316 (342)
Q Consensus       237 V~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~  316 (342)
                      |+++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++|| .+|++++||||++.+. |+|++++++++
T Consensus       131 V~~~T~g~I~~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~-~~y~~~~~~~~  208 (323)
T 1mtp_A          131 IADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTREGTFR-TPRGPKRVPFMHRTKT-MPYATARGWRM  208 (323)
T ss_dssp             HHHHTTTSCSCSSCTTCSCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEE-EEEEEETTEEE
T ss_pred             HHHHhcCcccccCCcCCCCcccceeeeeeeeeeccccCCCCcccCeeeeee-cCCeEEEeeEEEeeee-EeeEEeCCCCE
Confidence            999999999999999999999999999999999999999999999999999 9999999999999998 99999999999


Q ss_pred             EEEEEeCCCcEEEEEeecCCCC
Q psy2651         317 KMLELPYGVSISFIIKSQVVPE  338 (342)
Q Consensus       317 ~vLELPY~~~~SMlI~~~ILP~  338 (342)
                      +||||  ++++||+|   |||+
T Consensus       209 ~vleL--~~~~sm~i---iLP~  225 (323)
T 1mtp_A          209 VTLHA--HDELAVDV---LLPP  225 (323)
T ss_dssp             EEEEB--STTEEEEE---EECC
T ss_pred             EEEEE--CCcEEEEE---EecC
Confidence            99999  99999999   7998

>1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A*

Probab=100.00  E-value=1.2e-49  Score=400.51  Aligned_cols=228  Identities=26%  Similarity=0.452  Sum_probs=207.1

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhc--cCCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCC--
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAA--NKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH--  156 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~--~~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~--  156 (342)
                      ++.+.+ +||++||+                 ++.+  .+++|+||||+||+.+|+|+++||+|+|++||.++||++.  
T Consensus       107 l~~~~~-~Fa~~L~k-----------------~l~~~~~~~~NivfSP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~  168 (480)
T 1jmo_A          107 LNILNA-KFAFNLYR-----------------VLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFV  168 (480)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHH
T ss_pred             HHHHHH-HHHHHHHH-----------------HHHhccCCCCCEEEcHHHHHHHHHHHHHhcCcHHHHHHHHHhCCCccc
Confidence            344556 99999999                 8876  3678999999999999999999999999999999999975  


Q ss_pred             --ccc-chhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHH
Q psy2651         157 --SET-LLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAA  230 (342)
Q Consensus       157 --~~~-~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~  230 (342)
                        .+. ++.       .++..|+.++..+...+   .+++||+||+++++++.++|++.++++|+++++.+||.++.. +
T Consensus       169 ~~~~~~~~~-------~i~~~f~~ll~~l~~~~~~~~L~~AN~lfv~~~~~l~~~F~~~~~~~y~a~~~~vDF~~~~~-~  240 (480)
T 1jmo_A          169 NASSKYEIT-------TIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPAF-I  240 (480)
T ss_dssp             HHCTTCCHH-------HHHHHHHHHHHHHHSSCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHSCCEEEECTTCHHH-H
T ss_pred             cccccCCHH-------HHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCcccHHHHHHHHHhhccceeeecccCHHH-H
Confidence              210 011       18899999998886543   899999999999999999999999999999999999998876 8


Q ss_pred             HhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEE
Q psy2651         231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEE  310 (342)
Q Consensus       231 ~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~  310 (342)
                      +.||+||+++|+|+|++++  ++++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. |+|++
T Consensus       241 ~~IN~WV~~~T~gkI~~ll--~~l~~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~-f~y~~  317 (480)
T 1jmo_A          241 SKTNNHIMKLTKGLIKDAL--ENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGN-FLAAN  317 (480)
T ss_dssp             HHHHHHHHHHTTTSSCCTT--CSCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEE-EEEEE
T ss_pred             HHHHHHHHHhhCCChhhhh--cccCCCCeEEEEehHeeeccccCCCCCCCceeEEEEeCCCcEEEEEEEEEecc-eeeEE
Confidence            8999999999999999999  58999999999999999999999999999999999999999999999999998 99999


Q ss_pred             eCCCCeEEEEEeCCCcEEEEEeecCCCCCC
Q psy2651         311 AGEDGFKMLELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       311 ~~~l~~~vLELPY~~~~SMlI~~~ILP~~g  340 (342)
                      +++++++||||||.+++||+|   |||+++
T Consensus       318 ~~~l~~~vleLPY~~~~SM~I---iLP~~~  344 (480)
T 1jmo_A          318 DQELDCDILQLEYVGGISMLI---VVPHKM  344 (480)
T ss_dssp             ETTTTEEEEEEEETTTEEEEE---EEESSG
T ss_pred             eCCCceEEEEEecCCcEEEEE---EecCCC
Confidence            999999999999977799999   899864

>1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1

Probab=100.00  E-value=3.9e-49  Score=385.73  Aligned_cols=218  Identities=21%  Similarity=0.357  Sum_probs=203.6

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      .+.+..+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||   . 
T Consensus         9 ~l~~~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~---~-   66 (370)
T 1sng_A            9 FLRDDHL-EFALHLHR-----------------RLAEAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLG---T-   66 (370)
T ss_dssp             CCCHHHH-HHHHHHHH-----------------HHHHTSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHT---S-
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHHH---H-
Confidence            4455666 99999999                 88876 789999999999999999999999999999999998   2 


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCC-CcHHHHHhhchh
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFS-QPPAAAKEMNDW  236 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~-~~~~a~~~IN~W  236 (342)
                        +         ++..|+.+ ..+...+ .+.+||+||+++++++.++|.+.++++|+++++.+||. +++++++.||+|
T Consensus        67 --~---------~~~~~~~l-~~l~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~W  134 (370)
T 1sng_A           67 --D---------PAPLLAAL-DRAVTDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNAD  134 (370)
T ss_dssp             --C---------HHHHHHHH-HHTTTTCTTEEEEEEEEEETTSCCCHHHHHHHHTSTTEEEEEECTTTCHHHHHHHHHHH
T ss_pred             --H---------HHHHHHHH-HHHhCCCceEEEeeeeeeeCCCcccHHHHHHHHhhhCCeEEEecCcCCHHHHHHHHHHH
Confidence              3         78888888 7776333 89999999999999999999999999999999999997 778899999999


Q ss_pred             hhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCe
Q psy2651         237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGF  316 (342)
Q Consensus       237 V~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~  316 (342)
                      |+++|+|+|++++++++++++|+++|+||+||||.|+++|++..|++++|| .+|++++||||++.+. |+|++++++++
T Consensus       135 V~~~T~g~I~~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~-~~y~~~~~~~~  212 (370)
T 1sng_A          135 IADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTPFEAHLTRAGTFR-TPRGPKRVPFMHRTKT-MPYATARGWRM  212 (370)
T ss_dssp             HHHHTTTSSCCSSCTTSCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEE-EEEEEETTEEE
T ss_pred             HHHHhcCchhhccCccccCCcccEEEEEEEEEccccccCCCcccCeeeeEe-cCCeEEEeEEEEEeee-eeeEEeCCCCE
Confidence            999999999999999999999999999999999999999999999999999 9999999999999998 99999999999


Q ss_pred             EEEEEeCCCcEEEEEeecCCCC
Q psy2651         317 KMLELPYGVSISFIIKSQVVPE  338 (342)
Q Consensus       317 ~vLELPY~~~~SMlI~~~ILP~  338 (342)
                      +||||  ++++||+|   |||+
T Consensus       213 ~vleL--~~~~sm~i---iLP~  229 (370)
T 1sng_A          213 VTLHA--HDELAVDV---LLPP  229 (370)
T ss_dssp             EEEEB--STTCEEEE---EECC
T ss_pred             EEEEE--CCCEEEEE---EecC
Confidence            99999  99999999   7998

>2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A

Probab=100.00  E-value=4.2e-49  Score=394.74  Aligned_cols=234  Identities=17%  Similarity=0.216  Sum_probs=205.0

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCE-EEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENA-IISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHS  157 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Ni-v~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~  157 (342)
                      ++.+..+ +||++||+                 ++.+. +++|+ ||||+||+.+|+|+++||+|+|++||.++||++..
T Consensus        72 ~l~~~~~-~Fa~~L~~-----------------~l~~~~~~~Ni~v~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~  133 (453)
T 2wxy_C           72 QVAMITN-FVGFRMYK-----------------MLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVK  133 (453)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCCCSSEEEECHHHHHHHHHHHHHTCCTTHHHHHHHHTTCCCC
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhhcCCCCcEEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCcc
Confidence            3456667 99999999                 88776 78999 99999999999999999999999999999999865


Q ss_pred             ccchhcccchhHHHHHHHHHHHHHhCC-----C--c-chhhhhhhhhccCcccchHHHHHhhhhcccc-cEEecC-CCcH
Q psy2651         158 ETLLKDYKGIIDQLSKDYKGIIDQLSK-----S--P-ELKIANKIYFAKDIELNPAYQTQAVDNFNSE-LGKVDF-SQPP  227 (342)
Q Consensus       158 ~~~~~~~~~~~~~v~~~~~~l~~~l~~-----~--~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~-v~~vdF-~~~~  227 (342)
                      +..... ....+.++..|+.+...+..     +  . .+.+||+||+++++++.++|.+.++++|+++ ++.+|| .++.
T Consensus       134 ~~~~~~-~~~~~~~~~~~~~l~~~l~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~~~~  212 (453)
T 2wxy_C          134 EGDCTS-RLDGHKVLAALRAVQGLLVTQGGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQSLALFTPALFPRSLDLSTDPV  212 (453)
T ss_dssp             TTCGGG-SBCHHHHHHHHHHHHHHHHC--------CEEEEEEEEEEECTTCCEEHHHHHHHHTTCSCEEEEECCCSSCHH
T ss_pred             cccccc-cccHHHHHHHHHHHHHHHhhccccCCCCccEEEEEEeEeEeCCCCccHHHHHHHHHHcCCCceeeecccCCHH
Confidence            310000 00012277888888877753     1  1 6999999999999999999999999999996 999999 7888


Q ss_pred             HHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeee
Q psy2651         228 AAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYM  307 (342)
Q Consensus       228 ~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~  307 (342)
                      ++++.||+||+++|+|+|+++++  +++++|+++|+|||||||.|+++|++..  +++||..+|++++||||++.+. |+
T Consensus       213 ~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~-f~  287 (453)
T 2wxy_C          213 LATEKINRFIKAVTGWKMNLPLE--GVSTDSTLLFNTYVHFQGTMRGFSQLPG--VHEFWVDNSISVSVPMISGTGN-FQ  287 (453)
T ss_dssp             HHHHHHHHHHHHHHCCCCCCCCC--CCCTTCCEEEEEEEEEEEEEEEEEECSS--CEEEEEETTEEEEECEEEEEEE-EE
T ss_pred             HHHHHHHHHHHHhcCCchhhhhc--ccCCCCeEEEEehheeeccCCCCCCCcc--CCCcEeCCCeEEEEEEEEEeCC-CC
Confidence            89999999999999999999996  6999999999999999999999999988  8899999999999999999998 99


Q ss_pred             EEEeCCCCeEEEEEeCCCcEEEEEeecCCCCCC
Q psy2651         308 YEEAGEDGFKMLELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       308 y~~~~~l~~~vLELPY~~~~SMlI~~~ILP~~g  340 (342)
                      |+++++++++||||||++++||+|   |||+++
T Consensus       288 y~~~~~l~~~vleLPY~~~~sm~i---iLP~~~  317 (453)
T 2wxy_C          288 HWSDAQNNFSVTCVPLGERATLLL---IQPHCI  317 (453)
T ss_dssp             EEEETTTTEEEEEEESSSSEEEEE---EEESSG
T ss_pred             EEEecCCCcEEEEEECCCCEEEEE---EecCCC
Confidence            999999999999999944799999   899986

>2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A

Probab=100.00  E-value=3.4e-49  Score=386.44  Aligned_cols=221  Identities=26%  Similarity=0.413  Sum_probs=200.5

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhccCCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      +.++.+ +||++||+                 ++.. +++|+||||+||+.+|+|+++||+|+|++||.++||++... .
T Consensus         9 ~~~~~~-~Fa~~L~~-----------------~l~~-~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~-~   68 (373)
T 2pef_A            9 FIYNTA-DFSIELFK-----------------NSID-DKENSLISPLSAMLALAMTANGADNETLAQMEKALGKDISI-E   68 (373)
T ss_dssp             HHHHHH-HHHHHHHH-----------------TSCC-SSSCCEECHHHHHHHHHHHHTTCCHHHHHHHHHHHHTTCCH-H
T ss_pred             HHHHHH-HHHHHHHH-----------------HhhC-CCCCEEEccHHHHHHHHHHHhhccChHHHHHHHHhCCCCCH-H
Confidence            334455 99999999                 8743 68899999999999999999999999999999999985433 2


Q ss_pred             hhcccchhHHHHHHHHHHHHHhCCCc--chhhhhhhhhc-cCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhh
Q psy2651         161 LKDYKGIIDQLSKDYKGIIDQLSKSP--ELKIANKIYFA-KDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWV  237 (342)
Q Consensus       161 ~~~~~~~~~~v~~~~~~l~~~l~~~~--~l~~an~lfv~-~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV  237 (342)
                      +         ++..++.++..+...+  .+.+||+||++ +++++.++|.+.++++|+++++.+||.  +++++.||+||
T Consensus        69 ~---------~~~~~~~l~~~l~~~~~~~l~~an~l~~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~--~~a~~~IN~WV  137 (373)
T 2pef_A           69 D---------LNKYLYTYMKKLPNEEKSKLTIANSIWFKENDFMPSKDFLQIIADYYKADIFKAAFD--SSTVSDINNWV  137 (373)
T ss_dssp             H---------HHHHHHHHHHHSCCBTTEEEEEEEEEEEETTTEEECHHHHHHHHHHHCCEEEEECCS--HHHHHHHHHHH
T ss_pred             H---------HHHHHHHHHHHhhcCCCcEEEEEEEEEEecCCCchhHHHHHHHHHHhCCeeEecCch--HHHHHHHHHHH
Confidence            3         8899999999887633  89999999999 799999999999999999999999997  46889999999


Q ss_pred             hcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeE
Q psy2651         238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFK  317 (342)
Q Consensus       238 ~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~  317 (342)
                      +++|+|+|+++++  +++++|+++|+||+||||.|+++|++..|++++||..+|++++||||++.+. | |.+  +++++
T Consensus       138 ~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~-y~~--~~~~~  211 (373)
T 2pef_A          138 KSKTNGMIDKILN--KIDPEDVMYLINAVAFDAEWETVYEKASVHEDIFTDVYGNRQKVEFMNSEEN-L-YIE--EENAV  211 (373)
T ss_dssp             HHHTTTSCCCSCS--CCCTTCCEEEEEEEEEEEEBSSCCCGGGEEEEEEECTTSCEEEEEEEEEEEE-E-EEE--ETTEE
T ss_pred             HHhccCchhhhhc--cCCCCceEEEEEeeeeeccccccCChhhccccceecCCCeEEEechhhccCe-E-Eee--cCCeE
Confidence            9999999999996  7999999999999999999999999999999999999999999999999998 8 655  67899


Q ss_pred             EEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         318 MLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       318 vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      +||||| ++++||+|   |||+++.
T Consensus       212 vleLPy~~~~~sm~i---iLP~~~~  233 (373)
T 2pef_A          212 GFVKPYAKNHYSFVA---ILPDENI  233 (373)
T ss_dssp             EEEEEBGGGSEEEEE---EEECTTS
T ss_pred             EEEEecCCCcEEEEE---EECCCCC
Confidence            999999 99999999   8999863

>2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B

Probab=100.00  E-value=5.2e-49  Score=394.04  Aligned_cols=234  Identities=15%  Similarity=0.194  Sum_probs=205.6

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCE--EEChhhHHHHHHHHHccCChhHHHHHHHHcCCCC
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENA--IISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKH  156 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Ni--v~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~  156 (342)
                      .+.+..+ +||++||+                 ++... +++|+  ||||+||+.+|+|+++||+|+|++||.++||++.
T Consensus        73 ~l~~~~~-~Fa~~L~k-----------------~l~~~~~~~Nin~v~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~  134 (453)
T 2wxw_A           73 MVGMLAN-FLGFRIYG-----------------MHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPW  134 (453)
T ss_dssp             HHHHHHH-HHHHHHGG-----------------GCSCTTTSCSBSSEECHHHHHHHHHHHHHSCCTTHHHHHHHHHTCCC
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhhcCCCCCcCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCC
Confidence            3455666 99999999                 88776 77899  9999999999999999999999999999999986


Q ss_pred             cccchhcccchhHHHHHHHHHHHHHhCC-----Cc---chhhhhhhhhccCcccchHHHHHhhhhcccc-cEEecCCCcH
Q psy2651         157 SETLLKDYKGIIDQLSKDYKGIIDQLSK-----SP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSE-LGKVDFSQPP  227 (342)
Q Consensus       157 ~~~~~~~~~~~~~~v~~~~~~l~~~l~~-----~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~-v~~vdF~~~~  227 (342)
                      .+..... ....+.++..|+.+...+..     ++   .+.+||+||+++++++.++|++.++++|+++ ++.+||.++.
T Consensus       135 ~~~~~~~-~~~~~~~~~~~~~l~~~l~~~~~~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~~~  213 (453)
T 2wxw_A          135 KDKNCTS-RLDAHKVLSALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFTELD  213 (453)
T ss_dssp             CTTCTTT-SBCHHHHHHHHHHHHHHHSCCTTTCSCCCEEEEEEEEEECCTTCCEEHHHHHHHHHHCSCEEECBCCTTSHH
T ss_pred             ccccccc-cccHHHHHHHHHHHHHHHhhcccccCCCccEEEEEEeEeEECCCccCHHHHHHHHHHhCccceeeeCCCCHH
Confidence            4310000 00012278888888888763     11   6999999999999999999999999999995 9999998888


Q ss_pred             HHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeee
Q psy2651         228 AAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYM  307 (342)
Q Consensus       228 ~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~  307 (342)
                      ++++.||+||+++|+|+|+++++  +++++|+++|+|||||||.|+++|++..  +++||..+|++++||||++.+. |+
T Consensus       214 ~a~~~IN~WV~~~T~gkI~~ll~--~l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~-f~  288 (453)
T 2wxw_A          214 VAAEKIDRFMQAVTGWKTGCSLM--GASVDSTLAFNTYVHFQGKMKGFSLLAE--PQEFWVDNSTSVSVPMLSGMGT-FQ  288 (453)
T ss_dssp             HHHHHHHHHHHHHHCSCCSCSST--TCCSSCCCEEEEEEEEEEEETTEEECSS--CCCBCSSSSCCBCCCCEEEEEE-EE
T ss_pred             HHHHHHHHHHHHHhcCchhhhhc--CcCCCCeEEEEehhEEeccCCCCCCccc--CCCcEeCCCEEEEEEEEEEecc-cc
Confidence            89999999999999999999996  6999999999999999999999999988  7899999999999999999998 99


Q ss_pred             EEEeCCCCeEEEEEeCCCcEEEEEeecCCCCCC
Q psy2651         308 YEEAGEDGFKMLELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       308 y~~~~~l~~~vLELPY~~~~SMlI~~~ILP~~g  340 (342)
                      |+++++++++||||||++++||+|   |||+++
T Consensus       289 y~~~~~l~~~vleLPY~~~~sm~i---iLP~~~  318 (453)
T 2wxw_A          289 HWSDIQDNFSVTQVPFTESACLLL---IQPHYA  318 (453)
T ss_dssp             EECCTTTTEEEEECCBTTTEEEEE---EEESSC
T ss_pred             eEEecCCCeEEEEEecCCcEEEEE---EeCCCC
Confidence            999999999999999944799999   899986

>2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus}

Probab=100.00  E-value=3.2e-48  Score=385.74  Aligned_cols=224  Identities=24%  Similarity=0.420  Sum_probs=200.4

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCccc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET  159 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~  159 (342)
                      ++++.+ +||++||+                 ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++... 
T Consensus        21 l~~~~~-~Fa~~L~k-----------------~l~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~-   81 (430)
T 2r9y_A           21 LAQAMM-AFTTDLFS-----------------LVAQTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTGS-   81 (430)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHHHHCCSSSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCCTTS-
T ss_pred             HHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEECHHHHHHHHHHHHhhcCcHHHHHHHHHhCCCcHH-
Confidence            344555 99999999                 88766 78999999999999999999999999999999999997543 


Q ss_pred             chhcccchhHHHHHHHHHHHHHhCCCcchhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhc
Q psy2651         160 LLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN  239 (342)
Q Consensus       160 ~~~~~~~~~~~v~~~~~~l~~~l~~~~~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~  239 (342)
                       +         ++..++.+...+.. ..+.+||+||+++++++.++|++.++++|++++..+||. +.++++.||+||++
T Consensus        82 -~---------~~~~~~~l~~~~~~-~~L~~An~l~~~~~~~l~~~F~~~~~~~y~a~~~~~d~~-~~~a~~~IN~WV~~  149 (430)
T 2r9y_A           82 -C---------LPHLLSHFYQNLGP-GTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTGK-QEEDLANINQWVKE  149 (430)
T ss_dssp             -C---------HHHHHHHHHHTSCS-SSEEEEEEEEECTTCCCCHHHHHHHHHHHSSCCEECCSC-HHHHHHHHHHHHHH
T ss_pred             -H---------HHHHHHHHHhhccC-ceEEeeehhhhhCCCcccHHHHHHHHHHhCCceeecCCC-cHHHHHHHHHHHHH
Confidence             3         77778877765532 289999999999999999999999999999999999864 56688899999999


Q ss_pred             ccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEE
Q psy2651         240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKML  319 (342)
Q Consensus       240 ~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vL  319 (342)
                      +|+|+|+++++  +++++|+++|+|||||||.|+++|++..|++++|+..+|++++||||++.+..|+|++.++++++||
T Consensus       150 ~T~gkI~~ll~--~l~~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~l~~~vl  227 (430)
T 2r9y_A          150 ATEGKIEDFLS--ELPDSTVLLLLNAIHFHGFWRTKFDPSLTQKDFFHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVA  227 (430)
T ss_dssp             HTTTSCCCCCC--CCCSSCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSEEEEEEEEEEEEEEEEEEEETTTTEEEE
T ss_pred             hcCCCccchhh--ccCcccceeEeeeeEEecccCCCCCCCCcccceEEecCCeEEEEEeeeecccceeEEEecCCcEEEE
Confidence            99999999996  7999999999999999999999999999999999999999999999999863388999999999999


Q ss_pred             EEeCCCcEEEEEeecCCCCCC
Q psy2651         320 ELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       320 ELPY~~~~SMlI~~~ILP~~g  340 (342)
                      ||||.+++||+|   |||+++
T Consensus       228 eLPY~~~~SM~i---iLP~~~  245 (430)
T 2r9y_A          228 HFPFKNNMSFVV---VMPTYF  245 (430)
T ss_dssp             EEEBSSSEEEEE---EEESSS
T ss_pred             EeecCCCEEEEE---EecCCC
Confidence            999933599999   899875

>1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A

Probab=100.00  E-value=1.7e-47  Score=365.13  Aligned_cols=194  Identities=33%  Similarity=0.525  Sum_probs=173.2

Q ss_pred             hhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccchhHHHHHHHHHHHHHhCCCc-chhh
Q psy2651         113 NLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDYKGIIDQLSKSP-ELKI  190 (342)
Q Consensus       113 ~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~~~~~v~~~~~~l~~~l~~~~-~l~~  190 (342)
                      ++.+. +++|+||||+||+.+|+|+++||+|+|++||.++||++...  +         +             .. .+.+
T Consensus         6 ~l~~~~~~~N~~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~--~---------~-------------~~l~l~~   61 (305)
T 1f0c_A            6 EIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADK--N---------K-------------DDISFKS   61 (305)
T ss_dssp             HHHHTTTTSCEEECHHHHHHHHHHHHHHCCTHHHHHHHTTC---------------------------------CCSEEE
T ss_pred             HHhccCCCCCEEEchHHHHHHHHHHHHhcCChHHHHHHHHhCCCCcc--c---------c-------------chhhhhh
Confidence            88776 78999999999999999999999999999999999986432  1         3             12 4599


Q ss_pred             hhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeeccccc
Q psy2651         191 ANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKG  270 (342)
Q Consensus       191 an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg  270 (342)
                      ||+||+++++++.++|.+.++++|    +.+||.++ ++++.||+||+++|+|+|+++++ ..++.+|+++|+||+||||
T Consensus        62 an~l~~~~~~~l~~~f~~~~~~~y----~~vdF~~~-~a~~~IN~WV~~~T~g~I~~l~~-~~~~~~t~lvLvNaiyFkg  135 (305)
T 1f0c_A           62 MNKVYGRYSAVFKDSFLRKIGDNF----QTVDFTDC-RTVDAINKCVDIFTEGKINPLLD-EPLSPDTCLLAISAVYFKA  135 (305)
T ss_dssp             EEEEEEETTSCBCHHHHHHHGGGE----EEECSSST-HHHHHHHHHHHHHTTTSSCCSCC-SCCCTTEEEEEEEEEEEEE
T ss_pred             eeeEEEeCCCcHHHHHHHHHHHHh----hccCCCCH-HHHHHHHHHHHHHhCCCcccccc-CCCCCCceeeeeehHhhhh
Confidence            999999999999999999999999    89999988 89999999999999999999993 1355669999999999999


Q ss_pred             cccccCCCCCCcccCeeecCCCeEEEeeeeecc-eeeeEEEeCCC--CeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         271 KWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKD-SFYMYEEAGED--GFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       271 ~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~-~~f~y~~~~~l--~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      .|+++|++..|++++||..+|++++||||++.+ . |+|++++++  +++|||||| |+ +||+|   |||++++
T Consensus       136 ~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-~~y~~~~~~~~~~~vleLPy~~~-~sm~i---iLP~~~~  205 (305)
T 1f0c_A          136 KWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEA-FNHASVKESFGNFSIIELPYVGD-TSMVV---ILPDNID  205 (305)
T ss_dssp             EBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEE-EEEEEECCTTCCEEEEEEEBSSS-EEEEE---EEESSTT
T ss_pred             hhhccCCcccCeecEEEECCCEEEEEEEEEecCcc-eeeEEcccccCCCEEEEEeCCCC-EEEEE---EeCCCCC
Confidence            999999999999999999999999999999999 8 999999999  999999999 77 99999   8999863

>2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=375.81  Aligned_cols=218  Identities=26%  Similarity=0.402  Sum_probs=188.2

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhc-c-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAA-N-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~-~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++++.+ +||++||+                 ++.+ . +++|+||||+||+.+|+|+++||+|+|++||.++||++...
T Consensus        32 l~~~~~-~Fa~~L~~-----------------~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~   93 (390)
T 2oay_A           32 LGDALV-DFSLKLYH-----------------AFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDF   93 (390)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHCC----CCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTCCTTC
T ss_pred             HHHHHH-HHHHHHHH-----------------HHHhccCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCcH
Confidence            345556 99999999                 8864 2 68899999999999999999999999999999999997643


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCcchhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhh
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS  238 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~  238 (342)
                       .+         ++..++.+    .. ..+.+||+||+++++++.++|++.++++|+++++.+|+ ++.++++.||+||+
T Consensus        94 -~~---------i~~~~~~l----~~-~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~~~-~~~~a~~~IN~WV~  157 (390)
T 2oay_A           94 -TC---------VHQALKGF----TT-KGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSN-NSDANLELINTWVA  157 (390)
T ss_dssp             -TT---------HHHHHHTT----CC-SSEEEEEEEEECTTSCCCHHHHHHHHHHHSCCCEECCS-CHHHHHHHHHHHHH
T ss_pred             -HH---------HHHHHHHH----hh-CchhhhhhHhHhcCCcccHHHHHHHHHHhCceeeeccC-ChHHHHHHHHHHHH
Confidence             23         66666543    22 26889999999999999999999999999999999995 56678899999999


Q ss_pred             cccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeE--EEeCCCCe
Q psy2651         239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMY--EEAGEDGF  316 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y--~~~~~l~~  316 (342)
                      ++|+|+|+++++  +++++|+++|+||+||||.|+++|++.+|++++|+.. +.+++||||++. . ++|  .+++++++
T Consensus       158 ~~T~gkI~~ll~--~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~-~~~v~V~mM~~~-~-~~~~~~~~~~l~~  232 (390)
T 2oay_A          158 KNTNNKISRLLD--SLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFK-NSVIKVPMMNSK-K-YPVAHFIDQTLKA  232 (390)
T ss_dssp             HTTTTSCSCSCS--CCCTTCCEEEEEEEEEEEEBSSCCCTTSCEEEEECC---CCEEEEEEEEE-E-EEEEEEEETTTTE
T ss_pred             HhhCCccccccc--ccCcccceEEEeeEEEecccCCCCCccccEEeeeEEC-CceEEEEEEEeC-c-eeEEEEecccCce
Confidence            999999999996  7999999999999999999999999999999999995 567899999986 4 554  45678899


Q ss_pred             EEEEEeCCCcEEEEEeecCCCCCC
Q psy2651         317 KMLELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       317 ~vLELPY~~~~SMlI~~~ILP~~g  340 (342)
                      +|+||||++++||+|   |||+++
T Consensus       233 ~vleLpy~~~~sm~i---iLP~~~  253 (390)
T 2oay_A          233 KVGQLQLSHNLSLVI---LVPQNL  253 (390)
T ss_dssp             EEEEEEBSTTEEEEE---EEESST
T ss_pred             EEEEEecCCcEEEEE---EeCCcc
Confidence            999999955899999   899974

>1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1

Probab=100.00  E-value=1.4e-35  Score=274.43  Aligned_cols=144  Identities=32%  Similarity=0.559  Sum_probs=135.9

Q ss_pred             chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhcccCCccccCCCCCCCCcccceeeeeec
Q psy2651         187 ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAI  266 (342)
Q Consensus       187 ~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNai  266 (342)
                      .+++||+||++++++++++|.+.++++|.    .+||.+ +.+++.||+||+++|+|+|+++++++ ++++|+++|+||+
T Consensus         3 ~l~~an~l~~~~~~~l~~~f~~~~~~~~~----~vdF~~-~~a~~~IN~WV~~~T~gkI~~ll~~~-l~~~t~lvLvNai   76 (245)
T 1m93_B            3 SFKSMNKVYGRYSAVFKDSFLRKIGDNFQ----TVDFTD-SRTVDAINKSVDIFTEGKINPLLDEP-LSPDTSLLAISAV   76 (245)
T ss_dssp             SEEEEEEEEEETTSCBCHHHHHHHCSCEE----EECTTS-THHHHHHHHHHHHHTTTSSCCSCCSC-CCTTCCEEEEEEE
T ss_pred             EEEeEeeeeeeCCCCcCHHHHHHHHHHHH----hcCCCC-HHHHHHHHHHHHHHhcCchhhhcCCC-CCCCceEEEEEee
Confidence            57899999999999999999999998874    799998 77889999999999999999999876 9999999999999


Q ss_pred             cccccccccCCCCCCcccCeeecCCCeEEEeeee-ecceeeeEEEeCCC--CeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         267 HFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMF-VKDSFYMYEEAGED--GFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       267 yFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~-~~~~~f~y~~~~~l--~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      ||||.|+++|++..|++++||..+|+.++||||+ +.+. |+|++++++  +++|||||| ++ +||+|   |||+++.
T Consensus        77 yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-~~~~~~~~l~~~~~vleLPy~~~-~sm~i---iLP~~~~  150 (245)
T 1m93_B           77 YFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEA-FNHASVKESFGNFSIIELPYVGD-TSMVV---ILPDNID  150 (245)
T ss_dssp             EEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEECSCE-EEEEEECCTTCCEEEEEEEBSSS-EEEEE---EEESSTT
T ss_pred             eeechhcCCCCcccCceeeEEecCCcEEEEeeeeeccCc-eeEEEecccccCCEEEEEecCCC-eEEEE---EecCCCC
Confidence            9999999999999999999999999999999999 9998 999999999  999999999 77 99999   8999863

>1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1

Probab=99.38  E-value=1.4e-13  Score=97.94  Aligned_cols=46  Identities=39%  Similarity=0.524  Sum_probs=37.8

Q ss_pred             hhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651         113 NLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus       113 ~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++.+. +++|+||||+||+.+|+|++.||+|+|++||.++|+++..+
T Consensus         6 ~l~~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~   52 (55)
T 1m93_A            6 EIASSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADK   52 (55)
T ss_dssp             HHHHHTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHTTC------
T ss_pred             HHHhcCCCCCEEECHHHHHHHHHHHHhhccchHHHHHHHHhCCCccc
Confidence            77665 78899999999999999999999999999999999997654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	342
d1uhga_	385	e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId	1e-40
d1k9oi_	376	e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornwor	7e-40
d1lj5a_	379	e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Hu	2e-39
d1by7a_	381	e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Hu	2e-38
g1hle.1	375	e.1.1.1 (A:,B:) Elastase inhibitor {Horse (Equus c	3e-38
g1jjo.1	334	e.1.1.1 (A:,C:,E:) Neuroserpin {Mouse (Mus musculu	2e-37
d2b5ti1	426	e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapien	7e-37
g1as4.1	369	e.1.1.1 (A:,B:) Antichymotrypsin, alpha-1 {Human (	4e-36
d1xqga_	378	e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId:	2e-35
g1lq8.1	358	e.1.1.1 (A:,B:) Protein C inhibitor {Human (Homo s	5e-35
d1qlpa_	372	e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sap	4e-34
d1imva_	383	e.1.1.1 (A:) Pigment epithelium-derived factor, PE	6e-34
g1mtp.1	355	e.1.1.1 (A:,B:) Thermopin {Thermobifida fusca [Tax	9e-32
d1jmja_	420	e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin	3e-31
g1m93.1	322	e.1.1.1 (A:,B:,C:) Viral serpin crmA (cytokine res	4e-28

>d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} Length = 385

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Ovalbumin
species: Hen (Gallus gallus) [TaxId: 9031]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 9/225 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL---LKDYKGIIDQL 171
             +  EN    P ++   L +   GA  ST   + K +R          ++   G    +
Sbjct: 20  VHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNV 79

Query: 172 SKDYKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP- 227
               + I++Q++K        +A+++Y  +   + P Y     + +   L  ++F     
Sbjct: 80  HSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAAD 139

Query: 228 AAAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFY 287
            A + +N WV + TN  I+++++  S+D+ T +VL+NAI FKG W   FK E T+  PF 
Sbjct: 140 QARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFR 199

Query: 288 LDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           + +  S  V +M+    F +   A  +  K+LELP+   ++S ++
Sbjct: 200 VTEQESKPVQMMYQIGLFRVASMA-SEKMKILELPFASGTMSMLV 243

>d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} Length = 376

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Alaserpin (serpin 1)
species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]

 Score =  142 bits (358), Expect = 7e-40
 Identities = 70/218 (32%), Positives = 113/218 (51%), Gaps = 11/218 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            AN  +N ++S FS+   LG  +  + G + + +++ L + +       +  +   +   
Sbjct: 26  KANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVRAV 85

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
                    K  +LK+A+KIY AK +ELN  +   + D F SE+  VDF +   AA  +N
Sbjct: 86  ---------KGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSVEAAGAIN 136

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
            WV + TN++IK+L+  D+LD +T+ VL+NAI+FKG W   F  E T D  F++    ++
Sbjct: 137 KWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFVKERTMDRDFHVSKDKTI 196

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           +VP M  K      +   E   KM+E+ Y G   S II
Sbjct: 197 KVPTMIGKKDVRYADVP-ELDAKMIEMSYEGDQASMII 233

>d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 379

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 10/220 (4%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            A+K  N + SP+ +  VL +      G T + +   +  K  +      KG+   L   
Sbjct: 25  QASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDD------KGMAPALRHL 78

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
           YK  +       E+   + I+  +D++L   +       F S + +VDFS+   A   +N
Sbjct: 79  YK-ELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIIN 137

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
           DWV  HT   I +L+   ++D  T+LVL+NA++F G+W  PF   +T    F+  D ++V
Sbjct: 138 DWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTV 197

Query: 295 QVPLMFVKDSFYMYE--EAGEDGFKMLELPY-GVSISFII 331
            VP+M   + F   E        + +LELPY G ++S  I
Sbjct: 198 SVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFI 237

>d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 381

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 12/221 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
            A+  +N  +SP+S+   + +   G+ GST + M K L+         +     D++   
Sbjct: 20  KASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQ-------FNEVGAAADKIHSS 72

Query: 175 YKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPP-AAA 230
           ++ +   ++ S     L+  NK++  K       Y       ++SE   VDF +    A 
Sbjct: 73  FRSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEAR 132

Query: 231 KEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDD 290
           K++N WV   T  KI +L+   S+D  T++VL+NA++FKGKW  PF+ +     PF ++ 
Sbjct: 133 KKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNS 192

Query: 291 TNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
                V +M++++   +     +   ++LELPY   +S  +
Sbjct: 193 AQRTPVQMMYLREKLNIGYIE-DLKAQILELPYAGDVSMFL 232

>d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 426

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antithrombin
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 7e-37
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 8/232 (3%)

Query: 102 FSIQLSTLVEWNLAANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLL 161
           F+           + N  +N  +SP S+     +   GA   T + +M+  +        
Sbjct: 53  FATTF--YQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKT 110

Query: 162 KDYKGIIDQLSKDYKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKV 221
            D   I    +K    +  + +K+ +L  AN+++  K +  N  YQ  +   + ++L  +
Sbjct: 111 SDQ--IHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPL 168

Query: 222 DFSQPPA-AAKEMNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEA 280
           DF +    +   +N WVSN T  +I D+I +++++  T LVL+N I+FKG W   F PE 
Sbjct: 169 DFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPEN 228

Query: 281 TKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
           T+   FY  D  S    +M+ +  F        +G ++LELP+ G  I+ ++
Sbjct: 229 TRKELFYKADGESCSASMMYQEGKFRYRRV--AEGTQVLELPFKGDDITMVL 278

>d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} Length = 378

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Maspin
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 52/219 (23%), Positives = 105/219 (47%), Gaps = 11/219 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
                 N + SP +L   L LA  GA G TA  + + L  ++ + +   ++ +   ++  
Sbjct: 24  EKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVN-- 81

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPA-AAKEM 233
                 +LS    LK+  ++Y  K + L+  + +     +  EL  VDF         ++
Sbjct: 82  ------KLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQI 135

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N+ + + T+   ++++  +S++  TK++++NA +F GKW   F    TK+ PF ++ T++
Sbjct: 136 NNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFSESETKESPFRVNKTDT 195

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPY-GVSISFII 331
             V +M ++ +F M         K++ELP+    +S  I
Sbjct: 196 KPVQMMNMEATFSMGNID-SINSKIIELPFQNKHLSMFI 233

>d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 372

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antitrypsin, alpha-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-34
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 7/217 (3%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
             +   N   SP S+     + S G    T + +++GL    +E           +L + 
Sbjct: 21  HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRT 80

Query: 175 YKGIIDQLSKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMN 234
                 Q     +L   N ++ ++ ++L   +       ++SE   V+F     A K++N
Sbjct: 81  LN----QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQIN 136

Query: 235 DWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSV 294
           D+V   T  KI DL+K   LD  T   L+N I FKGKW  PF+ + T++  F++D   +V
Sbjct: 137 DYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTV 194

Query: 295 QVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
           +VP+M     F +     +    +L + Y  + + I 
Sbjct: 195 KVPMMKRLGMFNIQ-HCKKLSSWVLLMKYLGNATAIF 230

>d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} Length = 383

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Pigment epithelium-derived factor, PEDF
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 6e-34
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 13/218 (5%)

Query: 115 AANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKD 174
           + +   N ++SP S+   L   S GA   T   + + L      +           +   
Sbjct: 36  SMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISS---------PDIHGT 86

Query: 175 YKGIIDQL-SKSPELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEM 233
           YK ++D + +    LK A++I F K + +  ++      ++ +   +V    P    +E+
Sbjct: 87  YKELLDTVTAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRP-RVLTGNPRLDLQEI 145

Query: 234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNS 293
           N+WV      K+        +     ++L+   HFKG+W   F    T    FYLD+  +
Sbjct: 146 NNWVQAQMKGKLARST--KEIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERT 203

Query: 294 VQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
           V+VP+M    +   Y    +   K+ +LP   S+S I 
Sbjct: 204 VRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGSMSIIF 241

>d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} Length = 420

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Heparin cofactor II (Hc-II, leuserpin 2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 9/219 (4%)

Query: 116 ANKKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKGIIDQLSKDY 175
            N  +N  I+P  +   +G+ S G  G T E +   L  K        Y+  I  +   +
Sbjct: 66  VNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYE--ITTIHNLF 123

Query: 176 KGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKE 232
           + +  +L +      L+  N +Y  K   +   ++T+  + + +E    DFS P   +K 
Sbjct: 124 RKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPAFISK- 182

Query: 233 MNDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTN 292
            N+ +   T   IKD +  +++D +T+++++N I+FKG W   F  E T +  F L++  
Sbjct: 183 TNNHIMKLTKGLIKDAL--ENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNERE 240

Query: 293 SVQVPLMFVKDSFYMYEEAGEDGFKMLELPYGVSISFII 331
            V+V +M  K +F    +  E    +L+L Y   IS +I
Sbjct: 241 VVKVSMMQTKGNFLAANDQ-ELDCDILQLEYVGGISMLI 278

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	342
d2b5ti1	426	Antithrombin {Human (Homo sapiens) [TaxId: 9606]}	100.0
g1hle.1	375	Elastase inhibitor {Horse (Equus caballus) [TaxId:	100.0
d1lj5a_	379	Plasminogen activator inhibitor-1 {Human (Homo sap	100.0
d1k9oi_	376	Alaserpin (serpin 1) {Tobacco hornworm (Manduca se	100.0
d1uhga_	385	Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]}	100.0
d1by7a_	381	Plasminogen activator inhibitor-2 {Human (Homo sap	100.0
g1lq8.1	358	Protein C inhibitor {Human (Homo sapiens) [TaxId:	100.0
d1jmja_	420	Heparin cofactor II (Hc-II, leuserpin 2) {Human (H	100.0
d1xqga_	378	Maspin {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1imva_	383	Pigment epithelium-derived factor, PEDF {Human (Ho	100.0
g1as4.1	369	Antichymotrypsin, alpha-1 {Human (Homo sapiens) [T	100.0
d1qlpa_	372	Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId:	100.0
g1mtp.1	355	Thermopin {Thermobifida fusca [TaxId: 2021]}	100.0
g1jjo.1	334	Neuroserpin {Mouse (Mus musculus) [TaxId: 10090]}	100.0
g1m93.1	322	Viral serpin crmA (cytokine response modifier prot	100.0

>d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antithrombin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=385.47  Aligned_cols=232  Identities=28%  Similarity=0.536  Sum_probs=208.3

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      ++++.+ +||++|||                 +++..  +++|+||||+||+.+|+||++||+|+|++||.++||++...
T Consensus        46 l~~~~~-~Fa~~l~~-----------------~l~~~~~~~~N~v~SP~si~~aLa~l~~GA~g~T~~el~~~L~~~~~~  107 (426)
T d2b5ti1          46 LSKANS-RFATTFYQ-----------------HLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTIS  107 (426)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHHHTSCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGSC
T ss_pred             HHHHHH-HHHHHHHH-----------------HHHhcCCCCCEEEECHHHHHHHHHHHHHhCchHHHHHHHHhcCCCCCC
Confidence            556666 99999999                 88754  68899999999999999999999999999999999997543


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc----chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhh
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP----ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEM  233 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~----~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~I  233 (342)
                      ...      .+.++..++.+...+....    .+.++|+||++++++++++|++.++++|+++++.+||.++ +.++..|
T Consensus       108 ~~~------~~~~~~~~~~l~~~l~~~~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~I  181 (426)
T d2b5ti1         108 EKT------SDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAI  181 (426)
T ss_dssp             HHH------HHTHHHHHHHHHHHHTSCCCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECTTTCHHHHHHHH
T ss_pred             cch------HHHHHHHHHHHHHHHhccCCCCcEEeeeehhhhcccccchHHHHHHHHHhcCCeEEEecccccHHHHHHHH
Confidence            111      1127888888887764322    7999999999999999999999999999999999999875 5678899


Q ss_pred             chhhhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCC
Q psy2651         234 NDWVSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGE  313 (342)
Q Consensus       234 N~WV~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~  313 (342)
                      |+||+++|+|+|++++++++++++|.++|+||+||||.|+++|++..|..++|+..+|+.++||||++.+. |+|++.++
T Consensus       182 N~wv~~~T~g~I~~~~~~~~l~~~t~l~Lvna~yFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~-~~~~~~~~  260 (426)
T d2b5ti1         182 NKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGK-FRYRRVAE  260 (426)
T ss_dssp             HHHHHHHTTTSCSCSSCTTCSCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEECCSSSCCEEEEEEEEEEE-EEEEECGG
T ss_pred             HHHHHHhcCCCccCCCCccCCCchhHHHHHhhhhhccccccCccccccccceeecCCCeEEEeecceeecc-eeeEEccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998 99988755


Q ss_pred             CCeEEEEEeC-CCcEEEEEeecCCCCCCC
Q psy2651         314 DGFKMLELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       314 l~~~vLELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                       ++++||||| ++++||+|   |||+++.
T Consensus       261 -~~~vveLPy~~~~~sm~i---iLP~~~~  285 (426)
T d2b5ti1         261 -GTQVLELPFKGDDITMVL---ILPKPEK  285 (426)
T ss_dssp             -GCEEEEEEBTTSSEEEEE---EECCSSS
T ss_pred             -CeEEEEeecCCCceEEEE---EecCCCC
Confidence             899999999 99999999   8999764

>d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=374.36  Aligned_cols=228  Identities=27%  Similarity=0.502  Sum_probs=210.0

Q ss_pred             ccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCccc
Q psy2651          81 FSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSET  159 (342)
Q Consensus        81 ~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~  159 (342)
                      +++..+ +||++||+                 ++.+. +++|+||||+||+.+|+||+.||+|+|++||.++||++..+ 
T Consensus         8 ~~~~~~-~F~~~l~~-----------------~l~~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~-   68 (379)
T d1lj5a_           8 VAHLAS-DFGVRVFQ-----------------QVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDD-   68 (379)
T ss_dssp             HHHHHH-HHHHHHHH-----------------HHHHHSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTS-
T ss_pred             HHHHHh-HHHHHHHH-----------------HHHhhCcCCcEEECHHHHHHHHHHHHHhCCcHHHHHHHHHhCCCCCh-
Confidence            345566 99999999                 88776 78999999999999999999999999999999999998665 


Q ss_pred             chhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchh
Q psy2651         160 LLKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDW  236 (342)
Q Consensus       160 ~~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~W  236 (342)
                      .+         ++..++.+...+....   .++++|+||+++++++.++|.+.++++|+++++.+||.++..+++.||+|
T Consensus        69 ~~---------~~~~~~~~~~~l~~~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~a~~~IN~w  139 (379)
T d1lj5a_          69 KG---------MAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDW  139 (379)
T ss_dssp             TT---------HHHHHHHHHHHHHCGGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTSHHHHHHHHHHH
T ss_pred             HH---------HHHHHHHHHHHhhCcccccchhhhhHHHHhccCcccHHHHHHHHHhhcceeccccccchHHHHHHHHHH
Confidence            23         7778888888775433   79999999999999999999999999999999999999998899999999


Q ss_pred             hhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCC--
Q psy2651         237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGED--  314 (342)
Q Consensus       237 V~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l--  314 (342)
                      |+++|+|+|++++++++++++++++|+||+||+|.|+++|++..|...+|+..+|+++.||||++.+. ++|++++.+  
T Consensus       140 v~~~T~g~I~~~~~~~~l~~~t~~~lvna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~~M~~~~~-~~~~~~~~~~~  218 (379)
T d1lj5a_         140 VKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNK-FNYTEFTTPDG  218 (379)
T ss_dssp             HHHTTTTSCCCSSCTTSSCTTCCEEEEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEE-EEEEEEECTTS
T ss_pred             HHhhcCCccccccCccCCCccceeeeEeeEEEeeeecCcCCccccccccccccCCceEeecceeeccc-eeeEEeecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999 999988755  


Q ss_pred             -CeEEEEEeC-CCcEEEEEeecCCCCCC
Q psy2651         315 -GFKMLELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       315 -~~~vLELPY-~~~~SMlI~~~ILP~~g  340 (342)
                       +++|||||| ++++||+|   |||+++
T Consensus       219 ~~~~vv~Lp~~~~~~sm~i---ilP~~~  243 (379)
T d1lj5a_         219 HYYDILELPYHGDTLSMFI---AAPYEK  243 (379)
T ss_dssp             CEEEEEEEEBTTSSEEEEE---EEESST
T ss_pred             ceeEEEEeecCCCcEEEEE---ecCCcc
Confidence             489999999 99999999   899764

>d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Alaserpin (serpin 1)
species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]

Probab=100.00  E-value=8.2e-48  Score=373.83  Aligned_cols=226  Identities=31%  Similarity=0.560  Sum_probs=209.0

Q ss_pred             cccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          82 SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        82 ~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      .++.+ +||++||+                 ++++. +++|+|+||+||+.+|+||+.||+|+|++||.++||++...  
T Consensus        10 ~~~~~-~F~~~l~~-----------------~~~~~~~~~N~v~SP~si~~~La~l~~ga~g~T~~el~~~L~~~~~~--   69 (376)
T d1k9oi_          10 RESND-QFTAQMFS-----------------EVVKANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDN--   69 (376)
T ss_dssp             HHHHH-HHHHHHHH-----------------HHHTTSTTSCEEECSGGGHHHHHHHTTTBCTHHHHHHHHHTTCSCTT--
T ss_pred             HHHHH-HHHHHHHH-----------------HHHhhCCCCeEEECHHHHHHHHHHHHHhcChHHHHHHHHHcCCCCcc--
Confidence            34455 99999999                 98887 78999999999999999999999999999999999998654  


Q ss_pred             hhcccchhHHHHHHHHHHHHHhCCCc--chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhh
Q psy2651         161 LKDYKGIIDQLSKDYKGIIDQLSKSP--ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVS  238 (342)
Q Consensus       161 ~~~~~~~~~~v~~~~~~l~~~l~~~~--~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~  238 (342)
                      .         ....++.+...+....  .+.++|+||++++++++++|.+.++++|+++++.+||.++.++++.||+||+
T Consensus        70 ~---------~~~~~~~l~~~~~~~~~~~~~~~~~i~~~~~~~~~~~f~~~~~~~y~~~~~~vdf~~~~~a~~~IN~wv~  140 (376)
T d1k9oi_          70 V---------TKDVFADLNRGVRAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVKSVEAAGAINKWVE  140 (376)
T ss_dssp             H---------HHHHHHHHTSSCSCCSSBCCEEEEEEEEESSCCBCSGGGSTTTSSSCCCEEEECTTSHHHHHHHHHHHHH
T ss_pred             h---------HHHHHHHHHHHHhhcCCCcEEEeeehhhhcCCCcchHHHHHHHhhcCceeecccccccHHHHHHHHHHHH
Confidence            2         5566666665554433  7899999999999999999999999999999999999999889999999999


Q ss_pred             cccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEE
Q psy2651         239 NHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKM  318 (342)
Q Consensus       239 ~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~v  318 (342)
                      ++|+|+|++++++++++++++++|+||+||+|.|+++|++..|...+|+..+|+.++||||++.+. ++|++++++++++
T Consensus       141 ~~T~g~I~~~~~~~~l~~~~~~~lvna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~-~~~~~~~~l~~~v  219 (376)
T d1k9oi_         141 DQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFVKERTMDRDFHVSKDKTIKVPTMIGKKD-VRYADVPELDAKM  219 (376)
T ss_dssp             HHTTTSSCCCSCGGGCCTTCCEEEEEEEEEEBCBSSCCCGGGCEEEEECSSSSCCEEEEEEEEEEE-EEEEEETTTTEEE
T ss_pred             HhhCCceeeccCCCCCCcchhhhhhhhhhhhhhhcCCCCccccccceeecCCCceEEEEeeeeccc-EEEEeeCCCCEEE
Confidence            999999999999999999999999999999999999999999999999999999999999999999 9999999999999


Q ss_pred             EEEeC-CCcEEEEEeecCCCCCC
Q psy2651         319 LELPY-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       319 LELPY-~~~~SMlI~~~ILP~~g  340 (342)
                      ||||| ++++||+|   |||+++
T Consensus       220 veLP~~~~~~sm~i---ilP~~~  239 (376)
T d1k9oi_         220 IEMSYEGDQASMII---ILPNQV  239 (376)
T ss_dssp             EEEEBGGGSEEEEE---EEESST
T ss_pred             EEeecCCCceEEEE---EecCCC
Confidence            99999 99999999   899975

>d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Ovalbumin
species: Hen (Gallus gallus) [TaxId: 9031]

Probab=100.00  E-value=2.7e-47  Score=371.05  Aligned_cols=233  Identities=25%  Similarity=0.469  Sum_probs=206.7

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcc--
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDY--  164 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~--  164 (342)
                      +||++||+                 ++... +++|+|+||+||+.+|+||+.||+|+|++||.++||++.........  
T Consensus         9 ~Fa~~l~~-----------------~l~~~~~~~N~v~SP~si~~~Laml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~   71 (385)
T d1uhga_           9 EFCFDVFK-----------------ELKVHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEA   71 (385)
T ss_dssp             HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHT
T ss_pred             HHHHHHHH-----------------HHhccCcCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCCCccccchhhh
Confidence            99999999                 88777 88999999999999999999999999999999999987532100000  


Q ss_pred             -cchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchhhhc
Q psy2651         165 -KGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDWVSN  239 (342)
Q Consensus       165 -~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~WV~~  239 (342)
                       ......++..++.+...+.+.+   .+.++|++|++++++++++|.+.++++|+++++.+||.++ ..+++.||+||++
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~v~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~a~~~IN~wv~~  151 (385)
T d1uhga_          72 QCGTSVNVHSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVES  151 (385)
T ss_dssp             TTTSCTTTTHHHHHHHHHHTSCCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHH
T ss_pred             hcccHHHHHHHHHHHHHHhhCCCCCceEEEEEEEEEecCccccHHHHHHHHHHhCCcccccccccHHHHHHHHHHHHHHH
Confidence             0000116788999988887654   7999999999999999999999999999999999999765 4577899999999


Q ss_pred             ccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEE
Q psy2651         240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKML  319 (342)
Q Consensus       240 ~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vL  319 (342)
                      +|+|+|++++++++++++++++++||+||+|.|+++|++..|+..+|+..+|++++||||++.+. ++|++++++++++|
T Consensus       152 ~T~g~i~~~v~~~~l~~~t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~-~~~~~~~~~~~~~v  230 (385)
T d1uhga_         152 QTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGL-FRVASMASEKMKIL  230 (385)
T ss_dssp             HTTTCSCCCSCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEE-EEEEEEGGGTEEEE
T ss_pred             HccCCccccCCccCCCcccceeeeeeEEEecccccccccccccccccccCCCceeeehhheeccc-cccccccccCcEEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999 99999999999999


Q ss_pred             EEeC-CCcEEEEEeecCCCCCCC
Q psy2651         320 ELPY-GVSISFIIKSQVVPEMGR  341 (342)
Q Consensus       320 ELPY-~~~~SMlI~~~ILP~~g~  341 (342)
                      |||| ++++||+|   |||+++.
T Consensus       231 ~Lpy~~~~~sm~i---ilP~~~~  250 (385)
T d1uhga_         231 ELPFASGTMSMLV---LLPDEVS  250 (385)
T ss_dssp             EEEBTTSSEEEEE---EEESSTT
T ss_pred             EccccCCCeEEEE---EECCccC
Confidence            9999 99999999   8999763

>d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Plasminogen activator inhibitor-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=370.17  Aligned_cols=230  Identities=27%  Similarity=0.476  Sum_probs=204.8

Q ss_pred             cccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccc
Q psy2651          82 SSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETL  160 (342)
Q Consensus        82 ~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~  160 (342)
                      +.+.+ +||++||+                 ++++. +++|+||||+||+.+|+||++||+|+|++||.++||++.....
T Consensus         4 ~~~~~-~Fa~~L~~-----------------~l~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~   65 (381)
T d1by7a_           4 CVANT-LFALNLFK-----------------HLAKASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAA   65 (381)
T ss_dssp             HHHHH-HHHHHHHH-----------------HHHHHSSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTTTTTCCG
T ss_pred             HHHHH-HHHHHHHH-----------------HHHhcCCCCcEEECHHHHHHHHHHHHHhcchHHHHHHHHHhCCCCCCCC
Confidence            34445 99999999                 98877 8999999999999999999999999999999999999865432


Q ss_pred             hhcccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchh
Q psy2651         161 LKDYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDW  236 (342)
Q Consensus       161 ~~~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~W  236 (342)
                      .++       ++..++.+...+...+   .+.++|++|++++++++++|++.++++|+++++.+||.++ +.+++.||+|
T Consensus        66 ~~~-------~~~~~~~l~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~IN~w  138 (381)
T d1by7a_          66 ADK-------IHSSFRSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSW  138 (381)
T ss_dssp             -GG-------HHHHHHHHHHHHC------CEEEEEEEEEETTSCBCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHH
T ss_pred             HHH-------HHHHHHHHHHHHhcCCCCcEEeeccchhcccCCccCHHHHHHHHHhhCCceeccccccchHHHHHHHHHH
Confidence            222       8889999988876654   7899999999999999999999999999999999999876 5578899999


Q ss_pred             hhcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCe
Q psy2651         237 VSNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGF  316 (342)
Q Consensus       237 V~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~  316 (342)
                      |+++|+|+|++++++++++++|+++|+||+||+|.|+++|++..|+..+|+..+|++++||||++.+. ++|++++++++
T Consensus       139 v~~~T~g~I~~~~~~~~l~~~t~~~lvna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~-~~~~~~~~~~~  217 (381)
T d1by7a_         139 VKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREK-LNIGYIEDLKA  217 (381)
T ss_dssp             HHHHTTTSCTTSSCTTSCCTTCCEEEEEEEEECCCBSSCCEECC---EEEEEETTEEEEECEEEEEEE-EEEEEETTTTE
T ss_pred             HHHhhcCCccccCCcccCCCccHhhhhheeEEeecccCCCccccccccccccCCCeeEEEeeeeeccc-cccccccCcCe
Confidence            99999999999999999999999999999999999999999999999999999999999999999999 99999999999


Q ss_pred             EEEEEeCCCcEEEEEeecCCCCCC
Q psy2651         317 KMLELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       317 ~vLELPY~~~~SMlI~~~ILP~~g  340 (342)
                      ++|+|||+++.+|+|   |||+++
T Consensus       218 ~~v~lp~~~~~~m~i---ilp~~~  238 (381)
T d1by7a_         218 QILELPYAGDVSMFL---LLPDEI  238 (381)
T ss_dssp             EEEEEEETTTEEEEE---EEESSC
T ss_pred             EEEEeccCCCeEEEE---EecCCc
Confidence            999999954688988   688764

>d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Heparin cofactor II (Hc-II, leuserpin 2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=370.55  Aligned_cols=228  Identities=26%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             ccccccccccccCCcchhhhhhhhhhhhhcc--CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcc
Q psy2651          87 QRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN--KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDY  164 (342)
Q Consensus        87 ~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~--~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~  164 (342)
                      ++||++||+                 .+...  +++|+|+||+||+.+|+||++||+|+|++||.++||++......  -
T Consensus        52 ~~F~~~ly~-----------------~l~~~~~~~~Niv~SP~si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~--~  112 (420)
T d1jmja_          52 AKFAFNLYR-----------------VLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNAS--S  112 (420)
T ss_dssp             HHHHHHHHH-----------------HHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHC--T
T ss_pred             HHHHHHHHH-----------------HHHhhcCCCCcEEECHHHHHHHHHHHHhhcchhHHHHHHHHcCCCCcCCcc--c
Confidence            499999999                 88765  57899999999999999999999999999999999986321000  0


Q ss_pred             cchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhccc
Q psy2651         165 KGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSNHT  241 (342)
Q Consensus       165 ~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~~T  241 (342)
                      +...+.++..|+.+...+...+   .+.++|++|+++++++.++|++.++++|+++++.+||.++. ++++||+||+++|
T Consensus       113 ~~~~~~i~~~~~~l~~~l~~~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~~df~~~~-~~~~IN~wv~~~T  191 (420)
T d1jmja_         113 KYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDPA-FISKTNNHIMKLT  191 (420)
T ss_dssp             TCCHHHHHHHHHHHHHHHHSCCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHSSCCEEEECTTCHH-HHHHHHHHHHHHT
T ss_pred             chhHHHHHHHHHHHHHHHhcCCCCcEehhhHHHHhhCCccccHHHHHHHHHhhCceeeccccchHH-HHHHHhHhHHhcc
Confidence            0112338888999888875544   79999999999999999999999999999999999999875 5667999999999


Q ss_pred             CCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEE
Q psy2651         242 NDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLEL  321 (342)
Q Consensus       242 ~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLEL  321 (342)
                      +|+|++++.  +++++|+++|+||+||||.|+++|++..|+.++|+..+|++++||||++.+. |+|++++++++++|||
T Consensus       192 ~g~I~~~l~--~i~~~t~lvLvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~-~~~~~~~~l~~~vl~L  268 (420)
T d1jmja_         192 KGLIKDALE--NIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGN-FLAANDQELDCDILQL  268 (420)
T ss_dssp             TTSCCCTTS--SCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEE-EEEEEETTTTEEEEEE
T ss_pred             CCcccchhc--ccCCccHHHHHHHHHHHhhhhccCCcccccccceecCCCceeeeeeeeeecc-EEEeeccCCCEEEEEE
Confidence            999999996  6999999999999999999999999999999999999999999999999999 9999999999999999


Q ss_pred             eCCCcEEEEEeecCCCCCC
Q psy2651         322 PYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       322 PY~~~~SMlI~~~ILP~~g  340 (342)
                      ||.++++|+|   |||+++
T Consensus       269 py~~~~sm~i---iLP~~~  284 (420)
T d1jmja_         269 EYVGGISMLI---VVPHKM  284 (420)
T ss_dssp             EETTTEEEEE---EEESST
T ss_pred             eecCCeeEEE---EecCCC
Confidence            9944689999   799875

>d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Maspin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=370.66  Aligned_cols=221  Identities=24%  Similarity=0.471  Sum_probs=204.7

Q ss_pred             cccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchhcccc
Q psy2651          88 RFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLKDYKG  166 (342)
Q Consensus        88 ~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~~~~~  166 (342)
                      +||++||+                 ++... +++|+|+||+||+.+|+||++||+|+|++||.++||++...  +     
T Consensus        13 ~Fa~~L~~-----------------~l~~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~--~-----   68 (378)
T d1xqga_          13 AFAVDLFK-----------------QLSEKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFENVK--D-----   68 (378)
T ss_dssp             HHHHHHHH-----------------HHHHHSTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTGGGCS--S-----
T ss_pred             HHHHHHHH-----------------HHHhhCCCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCChH--H-----
Confidence            99999999                 88776 89999999999999999999999999999999999996443  3     


Q ss_pred             hhHHHHHHHHHHHHHhCCC---cchhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCc-HHHHHhhchhhhcccC
Q psy2651         167 IIDQLSKDYKGIIDQLSKS---PELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQP-PAAAKEMNDWVSNHTN  242 (342)
Q Consensus       167 ~~~~v~~~~~~l~~~l~~~---~~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~-~~a~~~IN~WV~~~T~  242 (342)
                          ++..++.+...+.+.   ..++++|++|++++++++++|++.++++|+++++.+||.++ +.++..||+||+++|+
T Consensus        69 ----~~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~~~~~f~~~~~~~y~~~v~~~dF~~~~~~~~~~IN~wv~~~T~  144 (378)
T d1xqga_          69 ----VPFGFQTVTSDVNKLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTD  144 (378)
T ss_dssp             ----HHHHHHHHHHHHHHHTTTSSEEEEEEEEEETTSCCCHHHHHHTTTTTTTCEEEECHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ----HHHHHHHHHHHHhcccCCceEEEeechhhcccccccHHHHHHhhhhccceeEeccccchhhHHHHHHHHHHHHhcc
Confidence                677777777665432   28999999999999999999999999999999999999775 5577899999999999


Q ss_pred             CccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEEEEe
Q psy2651         243 DKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKMLELP  322 (342)
Q Consensus       243 g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vLELP  322 (342)
                      |+|++++++.+++++|+++|+||+||+|.|+.+|++..|++.+|+..+++++.||||++.+. |+|++++++++++||||
T Consensus       145 g~i~~~~~~~~~~~~t~~~l~na~~f~~~W~~~F~~~~T~~~~F~~~~~~~~~v~mm~~~~~-~~~~~~~~l~~~vv~Lp  223 (378)
T d1xqga_         145 GHFENILADNSVNDQTKILVVNAAYFVGKWMKKFSESETKESPFRVNKTDTKPVQMMNMEAT-FSMGNIDSINSKIIELP  223 (378)
T ss_dssp             TSCSCCSCTTSCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEE-EEEEEEGGGTEEEEEEE
T ss_pred             CCcccccCCCCCCCCceEEEEEEeEEeeeecCCCccccceecceecCCCceEecccccccce-eeeeeccCCCeEEEEee
Confidence            99999999999999999999999999999999999999999999999999999999999998 99999999999999999


Q ss_pred             C-CCcEEEEEeecCCCCCC
Q psy2651         323 Y-GVSISFIIKSQVVPEMG  340 (342)
Q Consensus       323 Y-~~~~SMlI~~~ILP~~g  340 (342)
                      | ++++||+|   |||+.+
T Consensus       224 ~~~~~~sm~i---ilP~~~  239 (378)
T d1xqga_         224 FQNKHLSMFI---LLPKDV  239 (378)
T ss_dssp             BGGGSSEEEE---EEESSC
T ss_pred             cCCCcEEEEE---EecCcc
Confidence            9 99999999   899865

>d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Pigment epithelium-derived factor, PEDF
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=366.65  Aligned_cols=228  Identities=23%  Similarity=0.415  Sum_probs=207.9

Q ss_pred             cccccccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcc
Q psy2651          80 SFSSILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSE  158 (342)
Q Consensus        80 ~~~~~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~  158 (342)
                      +++++.+ +||++||+                 +++.. +++|+||||+||+.+|+||+.||+|+|++||.++||++..+
T Consensus        18 ~~~~~~~-~F~~~L~~-----------------~l~~~~~~~Niv~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~   79 (383)
T d1imva_          18 KLAAAVS-NFGYDLYR-----------------VRSSMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLIS   79 (383)
T ss_dssp             HHHHHHH-HHHHHHHH-----------------HHHHHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCC
T ss_pred             HHHHHHH-HHHHHHHH-----------------HHhccCcCCcEEECHHHHHHHHHHHHHhcChHHHHHHHHHhCCCCCC
Confidence            4566777 99999999                 88776 89999999999999999999999999999999999987555


Q ss_pred             cchhcccchhHHHHHHHHHHHHHhCCCc-chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhh
Q psy2651         159 TLLKDYKGIIDQLSKDYKGIIDQLSKSP-ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWV  237 (342)
Q Consensus       159 ~~~~~~~~~~~~v~~~~~~l~~~l~~~~-~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV  237 (342)
                      ..+         ++..+++++..+...+ .+.++|+||+++++++.++|.+.++++|++.++.+|| ++..+++.||+||
T Consensus        80 ~~~---------~~~~~~~l~~~~~~~~~~l~~~n~i~v~~~~~~~~~f~~~~~~~y~~~~~~~~~-~~~~~~~~IN~wv  149 (383)
T d1imva_          80 SPD---------IHGTYKELLDTVTAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTG-NPRLDLQEINNWV  149 (383)
T ss_dssp             CSC---------HHHHHHHHHHHHTSTTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECCS-CHHHHHHHHHHHH
T ss_pred             hHH---------HHHHHHHHHHhhhcCCcchHHHHHHHhccCCccchHHHHHHHhhcCceeeeccc-cHHHHHHHHHHHH
Confidence            444         8899999999887665 8999999999999999999999999999999999998 5666889999999


Q ss_pred             hcccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeE
Q psy2651         238 SNHTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFK  317 (342)
Q Consensus       238 ~~~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~  317 (342)
                      +++|+|+|++++.  ++++++.++|+||+||||.|+++|++..|+.++|+..+|+++.||||++.+..++|+++++++++
T Consensus       150 ~~~T~g~I~~~~~--~~~~~t~~~lvna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~  227 (383)
T d1imva_         150 QAQMKGKLARSTK--EIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCK  227 (383)
T ss_dssp             HHHTTTCSCCCCS--CCCSSCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEE
T ss_pred             HhhCccccccccc--ccCccceeeeecceeeecccccccccccccccccccCCCeEEEeecccccccceeeeeccccceE
Confidence            9999999999885  78999999999999999999999999999999999999999999999987543899999999999


Q ss_pred             EEEEeCCCcEEEEEeecCCCCCC
Q psy2651         318 MLELPYGVSISFIIKSQVVPEMG  340 (342)
Q Consensus       318 vLELPY~~~~SMlI~~~ILP~~g  340 (342)
                      +++|||.+++||+|   |||+++
T Consensus       228 vv~lp~~~~~sm~i---iLP~~~  247 (383)
T d1imva_         228 IAQLPLTGSMSIIF---FLPLKV  247 (383)
T ss_dssp             EEEEEETTTEEEEE---EEESSC
T ss_pred             EEEeecCCCeEEEE---EEeccc
Confidence            99999943799999   799864

>d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Multi-domain proteins (alpha and beta)
fold: Serpins
superfamily: Serpins
family: Serpins
domain: Antitrypsin, alpha-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-45  Score=351.41  Aligned_cols=220  Identities=26%  Similarity=0.471  Sum_probs=203.4

Q ss_pred             cccccccccccccccCCcchhhhhhhhhhhhhcc-CCCCEEEChhhHHHHHHHHHccCChhHHHHHHHHcCCCCcccchh
Q psy2651          84 ILDQRFNGKLHKKEDFKPFSIQLSTLVEWNLAAN-KKENAIISPFSLHVVLGLASFGAAGSTAEAMMKGLRIKHSETLLK  162 (342)
Q Consensus        84 ~~~~~Fa~~L~~~~~~~~~~~~~~~~~~~~l~~~-~~~Niv~SP~sI~~aLamL~~GA~G~T~~qL~~~Lgl~~~~~~~~  162 (342)
                      +.. +||++||+                 .++.. +++|+||||+||+.+|+||+.||+|+|++||.++||++..+....
T Consensus         7 ~~~-~Fa~~l~~-----------------~l~~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~   68 (372)
T d1qlpa_           7 NLA-EFAFSLYR-----------------QLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEA   68 (372)
T ss_dssp             HHH-HHHHHHHH-----------------HHHHHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHH
T ss_pred             hHH-HHHHHHHH-----------------HHhhhCCCCcEEECHHHHHHHHHHHHHhccHHHHHHHHHHhCCCCCCCcHH
Confidence            344 99999999                 88777 889999999999999999999999999999999999987653332


Q ss_pred             cccchhHHHHHHHHHHHHHhCCCc---chhhhhhhhhccCcccchHHHHHhhhhcccccEEecCCCcHHHHHhhchhhhc
Q psy2651         163 DYKGIIDQLSKDYKGIIDQLSKSP---ELKIANKIYFAKDIELNPAYQTQAVDNFNSELGKVDFSQPPAAAKEMNDWVSN  239 (342)
Q Consensus       163 ~~~~~~~~v~~~~~~l~~~l~~~~---~l~~an~lfv~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~a~~~IN~WV~~  239 (342)
                             .++..++.+++.+...+   .+.++|++|+++++++.++|.+.++++|+++++.+||.++..+++.||+|+++
T Consensus        69 -------~~~~~~~~~~~~~~~~~~~~~l~~~n~i~~~~~~~l~~~f~~~~~~~f~~~~~~~df~~~~~~~~~iN~wv~~  141 (372)
T d1qlpa_          69 -------QIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEK  141 (372)
T ss_dssp             -------HHHHHHHHHHHHHSCSSCCCCEEEEEEEEEETTCCBCHHHHHHHHHTSCCEEEEECTTSHHHHHHHHHHHHHH
T ss_pred             -------HHHHHHHHHHHHhhccCcchhhhhheeeeeccCCccCHHHHHHHHHHhCceeecccccchHHHHHHHHHHHHH
Confidence                   27888888888876644   78999999999999999999999999999999999999998899999999999


Q ss_pred             ccCCccccCCCCCCCCcccceeeeeeccccccccccCCCCCCcccCeeecCCCeEEEeeeeecceeeeEEEeCCCCeEEE
Q psy2651         240 HTNDKIKDLIKADSLDASTKLVLINAIHFKGKWTVPFKPEATKDGPFYLDDTNSVQVPLMFVKDSFYMYEEAGEDGFKML  319 (342)
Q Consensus       240 ~T~g~I~~ll~~~~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~VpMM~~~~~~f~y~~~~~l~~~vL  319 (342)
                      +|+|+|++++.  +++++++++|+||+||+|.|+.+|++.+|+..+|+..+|..+.||||++.+. |+|+++++++++++
T Consensus       142 ~T~g~i~~~~~--~~~~~t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~-f~~~~~~~l~~~~~  218 (372)
T d1qlpa_         142 GTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGM-FNIQHCKKLSSWVL  218 (372)
T ss_dssp             HTTTSSCSCCC--CCCTTCCEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEE-EEEEEETTTTEEEE
T ss_pred             HhCCCCccccc--CCCCcchhhhhhhheeecccccccchhccccccccccCCceEEEeeeecccc-eeeeccccCCeEEE
Confidence            99999999997  6899999999999999999999999999999999999999999999999999 99999999999999


Q ss_pred             EEeC-CCcEEEEE
Q psy2651         320 ELPY-GVSISFII  331 (342)
Q Consensus       320 ELPY-~~~~SMlI  331 (342)
                      |||| +..++|+|
T Consensus       219 ~lp~~~~~~~~il  231 (372)
T d1qlpa_         219 LMKYLGNATAIFF  231 (372)
T ss_dssp             EEEETTTEEEEEE
T ss_pred             ecccCCCceEEEE
Confidence            9999 88888776